Research classified by Journal of Economic Literature (JEL) codes

---

Top JEL
/ I: Health, Education, and Welfare
/ / I1: Health
/ / / I11: Analysis of Health Care Markets

---

This topic is covered by the following reading lists:

1. SOEP based publications

---

Most recent items first, undated at the end.

---

2015 Does quality disclosure improve quality? Responses to the introduction of nursing home report cards in Germany
by Herr, Annika & Nguyen, Thu-Van & Schmitz, Hendrik

2015 How Health Plan Enrollees Value Prices Relative to Supplemental Benefits and Service Quality
by Bunnings, C,; & Schmitz, H,; & Tauchmann, H,; & Ziebarth, N.R,;

2015 The design of insurance coverage for medical products under imperfect competition
by Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie

2015 Health Provider Networks, Quality and Costs
by Boone, J. & Schottmuller, C.

2015 Health Provider Networks, Quality and Costs
by Boone, J. & Schottmuller, C.

2015 The Effects of Introducing Mixed Payment Systems for Physicians – Experimental Evidence
by Jeannette Brosig-Koch & Heike Hennig-Schmidt & Nadja Kairies-Schwarz & Daniel Wiesen

2015 Social health insurance improves women’s healthcare use: Evidence from Indonesia
by Samarakoon, Shanika & Parinduri, Rasyad

2015 The Impact of Precarious Employment on Mental Health: the Case of Italy
by Moscone, Francesco & Tosetti, Elisa & Vittadini, Giorgio

2015 The Impact of Market Size and Composition on Health Insurance Premiums: Evidence from the First Year of the ACA
by Michael J. Dickstein & Mark Duggan & Joseph Orsini & Pietro Tebaldi

2015 The Local Influence of Pioneer Investigators on Technology Adoption: Evidence from New Cancer Drugs
by Leila Agha & David Molitor

2015 Impact of China's Urban Employee Basic Medical Insurance on Health Care Expenditure and Health Outcomes
by Feng Huang & Li Gan

2015 Health provider networks, quality and costs
by Jan Boone & Christoph Schottmüller

2015 The Design of Insurance Coverage for Medical Products under Imperfect Competition
by Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie

2015 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – BLMSE (Sweden) Case Study Report
by Daniel Smedberg & Francisco Lupiañez-Villanueva

2015 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – ETXEAN ONDO (Spain) Case Study Report
by Francisco Lupiañez-Villanueva & Alexandra Theben

2015 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – INAA (Netherlands) Case Study Report
by Anna Jansen & Francisco Lupiañez-Villanueva & Alexandra Theben

2015 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – BSA (Spain) Case Study Report
by Francisco Lupiañez-Villanueva & Alexandra Theben

2015 Health provider networks, quality and costs
by Boone, Jan & Schottmüller, Christoph

2015 The design of insurance coverage for medical products under imperfect competition
by David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur

2015 Doctors without Hospitals: What to do about Specialists Who Can’t Find Work
by Ake Blomqvist & Colin Busby & Will Falk & Aaron Jacobs

2015 Well-Paid Nurses are Good Nurses: An Analysis of Nursing Supply Based on Determinants of Work Motivation
by Alessandro Fedele

2015 Expanding Patients' Property Rights in Their Medical Records
by Laurence C. Baker & M. Kate Bundorf & Daniel P. Kessler

2015 More Insurers Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces
by Leemore Dafny & Jonathan Gruber & Christopher Ody

2015 The Role of Publication Selection Bias in Estimates of the Value of a Statistical Life
by W. Kip Viscusi

2015 How Much Favorable Selection Is Left in Medicare Advantage?
by Joseph P. Newhouse & Mary Price & John Hsu & J. Michael McWilliams & Thomas G. McGuire

2015 Pricing in the Market for Anticancer Drugs
by David H. Howard & Peter B. Bach & Ernst R. Berndt & Rena M. Conti

2015 Diagnosing Hospital System Bargaining Power in Managed Care Networks
by Matthew S. Lewis & Kevin E. Pflum

2015 Mergers When Prices Are Negotiated: Evidence from the Hospital Industry
by Gautam Gowrisankaran & Aviv Nevo & Robert Town

2014 The Effect of Publicized Quality Information on Home Health Agency Choice
by Kyoungrae Jung & Bingxiao Wu & Hyunjee Kim & Daniel Polsky

2014 PSY72 – Orphan Drug Pricing In France: Influence of Main Factors
by Grand, H. & Samson, Anne-Laure & Aulois-Griot, M.

2014 PCV60 – Burden Of Cardiovascular Complications In Patients With Atrial Fibrillation In France
by Bouee, S. & Emery, C. & Samson, Anne-Laure & Bailly, C. & Cotté, F.E.

2014 PCV26 – Real World Incidences And Hospital Cost Of Venous And Pulmonary Thromboembolic Events In France
by Bouee, S. & Emery, C. & Samson, Anne-Laure & Bailly, C. & Cotté, F.E.

2014 PMH35 – Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France
by Doutriaux, A. & Cognet, M. & Druais, S. & Lançon, C. & Samalin, L. & Levy, Pierre & Godet, A. & Guillon, P.

2014 Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
by Bocquet, François & Paubel, Pascal & Fusier, Isabelle & Cordonnier, Anne-Laure & Sinègre, Martine & Le Pen, Claude

2014 A Long War Begins: Biosimilars Versus Patented Biologics – A Retrospective Analysis Of The Eu-5 And Japanese Erythropoetins Markets
by Bocquet, François & Paubel, P. & Fusier, I. & Cordonnier, A.L. & Le Pen, Claude & Sinègre, M.

2014 Objective and Subjective Burden of Informal Caregivers 4 Years After a Severe Traumatic Brain Injury: Results From the PariS-TBI Study
by Bayen, Eléonore & Jourdan, Claire & Ghout, Idir & Darnoux, Emmanuelle & Azerad, Sylvie & Vallat-Azouvi, Claire & Weiss, Jean-Jacques & Aegerter, Philippe & Pradat-Diehl, Pascale & Joël, Marie-Eve & Azouvi, Philippe

2014 Vers un système d’information sur le coût des soins, les remboursements des couvertures obligatoire et complémentaire, et les restes à charge réels des ménages : Bilan et perspectives du projet Monaco
by Dourgnon, Paul & Evrard, Isabelle & Guillaume, Stéphanie

2014 Gender differences in French GPs’ activity: the contribution of quantile regressions
by Dumontet, Magali & Franc, Carine

2014 Médicaments biosimilaires : quels enjeux économiques et politiques ?
by Bocquet, François

2014 On Goals and Measures of Health Care Reform in Russia
by A. Aganbegyan.

2014 Mit maerkischen Innovationen die ambulante Versorgung gestalten
by Hans-Joachim Helming

2014 Aerztemangel im laendlichen Raum – Neue Anreizstrukturen und innovative Versorgungsmodelle als Ausweg? Zur Bedeutung einer patientenorientierten Steuerung
by Jürgen Zerth

2014 Rahmenbedingungen fuer eine effektive Versorgungssteuerung in Stadt und Land
by Stefan Greß & Klaus Stegmüller

2014 Medical insurance and free choice of physician shape patient overtreatment: A laboratory experiment
by Huck, Steffen & Lünser, Gabriele & Spitzer, Florian & Tyran, Jean-Robert

2014 How do Non-Monetary Performance Incentives for Physicians Affect the Quality of Medical Care? A Laboratory Experiment
by Kairies-Schwarz, Nadja & Krieger, Miriam

2014 Reference pricing and cost-sharing: Theory and evidence on German off-patent drugs
by Herr, Annika & Stühmeier, Torben & Wenzel, Tobias

2014 Do wage expectations influence the decision to enroll in nursing college?
by Schweri, Juerg & Hartog, Joop

2014 The Price Sensitivity of Health Plan Choice among Retirees: Evidence from the German Social Health Insurance
by Wuppermann, Amelie & Bauhoff, Sebastian & Grabka, Markus

2014 Selective-referral and unobserved patient heterogeneity - Bias in the volume-outcome relationship
by Hentschker, Corinna & Mennicken, Roman

2014 The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics
by Suppliet, Moritz & Duso, Tomaso & Herr, Annika

2014 Learning-by-Doing in a High-Skill Profession when Stakes are High: Evidence from Advanced Cancer Surgery
by Avdic, Daniel & Lundborg, Petter & Vikström, Johan

2014 Average-cost pricing and dynamic selection incentives in the hospital sector
by Kifmann, Mathias & Siciliani, Luigi

2014 Credence goods, costly diagnosis, and subjective evaluation
by Bester, Helmut & Dahm, Matthias

2014 The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics
by Duso, Tomaso & Herr, Annika & Suppliet, Moritz

2014 Optimal Price-Setting in Pay for Performance Schemes in Health Care
by Søren Rud Kristensen & Luigi Siciliani & Matt Sutton

2014 Social interactions in inappropriate behavior for childbirth services: Theory and evidence from the Italian hospital sector
by Guccio, C.; & Lisi, D.;

2014 Does quality affect patients’ choice of doctor? Evidence from the UK
by Santos, R.; & Gravelle, H.; & Propper, C.;

2014 Are physician fees responsive to competition?
by Choné, P.; & Coudin, É.; & Pla, A.;

2014 Effects of geographical accessibility on the use of outpatient care services: quasi-experimental evidence from administrative panel data
by Elek, P.; & Varadi, B.; & Varga, M.;

2014 Modelling nonlinearities and reference-dependence in general practitioners’ income preferences
by Holte, J.H.; & Sivey, P.; & Abelsen, B.; & Olsen, J.A.;

2014 Does the letter matter (and for everyone)? Quasi-experimental evidence on the effects of home invitation on mammography uptake
by Carrieri, V.; & Wuebker, A.;

2014 The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics
by Duso, T.; & Herr, A.; & Suppliet, M

2014 Attrition Bias in Panel Data: A Sheep in Wolf's Clothing? A Case Study Based on the MABEL Survey
by Cheng, T. C.; & Trivedi, P. K.;

2014 Testing exogeneity of multinomial regressors in count data models: does two stage residual inclusion work?
by Geraci, A.; & Fabbri, D.; & Monfardini, C.;

2014 Determinants of Access to Healthcare: A Survey in Istanbul
by Muhammed Ziya Paköz & Mehmet Ali Yüzer

2014 Break-ups of municipal health centre federations: Expenditure and efficiency effects
by Mika Kortelainen & Kalevi Luoma & Antti Moisio

2014 Fatal Attraction: health care agglomeration and its consequences
by Stephen Sheppard & Michael Hellstern

2014 Credence Goods, Costly Diagnosis, and Subjective Evaluation
by Bester, Helmut & Dahm, Matthias

2014 Prescribing Behavior of General Practitioners : Competition Matters!
by Schaumans, C.B.C.

2014 Prescribing Behavior of General Practitioners : Competition Matters!
by Schaumans, C.B.C.

2014 Provider Competition and Over-Utilization in Health Care
by Boone, J. & Douven, R.C.M.H.

2014 Selective-referral and Unobserved Patient Heterogeneity – Bias in the Volume-outcome Relationship
by Corinna Hentschker & Roman Mennicken

2014 Choice of Received Long-term Care – Individual Responses to Regional Nursing Home Provisions
by Adam Pilny & Magdalena A. Stroka

2014 Mergers and Acquisitions in the German Hospital Market – Who are the Targets?
by Adam Pilny

2014 Explaining Differentials in Subsidy Levels among Hospital Ownership Types in Germany
by Adam Pilny

2014 Does Hospital Reputation Influence the Choice of Hospital?
by Adam Pilny & Roman Mennicken

2014 Altruism Heterogeneity and Quality Competition Among Healthcare Providers
by Nadja Kairies-Schwarz

2014 Defining Hospital Markets – An Application to the German Hospital Sector
by Corinna Hentschker & Andreas Schmid & Roman Mennicken

2014 Information Presentation and Consumer Choice: Evidence from Assisted Reproductive Technology (ART) Success Rates Reports
by Bingxiao Wu

2014 Mismeasurement in Pay-for-Performance: Evidence from an Intervention to Reduce Health Care Spending in China
by Bingxiao Wu

2014 Gravity for Health: an Application to State Mental Hospital Admissions in Texas
by de Mello-Sampayo, Felipa

2014 What shapes patient's satisfaction in countries' health care systems?
by Xesfingi, Sofia & Vozikis, Athanasios

2014 How do supply-side factors influence informal payments for healthcare? The case of HIV patients in Cameroon
by Kankeu Tchewonpi, Hyacinthe & Boyer, Sylvie & Fodjo Toukan, Raoul & Abu-Zaineh, Mohammad

2014 Trade Policies, Health Care and Social Welfare: A General Equilibrium Analysis
by Chatterjee, Tonmoy & Gupta, Kausik

2014 Health Care Quality vs Health Care Quantity: A General Equilibrium Analysis
by Chatterjee, Tonmoy & Gupta, Kausik

2014 Readmission and Hospital Quality under Prospective Payment System
by Guccio, Calogero & Lisi, Domenico & Pignataro, Giacomo

2014 Racial Differences in Willingness to Pay for Hospital Access
by Leguizamon, Susane & Christafore, David

2014 Health care and social care: complements, substitutes and attributes
by Wildman, John & McMeekin, Peter

2014 The Impact of An Increase in User Costs on the Demand For Emergency Services: The Case of Portuguese Hospitals
by Pedro Ramos & Álvaro Almeida

2014 Comparison of Public, Non-Profit and Private Hospitals
by Bärbel Held

2014 Labor Market Outcomes of Informal Care Provision in Japan
by Hiroyuki Yamada & Satoshi Shimizutani

2014 Wage-setting in the Hospital Sector
by James Buchan & Ankit Kumar & Michael Schoenstein

2014 Pricing and competition in Specialist Medical Services: An Overview for South Africa
by Ankit Kumar & Grégoire de Lagasnerie & Frederica Maiorano & Alessia Forti

2014 How to Improve Israel's Health-care System
by Philip Hemmings

2014 Hospital Mergers with Regulated Prices
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2014 Price Regulation and Parallel Imports of Pharmaceuticals
by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume

2014 Can Health Insurance Competition Work? Evidence from Medicare Advantage
by Vilsa Curto & Liran Einav & Jonathan Levin & Jay Bhattacharya

2014 Measuring Consumer Valuation of Limited Provider Networks
by Keith Marzilli Ericson & Amanda Starc

2014 Sources of Geographic Variation in Health Care: Evidence from Patient Migration
by Amy Finkelstein & Matthew Gentzkow & Heidi Williams

2014 Expanding Patients' Property Rights In Their Medical Records
by Laurence C. Baker & Kate Bundorf & Daniel Kessler

2014 The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India
by Mark Duggan & Craig Garthwaite & Aparajita Goyal

2014 The Effect of Substance Use Disorder Treatment Use on Crime: Evidence from Public Insurance Expansions and Health Insurance Parity Mandates
by Hefei Wen & Jason M. Hockenberry & Janet R. Cummings

2014 Estimating the Value Added of Attending Physicians on Patient Outcomes
by Jason M. Fletcher & Leora I. Horwitz & Elizabeth Bradley

2014 Risk Corridors and Reinsurance in Health Insurance Marketplaces: Insurance for Insurers
by Timothy J. Layton & Thomas G. McGuire & Anna D. Sinaiko

2014 Does Privatized Health Insurance Benefit Patients or Producers? Evidence from Medicare Advantage
by Marika Cabral & Michael Geruso & Neale Mahoney

2014 Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?
by Keith M. Drake & Martha A. Starr & Thomas McGuire

2014 "Sticker Shock" in Individual Insurance under Health Reform
by Mark Pauly & Scott Harrington & Adam Leive

2014 Premium Transparency in the Medicare Advantage Market: Implications for Premiums, Benefits, and Efficiency
by Karen Stockley & Thomas McGuire & Christopher Afendulis & Michael E. Chernew

2014 To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda
by Greg Fischer & Dean Karlan & Margaret McConnell & Pia Raffler

2014 Public Health Insurance Expansions and Hospital Technology Adoption
by Seth Freedman & Haizhen Lin & Kosali Simon

2014 More Insurers Lower Premiums: Evidence from Initial Pricing in the Health Insurance Marketplaces
by Leemore Dafny & Jonathan Gruber & Christopher Ody

2014 How Do Providers Respond to Public Health Insurance Expansions? Evidence from Adult Medicaid Dental Benefits
by Thomas C. Buchmueller & Sarah Miller & Marko Vujicic

2014 Health Care in a Multipayer System: The Effects of Health Care Service Demand among Adults under 65 on Utilization and Outcomes in Medicare
by Sherry A. Glied

2014 Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
by Rena M. Conti & Ernst R. Berndt

2014 Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market
by Eric Helland & Darius N. Lakdawalla & Anup Malani & Seth A. Seabury

2014 Efficiency versus Equity in the Allocation of Medical Specialty Training Positions in Spain: A Health Policy Simulation Based on a Discrete Choice Model
by Jeffrey E. Harris & Beatriz G. López-Valcárcel & Patricia Barber & Vicente Ortún

2014 Cross Border Effects of State Health Technology Regulation
by Jill R. Horwitz & Daniel Polsky

2014 The Industrial Organization of Health Care Markets
by Martin Gaynor & Kate Ho & Robert Town

2014 Health Care Workers' Risk Perceptions of Personal and Work Activities and Willingness to Report for Work During an Influenza Pandemic
by Georges Dionne & Denise Desjardins & Martin Lebeau & Stéphane Messier & André Dascal

2014 Medical Insurance and Free Choice of Physician Shape Patient Overtreatment. A Laboratory Experiment
by Steffen Huck & Gabriele Lünser & Florian Spitzer & Jean-Robert Tyran

2014 Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach
by Alice Sanwald & Thomas Schober

2014 Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach
by Alice Sanwald & Thomas Schober

2014 Do Market Incentives in the Hospital Industry Affect Subjective Health Perceptions? Evidence from the Italian PPS-DRG Reform
by Cappellari, Lorenzo & De Paoli, Anna & Turati, Gilberto

2014 Consequences of ADHD Medication Use for Children's Outcomes
by Dalsgaard, Søren & Nielsen, Helena Skyt & Simonsen, Marianne

2014 Learning-by-Doing in a Highly Skilled Profession When Stakes Are High: Evidence from Advanced Cancer Surgery
by Avdic, Daniel & Lundborg, Petter & Vikström, Johan

2014 Public Health Insurance Expansions and Hospital Technology Adoption
by Seth Freedman & Haizhen Lin & Kosali Simon

2014 Formes du regroupement pluriprofessionnel en soins de premiers recours. Une typologie des maisons, pôles et centres de santé participant aux Expérimentations des nouveaux modes de rémunération (ENMR)
by Anissa Afrite & Julien Mousques

2014 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – NEXES (Spain) Case Study Report
by Francisco Lupiañez-Villanueva & Alexandra Theben

2014 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – eTrikala (Greece) Case Study Report
by Eleftheria Vellidou & Markela Psymarnou

2014 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) – Gesundes Kinzigtal (Germany) Case Study Report
by Francisco Lupiañez-Villanueva & Alexandra Theben

2014 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) Second report on outcome indicators
by Christian Boehler & Fabienne Abadie & Ramon Sabes-Figuera

2014 Title: Strategic Intelligence Monitor on Personal Health Systems Phase 3 (SIMPHS 3) - Report on the methodological set-up for the SIMPHS3 research
by Fabienne Abadie & Cristiano Codagnone & Francisco Lupiañez-Villanueva & Timea Helter

2014 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) Second update of the process indicators
by Fabienne Abadie & Christian Boehler & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora

2014 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) First update of the process indicators
by Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora

2014 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) First report on outcome indicators
by Fabienne Abadie & Christian Boehler & Maria Lluch & Ramon Sabes-Figuera

2014 Risk management and Organizational Communication: Two Cases in the Pharmaceutical Industry
by Guillaume Marceau

2014 Follow your Heart: Survival Chances and Costs after Heart Attacks - An Instrumental Variable Approach
by Alice Sanwald & Thomas Schober

2014 Does parental education affect the impact of provision of health care on health status of children? - Evidence from India
by Runu Bhakta & A. Ganesh Kumar

2014 Inequity in Formal Health Care Use: Evidence from Rural Bangladesh
by Syed Abdul Hamid & Syed M. Ahsan & Afroza Begum & Chowdhury Abdullah Al Asif

2014 Attrition Bias in Panel Data: A Sheep in Wolf’s Clothing? A Case Study Based on the MABEL Survey
by Terence C. Cheng & Pravin K. Trivedi

2014 Margin Rate Rule : A New Drug Pricing Policy in Japan
by Tamura, Masaoki

2014 Out-Of-Pocket Payments In The Post-Semashko Health Care System
by Sergey Shishkin & Elena Potapchik & Elena Selezneva

2014 Learning-by-Doing in a Highly Skilled Profession when Stakes are High: Evidence from Advanced Cancer Surgery
by Avdic, Daniel & Lundborg, Petter & Vikström, Johan

2014 Creaming and Dumping: Who on Whom?
by Socha-Dietrich, Karolina & Zweifel, Peter

2014 Does performance disclosure influence physicians’ medical decisions? An experimental study
by Godager, Geir & Hennig-Schmidt, Heike & Iversen, Tor

2014 Using artefactual field and lab experiments to investigate how fee-for-service and capitation affect medical service provision
by Brosig-Koch , Jeannette & Hennig-Schmidt , Heike & Kairies-Schwarz, Nadja & Wiesen, Daniel

2014 Hospital Mergers with Regulated Prices
by Brekke, Kurt R. & Siciliani, Luigi & Straume, Odd Rune

2014 Price Regulation and Parallel Imports of Pharmaceuticals
by Brekke, Kurt R. & Holmås, Tor Helge & Straume, Odd Rune

2014 Learning-by-doing in a highly skilled profession when stakes are high: evidence from advanced cancer surgery
by Avdic, Daniel & Lundborg, Petter & Vikström, Johan

2014 Reforming the Swedish pharmaceuticals market – consequences for costs per defined daily dose
by Bergman, Mats & Granlund, David & Rudholm, Niklas

2014 Nonmedical Prescription Drug Use: Theory and Policy Implications
by Gabriele Camera & Bryan Engelhardt

2014 Drug approval decision times, international reference pricing and strategic launches of new drugs
by Nicolas Houy & Izabela Jelovac

2014 Faithful Strategies: How Religion Shapes Nonprofit Management
by Lapo Filistrucchi & Jens Prufer

2014 The Effects of the Massachusetts Health Reform on Financial Distress
by Mazumder, Bhashkar & Miller, Sarah

2014 Efficiency of Hospitals in the Czech Republic: Conditional Efficiency Approach
by Lenka Šastná & Jana Votápková

2014 La spesa sanitaria delle Regioni in Italia - Saniregio 3
by Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Guido Borà

2014 Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo
by Laura Magazzini & Fabio Pammolli & Valentina Tortolini

2014 Medical tourism in Romania: the case study of cardiovascular rehabilitation in Covasna
by Roxana Oana Darabont & Paul Suceveanu & Mihaela Suceveanu & Clara Volintiru

2014 The changing role of government in financing health care: an international perspective
by Mark Stabile & Sarah Thomson

2014 To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda
by Greg Fischer & Dean Karlan & Margaret McConnell & Pia Raffler

2014 To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda
by Greg Fischer & Dean Karlan & Margaret McConnell & Pia Raffler

2014 The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics
by Tomaso Duso & Annika Herr & Moritz Suppliet

2014 Régulation des tarifs et comportments d’offre de soins des généralistes : les leçons de l’encadrement du secteur 2
by Coudin, Élise & Samson, Anne-Laure & Pla, Anne

2014 Quel impact attendre de la généralisation de la complémentaire santé d’entreprise sur le taux de non couverture en France ? Une simulation à partir de l’enquête Santé et Protection Sociale 2012
by Aurélie, Pierre & Jusot, Florence

2014 GPs’ response to price regulation: evidence from a nationwide French reform
by Coudiny, Elise & Plaz, Anne & Samson, Anne-Laure

2014 Does it pay to be a doctor in France?
by Samson, Anne-Laure & Dormont, Brigitte

2014 The Early Impact of the Affordable Care Act State-By-State
by Amanda E. Kowalski

2014 Does federalism induce patients’ mobility across regions? Evidence from the Italian experience
by Elenka Brenna & Federico Spandonaro

2014 GPs' Response to Price Regulation : Evidence from a Nationwide French Reform
by Elise Coudin & Anne Pla & Anne-Laure Samson

2014 To Charge or Not to Charge: Evidence from a Health Products Experiment in Uganda
by Fischer, Greg & Karlan, Dean S. & McConnell, Margaret & Raffler, Pia

2014 Optimal Price-Setting in Pay for Performance Schemes in Health Care
by Rud Kristensen, Søren & Siciliani, Luigi & Sutton, Matt

2014 Credence Goods, Costly Diagnosis, and Subjective Evaluation
by Bester, Helmut & Dahm, Matthias

2014 Provider competition and over-utilization in health care
by Boone, Jan & Douven, Rudy

2014 Average-cost Pricing and Dynamic Selection Incentives in the Hospital Sector
by Kifmann, Mathias & Siciliani, Luigi

2014 Unintended effects of reimbursement schedules in mental health care
by Rudy Douven & Minke Remmerswaal & Ilaria Mosca (Ecorys)

2014 Provider competition and over-utilization in health care
by Jan Boone & Rudy Douven

2014 Quality and hospital choice for cataract treatments: the winner takes most
by Suzanne Ruwaard & Rudy Douven

2014 La doble descentralización en el sector salud: evaluación y alternativas de política pública
by Ramiro Guerrero & Sergio I. Prada & Dov Chernichovsky

2014 La salud en Colombia: más cobertura pero menos acceso
by Jhorland Ayala

2014 Radiografía de la oferta de servicios de salud en Colombia
by Karelys Guzmán Finol

2014 The Performance of Risk Adjustment Models in Colombian Competitive Health Insurance Market
by Álvaro Riascos & Eduardo Alfonso & Mauricio Romero

2014 Competencia en el sector de la salud: énfasis en el caso colombiano
by David Bardey

2014 Patient choice and the effects of hospital market structure on mortality for AMI, hip fracture and stroke patients
by Hugh Gravelle & Giuseppe Moscelli & Rita Santos & Luigi Siciliani

2014 Average-cost Pricing and Dynamic Selection Incentives in the Hospital Sector
by Mathias Kifmann & Luigi Siciliani

2014 Patient Mobility, Health Care Quality and Welfare
by Kurt R. Brekke & Rosella Levaggi & Luigi Siciliani & Odd Rune Straume

2014 Walk This Way: Estimating Impacts of Walk in Centres at Hospital Emergency Departments in the English National Health Service
by Ted Pinchbeck

2014 Déterminants de la demande de soins en milieu péri-urbain dans un contexte de subvention à Pikine, Sénégal
by Jean-Yves LE HESRAN & Martine AUDIBERT & Moussa DIENG & Anta TA DIAL

2014 To Vaccinate or to Procrastinate? That is the Prevention Question
by Robert Nuscheler & Kerstin Roeder

2014 The Determinants of the Propensity to Receive Publicly Funded Home Care Services for the Elderly in Canada
by Gustavo Mery & Walter Wodchis & Audrey Laporte

2014 Patent Expiration and Competition: A dynamic limit price model
by Anastasios Papanastasiou

2014 The Impact of Informal Caregiving Intensity on Women's Retirement in the United States
by Josephine Jacobs & Courtney Van Houtven & Audrey Laporte & Peter Coyte

2014 Paying For Primary Care: The Factors Associated With Physician Self-Selection Into Payment Models
by David Rudoler & Raisa Deber & Janet Barnsley & Richard Glazier & Audrey Laporte

2014 Optimal Co-Payment Policy In Health Care: Competition, Ownership Structure And Quality Provision
by Rune Stenbacka & Mihkel Tombak

2014 Changing Healthcare Capital-To-Labor Ratios: Evidence and Implications for Bending the Cost Curve in Canada and Beyond
by Eric Nauenberg

2014 Baby Boomer caregivers in the workforce: Do they fare better or worse than their predecessors?
by Josephine Jacobs & Courtney Van Houtven & Audrey Laporte & Peter Coyte

2014 Assessing the Design of the Low-Income Subsidy Program in Medicare Part D: Working Paper 2014-07
by Andrew Stocking & James Baumgardner & Melinda Buntin & Anna Cook

2014 Examining the Number of Competitors and the Cost of Medicare Part D: Working Paper 2014-04
by Andrew Stocking & James Baumgardner & Melinda Buntin & Anna Cook

2014 First do no harm. Then do not cheat: DRG upcoding in German neonatology
by Hendrik Jürges & Juliane Köberlein

2014 Does the extension of primary care practice opening hours reduce the use of emergency services?
by M. Lippi Bruni & I. Mammi & C. Ugolini

2014 La responsiveness dei sistemi sanitari: un’analisi empirica sull’assistenza ospedaliera nel Servizio Sanitario Regionale dell’Emilia Romagna
by S. Robone & G. Fiorentini & M. A. Nicoli & S. Rodella

2014 Are bad health and pain making us grumpy? An empirical evaluation of reporting heterogeneity in rating health system responsiveness
by G. Fiorentini & G. Ragazzi & S. Robone

2014 Dealing with minor illnesses: the link between primary care characteristics and First Aid Clinics’ attendances
by Donatini A. & Fiorentini G. & Lippi Bruni M. & Mammi I. & Ugolini C.

2014 Testing exogeneity of multinomial regressors in count data models: does two stage residual inclusion work?
by A. Geraci & D. Fabbri & C. Monfardini

2014 How to reform western care payment systems according to physicians, policy makers, healthcare executives and researchers: A discrete choice experiment
by KESSELS, Roselinde & VAN HERCK, Pieter & DANCET, Eline & ANNEMANS, Lieven & SERMEUS, Walter

2014 Impacts des incitatifs économiques en médecine générale : Analyse des préférences et des motivations des médecins
by Sicsic, Jonathan

2014 Concurrence, prix et qualité de la prise en charge en EHPAD en France : Analyses micro-économétriques
by Martin, Cécile

2014 The Effect of Health Insurance on Emergency Department Visits: Evidence from an Age-Based Eligibility Threshold
by Michael L. Anderson & Carlos Dobkin & Tal Gross

2014 Priorities and Directions for Future Productivity Research: Health Care, Intangible Capital and High-tech
by Dan Sichel

2014 Medical Entities –Financing Types And Sources In Light Of The Act On Medical Activity
by Ma³gorzata Paszkowska

2014 Integrated It Systems And Their Influence On Managing The Finances
by Daniel Litwin

2014 Expenditures On Healthcare Versus Health Conditions Among New Member Countries Of The Eu
by Ma³gorzata Leœniowska & Anna Nedyalkova

2014 Strengths and Weaknesses of Financing Hospitals in Germany
by Yaman, Kemal

2014 Nurses’ perception of feedback on quality measurements: Development and validation of a measure
by Giesbers, Suzanne & Schouteten, Roel L.J. & Poutsma, Erik & van der Heijden, Beatrice I.J.M. & van Achterberg, Theo

2014 Untypisch atypisch Beschaeftigte. Honoraraerzte zwischen Befristung, Leiharbeit und (Solo-)Selbststaendigkeit (Untypical atypical employees. Locum doctors between limited contracts, temporary employment, and solo-self employment)
by Keller, Berndt & Wilkesmann, Maximiliane

2014 Atypische Beschaeftigungsverhaeltnisse – Einleitung zum Schwerpunktheft (Atypical employment - Introduction)
by Keller, Berndt & Nienhueser, Werner

2014 Von Florence Nightingale zu Adam Smith? Wenn PatientInnen zu KundInnen und Gesundheitsdienstleistungen zu Waren werden (Florence Nightingale to Adam Smith? When Patients Become Clients and Health Services Become Goods)
by Becker, Karina

2014 Health and Long-Term Care Expenditure in Finland When Living Alone Increases
by Jukka Lassila & Tarmo Valkonen

2014 Financial Incentives and Inappropriateness in Health Care: Evidence from Italian Cesarean Sections
by Marina Cavalieri & Calogero Guccio & Domenico Lisi & Giacomo Pignataro

2014 Public-sector outsourcing
by Panu Poutvaara

2014 The Risks and Dynamics of Health Care Expenditures in Urban China: An Illustration in Kunshan City
by Guan Gong & Hongmei Wang & Lingli Xu

2014 Antibiotic consumption and the role of dispensing physicians
by Filippini, M. & Heimsch, F. & Masiero, G.

2014 The role of life experience in long-term care insurance decisions
by Tennyson, Sharon & Yang, Hae Kyung

2014 The effects of retiree health insurance plan characteristics on retirees’ choice and employers’ costs
by Clark, Robert L. & Morrill, Melinda Sandler & Vanderweide, David

2014 How does retiree health insurance influence public sector employee saving?
by Clark, Robert L. & Mitchell, Olivia S.

2014 Price regulation and relative delays in generic drug adoption
by Costa-Font, Joan & McGuire, Alistair & Varol, Nebibe

2014 Hips and hearts: The variation in incentive effects of insurance across hospital procedures
by Doiron, Denise & Fiebig, Denzil G. & Suziedelyte, Agne

2014 Do hospitals cross-subsidize?
by David, Guy & Lindrooth, Richard C. & Helmchen, Lorens A. & Burns, Lawton R.

2014 Foreign nurse importation and the supply of native nurses
by Cortés, Patricia & Pan, Jessica

2014 Consequences of ADHD medication use for children's outcomes
by Dalsgaard, Søren & Nielsen, Helena Skyt & Simonsen, Marianne

2014 Plan choice, health insurance cost and premium sharing
by Kosteas, Vasilios D. & Renna, Francesco

2014 The impact of competition on quality and prices in the English care homes market
by Forder, Julien & Allan, Stephen

2014 Competition and the impact of online hospital report cards
by Chou, Shin-Yi & Deily, Mary E. & Li, Suhui & Lu, Yi

2014 The role of GP's compensation schemes in diabetes care: Evidence from panel data
by Iezzi, Elisa & Lippi Bruni, Matteo & Ugolini, Cristina

2014 Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems
by Huckfeldt, Peter J. & Sood, Neeraj & Escarce, José J. & Grabowski, David C. & Newhouse, Joseph P.

2014 Nurses’ labour supply elasticities: The importance of accounting for extensive margins
by Hanel, Barbara & Kalb, Guyonne & Scott, Anthony

2014 Measuring the effects of reducing subsidies for private insurance on public expenditure for health care
by Cheng, Terence Chai

2014 How does provider supply and regulation influence health care markets? Evidence from nurse practitioners and physician assistants
by Stange, Kevin

2014 Estimating demand elasticities using nonlinear pricing
by Dalton, Christina M.

2014 Product choice under price regulation: Evidence from out-patient dialysis markets
by Dai, Mian

2014 Concentration of gynaecology and obstetrics in Germany: Is comprehensive access at stake?
by Mennicken, Roman & Kolodziej, Ingo W.K. & Augurzky, Boris & Kreienberg, Rolf

2014 Analyzing regional variation in health care utilization using (rich) household microdata
by Eibich, Peter & Ziebarth, Nicolas R.

2014 Nudges at the dentist
by Altmann, Steffen & Traxler, Christian

2014 Health insurer market power and primary care consolidation
by Brunt, Christopher S. & Bowblis, John R.

2014 Insurance coverage and agency problems in doctor prescriptions: Evidence from a field experiment in China
by Lu, Fangwen

2014 Zahl privater Zusatzkrankenversicherungen hat sich verdoppelt
by Markus M. Grabka

2014 Market concentration and performance of general hospitals in Poland
by Blazej Lyszczarz

2014 Propuesta de mecanismos de pagos ex post para reducir la selección de riesgos en el Sistema de Salud colombiano
by Jorge Duarte & Ramiro Guerrero

2014 Gestión logística en la prestación de servicios de hospitalización domiciliaria en el Valle del Cauca: caracterización y diagnóstico
by Elena Valentina Gutiérrez & Oscar David Galvis & Diego Alejandro López & Juan Sebastián Mock-Kow, Ismael Zapata, Carlos Julio Vidal

2014 Haushaltssanierung auf Kosten der Krankenkassen: Folgen höhere Sozialabgaben?
by Doris Pfeiffer & Stefan Greß & Karl-Jürgen Bieback & Volker Ulrich

2014 The Case of the Vanishing Quebec Physicians: How to Improve Access to Care
by Claude Forget

2014 L'affaire des médecins disparus du Québec : comment améliorer l'accès aux soins
by Claude Forget Author- Workplace-Name: CEF Ganesh Corporation

2014 Quality of Primary Care in Low-Income Countries: Facts and Economics
by Jishnu Das & Jeffrey Hammer

2014 The effect of financing hospital health care providers through updated Diagnosis Related Groups. Case studies: the municipal hospitals in Romania
by Emil OLTEANU & Attila TAMAS SZORA & Iulian Bogdan DOBRA

2014 Medical Tourism in Romania. The Case Study of Cardiovascular Rehabilitation in Covasna
by Roxana Oana Darabont & Paul Suceveanu & Mihaela Suceveanu & Clara Alexandra Volintiru

2014 Analysis of Medical Tourism for Cardiovascular Diseases
by Catalina Liliana Andrei & Gabriela Tigu & Raluca Mariana Dragoescu & Crina Julieta Sinescu

2014 Hand Surgery – Postoperative Recovery and Medical Tourism
by Ruxandra Diana Sinescu & Andrea Anghel & Razvan Teohari Vulcanescu

2014 The Market for Blood
by Robert Slonim & Carmen Wang & Ellen Garbarino

2014 The Changing Role of Government in Financing Health Care: An International Perspective
by Mark Stabile & Sarah Thomson

2014 The Trillion Dollar Conundrum: Complementarities and Health Information Technology
by David Dranove & Chris Forman & Avi Goldfarb & Shane Greenstein

2014 Sequential Kidney Exchange
by Lawrence M. Ausubel & Thayer Morrill

2014 Human Capital and Productivity in a Team Environment: Evidence from the Healthcare Sector
by Ann P. Bartel & Nancy D. Beaulieu & Ciaran S. Phibbs & Patricia W. Stone

2014 The Demand for Medical Male Circumcision
by Jobiba Chinkhumba & Susan Godlonton & Rebecca Thornton

2014 The Effect of Patient Cost Sharing on Utilization, Health, and Risk Protection
by Hitoshi Shigeoka

2014 Getting More Organs for Transplantation
by Judd B. Kessler & Alvin E. Roth

2014 Physician Payment Reform and Hospital Referrals
by Kate Ho & Ariel Pakes

2014 Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?
by Jeffrey Clemens & Joshua D. Gottlieb

2014 Hospital Choices, Hospital Prices, and Financial Incentives to Physicians
by Kate Ho & Ariel Pakes

2014-01 Analyzing Regional Variation in Health Care Utilization Using (Rich) Household Microdata
by Eibich, Peter & Ziebarth, Nicolas R.

2013 Inequality of Opportunities in Health and the Principle of Natural Reward: Evidence from European Countries
by Tubeuf, Sandy & Trannoy, Alain & Jusot, Florence & Bricard, Damien

2013 Equity in Health And Equivalent Incomes
by Dormont, Brigitte & Samson, Anne-Laure & Thébaut, Clémence & Luchini, Stéphane & Fleurbaey, Marc & Van de Voorde, Carine & Schokkaert, Erik

2013 Strengthening weak primary care systems: Steps towards stronger primary care in selected Western and Eastern European countries
by Groenewegen, Peter P. & Dourgnon, Paul & Gress, Stefan & Jurgutis, Arnoldas & Willems, Sara

2013 The role of time and risk preferences in smoking inequalities: A population-based study
by Jusot, Florence & Khlat, Myriam

2013 Temporary Authorization for Use: Does the French Patient Access Programme for Unlicensed Medicines Impact Market Access After Formal Licensing?
by Degrassat-Théas, Albane & Paubel, Pascal & Parent de Curzon, Olivier & Le Pen, Claude & Sinègre, Martine

2013 Essais sur la qualité des soins : approches en économie et en santé publique
by Bahrami, Stéphane

2013 Private Health Care Sector in Russia: Present State and Development Prospects
by S. Shishkin & E. Potapchik & E. Selezneva.

2013 Limited Attention and the Demand for Health Insurance
by Fels, Markus

2013 Growth and Welfare Effects of Health Care in Knowledge Based Economies
by Kuhn, Michael & Prettner, Klaus

2013 Can Amputation Save the Hospital? The Impact of the Medicare Rural Flexibility Program on Demand and Welfare
by Schmidt-Dengler, Philipp & Gowrisankaran, Gautam & Lucarelli, Claudio & Town, Robert

2013 DRG upcoding in German neonatology
by Jürges, Hendrik & Köberlein, Juliane

2013 Externalities of national pharmaceutical policy when markets are integrated through parallel trade
by Birg, Laura

2013 Saving the public from the private? Incentives and outcomes in dual practice
by Kuhn, Michael & Nuscheler, Robert

2013 Pharmaceutical regulation at the wholesale level and parallel trade
by Birg, Laura

2013 Pharmaceutical cost-sharing systems and savings for health care systems from parallel trade
by Birg, Laura

2013 Externalities of national pharmaceutical policy when markets are integrated through parallel trade
by Birg, Laura

2013 Difference in Differences for Stayers and Movers with a Time-Varying QualiÂ…cation
by Lee, M.; & Kim, Y.;

2013 The Impact of a Public Option in the Health Insurance Market
by Andrei Barbos & Yi Deng

2013 Do Spanish informal caregivers come to the rescue of dependent people with formal care unmet needs?
by Sergi Jiménez-Martín & Cristina Vilaplana Prieto

2013 Does full insurance increase the demand for health care?
by Stefan Boes & Michael Gerfin

2013 Does Physician Dispensing Increase Drug Expenditures?
by Boris Kaiser & Christian Schmid

2013 Identification of Supplier-induced Demand What kind of consumer information matters?
by Christian Schmid

2013 The Impact of Private Hospital Insurance on the Utilization of Hospital Care In Australia
by Damien S.Eldridge & Ilke Onur & Malathi Velamuri & Cagatay Koc

2013 A shirking theory of referrals
by Damien S.Eldridge

2013 Faithful Strategies : How Religion Shapes Nonprofit Management
by Filistrucchi, L. & Prüfer, J.

2013 Salient Gender Difference in the Wage Elasticity of General Practitioners' Labour Supply
by Chunzhou Mu & Shiko Maruyama

2013 Hips and hearts: the variation in incentive effects of insurance across hospital procedures
by Denise Doiron & Denzil G Fiebig & Agne Suziedelyte

2013 How do Non-Monetary Performance Incentives for Physicians Affect the Quality of Medical Care? – A Laboratory Experiment
by Nadja Kairies & Miriam Krieger

2013 How Effective are Pay-for-Performance Incentives for Physicians? – A Laboratory Experiment
by Jeannette Brosig-Koch & Heike Hennig-Schmidt & Nadja Kairies & Daniel Wiesen

2013 How to Improve Patient Care? – An Analysis of Capitation, Fee-for-Service, and Mixed Payment Schemes for Physicians
by Jeannette Brosig-Koch & Heike Hennig-Schmidt & Nadja Kairies & Daniel Wiesen

2013 Biting Back at Malaria – Self-Medication, Traditional Healers, and the Public Sector
by Alfredo R. Paloyo & Arndt R. Reichert

2013 Gender Differences in Long Term Health Outcomes of Internal Migrants in Italy
by Vincenzo Atella & Partha Deb

2013 Migration, Risk-Adjusted Mortality, Varieties of Congestion and Patient Satisfaction in Turkish Provincial General Hospitals
by Davutyan, Nurhan & Bilsel, Murat & Tarcan, Menderes

2013 New Alternatives in a Plural Society: Care to Dependents and Foreign Care
by García Navarro, Esperanza Begoña

2013 Background Risk of Food Insecurity and Insurance Behaviour: Evidence from the West Bank
by Elisa Cavatorta & Luca Pieroni

2013 Survival or performance? Healthcare viewed through organization, information management, and personnel
by Kauhanen, Antti & Kulvik, Martti & Maijanen, Sirpa & Martikainen, Olli & Ranta, Paula & Kulvik, Silja

2013 Does Physician Compensation Impact Procedure Choice and Patient Health?
by Diane Alexander

2013 Fraud in the Workplace? Evidence from a Dependent Verification Program
by Michael Geruso & Harvey S. Rosen

2013 Standards of living and health status: the socioeconomic determinants of life expectancy gain in sub-Saharan Africa
by Keita, Moussa

2013 Trade in Health Services and Globalization: The Role of Infinitesimal Changes of Trade Policy
by Chatterjee, Tonmoy & Gupta, Kausik

2013 Health insurance and health care in India: a supply-demand perspective
by Perianayagam, Arokiasamy & Goli, Srinivas

2013 Un Test sulle Ipotesi delle Proiezioni a Medio-Lungo Termine della Spesa Farmaceutica
by SALERNO, Nicola Carmine

2013 Quality and health care performance in the Italian regions
by De Nicola, Arianna & Mancuso, Paolo & Valdmanis, Vivian

2013 Rising Mortality Rate in Andhra Pradesh: Towards a demystification
by Motkuri, Venkatanarayana & Mishra, Uday Shankar

2013 Demand Uncertainty and Hospital Costs: an Application to Portuguese NHS Hospitals
by Alvaro Almeida & Joana Cima

2013 Regulation and Capacity Competition in Health Care: Evidence from Dialysis Markets
by Mian Dai & Xun Tang

2013 Equilibrium Labor Market Search and Health Insurance Reform
by Naoki Aizawa & Hanming Fang

2013 Exploring the causal relationship between length of stay in hospitals and treatment outcome: Evidence from Japanese AMI patients
by Satoshi Shimizutani & Hiroyuki Yamada & Haruko Noguchi & Yuichiro Masuda & Masafumi Kuzuya

2013 Managing Hospital Volumes: Germany and Experiences from OECD Countries
by Ankit Kumar & Michael Schoenstein

2013 Health Workforce Planning in OECD Countries: A Review of 26 Projection Models from 18 Countries
by Tomoko Ono & Gaetan Lafortune & Michael Schoenstein

2013 Belgium: Enhancing the Cost Efficiency and Flexibility of the Health Sector to Adjust to Population Ageing
by Stéphane Sorbe

2013 Health Care Reform and Long-Term Care in the Netherlands
by Erik Schut & Stéphane Sorbe & Jens Høj

2013 Hospital Mergers: A Spatial Competition Approach
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2013 The Effect of Patient Cost Sharing on Utilization, Health, and Risk Protection
by Hitoshi Shigeoka

2013 Is This Time Different? The Slowdown in Healthcare Spending
by Amitabh Chandra & Jonathan Holmes & Jonathan Skinner

2013 Moral Hazard and Economies of Scope in Physician Ownership of Complementary Medical Services
by Brian K. Chen & Paul J. Gertler & Chuh-Yuh Yang

2013 How Product Standardization Affects Choice: Evidence from the Massachusetts Health Insurance Exchange
by Keith M Marzilli Ericson & Amanda Starc

2013 Pharmaceutical Followers
by Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley

2013 How Does Retiree Health Insurance Influence Public Sector Employee Saving?
by Robert Clark & Olivia S. Mitchell

2013 In the Shadow of a Giant: Medicare's Influence on Private Physician Payments
by Jeffrey Clemens & Joshua D. Gottlieb

2013 Impact of Mortality-Based Performance Measures on Hospital Pricing: the Case of Colon Cancer Surgeries
by Avi Dor & Partha Deb & Michael Grossman & Gregory Cooper & Siran Koroukian & Fang Xu

2013 Insurer Competition and Negotiated Hospital Prices
by Kate Ho & Robin S. Lee

2013 Equilibria in Health Exchanges: Adverse Selection vs. Reclassification Risk
by Benjamin R. Handel & Igal Hendel & Michael D. Whinston

2013 Perverse Reverse Price Competition: Average Wholesale Prices and Medicaid Pharmaceutical Spending
by Abby Alpert & Mark Duggan & Judith K. Hellerstein

2013 Hospital Choices, Hospital Prices and Financial Incentives to Physicians
by Kate Ho & Ariel Pakes

2013 Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending
by David Cutler & Jonathan Skinner & Ariel Dora Stern & David Wennberg

2013 International Health Economics
by Mark Egan & Tomas J. Philipson

2013 Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy
by Mireille Jacobson & Tom Y. Chang & Joseph P. Newhouse & Craig C. Earle, M.D.

2013 Healthcare Exceptionalism? Productivity and Allocation in the U.S. Healthcare Sector
by Amitabh Chandra & Amy Finkelstein & Adam Sacarny & Chad Syverson

2013 How Does Provider Supply and Regulation Influence Health Care Market? Evidence from Nurse Practitioners and Physician Assistants
by Kevin M. Stange

2013 Evolving Choice Inconsistencies in Choice of Prescription Drug Insurance
by Jason Abaluck & Jonathan Gruber

2013 Adverse Selection and an Individual Mandate: When Theory Meets Practice
by Martin B. Hackmann & Jonathan T. Kolstad & Amanda E. Kowalski

2013 Using Performance Incentives to Improve Medical Care Productivity and Health Outcomes
by Paul Gertler & Christel Vermeersch

2013 Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
by Tomas J. Philipson & George Zanjani

2013 Diagnosis and Unnecessary Procedure Use: Evidence from C-Section
by Janet Currie & W. Bentley MacLeod

2013 Can Amputation Save the Hospital? The Impact of the Medicare Rural Flexibility Program on Demand and Welfare
by Gautam Gowrisankaran & Claudio Lucarelli & Philip Schmidt-Dengler & Robert Town

2013 Mergers When Prices are Negotiated: Evidence from the Hospital Industry
by Gautam Gowrisankaran & Aviv Nevo & Robert Town

2013 How do Hospitals Respond to Negative Financial Shocks? The Impact of the 2008 Stock Market Crash
by David Dranove & Craig Garthwaite & Christopher Ody

2013 Effects of Pharmaceutical Promotion: A Review and Assessment
by Dhaval M. Dave

2013 Information and Quality when Motivation is Intrinsic: Evidence from Surgeon Report Cards
by Jonathan T. Kolstad

2013 Equilibrium Labor Market Search and Health Insurance Reform
by Naoki Aizawa & Hanming Fang

2013 The Production of and Market for New Physicians' Skill
by Andrew J. Epstein & Sean Nicholson & David A. Asch

2013 First do no harm. Then do not cheat: DRG upcoding in German neonatology
by Jürges, Hendrik & Köberlein, Juliane

2013 Antibiotic consumption and the role of dispensing physicians
by Massimo Filippini & Fabian Heimsch & Giuliano Masiero

2013 Cost Containment and Managed Care: Evidence from German Macro Data
by Andree Ehlert & Dirk Oberschachtsiek & Stefan Prawda

2013 Demand for primary healthcare in rural north India
by Richard Andrew Iles

2013 Old Boys’ Network in General Practitioner’s Referral Behavior
by Franz Hackl & Michael Hummer & Gerald Pruckner

2013 Old Boys’ Network in General Practitioner’s Referral Behavior
by Franz Hackl & Michael Hummer & Gerald Pruckner

2013 An experimental study on the effects of co-payment in public services
by Aurora García-Gallego & Nikolaos Georgantzis & Gianandrea Staffiero & Tarek Jaber-López

2013 Returns to Childbirth Technologies: Evidence from Preterm Births
by Daysal, N. Meltem & Trandafir, Mircea & van Ewijk, Reyn

2013 Public, Private or Both? Analysing Factors Influencing the Labour Supply of Medical Specialists
by Cheng, Terence Chai & Kalb, Guyonne & Scott, Anthony

2013 Does Full Insurance Increase the Demand for Health Care?
by Boes, Stefan & Gerfin, Michael

2013 The impact of fertility on household economic status in Cameroon, Mali and Senegal
by KUEPIE Mathias & SAIDOU HAMADOU Théophile

2013 Activité, productivité et qualité des soins des hôpitaux avant et après la T2A
by Zeynep Or & Julia Bonastre & Florence Journeau & Clément Nestrigue

2013 European Hospital Survey: Benchmarking deployment of e-Health services (2012–2013) – Country reports
by Ramon Sabes-Figuera

2013 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) – Interim Report on the defined process indicators
by Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Bernarda Zamora

2013 Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP) – Inception Report
by Ioannis Maghiros & Fabienne Abadie & Maria Lluch & Ramon Sabes-Figuera & Elena Villalba & Bernarda Zamora

2013 European Hospital Survey: Benchmarking deployment of e-Health services (2012–2013) – Methodological report
by Manuela Deidda & Francisco Lupiañez & Ioannis Maghiros

2013 European Hospital Survey: Benchmarking deployment of e-Health services (2012–2013) – Synthesis of outcomes
by Ramon Sabes-Figuera & Ioannis Maghiros

2013 European Hospital Survey: Benchmarking deployment of e-Health services (2012–2013) – Composite Indicators on eHealth Deployment and on Availability and Use of eHealth functionalities
by Ramon Sabes-Figuera & Ioannis Maghiros

2013 Integrated Healthcare in Andalusia - Analysis of primary care, specialised care, emergency care, social care and citizen support platforms
by Elena Villalba Mora & Jose A. Valverde Albacete

2013 Price of Medicaid and Uncompensated Care compared to Medicare and Private care: A translog shadow pricing approach for Floridian hospital outputs
by Jean-Philippe Boussemart & Hervé Leleu & Viviane Valdmanis

2013 Public, Private or Both? Analysing Factors Influencing the Labour Supply of Medical Specialists
by Terence Chai Cheng & Guyonne Kalb & Anthony Scott

2013 Competition, Prices and Quality in the Market for Physician Consultations
by Hugh Gravelle & Anthony Scott & Peter Sivey & Jongsay Yong

2013 A new perspective on the economic valuation of informal caare: The well-being approach revisited
by Konstantin Kehl & Stephan Stahlschmidt & &

2013 The social legitimation of biomedical Technologies in Russia: communication challenges for science and society
by Valentina Poliakova

2013 Patient choice in the post-Semashko health care system
by Sergey Shishkin & Alexandra Burdyak & Elena Potapchik

2013 Public provision and cross-border health care
by Granlund, David & Wikström, Magnus

2013 Immigrant Women and Entrepreneurship: A Study of the Health Care Sector in Sweden, 2002-2006
by Korpi, Martin & Hedberg, Charlotta & Pettersson, Katarina

2013 Viden om effekten af brugerbetaling i almen praksis og lægevagten
by Pedersen, Kjeld Møller

2013 Resolving the Coordination Problem in Health Care: Limited Responsibility HMO:s
by Lundbäck, Mattias

2013 Helseforetakenes interne organisering og ledelse
by Kjekshus, Lars Erik & Bernstrøm, Vilde

2013 Midtveisevaluering av Omsorgsplan 2015: Effekter for pleieårsverk og plasser i boliger og institusjoner
by Hagen, Terje P. & McArthur, David P. & Tjerbo, Trond

2013 Pasientbehandling og legeressurser i en sykehusavdeling
by Bratlid, Dag

2013 Kommunal finansiering av utskrivningsklare pasienter. Erfaringer fra første året
by Hagen, Terje P. & McArthur, David P. & Tjerbo, Trond

2013 Pasientrettigheter og bruk av private kommersielle sykehus
by Hagen, Terje P.

2013 Does performance disclosure influence physicians’ medical decisions? An experimental analysis
by Godager, Geir & Iversen, Tor & Hennig-Schmidt, Heike

2013 Hospital Mergers: A Spatial Competition Approach
by Brekke, Kurt R. & Siciliani, Luigi & Straume, Odd Rune

2013 Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs
by Brekke, Kurt R. & Dalen, Dag Morten & Holmås, Tor Helge

2013 Effects of Competition between Healthcare Providers on Prescription of Antibiotics
by Fogelberg, Sara

2013 Public Provision and Cross-Border Health Care
by Granlund, David & Wikström, Magnus

2013 How Do Hospitals Respond To Price Changes?Evidence From Norway
by Janueleviciute, Jurgita & Askildsen, Jan Erik & Kaarbøe, Oddvar & Siciliani, Luigi & Sutton, Matt

2013 Estimating the cost of Emergency Department presentations in NSW. CHERE Working Paper 2014/01
by Rebecca Reeve & Marion Haas

2013 Can we get there from here? Implementing health reform in Australia. CHERE Working Paper 2013/02
by Jane Hall & Patricia Kenny & Prue Power

2013 Stated Choice design comparison in a developing country: Attribute Nonattendance and choice task dominance
by Richard A Iles & John M Rose

2013 Interactions entre stratégies de promotion et fusions
by Laurent Granier

2013 Promotions prédatrice et coopérative sur le marché des médicaments
by Laurent Granier & Sébastien Trinquard

2013 Tarif forfaitaire de responsabilité : quels impacts sur le pharmacien ?
by Carine Franc & Laurent Granier & Sébastien Trinquard

2013 Drug launch timing and international reference pricing
by Nicolas Houy & Izabela Jelovac

2013 Nonprofits are not alike: The Role of Catholic and Protestant Affiliation
by Lapo Filistrucchi & Jens Prüfer

2013 Multiple criteria decision analysis for value based assessment of new medical technologies: a conceptual framework
by Panos Kanavos & Aris Angelis

2013 The burden of maternal health care expenditure in India: multilevel analysis of national data
by Tiziana Leone & K. S. James & Sabu S. Padmadas

2013 First Do No Harm. Then Do Not Cheat: DRG Upcoding in German Neonatology
by Hendrik Jürges & Juliane Köberlein

2013 Comment évaluer la productivité et l’efficacité des hôpitaux publics et privés ? Les enjeux de la convergence tarifaire
by Dormont, Brigitte & Milcent, Carine

2013 How would informal caregivers react to an increase in formal home-care use by their elderly dependent relatives in France?
by Goltz, Andreas & Arnault, Louis

2013 Male and Female GPs incomes: A study of the determinants through quantiles regressions
by Franc, Carine & Dumontet, Magali

2013 Inequalities of Opportunities in Health and Natural Reward: a European Perspective
by Tubeuf, Sandy & Trannoy, Alain & Jusot, Florence & Bricard, Damien

2013 Education and career path of French nursing home managers : impact on their human resources practices
by Joël, Marie-Eve & Sibille, Romain

2013 Stratégies de localisation des médecins généralistes français : mécanismes économiques ou hédonistes ?
by Delattre, Eric & Samson, Anne-Laure

2013 Adverse Selection and an Individual Mandate: When Theory Meets Practice
by Martin B. Hackmann & Jonathan T. Kolstad & Amanda E. Kowalski

2013 Hospital Aquired Infection (HAI): a cost-efficacy case study
by Greta Falavigna & Roberto Ippoliti & Grazia Lomolino

2013 Introducing activity-based payment in the hospital industry: Evidence from French data
by P. CHONÉ & F. EVAIN & L. WILNER & E. YILMAZ

2013 Does quality affect patients’ choice of doctor? Evidence from the UK
by Gravelle, Hugh S & Propper, Carol & Santos, Rita

2013 Competition, Equity and Quality in HealthCare
by Halonen-Akatwijuka, Maija & Propper, Carol

2013 Hospital competition with soft budgets
by Brekke, Kurt Richard & Siciliani, Luigi & Straume, Odd Rune

2013 Public and private hospitals, congestion, and redistribution
by CANTA, Chiara & LEROUX, Marie-Louise

2013 Competition, prices, and quality in the market for physician consultations
by Hugh Gravelle & Anthony Scott & Peter Sivey & Jongsay Yong

2013 Choice of contracts for quality in health care: Evidence from the British NHS
by Eleonora Fichera & Hugh Gravelle & Mario Pezzino & Matt Sutton

2013 Mixed Method Evaluation of a Passive Health Sexual Information Texting Service in Uganda-Working Paper 332
by Julian Jamison, Dean Karlan, Pia Raffler

2013 Heterogeneous Effects of a Nonlinear Price Schedule for Outpatient Care
by Helmut Farbmacher & Peter Ihle & Ingrid Schubert & Joachim Winter & Amelie C. Wuppermann

2013 First Do No Harm. Then Do Not Cheat: DRG Upcoding in German Neonatology
by Hendrik Jürges & Juliane Köberlein

2013 Introducing Activity-Based Payment in the Hospital Industry: Evidence from French Data
by Philippe Choné & Franck Evain & Lionel Wilner & Engin Yilmaz

2013 Recession Depression: Mental Health Effects of the 2008 Stock Market Crash
by Melissa McInerney & Jennifer M. Mellor & Lauren Hersch Nicholas

2013 Hospital Competition with Soft Budgets
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2013 Demand Side Cost-Sharing and Prescription Drugs Utilization: Evidence From a Quasi-Natural Experiment
by Eva Hromadkova & Michal Zdenek

2013 Free to choose? The impact of healthcare reform
by Martin Gaynor & Carol Propper & Stephan Seiler

2013 Accountability and Access to Medical Care: Lessons from the Use of Capitation Payments in Ontario
by Ake Blomqvist & Boris Kralj & Jasmin Kantarevic

2013 Do Spanish Informal Caregivers Come to the Rescue of Dependent People with Formal Care Unmet Needs?
by Sergi Jiménez-Martín & Cristina Vilaplana Prieto

2013 Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data
by Niels Skipper & Rune Vejlin

2013 India’s Health-care Sector under GATS: Inquiry into Backward and Forward Linkages
by Kausik Lahiri & Sarmila Banerjee

2013 Public Financing Of Healthcare Services
by Agnieszka Bem

2013 Private Health Insurance As A Source Of Financing The Healthcare System In Poland
by Jacek Rodzinka & Ma3gorzata Paszkowska

2013 Analysis Of Polish Healthcare System Financing In 2000-2009
by Joanna Hady & Ma3gorzata Leoniowska

2013 A note on hospitals incentives to collude on low quality in a spatial context
by Andree, Kai & Schwan, Mike

2013 Competition On The Wholesale Medication Distribution Market In Romania
by Cristina BALDAN & Alina HAGIU & Marinela BARBULESCU

2013 Characteristics Of Marketing In Profesional Services Delivered By The Healthcare System
by Flaviu MEGHISAN & Carmen Gabriela SECARA

2013 Efficiency of Hospitals in the Czech Republic
by Jana Votápková & Lenka Šťastná

2013 Corruption, with Emphasis on Health System
by Panã Cristina Elena & Niºulescu-Ashrafzadeh Ileana

2013 Evaluation Of Croatia’S Regional Hospital Efficiency: An Application Of Data Envelopment Analysis
by Danijela Rabar

2013 Incentive-Compatible Reimbursement Schemes for Physicians
by Winand Emons

2013 Not-for-Profit Hospitals and the Quality of Medical Care
by Kazuhiko Mikami

2013 Risk-Sharing Agreements in Pharmaceutical Markets/Los acuerdos de riesgo compartido en mercados farmacéuticos
by ANTOÑANZAS, FERNANDO & JUÁREZ-CASTELLÓ, CARMELO & RODRÍGUEZ-IBEAS, ROBERTO

2013 A Comparison of the Regulation of Health Professional Boundaries across OECD Countries
by Ivy Lynn Bourgeault & Michel Grignon

2013 Is tax funding of health care more likely to be regressive than systems based on social insurance in low and middle-income countries?
by Aurelio Mejía

2013 The Insurance Market and Social Wealth
by Roxana Ionescu

2013 La sanità elettronica in Italia: evidenze dall’indagine LITIS
by Elisabetta Santarelli & Claudio Di Carlo

2013 L’efficienza dei sistemi sanitari regionali in Italia: pubblico o privato?
by Greta Falavigna & Roberto Ippoliti

2013 The relationship between organizational culture and performance in acute hospitals
by Jacobs, Rowena & Mannion, Russell & Davies, Huw T.O. & Harrison, Stephen & Konteh, Fred & Walshe, Kieran

2013 Analyzing cost efficiency of Critical Access Hospitals
by Cristian Nedelea, I. & Matthew Fannin, J.

2013 Pharmaceutical advertising and Medicare Part D
by Lakdawalla, Darius & Sood, Neeraj & Gu, Qian

2013 Plan selection in Medicare Part D: Evidence from administrative data
by Heiss, Florian & Leive, Adam & McFadden, Daniel & Winter, Joachim

2013 Suit the action to the word, the word to the action: Hypothetical choices and real decisions in Medicare Part D
by Kesternich, Iris & Heiss, Florian & McFadden, Daniel & Winter, Joachim

2013 Competitive bidding in Medicare Advantage: Effect of benchmark changes on plan bids
by Song, Zirui & Landrum, Mary Beth & Chernew, Michael E.

2013 Practice budgets and the patient mix of physicians – The effect of a remuneration system reform on health care utilisation
by Schmitz, Hendrik

2013 Exploiting subjective information to understand impoverished children's use of health care
by Álvarez, Begoña & Vera-Hernández, Marcos

2013 Profit or patients’ health benefit? Exploring the heterogeneity in physician altruism
by Godager, Geir & Wiesen, Daniel

2013 Does health insurance improve health?
by Fink, Günther & Robyn, Paul Jacob & Sié, Ali & Sauerborn, Rainer

2013 An instrumental variables approach to post-acute care nursing home quality: Is there a dime's worth of evidence that continuing care retirement communities provide higher quality?
by Bowblis, John R. & McHone, Heather S.

2013 The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities
by Sood, Neeraj & Huckfeldt, Peter J. & Grabowski, David C. & Newhouse, Joseph P. & Escarce, José J.

2013 Does widowhood explain gender differences in out-of-pocket medical spending among the elderly?
by Goda, Gopi Shah & Shoven, John B. & Slavov, Sita Nataraj

2013 Does hospital ownership affect patient experience? An investigation into public–private sector differences in England
by Pérotin, Virginie & Zamora, Bernarda & Reeves, Rachel & Bartlett, Will & Allen, Pauline

2013 Using RD design to understand heterogeneity in health insurance crowd-out
by Koch, Thomas G.

2013 Feasible methods to estimate disease based price indexes
by Bradley, Ralph

2013 The effect of Medicaid physician fees on take-up of public health insurance among children in poverty
by Hahn, Youjin

2013 Shipping out instead of shaping up: Rehospitalization from nursing homes as an unintended effect of public reporting
by Konetzka, R. Tamara & Polsky, Daniel & Werner, Rachel M.

2013 Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?
by de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges

2013 Discrimination in a universal health system: Explaining socioeconomic waiting time gaps
by Johar, Meliyanni & Jones, Glenn & Keane, Micheal P. & Savage, Elizabeth & Stavrunova, Olena

2013 Endogenous cost-effectiveness analysis and health care technology adoption
by Jena, Anupam B. & Philipson, Tomas J.

2013 Effect of nursing home ownership on the quality of post-acute care: An instrumental variables approach
by Grabowski, David C. & Feng, Zhanlian & Hirth, Richard & Rahman, Momotazur & Mor, Vincent

2013 Provider competition and healthcare quality: More bang for the buck?
by Katz, Michael L.

2013 Pharmaceutical followers
by Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B.

2013 Informing the uninformed: How drug advertising affects check-up visits
by Hosken, Daniel & Wendling, Brett

2013 Direct-to-consumer advertising and consumer welfare
by Jayawardhana, Jayani

2013 Effects of regulated competition on key outcomes of care: Cataract surgeries in the Netherlands
by Heijink, Richard & Mosca, Ilaria & Westert, Gert

2013 Copayments, gatekeeping, and the utilization of outpatient public and private care at age 50 and above in Europe
by Bíró, Anikó

2013 Preconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
by van de Ven, Wynand P.M.M. & Beck, Konstantin & Buchner, Florian & Schokkaert, Erik & Schut, F.T. (Erik) & Shmueli, Amir & Wasem, Juergen

2013 The political economy of long-term care
by Nuscheler, Robert & Roeder, Kerstin

2013 Margins and market shares: Pharmacy incentives for generic substitution
by Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune

2013 Does more schooling improve health outcomes and health related behaviors? Evidence from U.K. twins
by Amin, Vikesh & Behrman, Jere R. & Spector, Tim D.

2013 Ramadan, fasting and educational outcomes
by Oosterbeek, Hessel & van der Klaauw, Bas

2013 Too few doctors or too low wages? Labor supply of health care professionals in China
by Qin, Xuezheng & Li, Lixing & Hsieh, Chee-Ruey

2013 The Transformation of the Structures of Health Care - Opportunity of Growth
by Barbel Held

2013 Elasticidad de la demanda por medicamentos en el mercado farmacéutico privado en Colombia
by Johanna Vásquez Velásquez & José Vicente Cadavid Herrera & Andrés Ramírez Hassan & Karoll Gómez Portilla

2013 Tratamiento farmacológico de primera línea para la depresión en la población adulta (>18 años): evaluación económica para Colombia
by María Ximena Rojas & Ludy Alexandra Parada & Adriana Bohorquez Peñaranda & María Nelcy Rodríguez Malagón

2013 Costos médicos directos del síndrome de dificultad respiratoria del recién nacido en Colombia
by María Ximena Rojas & Viviana Alejandra Rodríguez & Diana Carolina Tamayo & Rodolfo José Dennis

2013 Análisis de costo efectividad del zinc para la prevención de la enfermedad diarreica aguda en niños menores de 5 años en Colombia
by Aurelio Mejía & Sara Atehortúa & Iván Darío Flórez & Javier Mauricio Sierra

2013 Análisis costo utilidad: evolución, fundamentos e implicaciones
by Liliana Chicaíza-Becerra & Mario García-Molina & Giancarlo Romano Gómez

2013 Competencia en el sector de la salud: énfasis en el caso colombiano
by David Bardey

2013 Modelo plural-integral" de atención primaria a la salud y satisfacción de los usuarios"
by JOSÉ DE JESÚS JAIME GUZMÁN & JOSÉ G. VARGAS HERNÁNDEZ

2013 Mecanismos de compensación complementarios al ajuste de riesgo prospectivo en el SGSSS en Colombia y la Cuenta de Alto Costo
by Álvaro Riascos Villegas

2013 Vector Autoregressive Models Using “R”
by Ciprian ALEXANDRU & Nicoleta CARAGEA & Ana Maria DOBRE

2013 Reform des Gesundheitssystems: Kommt die Einheitskasse?
by Peter Oberender & Jürgen Zerth & Stefan Felder & Martin Nell & Bernd Raffelhüschen & Christian Hagist

2013 Wettbewerbliche Ordnungsdefizite in der Gesetzlichen Krankenversicherung
by Klaus-Dirk Henke & Wolfram Richter

2013 Kränkelnde Krankenhäuser – Ursachen und Auswirkungen des Rückgangs der Krankenhausinvestitionen der Länder
by Felix Rösel

2013 Paying Hospital-Based Doctors: Fee for Whose Service?
by Ake Blomqvist

2013 Rethinking Pharmacare in Canada
by Steve Morgan & Jamie R. Daw & Michael R. Law

2013 Rethinking Pharmacare in Canada
by Steve Morgan & Jamie R. Daw & Michael R. Law

2013 Paying for Hospital Services: A Hard Look at the Options
by Jason Sutherland & R. T. Crump & Nadya Repin & Erik Hellsten

2013 Paying for Hospital Services: A Hard Look at the Options
by Jason Sutherland & R. T. Crump & Nadya Repin & Erik Hellsten

2013 Considerations About Dental Tourism Development And Its Specific Marketing In Romania
by Elena, ENACHE & ; Manuela-Rozalia, GABOR & Cristian, MOROZAN

2013 Anreize der Gesetzgebung zu Arzneimitteln für seltene Leiden – Überlegungen zu Versorgung, Qualität und Effizienz
by Nguyen, Von Tristan & Rohlf, Karsten

2013 Death by Market Power: Reform, Competition, and Patient Outcomes in the National Health Service
by Martin Gaynor & Rodrigo Moreno-Serra & Carol Propper

2013 Effects of Federal Policy to Insure Young Adults: Evidence from the 2010 Affordable Care Act's Dependent-Coverage Mandate
by Yaa Akosa Antwi & Asako S. Moriya & Kosali Simon

2013 What Does Health Reform Mean for the Health Care Industry? Evidence from the Massachusetts Special Senate Election
by Mohamad M. Al-Ississ & Nolan H. Miller

2013 Information and Quality When Motivation Is Intrinsic: Evidence from Surgeon Report Cards
by Jonathan T. Kolstad

2013 Limited Life Expectancy, Human Capital and Health Investments
by Emily Oster & Ira Shoulson & E. Ray Dorsey

2013 Early Life Health Interventions and Academic Achievement
by Prashant Bharadwaj & Katrine Vellesen L?ken & Christopher Neilson

2013 Health Care Usage and Health Status of Immigrant Children: The Effects of Nativity versus Citizenship
by Mónica García-Pérez

2013 The Impact of Medical Liability Standards on Regional Variations in Physician Behavior: Evidence from the Adoption of National-Standard Rules
by Michael Frakes

2013,3rd quarter update nursing homes
by Edward C. Norton

2013,2nd quarter update design and impact of physician payment incentives: theory and evidence
by Douglas A. Conrad

2013 3Month: March Qualitative Study On Physicians’ Motivations And Drug Prescribing Behaviour
by Luminita Mihaela Ion

2012 Does it Matter if Your Health Insurer is For-Profit? Effects of Ownership on Premiums, Insurance Coverage, and Medical Spending
by Leemore Dafny & Subramaniam Ramanarayanan

2012 Comment les soins primaires peuvent-ils contribuer à réduire les inégalités de santé ? Revue de littérature
by Leleu, Henri & Bourgueil, Yann & Jusot, Florence

2012 Hospital Reimbursement Price Cap for Cancer Drugs: the French experience in controlling hospital drug expenditures
by Degrassat-Théas, Albane & Bensadon, M. & Rieu, C. & Angalakuditi, M. & Le Pen, Claude & Paubel, Pascal

2012 Is Orphan Designation a Driver of Orphan Drug Pricing?
by Degrassat-Théas, Albane & Paubel, Pascal & Parent de Curzon, Olivier & Berard, F. & Poisson, N. & Sinègre, Martine & Le Pen, Claude

2012 The Economic Value of Medical Progress, the Case of Cancer in France (1990-2010)
by Le Pen, Claude

2012 Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand
by Dhaval Dave & Henry Saffer

2012 Do Health Insurers Possess Market Power?
by Laurie J. Bates & James I. Hilliard & Rexford E. Santerre

2012 Rationalizing Waiting Times in Health Care Delivery: An International Comparison - Governare i tempi di attesa in sanità: un confronto internazionale Comparison -
by Testi, Angela

2012 More trade for better health? International trade and tariffs on health products
by Helble, Matthias

2012 Mutual health insurance and its contribution to improving child health in Rwanda
by Binagwaho, Agnes & Hartwig, Renate & Ingeri, Denyse & Makaka, Andrew

2012 Competition in the market for supplementary health insurance: The case of competing nonprofit sickness funds
by Ellert, Alexander & Urmann, Oliver

2012 Hospital market concentration and discrimination of patients
by Dewenter, Ralf & Jaschinski, Thomas & Kuchinke, Björn A.

2012 Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany
by Herr, Annika & Suppliet, Moritz

2012 The effects of rebate contracts on the health care system
by Graf, Julia

2012 Human capital and longevity. Evidence from 50,000 twins
by Petter Lundborg; & Carl Hampus Lyttkens; & Paul Nystedt;

2012 Non-linear price schedules, demand for health care and response behavior
by Helmut Farbmacher; & Joachim Winter

2012 An analysis of mammography decisions with a focus on educational differences
by Aniko Biro;

2012 What Drives Differences in Health Care Demand? The Role of Health Insurance and Selection Bias
by Dan Shane; & Pravin Trivedi;

2012 In absolute or relative terms? How framing prices affects the consumer price sensitivity of health plan choice
by Ziebarth, N.; & Schmitz, H.;

2012 Reimbursement and Investment: Propsective Payment and For-Profit Hospitals' Market Share
by Seungchul Lee & Robert Rosenman

2012 Filling the Gaps: Dentist Disparities along the Rural Urban Continuum
by Terance J. Rephann & Tanya Wanchek

2012 The determinants of home based long-term care utilisation in Western European countries
by Tomini, Sonila & Groot, Wim & Pavlova, Milena

2012 Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010
by Berndt, Ernst & Dubois, Pierre

2012 You Owe Me
by Malmendier, Ulrike & Schmidt, Klaus M.

2012 Mandatory Quality Disclosure and Quality Supply : Evidence from German Hospitals
by Filistrucchi, L. & Ozbugday, F.C.

2012 Mandatory Quality Disclosure and Quality Supply : Evidence from German Hospitals
by Filistrucchi, L. & Ozbugday, F.C.

2012 Saving Lives at Birth : The Impact of Home Births on Infant Outcomes
by Meltem Daysal, N. & Trandafir, M. & van Ewijk, R.

2012 Does Uninsurance Affect the Health Outcomes of the Insured? Evidence from Heart Attack Patients in California
by Meltem Daysal, N.

2012 Health Expenditures Risk, Purchase of Private Health Insurance, and Precautionary Saving in Turkey
by Evren Ceritoglu

2012 The Effect of U.S. Health Insurance Expansions on Medical Innovation
by Jeffrey Clemens

2012 Regulatory Redistribution in the Market for Health Insurance
by Jeffrey Clemens

2012 初探總額預算下同儕制約精神對醫療衝量行為的影響
by 林忠正

2012 Saving Lives at Birth: The Impact of Home Births on Infant Outcomes
by N. Meltem Daysal & Mircea Trandafir & Reyn van Ewijk

2012 Explaining Variations in Breast Cancer Screening Across European Countries
by Ansgar Wübker

2012 P4P, Reputation and the Reduction of Costly Overprovision
by Nadja Kairies

2012 Cost-containment policies and hospital efficiency: evidence from a panel of Italian hospitals
by Vincenzo Atella & Federico Belotti & Silvio Daidone & Giuseppe Ilardi & Giorgia Marini

2012 Regional density of private dentists: Empirical evidence from Austria
by Gächter, Martin & Schwazer, Peter & Theurl, Engelbert & Winner, Hannes

2012 Applications in Agent-Based Computational Economics
by Schuster, Stephan

2012 Benefit incidence of public health spending for public and faith-inspired health facilities in Ghana
by Coulombe, Harold & Wodon, Quentin

2012 Making quality care available for the poor: faith-inspired health facilities in Burkina Faso
by Gemignani, Regina & Tsimpo, Clarence & Wodon, Quentin

2012 Differences in the private cost of health care between providers and satisfaction with services: results for sub-Saharan African countries
by Tsimpo, Clarence & Wodon, Quentin

2012 Mapping religious health assets: are faith-inspired facilities located in poor areas in Ghana?
by Coulombe, Harold & Wodon, Quentin

2012 Layers of evidence: discourse and typologies of faith-inspired community response to HIV/AIDS in Africa
by Olivier, Jill & Wodon, Quentin

2012 Do faith-inspired health care providers in Africa reach the poor more than other providers?
by Olivier, Jill & Tsimpo, Clarence & Wodon, Quentin

2012 Satisfaction with and reasons for choosing faith-inspired health care provision in Ghana
by Shojo, Mari & Tsimpo, Clarence & Wodon, Quentin

2012 How do households choose between health providers? results from qualitative fieldwork in Burkina Faso
by Gemignani, Regina & Wodon, Quentin

2012 Satisfaction with faith-inspired health care services in Africa: review and evidence from household surveys
by Olivier, Jill & Wodon, Quentin

2012 Increased funding for AIDS-engaged (faith-based) civil society organizations in Africa?
by Olivier, Jill & Wodon, Quentin

2012 Faith-inspired Health Care Provision in Ghana: Market Share, Reach to the Poor, and Performance
by Olivier, Jill & Shojo, Mari & Wodon, Quentin

2012 The Impact of a Public Option in the Health Insurance Market
by Barbos, Andrei & Deng, Yi

2012 The other side of the coin: The privatization phenomenon and realization of public welfare in a Single European Health Care System? A sketch from the perspective of the economic theory of law
by Janoska, Wilfried

2012 Use of hospital services and socio-economic status in urban India: Does health insurance ensure equitable outcomes?
by Dutta, Mousumi & Husain, Zakir

2012 The effect of publishing hospital charges on healthcare costs: Evidence from Singapore
by Parinduri, Rasyad

2012 Item selection by an extended Latent Class model: An application to nursing homes evaluation
by Bartolucci, Francesco & Giorgio E., Montanari & Pandolfi, Silvia

2012 Risk-Adjusted Mortality, varieties of congestion and patient satisfaction in Turkish provincial general hospitals
by Davutyan, Nurhan & Bilsel, Murat & Tarcan, Menderes

2012 Complexity Science Models of Financing Health and Social Security Fiscal Gaps
by Hayes, James A

2012 Die Krankenhäuser Ostdeutschlands in Transition : eine registerbasierte Analyse amtlicher Paneldaten
by Hannes-Friedrich Ulbrich

2012 Pricing and Incentives in Publicly Subsidized Health Care Markets: the Case of Medicare Part D
by Francesco Decarolis

2012 Discrimination in a universal health system: Explaining socioeconomic waiting time gaps
by Michael Keane & Meliyanni Johar & Glenn Jones & Elizabeth Savage & Olena Stavrunova

2012 Improving Health Outcomes and System in Hungary
by Mehmet Eris

2012 Discrimination in a universal health system: Explaining socioeconomic waiting time gaps
by Meliyanni Johar & Glenn Jones & Michael P. Keane & Elizabeth Savage & Olena Stavrunova

2012 Hospital competition with soft budgets
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2012 Free to Choose? Reform and Demand Response in the English National Health Service
by Martin Gaynor & Carol Propper & Stephan Seiler

2012 Public Liabilities and Health Care Policy
by Kristopher J. Hult & Tomas J. Philipson

2012 You Owe Me
by Ulrike Malmendier & Klaus Schmidt

2012 Cost Effectiveness Analysis and the Design of Cost-Sharing in Insurance: Solving a Puzzle
by Mark Pauly

2012 Cost-Sharing and Productivity
by Teresa B. Gibson & A. Mark Fendrick & Michael E. Chernew

2012 Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange
by Keith M. Marzilli Ericson

2012 Private Information and Insurance Rejections
by Nathaniel Hendren

2012 The Effect of an Increase in Autism Prevalence on the Demand for Auxiliary Healthcare Workers: Evidence from California
by Dhaval M. Dave & Jose M. Fernandez

2012 The Need for (long) Chains in Kidney Exchange
by Itai Ashlagi & David Gamarnik & Michael A. Rees & Alvin E. Roth

2012 Plan Selection in Medicare Part D: Evidence from Administrative Data
by Florian Heiss & Adam Leive & Daniel McFadden & Joachim Winter

2012 Using Audit Studies to Test for Physician Induced Demand: The Case of Antibiotic Abuse in China
by Janet Currie & Wanchuan Lin & Juanjuan Meng

2012 Pricing Regulation and Imperfect Competition on the Massachusetts Health Insurance Exchange
by Keith M. Marzilli Ericson & Amanda Starc

2012 Medicare Reimbursements and Shortages of Sterile Injectable Pharmaceuticals
by Ali Yurukoglu

2012 Mandate-Based Health Reform and the Labor Market: Evidence from the Massachusetts Reform
by Jonathan T. Kolstad & Amanda E. Kowalski

2012 Nudges at the Dentist
by Steffen Altmann & Christian Traxler

2012 The Effect of Medicaid Physician Fees on Take-up of Public Health Insurance among Children in Poverty
by Youjin Hahn

2012 A Cross-Country Analysis of Health Care Expenditures
by Alex R. Horenstein & Manuel S. Santos

2012 The Economics of Grief
by van den Berg, Gerard J. & Lundborg, Petter & Vikström, Johan

2012 Spatial Disparities in Hospital Performance
by Gobillon, Laurent & Milcent, Carine

2012 Saving Lives at Birth: The Impact of Home Births on Infant Outcomes
by Daysal, N. Meltem & Trandafir, Mircea & van Ewijk, Reyn

2012 Nudges at the Dentist
by Altmann, Steffen & Traxler, Christian

2012 Nurses' Labour Supply Elasticities: The Importance of Accounting for Extensive Margins
by Hanel, Barbara & Kalb, Guyonne & Scott, Anthony

2012 Nurses' Labour Supply Elasticities: The Importance of Accounting for Extensive Margins
by Hanel, Barbara & Kalb, Guyonne & Scott, Anthony

2012 The Impact of Colombia's Pension and Health Insurance Systems on Informality
by Calderón-Mejía, Valentina & Marinescu, Ioana E.

2012 The Impact of Colombia's Pension and Health Insurance Systems on Informality
by Calderón-Mejía, Valentina & Marinescu, Ioana E.

2012 Does Uninsurance Affect the Health Outcomes of the Insured? Evidence from Heart Attack Patients in California
by Daysal, N. Meltem

2012 Does Uninsurance Affect the Health Outcomes of the Insured? Evidence from Heart Attack Patients in California
by Daysal, N. Meltem

2012 Qualité des soins et T2A : pour le meilleur ou pour le pire ?
by Zeynep Or & Unto Häkkinen

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Evidence consolidation - Report on best practices and key drivers of success
by Maria Lluch

2012 Strategic Intelligence Monitor on Personal Health Systems, Phase 2 -Interim Report on Impact Assessment State of the Art and Justifications
by Bernarda Zamora

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: The United Kingdom
by Maria Lluch

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: Spain
by Maria Lluch & Francisco Lupiañez Villanueva

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: Netherlands
by Arjanna Van Der Plas & Marc Van Lieshout

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: Italy
by Silvia Piai & Gabriella Cattaneo

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country study: Germany
by Tanja Bratan & Kathrin Engelhard & Victoria Ruiz

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country study: France
by Fabienne Abadie & Emmanuel Pavageau

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: Estonia
by Priit Kruus & Ain Aaviksoo & Riina Hallik & Maiu Uus

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2 (SIMPHS 2). Country Study: Denmark
by Claus F. Nielsen & Jens Branebjerg & Casper D. Marcussen & Mette A. Craggs & Lars Hulbaek & Claus Duedal Pedersen

2012 Strategic Intelligence Monitor on Personal Health Systems, Phase 2 - Interim Report on RMT for Disease Management: Country Studies Summary
by Elena Villalba Mora

2012 Strategic Intelligence Monitor on Personal Health Systems, Phase 2 - Citizens and ICT for Health in 14 European Countries: Results from an Online Panel
by Francisco Lupianez-Villanueva & Ioannis Maghiros & Fabienne Abadie

2012 Strategic Intelligence Monitor on Personal Health Systems Phase 2, Market Developments – Remote Patient Monitoring and Treatment, Telecare, Fitness/Wellness and mHealth
by Peter Baum & Fabienne Abadie

2012 EEG (Eletroencefalografia) e as Próteses auditivas: um Instrumento de Avaliação de Tecnologia? [EEG (Electroencephalography) and the Hearing aids: a Tool for Technology Assessment?]
by Isabel Marques Rosa

2012 Bridging Present and Future of Brain-Computer Interfaces: An Assessment of Impacts
by Gabriel T. Velloso

2012 Ambient Intelligence in Home Care in the Netherlands
by Meriete Horst

2012 Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010
by Berndt, Ernst & Dubois, Pierre

2012 Getting Doctors into the Bush: General Practitioners' Preferences for Rural Location
by Anthony Scott & Julia Lane & John Humphreys & Catherine Joyce & Guyonne Kalb & Sung-Hee Jeon & Matthew McGrail

2012 Nurses' Labour Supply Elasticities: The Importance of Accounting for Extensive Margins
by Barbara Hanel & Guyonne Kalb & Anthony Scott

2012 The effect of pharmacies’ right to negotiate discounts on the market share of parallel imported pharmaceuticals
by Granlund, David

2012 Can health promotion in the workplace save public money? Evidence from a quasi-experiment in Denmark
by Pedersen, Morten Saaby & Arendt, Jacob Nielsen

2012 Parallel imports of hospital pharmaceuticals: An empirical analysis of price effects from parallel imports and the design of procurement procedures in the Danish hospital sector
by Hostenkamp, Gisela & Kronborg, Christian & Arendt, Jacob Nielsen

2012 Hospital competition with soft budgets
by Brekke, Kurt R. & Siciliani, Luigi & Straume, Odd Rune

2012 The Intergenerational Transmission of Human Capital. The Role of Skills and Health
by Lundborg, Petter & Nordin, Martin & Rooth, Dan Olof

2012 Cost-Benefit Analyses of Sprinklers in Nursing Homes for Elderly
by Jaldell, Henrik

2012 The economics of grief
by van den Berg, Gerard J. & Lundborg, Petter & Vikström, Johan

2012 The effect of pharmacies’ right to negotiate discounts on the market share of parallel imported pharmaceuticals
by Granlund, David

2012 EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals - What’s to Blame? Derogation or Perception?
by Granlund, David & Yesim Köksal, Miyase

2012 Early Life Health Interventions And Academic Achievement
by Bharadwaj, Prashant & Løken, Katrine V. & Neilson, Christopher

2012 Predicting Hospital’s Costs to Treat Emergency Patient
by Rosella Levaggi & Marcello Montefiori

2012 Mandatory Quality Disclosure and Quality Supply: Evidence from German Hospitals
by Lapo Filistrucchi & Fatih Cemil Ozbugday

2012 Cost-containment policies in public pharmaceutical spending in the EU
by Giuseppe Carone & Christoph Schwierz & Ana Xavier

2012 I Farmaci Oncologici in Italia: innovazione e sostenibilità economica
by Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno

2012 Healthcare reform: the US policy debate
by Zack Cooper

2012 Free to choose?: reform and demand response in the English National Health Service
by Martin Gaynor & Carol Propper & Stephan Seiler

2012 Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana
by Abotsi, Anselm Komla & Inkoom, Ebenezer & Ribaira, Eric & Le Mentec, Rozenn & Lévy, Pierre & Lafarge, Herve & de Sousa, Alexandra

2012 Ownership and Hospital Productivity
by Dormont, Brigitte & Milcent, Carine

2012 Exploring and Predicting Online Collective Action on Patients' Virtual Communities: A Multi-method Investigation in France
by Laubie, Raphaëlle & Elie-dit-Cosaque, Christophe

2012 A micro-econometric analysis of care for the dependent elderly living at home in France: Is there a crowding-out effect of informal caregivers when an elderly dependent receives professional home care ?
by Arnaulty, Louis & Goltzy, Andreas

2012 Perception du risque dépendance et demande d'assurance : une analyse à partir de l'enquête PATER
by Fontaine, Roméo & Plisson, Manuel & Wittwer, Jérôme & Zerrar, Nina

2012 Quality Assurance Policies and Indicators for Long-Term Care in the European Union
by Fermon, Béatrice & Joël, Marie-Eve

2012 Mandate-Based Health Reform and the Labor Market: Evidence from the Massachusetts Reform
by Jonathan T. Kolstad & Amanda E. Kowalski

2012 Performance of the health care industry: the Italian case study
by Greta Falavigna & Roberto Ippoliti & Alessandro Manello

2012 Free to Choose? Reform and Demand Response in the English National Health Service
by Gaynor, Martin & Propper, Carol & Seiler, Stephan

2012 You Owe Me
by Malmendier, Ulrike M. & Schmidt, Klaus M.

2012 Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010
by Berndt, Ernst R & Dubois, Pierre

2012 Can governments do it better? Merger mania and hospital outcomes in the English NHS
by Gaynor, Martin & Laudicella, Mauro & Propper, Carol

2012 The economics of long-term care: a survey
by CREMER, Helmuth & PESTIEAU, Pierre & PONTHIERE, Grégory

2012 Evaluación de impacto del programa BETAPLUS de atención a pacientes con esclerosis múltiple en Colombia
by María Alejandra Sánchez Gómez & Elizabeth Karpf Benavides

2012 La sostenibilidad financiera del Sistema de Salud Colombiano - Dinámica del gasto y principales retos de cara al futuro
by Jairo Núñez Méndez & Juan Gonzalo Zapata & Carlos Castaneda & Sandra Milena Fonseca

2012 Pertinencia de incentivar la competencia en el mercado de medicamentos biotecnológicos en Colombia y su impacto sobre las finanzas del sector de la sa
by Juan Gonzalo Zapata & Roberto Steiner & Sergio Bernal & Jairo Castillo

2012 Elasticidad de la demanda por medicamentos en el mercado farmacéutico privado en Colombia
by Johanna Vásquez Velásquez & Karoll Gómez Portilla, Elkin Castaño Vélez & José Vicente Cadavid Herrera & Andrés Ramírez Hassan

2012 Competition between Managed Care Organizations and Indemnity Plans in Health Insurance Markets
by Edmond Baranes & David Bardey

2012 Value for Money in Malaria Programming: Issues and Opportunities - Working Paper 291
by Paul Wilson & Ya'ir Aizenman

2012 Margins and Market Shares: Pharmacy Incentives for Generic Substitution
by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume

2012 You Owe Me
by Ulrike M. Malmendier & Klaus Schmidt

2012 Adoption and Diffusion of Health Information Technology - The Case of Primary Care Clinics
by Brant Callaway & Vivek Ghosal

2012 Free to Choose? Reform and Demand Response in the English National Health Service
by Martin Gaynor & Carol Propper & Stephan Seiler

2012 Free to Choose? Reform and Demand Response in the English National Health ServiceAbstract: The impacts of choice in public services are controversial. We exploit a reform in the English National Health Service to assess the impact of relaxing constraints on patient choice. We estimate a demand model to evaluate whether increased choice increased demand elasticity faced by hospitals with regard to clinical quality and waiting time for an important surgical procedure. We find substantial impacts of the removal of restrictions. Patients became more responsive to clinical quality. Sicker patients and better informed patients were more affected. We leverage our model to calculate potential benefits. We find increased demand responsiveness led to a significant reduction in mortality and an increase in patient welfare. The elasticity of demand faced by hospitals increased post-reform, giving hospitals potentially large incentives to improve their quality of care and find suggestive evidence that hospitals responded strongly to the enhanced incentives due to increased demand elasticity. The results suggests greater choice can enhance quality. Length: 50 pages
by Martin Gaynor & Carol Propper & Stephan Seiler

2012 Competition, Equity and Quality in Health CareAbstract: In this paper we focus on the implications of consumer heterogeneity for whether competition will improve outcomes in health care markets. We show that competition generally favours the majority group as higher quality for the majority is an effective way to increase the quality signal and attract patients. A regulator who is concerned about equity may protect the minority group by not introducing competition. Alternatively, if the minority group is favoured by the providers under monopoly, competition can improve equity by forcing the providers to increase quality for the majority group. Length: 29 pages
by Maija Halonen-Akatwijuka & Carol Propper

2012 The Effect of a Hospital Nurse Staffing Mandate on Patient Health Outcomes: Evidence from California’s Minimum Staffing Regulation Abstract: We evaluate the impact of California Assembly Bill 394, which mandated maximum levels of patients per nurse in the hospital setting. When the law was passed, some hospitals already met the requirements, while others did not. Thus changes in staffing ratios from the pre- to post-mandate periods are driven in part by the legislation. We find persuasive evidence that AB394 had the intended effect of decreasing patient/nurse ratios in hospitals that previously did not meet mandated standards. However, these improvements in staffing ratios do not appear to be associated with relative improvements in measured patient safety in affected hospitals
by Andrew Cook & Martin Gaynor & Melvin Stephens, Jr. & Lowell Taylor

2012 Competition in Health Care Markets
by Martin Gaynor & Robert J Town

2012 Can governments do it better? Merger mania and hospital outcomes in the English NHS
by Martin Gaynor & Mauro Laudicella & Carol Propper

2012 GPs and hospital expenditures. Should we keep expenditure containment programs alive?
by G. Fiorentini & M. Lippi Bruni & C. Ugolini

2012 Health Care Reform and Health Care Stocks: Evidence from the Supreme Court Ruling
by Jonathan Hartley

2012 The Health and Wealth of a Nation: Employer-Based Health Insurance and the Affordable Care Act
by Nan L. Maxwell

2012 Inmigración y cuidados de mayores en la Comunidad de Madrid
by

2012 Ethique et évaluation économique des interventions de santé en vue d'une définition du périmètre de soins remboursables
by Thébaut, Clémence

2012 A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines
by Josie Messina & David. L. Grainger

2012 Estimating Preference-Based EQ-5D Health State Utilities or Item Responses from Neuropathic Pain Scores
by Ning Yan. Gu & Chris Bell & Marc F. Botteman & Xiang Ji & John A. Carter & Ben van Hout

2012 Patients' Perceptions of the Interpersonal Sensitivity of Their Healthcare Providers: The Potential Role of Patient-Provider Racial/Ethnic Concordance
by Karon L. Phillips & David A. Chiriboga & Yuri Jang

2012 Psychometric Evaluation of an Inpatient Consumer Survey Measuring Satisfaction with Psychiatric Care
by Glorimar Ortiz & Lucille Schacht

2012 Comparison of Expected Outcomes between Patients and Neurologists Using Kano's Methodology in Symptomatic Migraine Treatment
by J. Matas-Guiu & M.T. Caloto & G. Nocea

2012 Practicing Patient-Centered Care: The Questions Clinically Excellent Physicians Use to Get to Know their Patients as Individuals
by Laura A. Hanyok & David B. Hellmann & Cynthia Rand & Roy C. Ziegelstein

2012 Cognitive Testing and Readability of an Item Bank for Measuring the Impact of Headache on Health-Related Quality of Life
by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen

2012 Patient and Public Involvement in Patient-Reported Outcome Measures: Evolution Not Revolution
by Sophie Staniszewska & Kirstie L. Haywood & Jo Brett & Liz Tutton

2012 Patient and Public Involvement in Developing Patient-Reported Outcome Measures: Indispensable, Desirable, Challenging
by Oliver Groene

2012 Seeking What Matters: Patients as Research Partners
by Musa Mayer

2012 Assessing Stakeholder Opinion on Relations between Cancer Patient Groups and Pharmaceutical Companies in Europe
by Susanna Leto di Priolo & Andras Fehervary & Phil Riggins & Kathy Redmond

2012 Content Validity of Visual Analog Scales to Assess Symptom Severity of Acute Angioedema Attacks in Adults with Hereditary Angioedema: An Interview Study
by Carolyn Vivienne. McMillan & Jane Speight & Anurag Relan & Luca Bellizzi & Gerald Haase & Marco Cicardi

2012 Designing Family-Centered Male Circumcision Services: A Conjoint Analysis Approach
by John F.P. Bridges & Sarah C. Searle & Frederic W. Selck & Neil A. Martinson

2012 Burden of a Multiple Sclerosis Relapse: The Patient's Perspective
by MerriKay Oleen-Burkey & Jane Castelli-Haley & Maureen J. Lage & Kenneth P. Johnson

2012 A Comparison of Analytic Hierarchy Process and Conjoint Analysis Methods in Assessing Treatment Alternatives for Stroke Rehabilitation
by Maarten J. IJzerman & Janine A. van Til & John F.P. Bridges

2012 Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis: A Discrete-Choice Experiment
by Paul Hodgkins & Paul Swinburn & Dory Solomon & Linnette Yen & Sarah Dewilde & Andrew Lloyd

2012 Re-Engineering the Post-Discharge Appointment Process for General Medicine Patients
by Robert Chang & David Spahlinger & Christopher S. Kim

2012 Test-Retest Reliability of an Interactive Voice Response Version of the EQ-5D in a Sample of Cancer Survivors
by J. Jason. Lundy & Stephen Joel. Coons

2012 Patients' Perceptions of Sharing in Decisions: A Systematic Review of Interventions to Enhance Shared Decision Making in Routine Clinical Practice
by France Lgar & Stphane Turcotte & Dawn Stacey & Stphane Ratt & Jennifer Kryworuchko & Ian D. Graham

2012 The Authors' Reply
by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast

2012 Caregivers' Quality of Life and Economic Evaluations
by Afschin Gandjour

2012 Dabigatran Etexilate: A Pharmacoeconomic Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
by Kate McKeage

2012 A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease
by Petra Menn & Reiner Leidl & Rolf Holle

2012 Costs Associated with Febrile Neutropenia in the US
by Shannon L. Michels & Rich L. Barron & Matthew W. Reynolds & Karen Smoyer Tomic & Jingbo Yu & Gary H. Lyman

2012 Lost Productivity in Four European Countries among Patients with Rheumatic Disorders: Are Absenteeism and Presenteeism Transferable?
by Saskia Knies & Math J.J.M. Candel & Annelies Boonen & Silvia M.A.A. Evers & Andre J.H.A. Ament & Johan L. Severens

2012 Reimbursement Decisions of the All Wales Medicines Strategy Group: Influence of Policy and Clinical and Economic Factors
by Warren G. Linley & Dyfrig A. Hughes

2012 Cost of Illness of Cystic Fibrosis in Germany: Results from a Large Cystic Fibrosis Centre
by Mareike Heimeshoff & Helge Hollmeyer & Jonas Schreygg & Oliver Tiemann & Doris Staab

2012 Assessing the Quality of Pharmacoeconomic Studies in India: A Systematic Review
by Pooja R. Desai & Hitesh S. Chandwani & Karen L. Rascati

2012 Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
by Vanja Sikirica & M. Haim Erder & Jipan Xie & Dendy Macaulay & Melissa Diener & Paul Hodgkins & Eric Q. Wu

2012 Valuation of the Child Health Utility 9D Index
by Katherine Stevens

2012 Developing Adolescent-Specific Health State Values for Economic Evaluation: An Application of Profile Case Best-Worst Scaling to the Child Health Utility 9D
by Julie Ratcliffe & Terry Flynn & Frances Terlich & Katherine Stevens & John Brazier & Michael Sawyer

2012 A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
by Wendy J. Ungar & Katherine Boydell & Sharon Dell & Brian M. Feldman & Deborah Marshall & Andrew Willan & James G. Wright

2012 The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt: A Government Perspective Analysis
by Mark P. Connolly & Oleksandr Topachevskyi & Baudouin Standaert & Omayra Ortega & Maarten Postma

2012 Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments
by J. Mick. Tilford & Nalin Payakachat & Erica Kovacs & Jeffrey M. Pyne & Werner Brouwer & Todd G. Nick & Jayne Bellando & Karen A. Kuhlthau

2012 Economic Evaluations of Childhood Influenza Vaccination: A Critical Review
by Anthony T. Newall & Mark Jit & Philippe Beutels

2012 Comparative Effectiveness and Child Health
by Lisa A. Prosser

2012 Valuing Children's Health: Whose Quality of Life Matters?
by Eve Wittenberg

2012 Quetiapine: A Pharmacoeconomic Review of its Use in Bipolar Disorder
by Greg L. Plosker

2012 Duloxetine Use in Chronic Low Back Pain: Treatment Patterns and Costs
by Jasmina I. Ivanova & Howard G. Birnbaum & Evan Kantor & Matt Schiller & Ralph W. Swindle

2012 Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model
by Christine M. Nguyen & Mark Bounthavong & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale

2012 Hospital Reimbursement Price Cap for Cancer Drugs: The French Experience in Controlling Hospital Drug Expenditures
by A. Degrassat-Thas & M. Bensadon & C. Rieu & M. Angalakuditi & C. Le Pen & P. Paubel

2012 Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models
by Kristian Bolin

2012 Cost Effectiveness of Rituximab for Non-Hodgkin's Lymphoma: A Systematic Review
by Philipp W.P. Auweiler & Dirk Mller & Stephanie Stock & Andreas Gerber

2012 Corrigendum
by Adis International Limited

2012 The Authors' Reply
by A. George. Awad & Lakshmi N.P. Voruganti

2012 The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?
by Laurent Boyer & Pascal Auquier

2012 Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode
by Mattias Ekman & Peter Lindgren & Carolin Miltenburger & Genevieve Meier & Julie C. Locklear & Mary Lou. Chatterton

2012 Pharmacoeconomics of the Myeloid Growth Factors: A Critical and Systematic Review
by Bradford R. Hirsch & Gary H. Lyman

2012 Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal
by Dwayne Boyers & Xueli Jia & David Jenkinson & Graham Mowatt

2012 A Critical Review of Model-Based Economic Studies of Depression: Modelling Techniques, Model Structure and Data Sources
by Hossein Haji Ali Afzali & Jonathan Karnon & Jodi Gray

2012 Value of Information and Pricing New Healthcare Interventions
by Andrew R. Willan & Simon Eckermann

2012 The Authors' Reply
by Livio Garattini & Katelijne van de Vooren & Alessandro Curto

2012 Human Papillomavirus Vaccination Is Not Exclusively a Matter of Price
by Alessandro Capone & Giampiero Favato

2012 The Impact of Co-Morbidity Burden on Preference-Based Health-Related Quality of Life in the United States
by Patrick W. Sullivan & Vahram H. Ghushchyan & Elizabeth A. Bayliss

2012 Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma
by Joshua Pink & Steven Lane & Dyfrig A. Hughes

2012 Anti-Inflammatory Medication Adherence, Healthcare Utilization and Expenditures among Medicaid and Children's Health Insurance Program Enrollees with Asthma
by Jill Boylston. Herndon & Soeren Mattke & Alison Evans Cuellar & Seo Yeon. Hong & Elizabeth A. Shenkman

2012 Changes in Antipsychotic Medication Use after Implementation of a Medicaid Mental Health Carve-Out in the US
by John Robst

2012 Pharmacoeconomics of Bisphosphonates for Skeletal-Related Event Prevention in Metastatic Non-Breast Solid Tumours
by John A. Carter & Avani D. Joshi & Satyin Kaura & Marc F. Botteman

2012 Issues in the Economic Evaluation of Influenza Vaccination by Injection of Healthy Working Adults in the US: A Review and Decision Analysis of Ten Published Studies
by Thomas J. Hogan

2012 Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program
by Nadia Demarteau & Thomas Breuer & Baudouin Standaert

2012 Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006
by Howard G. Birnbaum & Crystal Pike & Ritesh Banerjee & Tracy Waldman & Mary Cifaldi

2012 Cost Effectiveness of Anticoagulation in Acute Coronary Syndromes
by Jaime Latour-Prez & Eva de-Miguel-Balsa

2012 Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease: A Review of the Evidence and Methodological Issues
by Maureen P.M.H. Rutten-van Mlken & Lucas M.A. Goossens

2012 Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal
by Huiqin Yang & Dawn Craig & David Epstein & Laura Bojke & Kate Light & Ian N. Bruce & Mark Sculpher & Nerys Woolacott

2012 Rufinamide: A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome
by Paul L. McCormack

2012 Common Drug Review Recommendations: An Evidence Base for Expectations?
by Angela Rocchi & Elizabeth Miller & Robert B. Hopkins & Ron Goeree

2012 Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands
by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel

2012 Pricing Human Papillomavirus Vaccines: Lessons from Italy
by Livio Garattini & Katelijne van de Vooren & Alessandro Curto

2012 Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7
by Frank R. Lichtenberg

2012 Measuring Quality of Life in Patients with Schizophrenia: An Update
by A. George. Awad & Lakshmi N.P. Voruganti

2012 Population- versus Cohort-Based Modelling Approaches
by Olivier Ethgen & Baudouin Standaert

2012 Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective
by Aurea Duran & Nishan Sengupta & Alexander Diamantopoulos & Fiona Forster & Louis Kwong & Michael Lees

2012 Health Utility Elicitation: Is There Still a Role for Direct Methods?
by Lisa A. Prosser & Scott D. Grosse & Eve Wittenberg

2012 Osteoporotic Fractures: A Systematic Review of US Healthcare Costs and Resource Utilization
by Sangeeta Budhia & Yeshi Mikyas & Michael Tang & Enkhe Badamgarav

2012 Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal
by Michael Holmes & Christopher Carroll & Diana Papaioannou

2012 Real Economics Needs to Reflect Real Decisions: A Response to Johnson
by Mark Sculpher & Karl Claxton

2012 Why Not Real Economics?
by F. Reed. Johnson

2012 Incorporating Calibrated Model Parameters into Sensitivity Analyses: Deterministic and Probabilistic Approaches
by Douglas C.A. Taylor & Vivek Pawar & Denise T. Kruzikas & Kristen E. Gilmore & Myrlene Sanon & Milton C. Weinstein

2012 Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer
by Robert I. Griffiths & Richard L. Barron & Michelle L. Gleeson & Mark D. Danese & Anthony OHagan & Victoria M. Chia & Jason C. Legg & Gary H. Lyman

2012 Erratum
by Adis International Limited

2012 A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
by Christopher Fitzpatrick & Katherine Floyd

2012 Does the EQ-5D Reflect Lost Earnings?
by Carl Tilling & Marieke Krol & Aki Tsuchiya & John Brazier & Job van Exel & Werner Brouwer

2012 Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal
by Claire McKenna & Emma Maund & Muhammad Sarowar & David Fox & Matt Stevenson & Chris Pepper & Nerys Woolacott & Stephen Palmer

2012 Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review
by Mathilda L. Bongers & Veerle M.H. Coup & Elise P. Jansma & Egbert F. Smit & Carin A. Uyl-de Groot

2012 Economic and Humanistic Burden of External Genital Warts
by Adam J.N. Raymakers & Mohsen Sadatsafavi & Fawziah Marra & Carlo A. Marra

2012 Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets
by Liv Ariane Augestad & Kim Rand-Hendriksen & Ivar Snb Kristiansen & Knut Stavem

2012 What's Good and Bad About Contraceptive Products?: A Best-Worst Attribute Experiment Comparing the Values of Women Consumers and GPs
by Stephanie A. Knox & Rosalie C. Viney & Deborah J. Street & Marion R. Haas & Denzil G. Fiebig & Edith Weisberg & Deborah Bateson

2012 Chemotherapy Administration: Modelling the Costs of Alternative Protocols
by Philip Haywood & Johan de Raad & Kees van Gool & Marion Haas & Gisselle Gallego & Sallie-Anne Pearson & Margaret Faedo & Robyn Ward

2012 Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex) for Spasticity in Multiple Sclerosis
by Lanting Lu & Hilary Pearce & Chris Roome & James Shearer & Iain A. Lang & Ken Stein

2012 Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review
by Ccile Gaujoux-Viala & Bruno Fautrel

2012 A Systematic Review and Critical Assessment of Health State Utilities: Weight Change and Type 2 Diabetes Mellitus
by Scott Doyle & Andrew Lloyd & Lee Moore & Joshua Ray & Alastair Gray

2012 Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
by Sophie Whyte & Abdullah Pandor & Matt Stevenson

2012 Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis
by Marta O. Soares & Lusa Canto e Castro

2012 Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal
by Jane Burch & Susan Griffin & Claire McKenna & Simon Walker & James Paton & Kath Wright & Nerys Woolacott

2012 Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis: A Case for Excluding Dialysis Costs
by Daniel T. Grima & Lisa M. Bernard & Elizabeth S. Dunn & Philip A. McFarlane & David C. Mendelssohn

2012 Erratum
by Adis International Limited

2012 The General Public's Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer's Disease Medication
by Mark Oremus & Jean-Eric Tarride & Parminder Raina & Lehana Thabane & Gary Foster & Charlie H. Goldsmith & Natasha Clayton

2012 The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes: A New Zealand Evaluation
by Laura Panattoni & Paul M. Brown & Braden Te Ao & Mark Webster & Patrick Gladding

2012 A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand
by Rajan Ragupathy & Katri Aaltonen & June Tordoff & Pauline Norris & David Reith

2012 Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach
by Paul Dolan & Henry Lee & Tessa Peasgood

2012 Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups: A Systematic Review
by Ava John-Baptiste & Man Wah Yeung & Victoria Leung & Gabrielle van der Velde & Murray Krahn

2012 The Burden of Moderate to Severe Psoriasis: An Overview
by Giovanna Raho & Daniela Mihajlova Koleva & Livio Garattini & Luigi Naldi

2012 The Authors' Reply
by Ties Hoomans & Johan L. Severens & Nicole van der Roer & Gepke O. Delwel

2012 Is There a Role for Pharmacoeconomics in Decision Making?
by Johan C.F. van Luijn

2012 Validity of Cost and Utility Results?
by Alex Diamantopoulos & Laura Sawyer & Sarika Ogale & Fred Dejonckheere

2012 The Authors' Reply
by Mark Bounthavong & Christine M. Nguyen & Margaret A.S. Mendes & Melissa L.D. Christopher & Josephine N. Tran & Rashid Kazerooni & Anthony P. Morreale

2012 Patient Preferences for Community Pharmacy Asthma Services: A Discrete Choice Experiment
by Pradnya Naik-Panvelkar & Carol Armour & John M. Rose & Bandana Saini

2012 Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting
by Laura McCullagh & Cathal Walsh & Michael Barry

2012 The State of Health Economic Research in South Africa: A Systematic Review
by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza

2012 The Cost Effectiveness of Newer Epilepsy Treatments: A Review of the Literature on Partial-Onset Seizures
by Kristian Bolin & Lars Forsgren

2012 Counting the Cost of Not Costing HIV Health Facilities Accurately: Pay Now, or Pay More Later
by Eduard J. Beck & Carlos Avila & Sofia Gerbase & Guy Harling & Paul De Lay

2012 New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
by Douglas W. Mapel & Melissa H. Roberts

2012 Private Manufacturers' Thresholds to Invest in Comparative Effectiveness Trials
by Anirban Basu & David Meltzer

2012 Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing?
by Jaume Puig-Junoy

2012 Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study
by Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jess Reviriego & Mara Costi

2012 What Explains Willingness to Pay for Smoking-Cessation Treatments - Addiction Level, Quit-Rate Effectiveness or the Opening Bid?
by Jan Abel. Olsen & Ole J. Rgeberg & Knut Stavem

2012 Insensitivity to Scope in Contingent Valuation Studies: Reason for Dismissal of Valuations?
by Rikke Sgaard & Jes Lindholt & Dorte Gyrd-Hansen

2012 Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison
by M. Haim Erder & Jipan Xie & James E. Signorovitch & Kristina S. Chen & Paul Hodgkins & Mei Lu & Eric Q. Wu & Vanja Sikirica

2012 Inclusion of Compliance and Persistence in Economic Models: Past, Present and Future
by Ananth Kadambi & Robert J. Leipold & Anuraag R. Kansal & Sonja Sorensen & Denis Getsios

2012 Insensitivity to Scope in Contingent Valuation Studies: New Direction for an Old Problem
by Jennifer A. Whitty

2012 Acknowledgement
by Adis International Limited

2012 Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
by Christine Carron & Pierre Voirol & Philippe Eggimann & Andr Pannatier & Ren Chiolro & Jean-Blaise Wasserfallen

2012 Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, Single-Arm Study in a Clinical Setting
by Ronald Vender & Charles Lynde & Vincent Ho & Dina Chau & Melanie Poulin-Costello

2012 Clopidogrel versus Aspirin in Patients with Atherothrombosis: A CAPRIE-Based Cost-Effectiveness Model for Greece
by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis

2012 Estimating Incremental Costs with Skew: A Cautionary Note
by Linnea A. Polgreen & John M. Brooks

2012 Lifetime Productivity Losses Associated with Obesity Status in Early Adulthood: A Population-Based Study of Swedish Men
by Kristian Neovius & Clas Rehnberg & Finn Rasmussen & Martin Neovius

2012 PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites: A NICE Medical Technology Guidance
by Judith White & Grace Carolan-Rees

2012 NICE Medical Technologies Guidance: A Novel and Rigorous Methodology to Address a New Health Technology Assessment Challenge
by Bruce Campbell & Mark Campbell

2012 Is More Expensive Medical Technology Better?: The Use of Analytics in the Evaluation of Clinical Outcomes for Different Material Compositions of Total Knee Implants
by Jeffrey Voigt & Michael Mosier

2012 Alcohol Reform in Viet Nam: Confronting Rising Consumption, Injury and Harm
by Nguyen Minh. Tam & Christopher M. Doran & Peter S. Hill & Michael P. Dunne

2012 Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures
by Avram A. Edidin & Kevin L. Ong & Edmund Lau & Jordana K. Schmier & Jason E. Kemner & Steven M. Kurtz

2012 Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis
by Georgia Kourlaba & Vassilis Fragoulakis & Nikos Maniadakis

2012 Resource Utilization and Outcomes in Patients with Atrial Fibrillation: A Case Control Study
by Rachael Boggon & Gregory Y.H. Lip & Arlene M. Gallagher & Tjeerd P. van Staa

2012 Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach
by Michael Bumler & Tom Stargardt & Jonas Schreygg & Reinhard Busse

2012 Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials
by K. Kaier & S. Moog

2012 A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
by Ulf Persson & Johanna Svensson & Billie Pettersson

2012 Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
by John Slof

2012 National Health Insurance Reform in South Africa: Estimating the Implications for Demand for Private Health Insurance
by Okore Apia Okorafor

2012 Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
by Antonio Roman & Joan A. Barber & Pilar Escribano & Maria L. Sala & Laia Febrer & Itziar Oyagez & Eliazar Sabater & Miguel . Casado

2012 Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy
by Hema N. Viswanathan & Jeffrey R. Curtis & Jingbo Yu & Jeffrey White & Bradley S. Stolshek & Claire Merinar & Akhila Balasubramanian & Joel D. Kallich & John L. Adams & Sally W. Wade

2012 Economic Evaluations of Adult Weight Management Interventions: A Systematic Literature Review Focusing on Methods Used for Determining Health Impacts
by Ulla K. Griffiths & Benedict Anigbogu & Kiran Nanchahal

2012 Understanding Consumer Preferences in the Context of Managed Competition: Evidence from a Choice Experiment in Colombia
by Antonio J. Trujillo & Fernando Ruiz & John F.P. Bridges & Jeannette L. Amaya & Christine Buttorff & Anglica M. Quiroga

2012 Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer
by Oren Shavit & Raanan Raz & Michal Stein & Gabriel Chodick & Eduardo Schejter & Yehuda Ben-David & Raanan Cohen & Daphna Arbel & Varda Shalev

2012 Using the Economics of Certification to Improve the Safety and Quality of Male Circumcision in Developing Countries: Three Models of Implementation
by Michael R. Richards

2012 The Need for Measurement of Efficiency in Greek Primary Healthcare: The Case for Rural Southern and Western Greece
by Nikolaos Oikonomou & Yannis Tountas & John Kyriopoulos

2012 Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain
by Juan Pasquau & Joana Gostkorzewicz & Francisco Ledesma & Anne Anceau & Andrew Hill & Christiane Moecklinghoff

2012 A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries
by Sergio Iannazzo & Michela Carsi & Silvia Chiroli

2012 Insights from Triangulation of Two Purchase Choice Elicitation Methods to Predict Social Decision Making in Healthcare
by Jennifer A. Whitty & Sharyn R. Rundle-Thiele & Paul A. Scuffham

2012 Alcohol Policy and Taxation in South Africa: An Examination of the Economic Burden of Alcohol Tax
by John Ele-Ojo. Ataguba

2012 Tackling Alcohol Misuse: Purchasing Patterns Affected by Minimum Pricing for Alcohol
by Anne Ludbrook & Dennis Petrie & Lynda McKenzie & Shelley Farrar

2012 The Efficiency of a Volumetric Alcohol Tax in Australia
by Joshua Byrnes & Dennis J. Petrie & Christopher M. Doran & Anthony Shakeshaft

2012 The Role of Health Economics in Alcohol Policy
by Christopher M. Doran & Joshua Byrnes

2012 Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis
by Kurinchi Gurusamy & Edward Wilson & Andrew K. Burroughs & Brian R. Davidson

2012 Triangulating Health Expenditure Estimates from Different Data Sources in Developing Countries: The Case of Pakistan's Private Health Expenditure
by Christian Lorenz

2012 Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
by Michael Eaddy & Brian Seal & Krishna Tangirala & Elizabeth Hackney. Davies & Ken ODay

2012 Several issues affecting sustainability of healthcare financing in Romania
by Andreea-Oana IACOBUTA

2012 Study regarding Primary Obesity in the Case of Children
by Antoanela GIOSAN

2012 Health Value for Sustainable Development, a Real Challenge
by PURCAREA, Theodor Purcarea

2012 Information Assymetry and Double Standard in the Doctor-Patient Relationship
by Martin Janíčko & Ivo Koubek

2012 Romania’s Private Health Insurance Market Potential
by Gheorghe Matei & Bianca Volintiru

2012 Energy saving opportunities in Jordanian pharmaceutical industries
by Mohammad Al-Tahat & Areen Al-Ali

2012 Labeling in Food Industries – a Marketing Strategy
by Neacºu Nicoleta Andreea

2012 Health Expenditure, Socio-Economic Context and Health Outcomes
by Iacobuþã Andreea-Oana & Asandului Mircea

2012 An Analysis of the Relationship Between Resources Allocated to Health Care and Quality of Health Services
by Asandului Mircea & Iacobuþã Andreea-Oana

2012 Identifying Factors Affecting Patients’ Satisfaction against Quality of Health Care Services: An Investigation from Aga Khan Hospital Karachi
by Fouzia Nasir & Gobind M. Herani & Nawaz Ahmad

2012 Der Mindestlohn in der Pflegebranche : Die Folgen eines Mindestlohns in einer Wachstumsbranche
by Harsch, Katrin & Verbeek, Hans

2012 Sağlık Bakanlığı Hastanelerinin Finansal Durumu Üzerinde Sağlıkta Dönüşüm Programının Etkileri
by Bedriye SARAÇOĞLU & Seher SÜLKÜ & Şenay AÇIKGÖZ

2012 Adverse selection in China's New Rural Cooperative Medical Scheme
by Lijian Qin & Suwen Pan & Chenggang Wang & Zhongyi Jiang

2012 Waiting times and socioeconomic status: Evidence from England
by Laudicella, Mauro & Siciliani, Luigi & Cookson, Richard

2012 The effect of Canadian imports on prescription drug prices in the U.S
by Hamilton, Jonathan H.

2012 Price elasticity of expenditure across health care services
by Duarte, Fabian

2012 Junior doctors’ preferences for specialty choice
by Sivey, Peter & Scott, Anthony & Witt, Julia & Joyce, Catherine & Humphreys, John

2012 Recessions and seniors’ health, health behaviors, and healthcare use: Analysis of the Medicare Current Beneficiary Survey
by McInerney, Melissa & Mellor, Jennifer M.

2012 Hospital volume responses to Medicare's Outpatient Prospective Payment System: Evidence from Florida
by He, Daifeng & Mellor, Jennifer M.

2012 Does uninsurance affect the health outcomes of the insured? Evidence from heart attack patients in California
by Daysal, N. Meltem

2012 Can governments do it better? Merger mania and hospital outcomes in the English NHS
by Gaynor, Martin & Laudicella, Mauro & Propper, Carol

2012 Regulation and competition in the Taiwanese pharmaceutical market under national health insurance
by Liu, Ya-Ming & Yang, Yea-Huei Kao & Hsieh, Chee-Ruey

2012 The utility of health and wealth
by Levy, Moshe & Nir, Adi Rizansky

2012 Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the Netherlands
by Varkevisser, Marco & van der Geest, Stéphanie A. & Schut, Frederik T.

2012 Hospital ownership type and treatment choices
by Bayindir, Esra Eren

2012 Moral hazard and selection among the poor: Evidence from a randomized experiment
by Spenkuch, Jörg L.

2012 Do consumers respond to publicly reported quality information? Evidence from nursing homes
by Werner, Rachel M. & Norton, Edward C. & Konetzka, R. Tamara & Polsky, Daniel

2012 Birds of a feather flock together: A study of doctor–patient matching
by Godager, Geir

2012 Private health insurance in South Korea: An international comparison
by Shin, Jaeun

2012 Physician density in a two-tiered health care system
by Gächter, Martin & Schwazer, Peter & Theurl, Engelbert & Winner, Hannes

2012 Economies of scale and scope in the Danish hospital sector prior to radical restructuring plans
by Kristensen, Troels & Olsen, Kim Rose & Kilsmark, Jannie & Lauridsen, Jørgen T. & Pedersen, Kjeld Møller

2012 Adverse event rates as measures of hospital performance
by Hauck, Katharina & Zhao, Xueyan & Jackson, Terri

2012 A dynamic analysis of the demand for health insurance and health care
by Bolhaar, Jonneke & Lindeboom, Maarten & van der Klaauw, Bas

2012 Insurance in vertically differentiated repair markets
by Urmann, Oliver

2012 Analysis of hospital technical efficiency in China: Effect of health insurance reform
by Hu, Hsin-Hui & Qi, Qinghui & Yang, Chih-Hai

2012 Pflegemarkt: drohendem Arbeitskräftemangel kann entgegengewirkt werden
by Erika Schulz

2012 Add-On Premiums Increase Price Transparency: More Policy Holders Switch Health Plans
by Peter Eibich & Hendrik Schmitz & Nicolas R. Ziebarth

2012 El SISBEN como mecanismo de focalización individual del régimen subsidiado en salud en Colombia: ventajas y limitaciones
by Martha Bottia & Lina Cardona-Sosa & Carlos Medina

2012 Willingness-to-pay for parallel private health insurance: evidence from a laboratory experiment
by Neil J. Buckley & Katherine Cuff & Jeremiah Hurley & Logan McLeod & Robert Nuscheler & David Cameron

2012 Überschüsse der Krankenkassen und des Gesundheitsfonds: Abschaffung der Praxisgebühren, Beitragssenkung oder Reservenbildung: Was ist sinnvoll?
by Daniel Bahr & Jürgen Graalmann & Hendrik Jürges & Wolfgang Greiner & Mathias Kifmann & Maximilian Rüger

2012 How to Pay Family Doctors: Why "Pay per Patient" is Better Than Fee for Service
by Ake Blomqvist & Colin Busby

2012 How to Pay Family Doctors: Why "Pay per Patient" is Better Than Fee for Service
by Ake Blomqvist & Colin Busby

2012 L'efficacité du marché des organes. Une discussion critique
by Cléa Sambuc

2012 Projection of health service consumption and patient payment revenues in Central and Eastern European countries using system dynamics modeling
by Milena Pavlova & Jelena Arsenijevic & Wim Groot & Godefridus G. Merode

2012 Willingness to pay for physician services: Comparing estimates from a discrete choice experiment and contingent valuation
by Andriy Danyliv & Milena Pavlova & Irena Gryga & Wim Groot

2012 Patient payments and the empirical analysis of consumer demand for hospital services: An application for Bulgaria
by Elka Atanasova & Milena Pavlova & Emanuela Moutafova & Todorka Kostadinova & Wim Groot

2012 Preferences of Hungarian consumers for quality, access and price attributes of health care services — result of a discrete choice experiment
by Petra Baji & Milena Pavlova & László Gulácsi & Wim Groot

2012 Is there a place for the patient in the Ukrainian health care system? Patient payment policies and investment priorities in health care in Ukraine
by Andriy Danyliv & Tetiana Stepurko & Irena Gryga & Milena Pavlova & Wim Groot

2012 Out-of-pocket payments on health in Poland: Size, tendency and willingness to pay
by Stanisława Golinowska & Marzena Tambor

2012 Towards a more comprehensive view on patient payments in Lithuania: New findings from a population survey
by Liuba Murauskiene & Milena Pavlova & Marija Veniute & Wim Groot

2012 Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries
by Petra Baji & Imre Boncz & György Jenei & László Gulácsi

2012 Assessment of patient payment policy in CEE countries: From a conceptual framework to policy indicators
by Milena Pavlova & Marzena Tambor & Tetiana Stepurko & Godefridus G. Merode & Wim Groot

2012 The Analysis Of Private Health Insurance Penetration Degree And Density In Europe
by Gheorghe Matei & Bianca Volintiru

2012 E-Health - A Solution For A Better Health System
by Georgeta Soava

2012 Eine wohlfahrtsökonomische Analyse der Übernutzung patentfreier Antibiotika und deren Auswirkungen auf die Verbreitung resistenter Infektionserreger
by Klaus Kaier

2012 Using Experiences from the U.S. to Implement Health Savings Accounts in German Statutory Health Insurance
by Renate Lange & Petra Steinorth

2012 Technology Growth and Expenditure Growth in Health Care
by Amitabh Chandra & Jonathan Skinner

2012 The Doctor Might See You Now: The Supply Side Effects of Public Health Insurance Expansions
by Craig L. Garthwaite

2012 Do Strikes Kill? Evidence from New York State
by Jonathan Gruber & Samuel A. Kleiner

2012 The Effect of Health Insurance Coverage on the Use of Medical Services
by Michael Anderson & Carlos Dobkin & Tal Gross

2012,1st quarter update risk adjustment
by Randall P. Ellis

2011 An Analysis of Specialist Surgeons and their Practices
by Steven F. Koch & Jean D. Slabbert

2011 Subjective well-being among preadolescents - Evidence from urban China
by Carlsson, Fredrik & Lampi, Elina & Li, Wanxin & Martinsson, Peter

2011 La dependencia (el quinto riesgo) y los cuidados de larga duración en Francia
by Dufour-Kippelen, Sandrine & Joël, Marie-Eve

2011 Le secteur optionnel : effet d’aubaine ou outil de régulation des dépassements ?
by Bellamy, Vanessa & Samson, Anne-Laure

2011 Le renoncement aux soins : une approche socio-anthropologique
by Jusot, Florence & Fantin, Romain & Dourgnon, Paul & Després, Caroline

2011 Le renoncement aux soins pour raisons financières : une approche économétrique
by Jusot, Florence & Després, Caroline & Dourgnon, Paul & Fantin, Romain

2011 Le défi de l’efficience
by Le Pen, Claude

2011 Systems medicine and integrated care to combat chronic noncommunicable diseases
by Bousquet, Jean & Anto, Josep M. & Sterk, Peter J. & Adcock, Ian M. & Chung, Kian F. & Roca, Josep & Agusti, Alvar & Brightling, Chris & Cambon-Thomsen, Anne & Cesario, Alfredo & Abdelhak, Sonia & Antonarakis, Stylianos E. & Avignon, Antoine & Ballabio, Andrea & Baraldi, Eugenio & Baranov, Alexander & Bieber, Thomas & Bockaert, Joël & Brahmachari, Samir & Brambilla, Christian & Bringer, Jacques & Dauzat, Michel & Ernberg, Ingemar & Fabbri, Leonardo & Froguel, Philippe & Galas, David & Gojobori, Takashi & Hunter, Peter & Jorgensen, Christian & Kauffmann, Francine & Kourilsky, Philippe & Kowalski, Marek L. & Lancet, Doron & Le Pen, Claude & Mallet, Jacques & Mayosi, Bongani & Mercier, Jacques & Metspalu, Andres & Nadeau, Joseph H. & Ninot, Grégory & Noble, Denis & Oztürk, Mehmet & Palkonen, Susanna & Préfaut, Christian & Rabe, Klaus & Renard, Eric & Roberts, Richard G. & Samolinski, Boleslav & Schünemann, Holger J. & Simon, Hans-Uwe & Soares, Marcelo B. & Superti-Furga, Giulio & Tegner, Jesper & Verjovski-Almeida, Sergio & Wellstead, Peter & Wolkenhauer, Olaf & Wouters, Emiel & Balling, Rudi & Brookes, Anthony J. & Charron, Dominique & Pison, Christophe & Chen, Zhu & Hood, Leroy & Auffray, Charles

2011 Manager les établissements de santé : des compétences fortes en pleine évolution
by Fermon, Béatrice

2011 Valuing Prearranged Paired Kidney Exchanges: A Stochastic Game Approach
by Murat Kurt & Mark S. Roberts & Andrew J. Schaefer & M. Utku Ünver

2011 Can Credence Advertising Effects Be Isolated? Can They Be Negative?: Evidence from Pharmaceuticals
by W. David Bradford & Andrew N. Kleit

2011 Who gets a Mammogram amongst European women aged 50-69 years and why are there such large differences across European countries?
by Wübker, Ansgar

2011 Who gets a mammogram amongst European women aged 50-69 years and why are there such large differences across European countries?
by Wübker, Ansgar

2011 Changes in hospital efficiency after privatization
by Tiemann, Oliver & Schreyögg, Jonas

2011 On the effect of prospective payment system on hospital efficiency and competition for patients in Germany
by Herwartz, Helmut & Strumann, Christoph

2011 Measuring and testing for gender discrimination in physician pay: English family doctors
by Hugh Gravelle & Arne Risa Hole & Rita Santos

2011 Measuring the effects of removing subsidies for private insurance on public expenditure for health care
by Chai Cheng, T.

2011 Opt Out Or Top Up? Voluntary Healthcare Insurance And The Public Vs. Private Substitution
by D. Fabbri ; & C. Monfardini ;

2011 Generic drugs in Spain: price competition vs. moral hazard
by Ivan Moreno-Torres

2011 What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion
by Ivan Moreno-Torres

2011 Oral Health and the Dental Care Workforce in Southwest Virginia
by Tanya Wanchek & Terance J. Rephann & William Shobe

2011 Geographic Differences in Hospital Waiting Times
by Meliyanni Johar & Glenn Jones & Michael Keane & Elizabeth Savage & Olena Stavrunova

2011 Discrimination in a Universal Health System: Explaining Socioeconomic Waiting Time Gaps
by Meliyanni Johar & Glenn Jones & Michael Keane & Elizabeth Savage & Olena Stavrunova

2011 Data Envelopment Analysis e sistemi sanitari regionali italiani
by Falavigna, Greta & Ippoliti, Roberto

2011 An Empirical Analysis on the European Market of Human Experimentation
by Ippoliti, Roberto

2011 The Impact of Private Hospital Insurance on Utilization of Hospital Care in Australia: Evidence from the National Health Survey
by Damien Eldridge & Catagay Koc & Ilke Onur & Malathi Velamuri

2011 Does Health Insurance Decrease Health Expenditure Risk in Developing Countries? The Case of China
by Juergen Jung & Jialu Liu

2011 Competition Leverage : How the Demand Side Affects Optimal Risk Adjustment
by Bijlsma, M. & Boone, J. & Zwart, G.

2011 Health Insurance without Single Crossing : Why Healthy People have High Coverage
by Boone, J. & Schottmuller, C.

2011 How does Risk-selection Respond to Risk-adjustment? Evidence from the Medicare Advantage Program
by Jason Brown & Mark Duggan & Ilyana Kuziemko & William Woolston

2011 Selection in Insurance Markets: Theory and Emprirics in Pictures
by Liran Einav & Amy Finkelstein

2011 Determinants of Obtaining Formal and Informal LTC across European Countries
by Agnieszka Sowa & Izabela Styczyñska

2011 Public Expenditures on Education and Health in Georgia before and during the Global Crisis
by Maka Chitanava & Maya Grigolia & Lasha Labadze

2011 An Analysis of Specialist Surgeons and their Practices
by Steven F. Koch & Jean D. Slabbert

2011 In Absolute or Relative Terms? How Framing Prices Affects the Consumer Price Sensitivity of
by Hendrik Schmitz & Nicolas R. Ziebarth

2011 Body weight of Italians: the weight of Education
by Vincenzo Atella & Joanna Kopinska

2011 Physician Density in a Two-Tiered Health Care System
by Gächter, Martin & Schwazer, Peter & Theurl, Engelbert & Winner, Hannes

2011 Access to Health Care in Andhra Pradesh : Availability of Manpower
by Motkuri, Venkatanarayana

2011 Sağlıkta Dönüşümün Ampirik Analizi
by Celikay, Ferdi & Gumus, Erdal

2011 Education, risk perceptions, and health behaviors
by You, Kai

2011 Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan
by Hsieh, Chee-Ruey & Liu, Ya-Ming & Chang, Chia-Lin

2011 Welfare costs of reclassification risk in the health insurance market
by Pashchenko, Svetlana & Porapakkarm, Ponpoje

2011 Modeling healthcare quality: life expectancy SURS in the G7 countries and Korea
by Firl, Daniel J.

2011 Analyzing the efficiency differences among basic health units in Sargodha District
by Abbas, Touqeer & Awan, Masood Sarwar & Aslam, Muhammad Amir & Waqas, Muhammad

2011 Empirical Analysis of Field Data on HIV/AIDS Epidemic in Khartoum State, Sudan
by Mohamed, Issam A.W.

2011 Surveying HIV/AIDS Incidence in Sudan
by Mohamed, Issam A.W.

2011 Adverse selection and moral hazard among the poor: evidence from a randomized experiment
by Spenkch, Jörg L.

2011 The impacts of health care reforms on the efficiency of the Turkish public hospitals: Provincial markets
by Sulku, Seher Nur

2011 Technical efficiency of hospital psychiatric care in Bulgaria – assessment using Data Envelopment Analysis
by Kundurjiev, T. & Salchev, Petko

2011 Testing for the Role of Prejudice in Emergency Departments Using Bounceback Rates
by Shamena Anwar & Hanming Fang

2011 A Theoretical Approach to Dual Practice Regulations in the Health Sector
by Paula González & Inés Macho-Stadler

2011 Do waiting times matter in primary care? GP visits and list sizes in England
by Matthew Polisson

2011 Reforming Austria's Highly Regarded but Costly Health System
by Rauf Gönenç & Maria M. Hofmarcher & Andreas Wörgötter

2011 Increasing Public Sector Efficiency in Slovakia
by Felix Hüfner

2011 Patient Mobility, Health Care Quality and Welfare
by Kurt R. Brekke & Rosella Levaggi & Luigi Siciliani & Odd Rune Straume

2011 Does Retiree Health Insurance Encourage Early Retirement?
by Steven Nyce & Sylvester Schieber & John B. Shoven & Sita Slavov & David A. Wise

2011 Can Governments Do It Better? Merger Mania and Hospital Outcomes in the English NHS
by Martin Gaynor & Mauro Laudicella & Carol Propper

2011 Organizational Economics and Physician Practices
by James B. Rebitzer & Mark E. Votruba

2011 The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
by Rena M. Conti & Haiden A. Huskamp & Ernst R. Berndt

2011 Estimating Patients' Preferences for Medical Devices: Does the Number of Profile in Choice Experiments Matter?
by John Bridges & Christine Buttorff & Karin Groothuis-Oudshoorn

2011 Human Capital and Organizational Performance: Evidence from the Healthcare Sector
by Ann P. Bartel & Ciaran S. Phibbs & Nancy Beaulieu & Patricia Stone

2011 Adverse Selection and Switching Costs in Health Insurance Markets: When Nudging Hurts
by Benjamin R. Handel

2011 Insuring Long Term Care In the US
by Jeffrey Brown & Amy Finkelstein

2011 Does Widowhood Explain Gender Differences in Out-of-Pocket Medical Spending Among the Elderly?
by Gopi Shah Goda & John B. Shoven & Sita Nataraj Slavov

2011 Comparison Friction: Experimental Evidence from Medicare Drug Plans
by Jeffrey R. Kling & Sendhil Mullainathan & Eldar Shafir & Lee Vermeulen & Marian Wrobel

2011 Comparative Effectiveness Research, COURAGE, and Technological Abandonment
by David H. Howard & Yu-Chu Shen

2011 Organ Allocation Policy and the Decision to Donate
by Judd B. Kessler & Alvin E. Roth

2011 Vertical Integration and Optimal Reimbursement Policy
by Christopher Afendulis & Daniel Kessler

2011 Do Hospitals Cross Subsidize?
by Guy David & Richard Lindrooth & Lorens A. Helmchen & Lawton R. Burns

2011 Has the Shift to Managed Care Reduced Medicaid Expenditures? Evidence from State and Local-Level Mandates
by Mark Duggan & Tamara Hayford

2011 Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets
by Patricia M. Danzon & Michael F. Furukawa

2011 Competition in Health Care Markets
by Martin Gaynor & Robert J. Town

2011 Vaccine Supply: Effects Of Regulation And Competition
by Patricia M. Danzon & Nuno S. Pereira

2011 Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry
by Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins

2011 Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement
by Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse

2011 The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities
by Neeraj Sood & Peter J. Huckfeldt & David C. Grabowski & Joseph P. Newhouse & José J. Escarce

2011 Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
by Anup Malani & Tomas J. Philipson

2011 The Demand for Health Insurance Among Uninsured Americans: Results of a Survey Experiment and Implications for Policy
by Alan B. Krueger & Ilyana Kuziemko

2011 How does Risk Selection Respond to Risk Adjustment? Evidence from the Medicare Advantage Program
by Jason Brown & Mark Duggan & Ilyana Kuziemko & William Woolston

2011 Testing for the Role of Prejudice in Emergency Departments Using Bounceback Rates
by Shamena Anwar & Hanming Fang

2011 A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
by Ernst R. Berndt & Thomas G. McGuire & Joseph P. Newhouse

2011 Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries
by Roger Bate & Ginger Zhe Jin & Aparna Mathur

2011 The Impact of National Health Insurance on Birth Outcomes: A Natural Experiment in Taiwan
by Shin-Yi Chou & Michael Grossman & Jin-Tan Liu

2011 A Simple Test of Private Information in the Insurance Markets with Heterogeneous Insurance Demand
by Li Gan & Feng Huang & Adalbert Mayer

2011 Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchange
by Itai Ashlagi & Alvin E. Roth

2011 Does Decreased Access to Emergency Departments Affect Patient Outcomes? Analysis of AMI Population 1996-2005
by Yu-Chu Shen & Renee Y. Hsia

2011 A Structural Approach to Market Definition With an Application to the Hospital Industry
by Martin Gaynor & Samuel A. Kleiner & William B. Vogt

2011 Perspectives on Public Private Partnership: The R&D Based Vaccine Industry
by Edith Maes & Rutger Daems

2011 Risk Classification in Insurance Contracting
by Georges Dionne & Casey G. Rothschild

2011 The Impact of Private Hospital Insurance on Utilization of Hospital Care in Australia: Evidence from the National Health Survey
by Damien Eldridge & Catagay Koc & Ilke Onur & Malathi Velamuri

2011 The dependence of health insurance availability on years left before Medicare
by Ismail Saglam & Esra Eren Bayindir & Mehmet Yigit Gurdal

2011 Medizinisch-technischer Fortschritt im Gesundheitswesen: Zentrale Kosten-Nutzen-Bewertung ohne Alternative?
by Christine Arentz

2011 Entry and Exit of Physicians in a two-tiered public/private Health Care System
by Martin Gächter & Peter Schwazer & Engelbert Theurl

2011 Racial and Ethnic Inequality in Employer Provided Fringe Benefits
by Mok, Wallace & Siddique, Zahra

2011 Racial and Ethnic Inequality in Employer Provided Fringe Benefits
by Mok, Wallace & Siddique, Zahra

2011 In Absolute or Relative Terms? How Framing Prices Affects the Consumer Price Sensitivity of Health Plan Choice
by Schmitz, Hendrik & Ziebarth, Nicolas R.

2011 In Absolute or Relative Terms? How Framing Prices Affects the Consumer Price Sensitivity of Health Plan Choice
by Schmitz, Hendrik & Ziebarth, Nicolas R.

2011 Bargaining Over Labor: Do Patients Have Any Power?
by Gans, Joshua S. & Leigh, Andrew

2011 Bargaining Over Labor: Do Patients Have Any Power?
by Gans, Joshua S. & Leigh, Andrew

2011 The Intergenerational Transmission of Human Capital: Exploring the Role of Skills and Health Using Data on Adoptees and Twins
by Lundborg, Petter & Nordin, Martin & Rooth, Dan-Olof

2011 The Intergenerational Transmission of Human Capital: Exploring the Role of Skills and Health Using Data on Adoptees and Twins
by Lundborg, Petter & Nordin, Martin & Rooth, Dan-Olof

2011 Opt Out or Top Up? Voluntary Healthcare Insurance and the Public vs. Private Substitution
by Fabbri, Daniele & Monfardini, Chiara

2011 Opt Out or Top Up? Voluntary Healthcare Insurance and the Public vs. Private Substitution
by Fabbri, Daniele & Monfardini, Chiara

2011 Patients Whose GP Knows Complementary Medicine Tend to Have Lower Costs and Live Longer
by Kooreman, Peter & Baars, Erik W.

2011 Patients Whose GP Knows Complementary Medicine Tend to Have Lower Costs and Live Longer
by Kooreman, Peter & Baars, Erik W.

2011 Assessing the Effectiveness of Health Care Cost Containment Measures
by Ziebarth, Nicolas R.

2011 Assessing the Effectiveness of Health Care Cost Containment Measures
by Ziebarth, Nicolas R.

2011 A Labor Market Approach to the Crisis of Health Care Professionals in Africa
by Andalón, Mabel & Fields, Gary

2011 A Labor Market Approach to the Crisis of Health Care Professionals in Africa
by Andalón, Mabel & Fields, Gary S.

2011 Entry and Exit of Physicians in a two-tiered public/private Health Care System
by Martin Gächter & Peter Schwazer & Engelbert Theurl

2011 Measuring the Effects of Removing Subsidies for Private Insurance on Public Expenditure for Health Care
by Terence Chai Cheng

2011 Demand for Hospital Care and Private Health Insurance in a Mixed Public–Private System: Empirical Evidence Using a Simultaneous Equation Modeling Approach
by Terence Chai Cheng & Farshid Vahid

2011 Differences in Length of Stay between Public Hospitals, Treatment Centres and Private Providers: Selection or Efficiency?
by Luigi Siciliani & Peter Sivey & Andrew Street

2011 Sårvice Refusal in Regulated Markets for Credence Goods
by Maarten Janssen & Alexei Parakhonyak

2011 Welfare costs of reclassification risk in the health insurance market
by Pashchenko, Svetlana & Porapakkarm, Ponpoje

2011 EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals - What’s to Blame? Derogation or Perception?
by Granlund, David & Yesim Köksal, Miyase

2011 Parallel Imports and Mandatory Substitution Reform - A Kick or A Muff for Price Competition in Pharmaceuticals?
by Granlund, David & Köksal , Miyase Yesim

2011 Profit or Patients' Health Benefit? Exploring the Heterogeneity in Physician Altruism
by Godager, Geir & Wiesen, Daniel

2011 Patient Mobility, Health Care Quality and Welfare
by Brekke, Kurt R. & Levaggi, Rosella & Siciliani, Luigi & Straume, Odd Rune

2011 Health, Economics and Ancient Greek Medicine
by Lyttkens, Carl Hampus

2011 Parallel Imports and Mandatory Substitution Reform - A Kick or A Muff for Price Competition in Pharmaceuticals?
by Granlund, David & Köksal, Miyase Yesim

2011 EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals. What's blame? Derogation or perception?
by Granlund, David & Yesim Köksal, Miyase

2011 Parallel Imports and Mandatory Substitution Reform: A kick or a muff for price competition in pharmaceuticals
by Granlund, David & Yesim Köksal, Miyase

2011 Does variation in GP practice matter for the length of sick leave? A multilevel analysis based on Norwegian GP—patient data
by Aakvik, Arild & Holmås, Tor Helge & Islam, M. Kamrul

2011 Multitasking, Quality and Pay for Performance
by Kaarbøe, Oddvar M. & Siciliani, Luigi

2011 Spousal Labor Market Effects from Government Health Insurance: Evidence from a Veterans Affairs Expansion
by Melissa A. Boyle & Joanna N. Lahey

2011 Shifting the risk in pricing and reimbursement schemes? A model of risk-sharing agreements for innovative drugs
by Stefano Capri & Rosella Levaggi

2011 Efficiency of Hospitals in the Czech Republic
by Jana Procházková & Lenka Šťastná

2011 Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030
by Fabio Pammolli & Nicola Carmine Salerno

2011 Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011
by Fabio Pammolli & Nicola Carmine Salerno

2011 Federalismo e riparto del Fsn-2011: Much Ado About Nothing?
by Fabio Pammolli & Nicola Carmine Salerno

2011 Does competition between hospitals improve clinical quality?: a review of evidence from two eras of competition in the English NHS
by Gwyn Bevan & Matthew Skellern

2011 Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008
by Joan Costa-i-Font & Nebibe Varol & Alistair McGuire

2011 Demand and pricing of preventative healthcare
by Sotiris Vandoros & Katherine Grace Carman

2011 Determinants of branded prescription medicine prices in OECD countries
by Panos G. Kanavos & Sotiris Vandoros

2011 Comparing the treatment provided by migrant and non-migrant health professionals: dentists in Scotland
by Martin Chalkley & Colin Tilley & Shaolin Wang

2011 In Absolute or Relative Terms?: How Framing Prices Affects the Consumer Price Sensitivity of Health Plan Choice
by Hendrik Schmitz & Nicolas R. Ziebarth

2011 Assessing the Effectiveness of Health Care Cost Containment Measures
by Nicolas R. Ziebarth

2011 Conditions de vie dans un quartier pauvre de Djibouti : analyse de l’enquête de référence pour évaluer l’impact d’un projet de développement urbain intégré à Balbala
by Sandrine Mesplé-Somps & Laure Pasquier-Doumer

2011 Micro-econometric analysis of care for the dependent elderly in France : How do formal and informal care interact ?
by Arnault, Louis & Goltz, Andreas & Wittwer, Jérôme

2011 Stratégies de localisation des médecins généralistes français : mécanismes économiques ou hédonistes ?
by Samson, Anne-Laure & Delattre, Eric

2011 Dépense de santé et accès financier aux services de santé : une étude du renoncement aux soins
by Jusot, Florence & Fantin, Romain & Dourgnon, Paul & Després, Caroline

2011 Choix du secteur de conventionnement et déterminants des dépassements d'honoraires des médecins
by Samson, Anne-Laure & Bellamy, Vanessa

2011 Do French Low-Income GPs Choose to Work Less ?
by Samson, Anne-Laure

2011 Conditions de vie dans un quartier pauvre de Djibouti : analyse de l'enquête de référence pour évaluer l'impact d'un projet de développement urbain intégré à Balbala
by Mesplé-Somps, Sandrine & Pasquier-Doumer, Laure

2011 The Choice of Detecting Down Syndrome: Does Money Matter?
by Le, Jérôme & Maurin, Eric & Garrouste, Clémentine

2011 L'accessibilité financière à la complémentaire santé en France : les résultats de l'enquête Budget de Famille 2006
by Jusot, Florence & Perraudin, Clémence & Wittwer, Jérôme

2011 Hedging and vertical integration in electricity markets
by Chemla, Gilles & Porchet, Arnaud & Aïd, René & Touzi, Nizar

2011 Health insurance, efficiency and equity: French debates
by Dormont, Brigitte

2011 Fighting poverty and child malnutrition: on the design of foreign aid policies
by Chrysovalantis VASILAKIS

2011 Sinking, Swimming, or Learning to Swim in Medicare Part D
by Ketcham, Jonathan D. & Lucarelli, Claudio & Miravete, Eugenio J & Roebuck, M Christopher

2011 Patient Mobility, Health Care Quality and Welfare
by Brekke, Kurt Richard & Levaggi, Rosella & Siciliani, Luigi & Straume, Odd Rune

2011 Health Insurance without Single Crossing: why healthy people have high coverage
by Boone, Jan & Schottmüller, Christoph

2011 Competition leverage: how the demand side affects optimal risk adjustment
by Bijlsma, Michiel & Boone, Jan & Zwart, Gijsbert

2011 Investments in Pharmaceuticals Before and After TRIPS
by Kyle, Margaret K & McGahan, Anita M

2011 Hedging and Vertical Integration in Electricity Markets
by Aïd, René & Chemla, Gilles & Porchet, Arnaud & Touzi, Nizar

2011 Death by Market Power: Reform, Competition and Patient Outcomes in the National Health Service
by Gaynor, Martin & Moreno-Serra, Rodrigo & Propper, Carol

2011 Competition leverage: How the demand side affects optimal risk adjustment
by Michiel Bijlsma & Gijsbert Zwart & Jan Boone

2011 Vertical integration and exclusive vertical restraints in health-care markets
by Rudy Douven & Victoria Shestalova & Rein Halbersma & Katalin Katona

2011 Private, social and self insurance for long-term care: A political economy analysis
by DE DONDER, Philippe & PESTIEAU, Pierre

2011 Costo-Efectividad De Realizar Plasmaféresis Previa A Timectomía Abierta En El Tratamiento De La Miastenia Gravis
by Liliana Chicaíza Becerra [et-al]

2011 Costo-Efectividad De Añadir El Péptido Natriurético Tipo B Al Índice De Lee En La Evaluación
by Mario García Molina & Liliana Chicaíza & Oscar Gamboa

2011 Do hospitals respond to greater autonomy? Evidence from the English NHS
by Rossella Verzulli & Rowena Jacobs & Maria Goddard

2011 Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale
by Nebibe Varol & Joan Costa-i-Font & Alistair McGuire

2011 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
by Nebibe Varol & Joan Costa-i-Font & Alistair McGuire

2011 Disentangling spillover effects of antibiotic consumption: a spatial panel approach
by Laura Guadalupe González Ortiz & Giuliano Masiero

2011 How Payment Systems Affect Physicians' Provision Behaviour – An Experimental Investigation
by Heike Hennig-Schmidt & Reinhard Selten & Daniel Wiesen

2011 Opt Out Or Top Up? Voluntary Healthcare Insurance And The Public Vs. Private Substitution
by D. Fabbri & C. Monfardini

2011 The role of GP’s compensation schemes in diabetes care: evidence from panel data
by E. Iezzi & M. Lippi Bruni & C. Ugolini

2011 Improving Compliance With Preventive Care: Cooperation in Mutual Health Insurance
by F. Barigozzi & R. Bourles & D. Henriet & G. Pignataro

2011 The Dynamics of Disease in a Regulated Vertically Differentiated Health System
by L. Lambertini & A. Tampieri

2011 Stock Prices and the Doctor Supply: Effect of Medicare Residency Policy on Healthcare Industry Firms
by Jonathan Hartley

2011 Disability Care and Support
by Commission, Productivity

2011 Caring for older Australians
by Commission, Productivity

2011 Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?
by John F.P. Bridges & Elizabeth T. Kinter & Annette Schmeding & Ina Rudolph & Axel Mhlbacher

2011 Comparison of Scores Derived from the Box Score-11 Scale and the Pain Attribute of the Health Utilities Index-3
by Michael Iskedjian & Barbara Jaszewski & Olivier Desjardins

2011 Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations
by Andrew Lloyd & Paul Hodgkins & Rahul Sasane & Ron Akehurst & Edmund J.S. Sonuga-Barke & Patrick Fitzgerald & Annabel Nixon & Haim Erder & John Brazier

2011 Offering Results to Participants in a Diabetes Survey: Effects on Survey Response Rates
by Jeanette Y. Ziegenfuss & Nilay D. Shah & James R. Deming & Holly K. Van Houten & Steven A. Smith & Timothy J. Beebe

2011 Treatment Satisfaction Instruments for Different Purposes during a Product's Lifecycle: Keeping the End in Mind
by Diana Rofail & Fiona Taylor & Antoine Regnault & Anna Filonenko

2011 Societal Values in the Allocation of Healthcare Resources: Is it All About the Health Gain?
by Tania Stafinski & Devidas Menon & Deborah Marshall & Timothy Caulfield

2011 Acknowledgment
by Adis International Limited

2011 Medication Non-Compliance in Zagreb, Croatia
by Marcel Leppe & Josip Culig & Jelena Boskovic

2011 Impact of Walking Impairment in Multiple Sclerosis: Perspectives of Patients and Care Partners
by Nicholas G. LaRocca

2011 Establishing the Content Validity of the King's Health Questionnaire in Men and Women with Overactive Bladder in the US
by Mary Kay. Margolis & Vasudha Vats & Karin S. Coyne & Con Kelleher

2011 Elicitation of Ostomy Pouch Preferences: A Discrete-Choice Experiment
by Ole Bonnichsen

2011 Integrating Evidence and Individual Preferences Using a Web-Based Multi-Criteria Decision Analytic Tool: An Application to Prostate Cancer Screening
by Michelle Cunich & Glenn Salkeld & Jack Dowie & Joan Henderson & Clare Bayram & Helena Britt & Kirsten Howard

2011 Exploring Qualitative Research Synthesis: The Role of Patients' Perspectives in Health Policy Design and Decision Making
by Helle Ploug. Hansen & Eva Draborg & Finn Brlum. Kristensen

2011 Great Expectations: What Do Patients Using Complementary and Alternative Medicine Hope For?
by E. Ernst & S.K. Hung

2011 Analysis of Health-Related Quality-of-Life Instruments Measuring the Impact of Bariatric Surgery: Systematic Review of the Instruments Used and their Content Validity
by Raed Tayyem & Abdulmajid Ali & John Atkinson & Colin R. Martin

2011 Patient Advocacy in Research: Merely an Afterthought?
by Musa Mayer

2011 Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis
by Michael Iskedjian & David W. Covert & John H. Walker

2011 Eliciting Preferences for Reimbursed Drugs Selection Criteria in C�te d'Ivoire
by Vakaramoko Diaby & Henri Di Kakou & Jean Lachaine

2011 An Instrument to Assess the Needs of Patients with Type 2 Diabetes Mellitus for Health-Promotion Activities
by Anneke N. van Dijk-de Vries & Inge G.P. Duimel-Peeters & Hubertus J.M. Vrijhoef

2011 Impact of Gastrointestinal Problems on Adherence to Low-Dose Acetylsalicylic Acid: A Quantitative Study in Patients with Cardiovascular Risk
by Christina Moberg & Jrgen Naesdal & Lars-Erik Svedberg & Delphine Duchateau & Nicola Harte

2011 A Qualitative Study on Feasibility of a Web-Based Women's Health Portal and Information System
by Min Yang & Mark Kosinski & Rosemarie Boulanger

2011 Family Burden after Severe Brain Injury: The Italian Experience with Families and Volunteer Associations
by Paola Mosconi & Mariangela Taricco & Mirna Bergamini & Luisella Bosisio Fazzi & Cinzia Colombo & Valentina Patrucco & Marinella Corti & Dario Giobbe & Massimo Guerreschi & Maria Rita. Magnarella & Giovanni Sallemi

2011 Patient Preferences for Treatment of Achilles Tendon Pain: Results from a Discrete-Choice Experiment
by Kent R. Sweeting & Jennifer A. Whitty & Paul A. Scuffham & Michael J. Yelland

2011 Development of an Electronic Daily Uterine Fibroid Symptom Diary
by Linda S. Deal & Valerie S.L. Williams & Sheri E. Fehnel

2011 Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life: A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess Health-Related Quality of Life in End-Stage Renal Disease
by Cheryl Glover & Pauline Banks & Amanda Carson & Colin R. Martin & Tim Duffy

2011 Patient-Reported Outcomes, Patient-Reported Information: From Randomized Controlled Trials to the Social Web and Beyond
by Mike Baldwin & Andrew Spong & Lynda Doward & Ari Gnanasakthy

2011 Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence
by Leela Barham

2011 Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease
by Greg L. Plosker

2011 Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
by Naiyana Praditsitthikorn & Yot Teerawattananon & Sripen Tantivess & Supon Limwattananon & Arthorn Riewpaiboon & Saibua Chichareon & Nantakan Ieumwananonthachai & Viroj Tangcharoensathien

2011 To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies
by Tania Stafinski & Devidas Menon & Christopher McCabe & Donald J. Philippon

2011 Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review
by Alexander Goehler & Benjamin P. Geisler & Jennifer M. Manne & Beate Jahn & Annette Conrads-Frank & Petra Schnell-Inderst & G. Scott. Gazelle & Uwe Siebert

2011 Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence
by Petros Pechlivanoglou & Robin De. Vries & Simon M.G.J. Daenen & Maarten J. Postma

2011 Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?
by Dyfrig A. Hughes

2011 Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation: Challenges in Practice
by Mark Parker & Alan Haycox & Jane Graves

2011 Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients
by Annette C. Reboli & Coleman Rotstein & Daniel H. Kett & Michael Maschio & Shannon Cartier & Richard Chambers & Miriam Tarallo

2011 Cost Estimation of Cardiovascular Disease Events in the US
by Amy K. OSullivan & Jaime Rubin & Joshua Nyambose & Andreas Kuznik & David J. Cohen & David Thompson

2011 US FDA Modernization Act, Section 114: Uses, Opportunities and Implications for Comparative Effectiveness Research
by Peter J. Neumann & Pei-Jung Lin & Tom E. Hughes

2011 Using QALYs in Cancer: A Review of the Methodological Limitations
by Martina Garau & Koonal K. Shah & Anne R. Mason & Qing Wang & Adrian Towse & Michael F. Drummond

2011 Cost-of-Illness Studies: A Guide to Critical Evaluation
by Allison Larg & John R. Moss

2011 Challenges in Health State Valuation in Paediatric Economic Evaluation: Are QALYs Contraindicated?
by Wendy J. Ungar

2011 The Case for Less, Not More, US FDA Regulation
by John A. Vernon & Joseph H. Golec

2011 Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder
by Arnie P. Aldridge & Larry A. Kroutil & Alexander J. Cowell & Daniel B. Reeves & David L. Van Brunt

2011 Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders
by Marieke Krol & Joc Papenburg & Marc Koopmanschap & Werner Brouwer

2011 Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries
by Omar Galrraga & Veronika J. Wirtz & Alejandro Figueroa-Lara & Yared Santa-Ana-Tellez & Ibrahima Coulibaly & Kirsi Viisainen & Antonieta Medina-Lara & Eline L. Korenromp

2011 Presenting Evidence and Summary Measures to Best Inform Societal Decisions When Comparing Multiple Strategies
by Simon Eckermann & Andrew R. Willan

2011 Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?
by Afschin Gandjour

2011 Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing?
by Andreas Gerber & Stephanie Stock & Charalabos-Markos Dintsios

2011 PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations
by Pieter van Baal & Werner Brouwer

2011 Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding
by Gillian M. Keating

2011 A Value Set for the EQ-5D Based on Experienced Health States: Development and Testing for the German Population
by Reiner Leidl & Peter Reitmeir

2011 The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia
by Natasha Nanwa & Nicole Mittmann & Sandra Knowles & Claudia Bucci & Rita Selby & Neil Shear & Scott E. Walker & William Geerts

2011 A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data
by James G. Xenakis & Elizabeth T. Kinter & K. Jack. Ishak & Alexandra J. Ward & Jen P. Marton & Richard J. Willke & Simon Davies & J. Jaime. Caro

2011 Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different
by Tania Stafinski & Devidas Menon & Donald J. Philippon & Christopher McCabe

2011 Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review
by Bin Zhang & Prina Z. Donga & Mitra Corral & Medha Sasane & Jeffrey D. Miller & Chris L. Pashos

2011 The Appropriate Elicitation of Expert Opinion in Economic Models: Making Expert Data Fit for Purpose
by William Sullivan & Katherine Payne

2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developed Countries
by Greg L. Plosker

2011 The Authors' Reply
by Zaheer-Ud-Din Babar & Shane L. Scahill

2011 Is There a Role for Pharmacoeconomics in Developing Countries?
by Jonathan R. Harper

2011 Is There a Role for Pharmacoeconomics in Developing Countries?
by Romn Prez Velasco & Yot Teerawattananon

2011 Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence
by Peter S. Hall & Claire Hulme & Christopher McCabe & Yemi Oluboyede & Jeff Round & David A. Cameron

2011 Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives
by Nicole Mittmann & Paul Hernandez & Carl Mellstrm & Lance Brannman & Tobias Welte

2011 Cost Effectiveness of Treatments for Inflammatory Bowel Disease
by Keith Bodger

2011 Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer
by Mark Jit & Marc Brisson

2011 Health Economic and Infectious Disease Modelling: A Guide to Merging Streams
by Andrea Anonychuk & Murray Krahn

2011 Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial
by Tallal Younis & Chris Skedgel

2011 Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes
by Katherine A. Lyseng-Williamson

2011 Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis
by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz

2011 Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review
by Ya-Chen T. Shih & Chun-Ru Chien & Ying Xu & I-Wen Pan & Grace L. Smith & Thomas A. Buchholz

2011 Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice
by Rahul Jain & Michael Grabner & Eberechukwu Onukwugha

2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay
by Henry A. Glick

2011 The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information
by Andrea Messori & Dario Maratea & Chiara Nozzoli & Alberto Bosi

2011 Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts
by Katherine A. Lyseng-Williamson

2011 Comparing Methods of Data Synthesis: Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model
by Mark Oppe & Maiwenn Al & Maureen Rutten-van Mlken

2011 Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
by Nicholas Latimer & Joanne Lord & Robert L. Grant & Rachel OMahony & John Dickson & Philip G. Conaghan

2011 Advances in Cancer Therapeutics and Patient Access to New Drugs
by George Dranitsaris & Ilse Truter & Martie S. Lubbe & Eitan Amir & William Evans

2011 Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review
by Chantal W.B. Boonacker & Pieter H. Broos & Elisabeth A.M. Sanders & Anne G.M. Schilder & Maroeska M. Rovers

2011 Sample Size and Power for Cost-Effectiveness Analysis (Part 1)
by Henry A. Glick

2011 Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations
by Pieter H.M. van Baal & Albert Wong & Laurentius C.J. Slobbe & Johan J. Polder & Werner B.F. Brouwer & G. Ardine. de Wit

2011 Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations
by John A. Nyman & Hawre J. Jalal

2011 A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice
by Afschin Gandjour

2011 Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest
by Simon Eckermann & Michael Coory & Andrew R. Willan

2011 Impact of Treatment Success on Health Service Use and Cost in Depression: Longitudinal Database Analysis
by Sarah Byford & Barbara Barrett & Nicolas Despigel & Alan Wade

2011 A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada
by Mark Oremus & S. Carolina. Aguilar

2011 Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal
by Matt Stevenson & Abdullah Pandor

2011 Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
by Paul Mitchell & Lieven Annemans & Richard White & Meghan Gallagher & Simu Thomas

2011 The Authors' Reply
by Zaheer-Ud-Din Babar & Shane Scahill

2011 Is There a Role for Pharmacoeconomics in Developing Countries?
by Asrul Akmal. Shafie & Mohamed Azmi. Hassali

2011 Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia
by Carl Rudolf. Blankart & Tom Stargardt & Jonas Schreygg

2011 Calibrating Models in Economic Evaluation: A Comparison of Alternative Measures of Goodness of Fit, Parameter Search Strategies and Convergence Criteria
by Jonathan Karnon & Tazio Vanni

2011 Calibrating Models in Economic Evaluation: A Seven-Step Approach
by Tazio Vanni & Jonathan Karnon & Jason Madan & Richard G. White & W. John. Edmunds & Anna M. Foss & Rosa Legood

2011 Effects of Reference Pricing in Pharmaceutical Markets: A Review
by Matteo Maria. Galizzi & Simone Ghislandi & Marisa Miraldo

2011 Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis
by Martin Hoyle

2011 Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective
by Helen Dakin & Morris Sherman & Scott Fung & Carrie Fidler & Anthony Bentley

2011 Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection
by Hui-Fang Hung & Hsiu-Hsi Chen

2011 Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal
by Rumona Dickson & Adrian Bagust & Angela Boland & Michaela Blundell & Helen Davis & Yenal Dundar & Juliet Hockenhull & Carlos Martin Saborido & James Oyee & Vidhya Sagar. Ramani

2011 Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review
by Judith Dams & Bernhard Bornschein & Jens Peter Reese & Annette Conrads-Frank & Wolfgang H. Oertel & Uwe Siebert & Richard Dodel

2011 QALYs and Carers
by Hareth Al-Janabi & Terry N. Flynn & Joanna Coast

2011 Erratum
by Adis International Limited

2011 Acknowledgement
by Adis International Limited

2011 Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries
by Greg L. Plosker

2011 Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma
by Ateesha F. Mohamed & A. Brett. Hauber & Maureen P. Neary

2011 Willingness to Pay for Adverse Drug Event Regulatory Actions
by Jacoline Bouvy & Just Weemers & Huub Schellekens & Marc Koopmanschap

2011 Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal
by Graham Scotland & Norman Waugh & Pamela Royle & Paul McNamee & Rob Henderson & Rosemary Hollick

2011 Sample Size Determination for Cost-Effectiveness Trials
by Andrew R. Willan

2011 Utility Estimation in Chronic Obstructive Pulmonary Disease: A Preference for Change?
by Jennifer Petrillo & Floortje van Nooten & Paul Jones & Maureen Rutten-van Mlken

2011 The Importance of the Comparator in Economic Evaluations: Working on the Efficiency Frontier
by Mattias Neyt & Hans Van Brabandt

2011 Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
by Mickal Hiligsmann & Jean-Yves Reginster

2011 Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs
by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Frank Hulstaert & Steven Simoens

2011 Does the Market Share of Generic Medicines Influence the Price Level?: A European Analysis
by Pieter Dylst & Steven Simoens

2011 Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature
by Gery P. Guy & Donatus U. Ekwueme

2011 A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy
by Joseph Menzin & Lisa M. Lines & Daniel E. Weiner & Peter J. Neumann & Christine Nichols & Lauren Rodriguez & Irene Agodoa & Tracy Mayne

2011 Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer
by Martin Connock & Chris Hyde & David Moore

2011 Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models
by Hossein Haji Ali Afzali & Jonathan Karnon

2011 A Review of the Cost Effectiveness of Bisphosphonates in the Treatment of Post-Menopausal Osteoporosis in Switzerland
by Kurt Lippuner & Richard F. Pollock & Jayne Smith-Palmer & Thomas Meury & William J. Valentine

2011 An Application of a Proposed Framework for Formulary Listing in Low-Income Countries: The Case of C�te d'Ivoire
by Vakaramoko Diaby & Jean Lachaine

2011 Excess Costs Associated with Patients with Chronic Thromboembolic Pulmonary Hypertension in a US Privately Insured Population
by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson

2011 Early Retirement and Income Loss in Patients with Early and Advanced Parkinson's Disease
by Scott Johnson & Matthew Davis & Anna Kaltenboeck & Howard Birnbaum & ElizaBeth Grubb & Marcy Tarrants & Andrew Siderowf

2011 Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings
by Sandra L. Tunis

2011 Early Assessment of Medical Technologies to Inform Product Development and Market Access: A Review of Methods and Applications
by Maarten J. IJzerman & Lotte M.G. Steuten

2011 Assessing Quality of Life among British Older People Using the ICEPOP CAPability (ICECAP-O) Measure
by Terry N. Flynn & Phil Chan & Joanna Coast & Tim J. Peters

2011 Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial
by Michael W. Kattan & Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Gerald L. Andriole

2011 Excess Costs Associated with Patients with Pulmonary Arterial Hypertension in a US Privately Insured Population
by Noam Y. Kirson & Howard G. Birnbaum & Jasmina I. Ivanova & Tracy Waldman & Vijay Joish & Todd Williamson

2011 Nutrition Therapy Cost Analysis in the US: Pre-Mixed Multi-Chamber Bag vs Compounded Parenteral Nutrition
by Robin S. Turpin & Todd Canada & Frank Xiaoqing. Liu & Catherine J. Mercaldi & Alessandro Pontes-Arruda & Paul Wischmeyer

2011 Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
by Eline Picavet & Marc Dooms & David Cassiman & Steven Simoens

2011 Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis
by Dirk Mueller & Afschin Gandjour

2011 The Use of Decision-Analytic Models in Parkinson's Disease: A Systematic Review and Critical Appraisal
by James Shearer & Colin Green & Carl E. Counsell & John P. Zajicek

2011 Ordering Errors, Objections and Invariance in Utility Survey Responses: A Framework for Understanding Who, Why and What to Do
by Eve Wittenberg & Lisa A. Prosser

2011 Cost-Efficacy Analysis of the MONET Trial Using UK Antiretroviral Drug Prices
by Brian Gazzard & Andrew Hill & Anne Anceau

2011 Design of Patient Access Schemes in the UK: Influence of Health Technology Assessment by the National Institute for Health and Clinical Excellence
by Szymon Jarosawski & Mondher Toumi

2011 Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US
by Keith L. Davis & Timothy J. Bell & Jacqueline M. Miller & Derek A. Misurski & Bela Bapat

2011 Cost Effectiveness of Tobacco Control Policies in Vietnam: The Case of Population-Level Interventions
by Hideki Higashi & Khoa D. Truong & Jan J. Barendregt & Phuong K. Nguyen & Mai L. Vuong & Thuy T. Nguyen & Phuong T. Hoang & Angela L. Wallace & Tien V. Tran & Cuong Q. Le & Christopher M. Doran

2011 Patent Extension Policy for Paediatric Indications: An Evaluation of the Impact within Three Drug Classes in a State Medicaid Programme
by Richard E. Nelson & Carrie McAdam-Marx & Megan L. Evans & Robert Ward & Benjamin Campbell & Diana Brixner & Joanne Lafleur

2011 Assessing the Performance of a New Generic Measure of Health-Related Quality of Life for Children and Refining it for Use in Health State Valuation
by Katherine Stevens

2011 Valuing Health at Different Ages: Evidence from a Nationally Representative Survey in the US
by Daniel Eisenberg & Gary L. Freed & Matthew M. Davis & Dianne Singer & Lisa A. Prosser

2011 The Impact of Inclusion Criteria in Health Economic Assessments
by Anke Richter & Patricia Thieda & Kylie Thaler & Gerald Gartlehner

2011 The Economics of the NHS Cancer Drugs Fund
by Alan Maynard & Karen Bloor

2011 Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer
by O. Yu. Atkov & A.V. Azarov & D.A. Zhukov & N. Nicoloyannis & L. Durand

2011 Citizens' Preferences for Brand Name Drugs for Treating Acute and Chronic Conditions: A Pilot Study
by Arina Denoth & Christophe Pinget & Jean-Blaise Wasserfallen

2011 Public and Decision Maker Stated Preferences for Pharmaceutical Subsidy Decisions: A Pilot Study
by Jennifer A. Whitty & Paul A. Scuffham & Sharyn R. Rundle-Thiele

2011 Germany's Decision Rule for Setting Ceiling Prices of Drugs: A Comparative Analysis with Other Decision Rules
by Afschin Gandjour

2011 Impact of Fibromyalgia Severity on Health Economic Costs: Results from a European Cross-Sectional Study
by Andreas Winkelmann & Serge Perrot & Caroline Schaefer & Kellie Ryan & Arthi Chandran & Alesia Sadosky & Gergana Zlateva

2011 Current and Future Economic Burden of Osteoporosis in New Zealand
by Paul Brown & Rob McNeill & William Leung & Eman Radwan & Jane Willingale

2011 Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland: Implications Once Generic Atypicals are Available
by Magda Wladysiuk & Aleksander Araszkiewicz & Brian Godman & Katarzyna Szabert; Prescribing Research Group, University of Liverpool Management School, Liverpool, UK; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden & Corrado Barbui & Alan Haycox

2011 The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS: Costs, Healthcare Resources and Health Outcomes
by Alison Sweet & David Lee & Kerry Gairy & Denver Phiri & Timothy Reason & Kevin Lock

2011 Determinants of Out-of-Pocket Health Expenditure in China: Analysis Using China Health and Nutrition Survey Data
by Xuedan You & Yasuki Kobayashi

2011 Costs to Hospitals of Acquiring and Processing Blood in the US: A Survey of Hospital-Based Blood Banks and Transfusion Services
by Richard W. Toner & Laura Pizzi & Brian Leas & Samir K. Ballas & Alyson Quigley & Neil I. Goldfarb

2011 Valuing Child Health Utility 9D Health States with a Young Adolescent Sample: A Feasibility Study to Compare Best-Worst Scaling Discrete-Choice Experiment, Standard Gamble and Time Trade-Off Methods
by Julie Ratcliffe & Leah Couzner & Terry Flynn & Michael Sawyer & Katherine Stevens & John Brazier & Leonie Burgess

2011 The Chinese Healthcare System: Structure, Problems and Challenges
by Jens Leth. Hougaard & Lars Peter. sterdal & Yi Yu

2011 Adverse Selection in the Private Health Insurance Markets: a Two-Step Approach
by Cinzia Di Novi

2011 Markets and Healthcare Services in Malaysia: Critical Issues
by Rajah Rasiah & Nik Rosnah Wan Abdullah & Makmor Tumin

2011 Types of Private Financing of Medical Care by Patients in Poland
by Ma³gorzata Paszkowska

2011 Management of Health System for Ethnic Minorities
by Cristina Teodora NEAGU

2011 New Medical Management Trends and Policies throughout Central and Eastern Europe
by Cristina Teodora NEAGU

2011 Data mining in medical records for the enhancement of strategic decisions: a case study
by Yilmaz GOKSEN & Mete EMINAGAOGLU & Onur DOGAN

2011 Consumer Behavior in Spa Tourism in the Czech Republic
by Lena Mlejnková

2011 An analysis of specialist surgeons and their practices
by Steve Koch, & Jean D Slabbert

2011 The supplementary health insurance and the voluntary health saving funds
by Andrea Vallyon

2011 Medical savings accounts – in search of an alternative method of health care financing in European countries
by Marta Borda

2011 Romanian Consumers Habits regarding Dental Hygiene
by Cetinã Iuliana & Gârdan Daniel Adrian & Geangu Iuliana Petronela

2011 How Could Hospitals Act In An Ageing Society?
by Leuca Mirela

2011 The Role Of The Preventive Medicine In Sustainable Development. A Study Case On The Private Medicine Sector In Oradea
by Unita Lucian & Rahota Daniela & Maghiar Teodor Traian & Straciuc Oreste

2011 Investigating The Patient Satisfaction Within Romanian Public And Private Hospitals
by Popa Adela Laura & Rosca Remus Dorel & Mihoc Florin

2011 Problems And Chances At The Interface Between Hospital Care And Geriatric Rehabilitation
by Leuca Mirela & Fastenmeier Heribert

2011 Strategic Development Trends in the World Pharmaceutical Industry
by Dragan Kesic

2011 The Rural Pharmacy and Rural Health Services in the Perspective of the Individuals Community Protection (English version)
by Alina Monica MIFTODE & Alina STEFANACHE

2011 Optimal Environmental Taxes Due to Health Effect
by Haradhan Kumar Mohajan

2011 Medical Savings Accounts and Preventative Health Care Utilization
by Justin R. Cress & David M. Zimmer

2011 Correlation between Coronary Calcium Score and risk of Artery Disease in presence of Conventional Cardiac Risk Factors
by Riaz Soomro & Nayyar Jabeen & Nayyar Jabeen

2011 The Effects of Inappropriate Emercency Department Use
by Marta Ameri & Paolo Cremonesi & Marcello Montefiori

2011 La distribuzione dei farmaci tra progetti di riforma e incertezze
by Fabio Pammolli & Nicola C. Salerno

2011 Are Health Systems of Central European Countries the Least Efficient? A Cross Country Comparative Study
by Anna Forgacs & Judit Beke Lisanyi

2011 A comparative study on the health care and medical service consumption of urban and rural households in China
by Xianbo Zhou & Fengping Tian

2011 Gender inequality and the spread of HIV-AIDS in India
by Aparna Mitra & Dipanwita Sarkar

2011 The impact of state tax subsidies for private long-term care insurance on coverage and Medicaid expenditures
by Goda, Gopi Shah

2011 Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
by Brekke, Kurt R. & Holmas, Tor Helge & Straume, Odd Rune

2011 Optimal public rationing and price response
by Grassi, Simona & Ma, Ching-to Albert

2011 Patient knowledge and antibiotic abuse: Evidence from an audit study in China
by Currie, Janet & Lin, Wanchuan & Zhang, Wei

2011 Physicians on board: An examination of physician financial interests in ASCs using longitudinal data
by Yee, Christine A.

2011 Patient switching in general practice
by Iversen, Tor & Lurås, Hilde

2011 The impact of Medicaid insurance coverage on dental service use
by Choi, Moonkyung Kate

2011 Direct evidence of risk aversion as a source of advantageous selection in health insurance
by Schmitz, Hendrik

2011 Monopsony’ in the Market for Nurses? A Semiparametric Note
by Mukherjee, D

2011 Zusatzbeiträge erhöhen die Preistransparenz: mehr Versicherte wechseln die Krankenkasse
by Peter Eibich & Hendrik Schmitz & Nicolas R. Ziebarth

2011 Horizontal Inequity in Access to Health Care in Four South American Cities
by Ana I. Balsa & Máximo Rossi & Patricia Triunfo

2011 Healthcare Financing In Recession
by Bianca Mihart

2011 Considerations Regarding 111e Economic Models For The Evaluation Of Health
by Bianca Mihart Ph. D Student

2011 The Effect of Private Health Insurance on Doctor Visits, Hospital Nights, and Self-Assessed Health: Evidence from the German Socio-Economic Panel
by Patrick Hullegie & Tobias J. Klein

2011 Evaluating the Medical Malpractice System and Options for Reform
by Daniel P. Kessler

2011 Reforming Payments to Healthcare Providers: The Key to Slowing Healthcare Cost Growth While Improving Quality?
by Mark McClellan

2011 Patient Cost-Sharing and Healthcare Spending Growth
by Katherine Baicker & Dana Goldman

2011 The (Paper)Work of Medicine: Understanding International Medical Costs
by David M. Cutler & Dan P. Ly

2011 The Pragmatist's Guide to Comparative Effectiveness Research
by Amitabh Chandra & Anupam B. Jena & Jonathan S. Skinner

2011 Returns to Local-Area Health Care Spending: Evidence from Health Shocks to Patients Far from Home
by Joseph J. Doyle

2011 Aftershocks: The Impact of Clinic Violence on Abortion Services
by Mireille Jacobson & Heather Royer

2010 Quality differentiation if market share matters
by Ellert, Alexander & Urmann, Oliver

2010 Can the Health Insurance Reforms stop an increase in medical costs of middle- and old-aged persons in Japan?
by Tamie Matsuura & Masaru Sasaki

2010 Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluation
by Deconinck, Eric & Miadi-Fargier, Houda & Le Pen, Claude & Brice, Pauline

2010 Le vieillissement ne fera pas exploser les dépenses de santé
by Dormont, Brigitte

2010 Liberté ou solidarité : le dilemme des complémentaires
by Dormont, Brigitte

2010 Comment financer les dépenses de santé?
by Dormont, Brigitte

2010 Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging
by Soussan, Michael & Aubé, Christophe & Bahrami, Stéphane & Boursier, Jérôme & Valla, Dominique Charles & Vilgrain, Valérie

2010 Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies
by Lévy, Pierre & Beauté, J. & Millet, V. & Debré, M. & Dudoit, Y. & Le Mignot, L. & Tajahmady, A. & Thomas, C. & Suarez, F. & Pellier, I. & Hermine, O. & Aladjidi, N. & Mahlaoui, N. & Fischer, A.

2010 Optimal public rationing and price response
by Ching-to Albert MA & Simona Grassi

2010 Market conditions and general practitioners’ referrals
by Ching-to Albert MA & Tor Iversen

2010 Markets of Well-being. Navigating health and healing in Africa
by

2010 The Effects of Health Shocks on labour Market Exits: Evidence from the HILDA Survey
by Eugenio Zucchelli & Andrew M. Jones & Nigel Rice & Anthony Harris

2010 A simple model of health insurance competition
by Kemnitz, Alexander

2010 The impact of pricing and patent expiration on the demand for pharmaceuticals: An examination of the use of broad-spectrum antimicrobials
by Kaier, Klaus

2010 Demand for hospital care and private health insurance in a mixed publicprivate system: empirical evidence using a simultaneous equation modeling approach
by Chai Cheng, T; & Vahid, F;

2010 Risk Preference Heterogeneity And Multiple Demand For Insurance
by LI DONNI, P.;

2010 The effect of waiting time and distance on hospital choice for English cataract patients
by Peter Sivey

2010 Waiting Times and Socioeconomic Status: Evidence from England
by Laudicella, M.; & Siciliani, L.; & Cookson, R.;

2010 Die Schweiz als Vorbild? Bemerkungen zur Diskussion um eine Reform des deutschen Gesundheitswesens
by Gebhard Kirchgässner

2010 Intrinsic motivations and the non-profit health sector: Evidence from Ethiopia
by Danila Serra & Pieter Serneels & Abigail Barr

2010 Incentive Compatible Reimbursement Schemes for Physicians
by Winand Emons

2010 Health Care Network Formation and Policyholders' Welfare
by Bardey, David & Bourgeon, Jean Marc

2010 Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry
by Appelt, Silvia

2010 Medical Consumption over the Life Cycle: Facts from a U.S. Medical Expenditure Panel Survey
by Juergen Jung & Chung Tran

2010 Health Insurance Competition : The Effect of Group Contracts
by Boone, J. & Douven, R.C.M.H. & Droge, C. & Mosca, I.

2010 Medical Consumption Over the Life Cycle: Facts from a U.S. Medical Expenditure Panel Survey
by Juergen Jung & Chung Tran

2010 Explaining Differences in Remuneration Rates of Nursing Homes in Germany
by Roman Mennicken & Boris Augurzky & Heinz Rothgang & Jürgen Wasem

2010 Is there a Future for Small Hospitals in Germany?
by Boris Augurzky & Hendrik Schmitz

2010 The Eff ect of Self-assessed Job Security on the Demand for Medical Rehab
by Boris Augurzky & Arndt Reichert & Harald Tauchmann

2010 The male-female gap in physician earnings: Evidence from a public health insurance system
by Theurl, Engelbert & Winner, Hannes

2010 Childhood Obesity: An Economic Perspective
by Crowle , Jacqueline & Turner, Erin

2010 State Level Efficiency Measures for Healthcare Systems
by Makiela, Kamil

2010 Non-Economic and Economic Factors in the Decision to Obtain a Pap Smear: The Case of Women Residents in the State of Florida
by Alexander, Gigi & Cebula, Richard

2010 Health insurance reform and bankruptcy
by Kuklik, Michal

2010 Public health services and health care utilization in Viet Nam
by Nguyen Viet, Cuong

2010 An Empirical Analysis of the Effects of GP Competition
by Pike, Chris

2010 Exclusive contracts in health insurance
by Rahkovsky, Ilya

2010 Selbstbeteiligung als Lösung für das Moral-Hazard-Problem auf dem Arzneimittelmarkt?
by Carolin, Hoh & Ivonne, Honekamp

2010 Stress test of hospitals in Bulgaria - proposed methodology
by Salchev, Petko & Hristov, Nikolai

2010 A Competing Risk Model for Health and Food Insecurity in the West Bank
by Cavatorta, Elisa & Pieroni, Luca

2010 Influence of body image in urbanized areas: Differences in long-term changes in teenage body mass index between boys and girls in Japan
by Yamamura, Eiji

2010 Possible approaches to benchmarking voluntary health insurance funds in Bulgaria
by Salchev, Petko & Hristov, Nikolai & Georgieva, Lydia

2010 On the estimation of hospital cost: the approach
by Kurup, Hari K K

2010 Comparison of long-term changes in teenage body mass index between urban and other areas in Japan from 1986 to 2003
by Yamamura, Eiji

2010 The effects of the social norm on cigarette consumption: evidence from Japan using panel data
by Yamamura, Eiji

2010 Intrinsic motivations and the non-profit health sector: Evidence from Ethiopia
by Abigail Barr & Danila Serra and Pieter Serneels

2010 Can the health insurance reforms stop an increase in medical expenditures for middle- and old-aged persons in Japan?
by Tamie Matsuura & Masaru Sasaki

2010 Health Care Systems: Efficiency and Institutions
by Isabelle Joumard & Christophe André & Chantal Nicq

2010 Margins and Market Shares:Pharmacy Incentives for Generic Substitution
by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume

2010 Price effects of Dutch hospital mergers, An ex post assessment of hip surgery
by Ron Kemp & Astrid Severijnen

2010 Patient Knowledge and Antibiotic Abuse: Evidence from an Audit Study in China
by Janet Currie & Wanchuan Lin & Wei Zhang

2010 Battles Among Licensed Occupations: Analyzing Government Regulations on Labor Market Outcomes for Dentists and Hygienists
by Morris M. Kleiner & Kyoung Won Park

2010 Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
by Ernst R. Berndt & Murray L. Aitken

2010 The Impact of State Tax Subsidies for Private Long-Term Care Insurance on Coverage and Medicaid Expenditures
by Gopi Shah Goda

2010 Bundling Among Rivals: A Case of Pharmaceutical Cocktails
by Claudio Lucarelli & Sean Nicholson & Minjae Song

2010 Pricing and Reimbursement in U.S. Pharmaceutical Markets
by Ernst R. Berndt & Joseph P. Newhouse

2010 Has the European Union Achieved a Single Pharmaceutical Market?
by Aysegul Timur & Gabriel Picone & Jeffrey S. DeSimone

2010 Insurers' Negotiating Leverage and the External Effects of Medicare Part D
by Darius N. Lakdawalla & Wesley Yin

2010 Do Bad Report Cards Have Consequences? Impacts of Publicly Reported Provider Quality Information on the CABG Market in Pennsylvania
by Justin Wang & Jason Hockenberry & Shin-Yi Chou & Muzhe Yang

2010 What Does Health Reform Mean for the Healthcare Industry? Evidence from the Massachusetts Special Senate Election
by Mohamad Al-Ississ & Nolan H. Miller

2010 How Do Employers React to A Pay-or-Play Mandate? Early Evidence from San Francisco
by Carrie Hoverman Colla & William H. Dow & Arindrajit Dube

2010 Death by Market Power: Reform, Competition and Patient Outcomes in the National Health Service
by Martin Gaynor & Rodrigo Moreno-Serra & Carol Propper

2010 Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
by Mark Trusheim & Murray L. Aitken & Ernst R. Berndt

2010 The Impact of Health Care Reform On Hospital and Preventive Care: Evidence from Massachusetts
by Jonathan T. Kolstad & Amanda E. Kowalski

2010 The Impact of Direct-to-Consumer Advertising on Pharmaceutical Prices and Demand
by Dhaval Dave & Henry Saffer

2010 The Effect of Malpractice Liability on the Specialty of Obstetrics and Gynecology
by Jessica Wolpaw Reyes

2010 The Effect of Health Insurance Coverage on the Use of Medical Services
by Michael Anderson & Carlos Dobkin & Tal Gross

2010 Measuring the Impact of Health Insurance on Levels and Trends in Inequality
by Richard V. Burkhauser & Kosali I. Simon

2010 Public vs. Private Provision of Charity Care? Evidence from the Expiration of Hill-Burton Requirements in Florida
by Douglas Almond & Janet Currie & Emilia Simeonova

2010 Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
by Joseph P. Cook & Graeme Hunter & John A. Vernon

2010 Does Prescription Drug Adherence Reduce Hospitalizations and Costs?
by William Encinosa & Didem Bernard & Avi Dor

2010 Let them Have Choice: Gains from Shifting Away from Employer-Sponsored Health Insurance and Toward an Individual Exchange
by Leemore Dafny & Katherine Ho & Mauricio Varela

2010 The Impact of Comparative Effectiveness Research on Health and Health Care Spending
by Anirban Basu & Tomas J. Philipson

2010 Adverse events in surgical inpatients: A comparative analysis of public hospitals in Victoria
by Katharina Hauck & Xueyan Zhao & Terri Jackson

2010 A structural equation model of adverse events and length of stay in hospitals
by Katharina Hauck & Xueyan Zhao

2010 Is There an Age Pattern in the Treatment of AMI? Evidence from Ontario
by Michel Grignon & Byron G. Spencer & Li Wang

2010 The Private Cost of Long-Term Care in Canada: Where You Live Matters
by Natasha Fernandes & Byron G. Spencer

2010 Is There an Age Pattern in the Treatment of AMI? Evidence from Ontario
by Michel Grignon & Byron G. Spencer & Li Wang

2010 The Private Cost of Long-Term Care in Canada: Where You Live Matters
by Natasha Fernandes & Byron G. Spencer

2010 Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry
by Appelt, Silvia

2010 Health Insurance Competition in Germany - The Role of Advertising
by Bettina Becker & Silke Uebelmesser

2010 Risk and Uncertainty in Health Investment
by Takao Asano & Akihisa Shibata

2010 The Male-Female Gap in Physician Earnings: Evidence from a Public Health Insurance System
by Engelbert Theurl & Hannes Winner

2010 The Effect of Private Health Insurance on Medical Care Utilization and Self-Assessed Health in Germany
by Hullegie, Patrick & Klein, Tobias J.

2010 The Effect of Private Health Insurance on Medical Care Utilization and Self-Assessed Health in Germany
by Hullegie, Patrick & Klein, Tobias J.

2010 Racial and Ethnic Disparities in the Use of Drug Therapy
by Bowblis, John R. & Yun, Myeong-Su

2010 Racial and Ethnic Disparities in the Use of Drug Therapy
by Bowblis, John R. & Yun, Myeong-Su

2010 Who Wants to Work in a Rural Health Post? The Role of Intrinsic Motivation, Rural Background and Faith-Based Institutions in Rwanda and Ethiopia
by Serneels, Pieter & Montalvo, Jose G. & Pettersson, Gunilla & Lievens, Tomas & Butera, Jean Damascene & Kidanu, Aklilu

2010 Who Wants to Work in a Rural Health Post? The Role of Intrinsic Motivation, Rural Background and Faith-Based Institutions in Rwanda and Ethiopia
by Serneels, Pieter & Montalvo, Jose G. & Pettersson, Gunilla & Lievens, Tomas & Butera, Jean Damascene & Kidanu, Aklilu

2010 The ART of Life: IVF or Child Adoption?
by Gumus, Gulcin & Lee, Jungmin

2010 The ART of Life: IVF or Child Adoption?
by Gumus, Gulcin & Lee, Jungmin

2010 Intrinsic Motivations and the Non-Profit Health Sector: Evidence from Ethiopia
by Serra, Danila & Serneels, Pieter & Barr, Abigail

2010 Intrinsic Motivations and the Non-Profit Health Sector: Evidence from Ethiopia
by Serra, Danila & Serneels, Pieter & Barr, Abigail

2010 Do Minimum Quality Standards Improve Quality? A Case Study of the Nursing Home Industry
by Haizhen Lin

2010 Mesure de l'influence des facteurs socioéconomiques sur l'obésité : regards croisés des modèles logistiques et quantiles
by TCHICAYA Anastase & DIA Modou

2010 Subscribing to Supplemental Health Insurance in France: A Dynamic Analysis of Adverse Selection
by Carine Franc & Marc Perronnin & Aurélie Pierre

2010 Strategic Intelligence Monitor on Personal Health Systems (SIMPHS): Report on Typology/Segmentation of the PHS Market
by Fabienne Abadie & Cristiano Codagnone & Marc van Lieshout & Corina Pascu & Peter Baum & Anssi Hoikkanen & José Antonio Valverde & Ioannis Maghiros

2010 Strategic Intelligence Monitor on Personal Health Systems (SIMPHS): Structure of Available Data and New Measurement Framework with Selected Indicators
by Cristiano Codagnone & Fabienne Abadie

2010 Strategic Intelligence Monitor on Personal Health Systems (SIMPHS) Market Structure and Innovation Dynamics
by Fabienne Abadie & Cristiano Codagnone & Marc van Lieshout & Corina Pascu & Peter Baum & Anssi Hoikkanen & José Antonio Valverde & Ioannis Maghiros

2010 Health Risks in Bangladesh: Can Microinsurance Prevent Vulnerability to Poverty?
by Syed M. Ahsan & Shubhasish Barua

2010 Why Junior Doctors Don’t Want to Become General Practitioners: A Discrete Choice Experiment from the MABEL Longitudinal Study of Doctors
by Peter Sivey & Anthony Scott & Julia Witt & Catherine Joyce & John Humphreys

2010 What Factors Influence the Earnings of GPs and Medical Specialists in Australia? Evidence from the MABEL Survey
by Terence Chai Cheng & Anthony Scott & Sung-Hee Jeon & Guyonne Kalb & John Humphreys & Catherine Joyce

2010 The Effect of Waiting Time and Distance on Hospital Choice for English Cataract Patients
by Peter Sivey

2010 Optimality of no-fault medical liability systems
by Kao, Tina & Vaithianathan, Rhema

2010 Does better structure and process management provide higher outcome quality for the individual patient and among Danish hospital departments?
by Hvenegaard, Anne & Gyrd-Hansen, Dorte & Arendt, Jacob & Højmark Sørensen, Torben & Laustsen, Jesper & Panduro Jensen, Leif

2010 A survey investigation of public hospital physicians’ working time, income and work satisfaction in the primary and secondary job: Descriptive statistics
by Socha, Karolina

2010 Dokumentationsrapport Spørgeskemaundersøgelse Nyorganisering af organdonation i Region Syddanmark
by Draborg et al. , Eva

2010 Exploring the relationship between costs and quality - Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?
by Anne, Hvenegaard & Nielsen Arendt, Jacob & Gyrd-Hansen, Dorte & Street, Andrew

2010 Dokumentationsrapport Spørgeskemaundersøgelse PaRIS – Patientens Rejse i Sundhedssektoren
by Eva, Draborg & Kjær, Trine & Bech, Mickael & Mollerup, Mette

2010 Udviklingen af et sundhedsvæsen - illustreret ved Vejle Amt
by Møller Pedersen, Kjeld

2010 Hjemtagning af dialysebehandling til grønlandske patienter med kronisk nyresvigt
by Kronborg, Christian & Bech, Mickael & Kjær, Trine

2010 Scandinavian long-term care financing
by Karlsson, Martin & Iversen, Tor & Øien, Henning

2010 Brukernes erfaringer med fastlege-ordningen 2001-2008 - Trender i bruk, tilgjengelighet og fornøydhet
by Godager, Geir & Iversen, Tor

2010 Near and Generous? Gift Propensity and Chosen Emotional Distance
by H. Eika, Kari

2010 Margins and Market Shares: Pharmacy Incentives for Generic Substitution
by Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune

2010 Integration and Cooperation in Public Hospitals
by Rehn, Eric

2010 (Re)centralizing tendencies within Health Care Services: Implementation of a new idea?
by Minas, Renate

2010 Health Care Developments in EU Member States: Regressing Trensds and Institutional Similarity?
by Montanari, Ingalill & Nelson, Kenneth

2010 Waiting times and socioeconomic status. Evidence from Norway
by Carlsen, Fredrik & Kaarbøe, Oddvar Martin

2010 Price Sensitivity of Demand for Prescription Drugs: Exploiting a Regression Kink Design
by Simonsen, Marianne & Skipper, Lars & Skipper, Niels

2010 Waiting times and the decision to buy private health insurance. CHERE Working Paper 2010/9
by Meliyanni Johar & Glenn Jones & Michael Keane & Elizabeth Savage & Olena Stavrunova

2010 The demand for private health insurance: do waiting lists or waiting times matter? CHERE Working Paper 2010/8
by Meliyanni Johar & Glenn Jones & Michael Keane & Elizabeth Savage & Olena Stavrunova

2010 Differences in waiting times for elective admissions in NSW public hospitals: A decomposition analysis by non-clinical factors. CHERE Working Paper 2010/7
by Meliyanni Johar & Glenn Jones & Michael Keane & Elizabeth Savage & Olena Stavrunova

2010 Price Discrimination in Practice: The Market for Drugs in Egypt and the U.S
by Rania Zaher Naguib

2010 Predation in Off-Patent Drug Markets
by Laurent Granier & Sébastien Trinquart

2010 I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale
by Fabio Pammolli & Nicola Carmine Salerno

2010 L'integrazione pubblico-privato in sanità e assistenza alla persona
by Fabio Pammolli & Nicola Carmine Salerno

2010 La regolamentazione delle farmacie in Italia
by Fabio Pammolli & Nicola Carmine Salerno

2010 I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età
by Fabio Pammolli & Nicola Carmine Salerno

2010 I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009
by Fabio Pammolli & Nicola Carmine Salerno

2010 I numeri del federalismo: una simulazione per la sanità
by Fabio Pammolli & Nicola Carmine Salerno

2010 The Budget Deficit Scare Story and the Great Recession
by Dean Baker

2010 Pricing and Reimbursement in U.S. Pharmaceutical Markets
by Berndt, Ernst R. & Newhouse, Joseph P.

2010 How Are Government Hospitals Performing? A Study of Resource Management in DOH-retained Hospitals
by Rouselle F. Lavado & Abigail Barbara Sanglay-Dunleavy & Jeanette Jimenez & Yasuhiko Matsuda

2010 Les priorités de la prise en charge financière des soins. Une approche par la philosophie du besoin
by Philippe Batifoulier & John Latsis & Jacques Merchiers

2010 The Long-Term Care System for the Elderly in Portugal
by Samitca, Sanda & Joël, Marie-Eve & Dufour-Kippelen, Sandrine

2010 The Long-Term Care System for the Elderly in France
by Marmier, Mathilde & Duchêne, Catherine & Joël, Marie-Eve & Dufour-Kippelen, Sandrine

2010 L’assurance dépendance privée en France : Spécificité du risque dépendance, caractéristiques des contrats, acteurs, prospective
by Dufour-Kippelen, Sandrine

2010 Health, Expenditure, Longevity and Growth
by Dormont, Brigitte & Oliveira Martins, Joaquim & Pelgrin, Florian & Suhrcke, Marc

2010 The role of psychological reactance and relationship proneness in the commitment decision: An application to a dental prevention program
by Prim-Allaz, Isabelle & Darpy, Denis

2010 The impact of reference pricing system on brand name’s prices : the case of Tunisia
by Ayadi, Inès

2010 Intrinsic motivations and the non-profit health sector: Evidence from Ethiopia
by Danila Serra & Pieter Serneels & Abigail Barr

2010 Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?
by de Frutos, Maria-Angeles & Ornaghi, Carmine & Siotis, Georges

2010 Health insurance competition: the effect of group contracts
by Boone, Jan & Douven, Rudy & Droge, Carline & Mosca, Ilaria

2010 Spatial Disparities in Hospital Performances
by Gobillon, Laurent & Milcent, Carine

2010 Incentive Compatible Reimbursement Schemes for Physicians
by Emons, Winand

2010 Spatial disparities in hospital performances
by Gobillon, Laurent & Milcent, Carine

2010 Health insurance competition: The effect of group contracts
by Jan Boone & C. Droge & I. Mosca

2010 Selective contracting and foreclosure in health care markets
by Michiel Bijlsma & Jan Boone & Gijsbert Zwart

2010 Condiciones Del Acceso A Los Servicios De Salud En La Población De Cartagena De Indias. 2006
by Nelson Alvis Guzmán & Luis Alvis Estrada & Aura Medina Fuentes & María Murillo Ibáñez

2010 Cost-Effectiveness Of Ct, Eus And Pet/Ct In Evaluating Patients With Symptoms Of Pancreatic Cancer In Colombia
by Mario Garcia-Molina & Liliana Alejandra Chicaiza & Oscar Gamboa

2010 Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment
by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume

2010 A Simple Model of Health Insurance Competition
by Alexander Kemnitz

2010 Demand Patterns for Treatment Insurance in Norway
by Karl Ove Aarbu

2010 Passive smoking: the effect of bans and taxes
by Jérôme Adda & Francesca Cornaglia

2010 Indicadores de gastos com serviços médicos no setor de saúde suplementar no Brasil : o caso Sabesprev
by Mônica Viegas Andrade & Ana Carolina Maiab & Cristina Guimarães Rodrigues

2010 Estrutura de mercado do setor de saúde suplementar no Brasil
by Mônica Viegas Andrade & Marina Moreira da Gama & Ricardo Machado Ruiz & Ana Carolina Maia & Bernardo Modenesi & Daniel Matos Tiburcio

2010 Income Growth, Price Variation and Health Care Demand: A Mixed Logit Model Applied to Tow-period Comparison in Rural China
by Martine AUDIBERT & Jacky MATHONNAT & Yong HE

2010 Critical Condition: A Historian's Prognosis on Canada's Aging Healthcare System
by Michael Bliss

2010 Are Assets in Medical Savings Accounts Discounted? Evidence from a Natural Experiment in China
by Maoyong Fan & Zhen Lei & Guoen Liu

2010 Death by Market Power. Reform, Competition and Patient Outcomes in the National Health Service
by Martin Gaynor & Rodrigo Moreno-Serra & Carol Propper

2010 Dynamics of health insurance ownership in Vietnam, 2004 – 06
by Trong-Ha Nguyen & Suiwah Leung

2010 On Utilization and Stockpiling of Prescription Drugs when Co-payments Increase: Heterogeneity across Types of Drugs
by Niels Skipper

2010 Income and the use of prescription drugs for near retirement individuals
by Søren Leth-Petersen & Niels Skipper

2010 Price Sensitivity of Demand for Prescription Drugs: Exploiting a Regression Kink Design
by Marianne Simonsen & Lars Skipper & Niels Skipper

2010 Arzt und Patient. Die Dienstleistung zwischen Hausarzt und Patient im deutschen Gesundheitssystem – eine handlungsfundierte Institutionenanalyse
by Monika Wilken

2010 L’économie de la médecine libérale
by Ducos, Jean

2010 Analysis of Patients' Preferences: Direct Assessment and Discrete-Choice Experiment in Therapy of Adults with Attention-Deficit Hyperactivity Disorder
by Axel C. Mhlbacher & Matthias Nbling

2010 Using Best-Worst Scaling Choice Experiments to Measure Public Perceptions and Preferences for Healthcare Reform in Australia
by Jordan J. Louviere & Terry N. Flynn

2010 Adaptive Choice-Based Conjoint Analysis: A New Patient-Centered Approach to the Assessment of Health Service Preferences
by Charles E. Cunningham & Ken Deal & Yvonne Chen

2010 Conjoint Analysis Applications in Health - How are Studies being Designed and Reported?: An Update on Current Practice in the Published Literature between 2005 and 2008
by Deborah Marshall & John F.P. Bridges & Brett Hauber & Ruthanne Cameron & Lauren Donnalley & Ken Fyie & F. Reed. Johnson

2010 Multi-Criteria Clinical Decision Support: A Primer on the Use of Multiple-Criteria Decision-Making Methods to Promote Evidence-Based, Patient-Centered Healthcare
by James G. Dolan

2010 Patient Preferences and Linear Scoring Rules for Patient-Reported Outcomes
by Ateesha F. Mohamed & A. Brett. Hauber & F. Reed. Johnson & Cheryl D. Coon

2010 Feasibility of Using Modified Adaptive Conjoint Analysis Importance Questions
by Liana Fraenkel

2010 Deborah Marshall, PhD: An Advocate for Patient-Centered Research
by Rebecca L. Hancock-Howard

2010 Quality of Life in Restless Legs Syndrome: A Systematic Review of Clinical Trials and a Critical Review of Instruments
by Jane Speight & Ana Howarth

2010 Electronic Patient Diaries and Questionnaires - ePRO Now Delivering on the Promise?
by Brian Tiplady

2010 Technology, Reform, and Personal Medical Care
by Norman Makous

2010 Patient Views on Determinants of Compliance with Tuberculosis Treatment in the Eastern Cape, South Africa: An Application of Q-Methodology
by Jane Murray. Cramm & Job van Exel & Valerie Mller & Harry Finkenflgel

2010 Towards Patient-Centered Care for Depression: Conjoint Methods to Tailor Treatment Based on Preferences
by Marsha N. Wittink & Mark Cary & Thomas TenHave & Jonathan Baron & Joseph J. Gallo

2010 Patient-Reported Outcomes in Rheumatoid Arthritis: Assessing the Equivalence of Electronic and Paper Data Collection
by Brian Tiplady & Kirsteen Goodman & Geraldine Cummings & Dawn Lyle & Robert Carrington & Clare Battersby & Stuart H. Ralston

2010 Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control
by Robert A. Nathan & Anand A. Dalal & Richard H. Stanford & Eli O. Meltzer & Michael Schatz & Jennifer Derebery & Matthew Mintz & Michelle A. Thompson & Dana B. DiBenedetti

2010 Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?
by Deborah Marshall & S. Elizabeth McGregor & Gillian Currie

2010 'New' Evidence for Clinical Practice Guidelines: Should we Search for 'Preference Evidence'?
by Murray Krahn

2010 Explorative Evaluation of the Impact of Premenstrual Disorder on Daily Functioning and Quality of Life
by Lothar A.J. Heinemann & Thai Do Minh & Anna Filonenko & Kerstin Uhl-Hochgrber

2010 Assessing Drug Treatment Preferences of Patients with Crohn's Disease: A Conjoint Analysis
by Gary R. Lichtenstein & Heidi C. Waters & Jenna Kelly & Susan S. McDonald & Elaine L. Zanutto & David Hendricks & Mirza I. Rahman

2010 Contemporary Adult Diabetes Mellitus Management Perceptions
by William Corser & Catherine Lein & Margaret Holmes-Rovner & Ved Gossain

2010 Effects of HIV Medication Complexity and Depression on Adherence to HIV Medication
by Virender Kumar & William Encinosa

2010 Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ)
by Jrn Moock & Franz Hessel & Diana Ziegeler & Thomas Kubiak & Thomas Kohlmann

2010 Pharmacological Rhythm and Rate Control Treatment for Atrial Fibrillation: Patient and Physician Satisfaction
by Nils Edvardsson & Anders Westlund & Margareta Thimell & Karin Rise & Alexander Todoran & Tanja berg Kurn & John Kindblom & Olle Almgren

2010 Is it Possible to Measure What Truly Matters? The Paradox of Clinical Audit in Developing Continence Service Standards for Older People
by Patrick Brown & Jenny Billings & Adrian Wagg & Jonathan Potter

2010 Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes: An Overview of Clinical Studies
by Brent C. Opmeer & Corianne A.J.M. de Borgie & Ben W.J. Mol & Patrick M.M. Bossuyt

2010 Cost Effectiveness of Darunavir/Ritonavir in Highly Treatment-Experienced, HIV-1-Infected Adults in the USA
by Josephine Mauskopf & Anita Brogan & Silas Martin & Erik Smets

2010 Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients: The POWER Experience
by Andrew M. Hill & Bonaventura Clotet & Margaret Johnson & Matthias Stoll & Nicholas Bellos & Erik Smets

2010 The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France
by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Jean-Marie Lang & Pascal Guillon

2010 Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden
by Ola Ghatnekar & Catharina Hjortsberg & Magnus Gissln & Stefan Lindbck & Mickael Lthgren

2010 The Impact of Disease Stage on Direct Medical Costs of HIV Management: A Review of the International Literature
by Adrian Levy & Karissa Johnston & Lieven Annemans & Andrea Tramarin & Julio Montaner

2010 Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France
by Xavier Colin & Antoine Lafuma & Dominique Costagliola & Erik Smets & Josephine Mauskopf & Pascal Guillon

2010 Clinical Management of Treatment-Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era
by Mark A. Boyd & Andrew M. Hill

2010 Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER
by Andrew M. Hill & Kelly Gebo & Lindsay Hemmett & Mickael Lthgren & Gabriele Allegri & Erik Smets

2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK
by Karen Moeremans & Lindsay Hemmett & Jonas Hjelmgren & Gabriele Allegri & Erik Smets

2010 US Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, HIV-Infected Adults with Evidence of Protease Inhibitor Resistance Included in the TITAN Trial
by Anita Brogan & Josephine Mauskopf & Sandra E. Talbird & Erik Smets

2010 Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK
by Karen Moeremans & Lieven Annemans & Mickael Lthgren & Gabriele Allegri & Veronique Wyffels & Lindsay Hemmet & Karin Caekelbergh & Erik Smets

2010 A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection
by Josephine Mauskopf & Lieven Annemans & Andrew M. Hill & Erik Smets

2010 The Authors' Reply
by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry

2010 The Authors' Reply
by Alok Kapoor & Nila Radhakrishnan & Kenneth J. Smith

2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review
by Jonathan M. Plumb & Andreas Clemens & Brigitta U. Monz

2010 An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus
by W. Robert. Simons & Michael A. Hagan

2010 Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
by Tatia Chay. Woodward & Eskinder Tafesse & Peter Quon & Arthur Lazarus

2010 A New Method for Examining the Cost Savings of Reducing COPD Exacerbations
by Douglas W. Mapel & Michael Schum & Eva Lydick & Jeno P. Marton

2010 Frequency of Treatment-Effect Modification Affecting Indirect Comparisons: A Systematic Review
by Michael Coory & Susan Jordan

2010 Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider
by Terry N. Flynn

2010 The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods
by Simon Eckermann & Jon Karnon & Andrew R. Willan

2010 Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome
by Kate McKeage & Katherine A. Lyseng-Williamson

2010 Economic Burden of Epilepsy among the Privately Insured in the US
by Jasmina I. Ivanova & Howard G. Birnbaum & Yohanne Kidolezi & Ying Qiu & David Mallett & Sue Caleo

2010 Assessing the Relationship between Computational Speed and Precision: A Case Study Comparing an Interpreted versus Compiled Programming Language using a Stochastic Simulation Model in Diabetes Care
by Phil McEwan & Klas Bergenheim & Yong Yuan & Anthony P. Tetlow & Jason P. Gordon

2010 Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review
by Jaume Puig-Junoy

2010 Cost Effectiveness of Cytotoxic and Targeted Therapy for Metastatic Breast Cancer: A Critical and Systematic Review
by Patricia R. Blank & Konstantin J. Dedes & Thomas D. Szucs

2010 Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms
by Joseph Golec & John A. Vernon

2010 Time for Cooperation in Health Economics among the Modelling Community
by Rene J.G. Arnold & Sean Ekins

2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial
by Edward C.F. Wilson & David Price & Stanley D. Musgrave & Erika J. Sims & Lee Shepstone & Jamie Murdoch & H. Miranda. Mugford & Annie Blyth & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Elizabeth V. Hillyer & Ian Harvey

2010 Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy: A Pragmatic Trial
by Edward C.F. Wilson & Erika J. Sims & Stanley D. Musgrave & Lee Shepstone & Annie Blyth & Jamie Murdoch & H. Miranda. Mugford & Elizabeth F. Juniper & Jon G. Ayres & Stephanie Wolfe & Daryl Freeman & Richard F.T. Gilbert & Ian Harvey & Elizabeth V. Hillyer & David Price

2010 Q-TWiST Analysis of Patients Receiving Temsirolimus or Interferon Alpha for Treatment of Advanced Renal Cell Carcinoma
by Arthur S. Zbrozek & Gary Hudes & Donna Levy & Andrew Strahs & Anna Berkenblit & Robert DeMarinis & Shreekant Parasuraman

2010 Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia: A Decision Model
by Jack Brown & Joseph A. Paladino

2010 The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study
by Jihyung Hong & Catherine Reed & Diego Novick & Josep Maria. Haro & Frank Windmeijer & Martin Knapp

2010 The State of Health Economic Evaluation Research in Nigeria: A Systematic Review
by Paul Gavaza & Karen L. Rascati & Abiola O. Oladapo & Star Khoza

2010 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review
by Alok Kapoor & Warren Chuang & Nila Radhakrishnan & Kenneth J. Smith & Dan Berlowitz & Jodi B. Segal & Jeffrey N. Katz & Elena Losina

2010 Does the Inclusion of a Cost Attribute Result in Different Preferences for the Surgical Treatment of Primary Basal Cell Carcinoma?: A Comparison of Two Discrete-Choice Experiments
by Brigitte A.B. Essers & Debby van Helvoort-Postulart & Martin H. Prins & Martino Neumann & Carmen D. Dirksen

2010 Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations
by Stephanie R. Earnshaw & Cheryl L. McDade & Libby K. Black & Christopher F. Bell & Michael W. Kattan

2010 Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
by Roisin Adams & Cathal Walsh & Douglas Veale & Barry Bresnihan & Oliver FitzGerald & Michael Barry

2010 Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?
by Lesley Chim & Patrick J. Kelly & Glenn Salkeld & Martin R. Stockler

2010 Methodological Concerns with Economic Evaluations of Meningococcal Vaccines
by Teresa L. Kauf

2010 Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal
by Adrian Bagust & Janette Greenhalgh & Angela Boland & Nigel Fleeman & Claire McLeod & Rumona Dickson & Yenal Dundar & Christine Proudlove & Richard Shaw

2010 Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs
by D. Clay. Ackerly & Seth W. Glickman & Kevin A. Schulman

2010 Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer's Disease: A UK Evaluation Using Discrete-Event Simulation
by Denis Getsios & Steve Blume & K. Jack. Ishak & Grant D.H. Maclaine

2010 Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US
by Crystal Pike & Howard G. Birnbaum & Matt Schiller & Hari Sharma & Russel Burge & Eric T. Edgell

2010 Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting
by Richard Dodel & Svenja Happe & Ines Peglau & Geert Mayer & Jrgen Wasem & Jens-Peter Reese & Guido Giani & Max Geraedts & Claudia Trenkwalder & Wolfgang H. Oertel & Karin Stiasny-Kolster

2010 Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature
by Huseyin Naci & Rachael Fleurence & Julie Birt & Amy Duhig

2010 Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal
by Mark Rodgers & Susan Griffin & Mike Paulden & Russell Slack & Steven Duffy & John R. Ingram & Nerys Woolacott & Mark Sculpher

2010 Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally
by Mark Sculpher

2010 Towards More Consistent Use of Generic Quality-of-Life Instruments
by Mattias Neyt

2010 Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
by Jeroen P. Jansen & Sabine Gaugris & Ernest H. Choy & Andrew Ostor & Julian T. Nash & Wiro Stam

2010 Pharmacoeconomic Evaluation in Ireland: A Review of the Process
by Lesley Tilson & Aisling OLeary & Cara Usher & Michael Barry

2010 Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis
by Rachael L. Fleurence & D. Eldon. Spackman & Christopher Hollenbeak

2010 Cost Effectiveness of Respiratory Syncytial Virus Prophylaxis: A Critical and Systematic Review
by William A. Prescott & Fred Doloresco & Jack Brown & Joseph A. Paladino

2010 A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
by Jean-Eric Tarride & Robert Hopkins & Gord Blackhouse & James M. Bowen & Matthias Bischof & Camilla Von Keyserlingk & Daria OReilly & Feng Xie & Ron Goeree

2010 Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation
by Gillian M. Keating & Katherine A. Lyseng-Williamson

2010 Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding
by Alan N. Barkun & Viviane Adam & Joseph J.Y. Sung & Ernst J. Kuipers & Joachim Mossner & Dennis Jensen & Robert Stuart & James Y. Lau & Emma Naucler & Jan Kilhamn & Helena Granstedt & Bengt Liljas & Tore Lind

2010 Estimation of a Valuation Function for a Diabetes Mellitus-Specific Preference-Based Measure of Health: The Diabetes Utility Index�
by Murali Sundaram & Michael J. Smith & Dennis A. Revicki & Lesley-Ann Miller & Suresh Madhavan & Gerry Hobbs

2010 The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
by Agnes Benedict & Lara Verdian & Grant Maclaine

2010 Healthcare Rationing by Proxy: Cost-Effectiveness Analysis and the Misuse of the $50 000 Threshold in the US
by John F.P. Bridges & Eberechukwu Onukwugha & C. Daniel. Mullins

2010 Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time
by Mattias Neyt

2010 Can't Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products
by Adrian Towse & Louis P. Garrison

2010 Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential
by Andrew Briggs & Karen Ritchie & Elisabeth Fenwick & Kalipso Chalkidou & Peter Littlejohns

2010 Access with Evidence Development: The US Experience
by Penny E. Mohr & Sean R. Tunis

2010 Access with Evidence Development Schemes: A Framework for Description and Evaluation
by Christopher J. McCabe & Tania Stafinski & Richard Edlin & Devidas Menon

2010 Funding the Unfundable: Mechanisms for Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies into Healthcare Systems
by Tania Stafinski & Christopher J. McCabe & Devidas Menon

2010 Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit
by Devidas Menon & Christopher J. McCabe & Tania Stafinski & Richard Edlin

2010 We Know Accurately Only When We Know Little
by Stuart MacLeod & Craig Mitton

2010 Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer
by Katherine A. Lyseng-Williamson

2010 Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US
by Virginia M. Rosen & Douglas C.A. Taylor & Hemangi Parekh & Ankur Pandya & David Thompson & Andreas Kuznik & David D. Waters & Michael Drummond & Milton C. Weinstein

2010 Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma: Long-Term Economic Evaluation
by Eric Deconinck & Houda Miadi-Fargier & Claude Le. Pen & Pauline Brice

2010 The Cost and Incidence of Prescribing Errors Among Privately Insured HIV Patients
by Fred J. Hellinger & William E. Encinosa

2010 Adverse Drug Interactions: Moving from Perception to Action
by Ryan Mayhew & June M. McKoy & Thanh Ha Luu & Isaac Lopez & Melissa Frick & Charles L. Bennett

2010 Should Financial Incentives be Used to Differentially Reward 'Me-Too' and Innovative Drugs?
by Brita Pekarsky

2010 The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect in Symptomatic Knee Cartilage Lesions in Belgium
by Laetitia Gerlier & Mark Lamotte & Micheline Wille & Peter C. Kreuz & Johan Vanlauwe & Dominique Dubois & Franois M. Meurgey

2010 Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance
by Klaus Kaier & Uwe Frank

2010 A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States
by Ifigeneia Mavranezouli

2010 Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices
by Lizheng Shi & Jinan Liu & Yordanka Koleva & Vivian Fonseca & Anupama Kalsekar & Manjiri Pawaskar

2010 The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments
by Andrea Manca & Mark J. Sculpher & Ron Goeree

2010 The Economics of a 'Liberated' NHS
by Nancy J. Devlin

2010 Is There a Role for Pharmacoeconomics in Developing Countries?
by Babar Zaheer-Ud-Din & Shane Scahill

2010 Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer
by Douglas C.A. Taylor & Vivek Pawar & Denise Kruzikas & Kristen E. Gilmore & Ankur Pandya & Rowan Iskandar & Milton C. Weinstein

2010 An Analysis of NICE's 'Restricted' (or 'Optimized') Decisions
by Phill ONeill & Nancy J. Devlin

2010 Evaluation of Benefit-Risk
by Silvio Garattini

2010 New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition
by Fernando Antoanzas & Pedro Gmez

2010 Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model
by Edward C.F. Wilson

2010 Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy
by Mario Eandi & Lorenzo Pradelli & Sergio Iannazzo & Silvia Chiroli & Giuseppe Pontoriero

2010 Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV
by Teresa L. Kauf & Raymond A. Farkouh & Stephanie R. Earnshaw & Maria E. Watson & Penny Maroudas & Mike G. Chambers

2010 Economic Implications of Sleep Disorders
by Tracy L. Skaer & David A. Sclar

2010 Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review
by William B. Wong & Josh J. Carlson & Rahber Thariani & David L. Veenstra

2010 Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials
by C. Daniel. Mullins & Danielle Whicher & Emily S. Reese & Sean Tunis

2010 No Head-to-Head Trial? Simulate the Missing Arms
by J. Jaime. Caro & K. Jack. Ishak

2010 There's a Reason They Call Them Dummy Variables: A Note on the Use of Structural Equation Techniques in Comparative Effectiveness Research
by William H. Crown

2010 Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
by James E. Signorovitch & Eric Q. Wu & Andrew P. Yu & Charles M. Gerrits & Evan Kantor & Yanjun Bao & Shiraz R. Gupta & Parvez M. Mulani

2010 Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs
by Judith Cahill & Neal Learner

2010 Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward
by Adrian Thomas & Audrey Phillips & Robert Donnelly & Catherine Tak. Piech

2010 Comparative Effectiveness Research: The View from a Pharmaceutical Company
by Marc L. Berger & David Grainger

2010 Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?
by Robert S. Epstein & J. Russell. Teagarden

2010 Comparative Effectiveness Research and the Psychology of Medical Practice: The Vicissitudes of Knowledge Implementation
by Jerome P. Kassirer & John B. Wong

2010 Perspective and Desire in Comparative Effectiveness Research: The Relative Unimportance of Mere Preferences, the Central Importance of Context
by Anthony J. Culyer

2010 Comparative Effectiveness Regulations and Pharmaceutical Innovation
by John A. Vernon & Joseph H. Golec & J. Stedman. Stevens

2010 Cost-Effectiveness Analysis in Markets with High Fixed Costs
by David M. Cutler & Keith M. Marzilli. Ericson

2010 Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows?
by Louis P. Garrison

2010 The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research
by David Meltzer & Anirban Basu & Rena Conti

2010 Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia: South Korea, Taiwan, Thailand and Japan
by Isao Kamae

2010 International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US
by Adrian R. Levy & Craig Mitton & Karissa M. Johnston & Brian Harrigan & Andrew H. Briggs

2010 Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future
by Kalipso Chalkidou & Tom Walley

2010 Perspectives on Comparative Effectiveness Research: Views from Diverse Constituencies
by Dave Nellesen & Howard G. Birnbaum & Paul E. Greenberg

2010 Introducing Perspectives on Comparative Effectiveness Research
by Howard G. Birnbaum & Paul E. Greenberg

2010 Cost Effectiveness of Establishing a Neonatal Screening Programme for Phenylketonuria in Libya
by Erikas Sladkevicius & Rodney J. Pollitt & Ali Mgadmi & Julian F. Guest

2010 Catastrophic Healthcare Payments and Impoverishment in the Occupied Palestinian Territory
by Awad Mataria & Firas Raad & Mohammad Abu-Zaineh & Cam Donaldson

2010 The Use of Research Abstracts in Formulary Decision Making by the Joint Oncology Drug Review of Canada
by Adam V. Weizman & Josh Griesman & Chaim M. Bell

2010 Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa) in Sweden
by Michael Willis & Ulf Persson & York Zoellner & Birgit Gradl

2010 Reforming the English NHS: A Continuing Journey
by Karen Bloor & Alan Maynard

2010 The Missing Technology: An International Comparison of Human Capital Investment in Healthcare
by Bianca K. Frogner

2010 Critique of an Economic Evaluation Using the Drummond Checklist
by Christopher M. Doran

2010 Economic Efficiency of Alcohol Policy
by Christopher M. Doran & Thameemul A. Jainullabudeen

2010 Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe
by Alain Denis & Lut Mergaert & Christel Fostier & Irina Cleemput & Steven Simoens

2010 Cost Effectiveness of Long-Acting Risperidone in Sweden
by Marja Hensen & Bart Heeg & Mickael Lthgren & Ben van Hout

2010 Cost of Illness and Drivers of Cost in Atrial Fibrillation in Sweden and Germany
by Linus Jnsson & sa Eliasson & John Kindblom & Olle Almgren & Nils Edvardsson

2010 Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007
by Javier Orofino & Javier Soto & Miguel A. Casado & Itziar Oyagez

2010 Burden and Cost of Hospital Admissions for Vaccine-Preventable Paediatric Pneumococcal Disease and Non-Typable Haemophilus influenzae Otitis Media in New Zealand
by Richard J. Milne & Stephen Vander Hoorn

2010 Cost Effectiveness of Insulin Glargine plus Oral Antidiabetes Drugs Compared with Premixed Insulin Alone in Patients with Type 2 Diabetes Mellitus in Canada
by Sandra L. Tunis & Luc Sauriol & Michael E. Minshall

2010 Costs and Consequences of Clopidogrel versus Aspirin for Secondary Prevention of Ischaemic Events in (High-Risk) Atherosclerotic Patients in Sweden: A Lifetime Model Based on the CAPRIE Trial and High-Risk CAPRIE Subpopulations
by J. Floris S. Logman & Bart M.S. Heeg & Johan Herlitz & Ben A. van Hout

2010 Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] Questionnaire: Reliability and Validity among Singaporeans with Type 2 Diabetes Mellitus
by Swee Sung. Soon & Su Yen. Goh & Yong Mong. Bee & Jiat Ling. Poon & Shu Chuen. Li & Julian Thumboo & Hwee Lin. Wee

2010 The Effect of Protest Zeros on Estimates of Willingness to Pay in Healthcare Contingent Valuation Analysis
by William M. Fonta & H. Eme. Ichoku & Jane Kabubo-Mariara

2010 Oncologist Preferences for Health States Associated with the Treatment of Advanced Ovarian Cancer
by Lisa M. Hess & Daniel C. Malone & Grant H. Skrepnek & Pamela G. Reed & Edward Armstrong & Stephen Joel. Coons

2010 Gary Buurman, 1944-2010
by Stuart Birks

2010 A Systematic Data Review of the Cost of Rehydration Therapy
by Jay Pershad

2010 Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
by Thilo M. Schaufler & Malte Wolff

2010 Productivity Loss Resulting from Coronary Heart Disease in Australia
by Henry Zheng & Fred Ehrlich & Janaki Amin

2010 Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Programme
by Ying Qiu & Alex Z. Fu & Gordon G. Liu & Dale B. Christensen

2010 Public Option and Private Profits: What do Markets Expect?
by Fabio Milani

2010 Cost Effectiveness of CT Colonography for UK NHS Colorectal Cancer Screening of Asymptomatic Adults Aged 60-69 Years
by David Lee & Dominic Muston & Alison Sweet & Chris Cunningham & Andrew Slater & Kevin Lock

2010 Willingness to Pay for Maternal Health Outcomes: Are Women Willing to Pay More than Men?
by Laura Ternent & Paul McNamee & David Newlands & Danielle Belemsaga & Adjima Gbangou & Suzanne Cross

2010 Health System Choice: A Pilot Discrete-Choice Experiment Eliciting the Preferences of British and Australian Citizens
by Paul A. Scuffham & Jennifer A. Whitty & Matthew Taylor & Ruth C. Saxby

2010 Do Reduced Inpatient Costs Associated with Highly Active Antiretroviral Therapy (HAART) Balance the Overall Cost for HIV Treatment?
by Paul G. Farnham

2010 Cost-Effectiveness Analysis of Treatments for Premenstrual Dysphoric Disorder
by Regina Rendas-Baum & Min Yang & Joseph Gricar & Gene V. Wallenstein

2010 Organization and Estimated Patient-Borne Costs of Oral Anticoagulation Therapy in Italy: Results from a Survey
by Lorenzo Pradelli & Sergio Iannazzo & Orietta Zaniolo & Paola Botrugno

2010 Outpatient Medication Costs of Patients with Cystic Fibrosis in Germany
by Daniela Eidt-Koch & Thomas O.F. Wagner & Thomas Mittendorf & J.-Matthias Graf von der Schulenburg

2010 The Authors' Reply
by George Dranitsaris & Sanjay Mehta

2010 Ongoing Pharmaceutical Reforms in France: Implications for Key Stakeholder Groups
by Catherine Sermet & Veronique Andrieu & Brian Godman & Eric Van Ganse & Alan Haycox & Jean-Pierre Reynier

2010 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: a Population-Based Cost-Minimization Analysis
by Marie-Claude Lefebvre & Elke Hunsche

2010 Healthcare Costs in Renal Transplant Recipients Using Branded versus Generic Ciclosporin
by J. Harold. Helderman & Ning Kang & Antonio P. Legorreta & Judy Y. Chen

2010 Inpatient Costs of Endophthalmitis Evaluated for the Whole of France
by Xavier Colin & Gilles Berdeaux & Antoine Lafuma & Annie Salvanet-Bouchara & Laurent Kodjikian

2010 Analytical Strategies for Characterizing Chemotherapy Diffusion with Patient-Level Population-Based Data
by Cami S. Sima & Katherine S. Panageas & Glenn Heller & Deborah Schrag

2010 Is the Societal Approach Wide Enough to Include Relatives?: Incorporating Relatives' Costs and Effects in a Cost-Effectiveness Analysis
by Thomas Davidson & Lars-ke Levin

2010 Considering the Value Associated with Innovation in Health Technology Appraisal Decisions (Deliberations): A NICE Thing to do?
by Colin Green

2010 Working for God? Evidence from a Change in Financing of Nonprofit Health Care Providers in Uganda
by Ritva Reinikka & Jakob Svensson

2010 Vertical Integration in High-Transaction Cost Sectors: the Case of the Bulgarian Pharmaceutical Industry
by Tamara TODOROVA

2010 Competition Among Hospitals And Its Measurement: Theory And A Case Study
by Eyyup Ecevit & Fatih Ciftci & Yusuf Ag

2010 New medical trends and policies throughout Central and Eastern Europe
by Cristina Teodora NEAGU

2010 The power of management in medical services. Can we manage better for higher quality and more productive medical services?
by Magdalena BARBU & Marian NASTASE

2010 How The Marketing Research Affects The Improvement In The Dental Doctor-Patient Relation
by GEANGU, Petronela Iuliana & GÂRDAN, Daniel Adrian & CETINĂ, Iuliana & GURGU, Elena

2010 Dancing With The Pharmaceutical Industry – Medical Practice Between Ethics And Business
by CRĂCIUNAŞ, Sorin & CRĂCIUNAŞ, Diana

2010 Improving Risk Adjustment in the Czech Republic
by Radovan Chalupka

2010 Problems encountered by tourists
by Madhavi Chockalingam & A. Auroubindo Ganesh

2010 Interconnected firms’ relationships as a source of a competitive advantage
by Iga Rudawska

2010 The SWOT Analysis in the Surgery Section: Instrument of Elaborating the Management Strategy Oriented Towards Marketing
by Dumitru Graziella Corina & Bâtca Viorel & Irimescu Alina Mihaela

2010 The Bearers of Information in Healthcare and their Dynamics
by Ileana G. R?ducanu & ileanaghraducanu@yahoo.com

2010 Application Of “Double Pyramid Of The Leadership” And “Quality Circles” In Health Care Facilities
by Mario Bajto & Igor Alfirevic

2010 Structure And Operational Management In Laboratory Animal Practice
by Iris Broman

2010 Efficiency Audit Within The Social Health Insurance System. Hospital Services Providers In Romania
by Dobra Iulian Bogdan

2010 Building Patient Loyalty Using Online Tools
by Popa Adela Laura & Vladoi Anca Daniela

2010 Consumers of human services: powerless or poorly informed?
by Kari H. Eika

2010 A Study on Global Human-Immunodeficiency Virus and its Effect in Bangladesh
by Jamal Nazrul Islam & Haradhan Kumar Mohajan & Pahlaj Moolio & Raymond Peter

2010 Beeinflussen bessere Qualitätsinformationen die Krankenhauswahl in Deutschland?
by Ansgar Wübker & Dirk Sauerland & Achim Wübker

2010 Hospital competition and prescribing behaviors:empirical evidence from Taiwan
by Ya-Ming Liu & Yea-Huei Kao Yang & Huang-Tz Ou

2010 De-mystifying the Inconvenient Truth : Does Ex Post Moral Hazard Indeed Exist in Korean Private Health Insurance Market?
by Lim, Jae-Young

2010 Análise econômica da interação entre a infraestrutura da saúde pública e privada no Brasil
by Biasoto Jr, Geraldo & Nishijima, Marislei & Cyrillo, Denise Cavallini

2010 Gesundheitspolitik
by Friedrich Breyer

2010 Effective Management of Medical Centers
by Alexander Valkov

2010 Antibiotic Effectiveness: New Challenges in Natural Resource Management
by Markus Herrmann & Ramanan Laxminarayan

2010 New options of financing the health insurance system in Romania
by Bianca MIHART

2010 The Private Health Insurance Market In The European Union
by Bianca Mihart Ph. D Student

2010 An Econometric model for the evolution of the Romanian Interbank Bid Rate (ROBID) in the context of the international financial crisis
by Zapodeanu Daniela Author & Cociuba Mihail-Ioan

2010 Health Insurance Competition in Germany - the Role of Advertising
by Bettina Becker & Silke Uebelmesser

2010 Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
by David M. Cutler & Robert S. Huckman & Jonathan T. Kolstad

2010 Are Health Insurance Markets Competitive?
by Leemore S. Dafny

2010 An Individual Health Plan Exchange: Which Employees Would Benefit and Why?
by Leemore Dafny & Katherine Ho & Mauricio Varela

2010 The Education-Health Gradient
by Gabriella Conti & James Heckman & Sergio Urzua

2009 Factors Affecting Hospital Choice for Rural Iowa Residents
by Barr, Kanlaya Jintanakul & Otto, Daniel

2009 Does Increased Price Competition Affect Entry of New Pharmaceutical Products?
by Granlund, David & Rudholm, Niklas

2009 Price and welfare effects of a pharmaceutical substitution reform
by Granlund, David

2009 Effectiveness of a Lumbar Belt in Subacute Low Back Pain: An Open, Multicentric, and Randomized Clinical Study
by Lerouvreur, Claire & Maurel, Frederique & Le Pen, Claude & Hamonet, Claude & Queneau, Patrice & Calmels, Paul & Thoumie, Philippe

2009 Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
by Bergström, Anders & Maurel, Frédérique & Le Pen, Claude & Lamure, Emilie & Kent, Michael & Bardoulat, Isabelle & Berdeaux, Gilles

2009 Indirect costs of rheumatoid arthritis and their Determinants
by Le Pen, Claude & Schadtler Law, L. & Camara, C. & Bardoulat, I. & Maurel, F.

2009 Public regulation of the cancer drugs market in French hospitals
by Le Pen, Claude & Rieu, C. & Bensadon, M. & Degrassat-Théas, Albane & Paubel, Pascal

2009 Primary care and avoidable hospitalizations : A comparative analysis between france and the uk
by Le Pen, Claude & Mansour, E. & Nestrigue, C. & Amalric, F.

2009 Does pharmaceutical consumption improve health care Status ?
by Amalric, F. & Hauser, S. & Grandfils, N. & Le Pen, Claude

2009 Is There a 'Continental' View of Health Economics Evaluation ?
by Le Pen, Claude

2009 Vieillissement et dépenses de santé
by Dormont, Brigitte

2009 L'accès financier aux soins en France : bilan et perspective
by Jusot, Florence & Wittwer, Jérôme

2009 « Patient » ou « personne malade » ? Les nouvelles figures du consommateur de soins
by Le Pen, Claude

2009 Pharmaceutical Patents: Incentives for Research and Development or Marketing?
by Kurt R. Brekke & Odd Rune Straume

2009 The Diffusion of a Medical Innovation: Is Success in the Stars? Further Evidence
by Mary A. Burke & Gary M. Fournier & Kislaya Prasad

2009 Comment on ‘‘The Diffusion of a Medical Innovation: Is Success in the Stars?’’
by Marco D. Huesch*

2009 Sağlık Bakanlığı'na devredilen SSK hastanelerinin teknik etkinliği ve toplam faktör verimliliği analizi
by İsmet ŞAHİN

2009 Demographic and geographic determinants of regional physician supply
by Kuhn, Michael & Ochsen, Carsten

2009 Waiting Time Targets in Healthcare Markets: How Long Are We Waiting?
by Huw Dixon & Luigi Siciliani

2009 “Do I really need to go to rehab? I’d say no, no, no.” Estimating Price Elasticities of Convalescent Care Programs
by Ziebarth N

2009 The costs of new organisational and financial freedom: The case of English NHS trusts
by Marini G & Miraldo M

2009 Double coverage and demand for health care: Evidence from quantile regression
by Moreira S & Pita Barros P

2009 The effect of private health insurance on medical care utilization and self-assessed health in Germany
by Hullegie P & Klein TJ

2009 Dynamic Cost-offsets of Prescription Drug Expenditures: Panel Data Analysis Using a Copula-based Hurdle Model
by Deb P & Trivedi PK & Zimmer DM

2009 Why Does the Utilization of Pharmaceuticals Vary So Much Across Europe? Evidence from Micro Data on Older Europeans
by Lambrelli D & O’Donnell O

2009 Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?
by Costa-Font, J & Gemmill M & Rubert G

2009 Human Health Care and Selection Effects. Understanding Labour Supply in the Market for Nurses
by Francesca Barigozzi & Gilberto Turati

2009 New Estimates for CRNA Vacancies
by Steven Stern & Elizabeth Merwin & Lorraine Jordan & Lorraine Jordan & Michelle Bucci

2009 Dental Hygiene Regulation and Access to Care
by Tanya Wanchek

2009 The Effect of CSB Services on Hospitalization Rates
by Tanya Wanchek

2009 Estimates of patient costs related with population morbidity: Can indirect costs affect the results?
by M. Carreras & Manuel García-Goñi & Pere Ibern & J. Coderch & L. Vall-Llosera & José María Inoriza

2009 Estimates of patient costs related with population morbidity: Can indirect costs affect the results?
by M. Carreras & Manuel García-Goñi & Pere Ibern & J. Coderch & L. Vall-Llosera & José María Inoriza

2009 Horizontal Inequity in Access to Health Care in Four South American Cities
by Ana Balsa & Máximo Rossi & Patricia Triunfo

2009 Sample selection correction in panel data models when selectivity is due to two sources
by Di Novi, Cinzia

2009 Selective Contracting and Foreclosure in Health Care Markets
by Bijlsma, M. & Boone, J. & Zwart, G.

2009 What Belongs Where? Variable Selection for Zero-Inflated Count Models with an Application to the Demand for Health Care
by Markus Jochmann

2009 Health Status After Cancer. Does It Matter Which Hospital You Belong To?
by Jon H. Fiva & Torbjørn Hægeland & Marte Rønning

2009 Why the Linear Utility Function is a Risky Choice in Discrete-Choice Experiments
by Michele Sennhauser

2009 A Pharmaceutical Innovation – Is it Worth the Money? Whose Money?
by Michele Sennhauser & Peter Zweifel

2009 GPs' preferences: What price fee-for-service?
by Peter Zweifel & Maurus Rischatsch & Angelika Braendle

2009 Advantageous Selection in the Private Hospital Insurance Market in Europe: Evidence on the Role of Education and Cognitive Ability
by Ciro Avitabile

2009 Does Higher Cost Inefficiency Imply Higher Profit Inefficiency? - Evidence on Inefficiency and Ownership of German Hospitals
by Annika Herr & Hendrik Schmitz & Boris Augurzky

2009 Ownership and Financial Performance in the German Hospital Sector
by Boris Augurzky & Dirk Engel & Christoph M. Schmidt & Christoph Schwierz

2009 The Impact of Private versus Social Health Insurance on Offered Waiting Times in German Acute Care Hospitals
by Christoph Schwierz & Ansgar Wübker & Björn A. Kuchinke

2009 Dealing with Excessive Off-label Drug Use: Liability vs. Patent Prolongation
by Stefan Felder & Anja Olbrich

2009 Expansion in Markets with Decreasing Demand – For-Profits in the German Hospital Industry
by Christoph Schwierz

2009 Does Competition from Ambulatory Surgical Centers Affect Hospital Surgical Output and Hospital Profit?
by Plotzke, Michael & Courtemanche, Charles

2009 Does the Profitability of an Outpatient Surgery Influence where it is Performed? A Look at Ambulatory Surgery Centers and Hospitals
by Plotzke, Michael & Courtemanche, Charles

2009 Modeling Internal Decision Making Process: An Explanation of Conflicting Empirical Results on Behavior of Nonprofit and For-Profit Hospitals
by Carroll, Kathleen & Ruseski, Jane

2009 What Belongs Where? Variable Selection for Zero-Inflated Count Models with an Application to the Demand for Health Care
by Markus Jochmann

2009 Itsehoitolääkkeiden kaupan vapauttamisen merkitys kaupalle ja kuluttajille
by Mankinen, Reijo & Rantala, Olavi

2009 Double Coverage and Health Care Utilisation:Evidence from Quantile Regression
by Sara Moreira & Pedro Pita Barros

2009 Estimating the Employer Switching Costs and Wage Responses of Forward-Looking Engineers
by Jeremy T. Fox

2009 Does a Lack of Health Insurance Elicit an Increase in the Rate of Voluntary Military Enlistment in the U.S.? The "Military Health Care Magnet Hypothesis," 1974-2007
by Cebula, Richard & Nair-Reichert, Usha & Taylor, Kyle

2009 Demand for Public Health Care in Pakistan
by Akbari, Ather H. & Rankaduwa, Wimal & Kiani, Adiqa

2009 Role of Quality Management in Pharmaceutical Development: Evidence from Islamabad and Lahore
by Rana, Tariq Mehmood & Salaria, M. Rashid & Herani, Gobind M. & Qureshi, M.A.

2009 On the Determinants of Organizational Forgetting
by Brachet, Tanguy & David, Guy

2009 Social Interaction in Patients'�Hospital Choice: Evidences from Italy
by Moscone, Francesco & Tosetti, Elisa & Vittadini, Giorgio

2009 The effects of upcoding, cream skimming and readmissions on the Italian hospitals efficiency: a population–based investigation
by Berta, P & Callea, G & Martini, G & Vittadini, G

2009 Partnerships for Women's Health - Striving for Best Practice within the UN Global Compact / United Nations University Research Brief 1/2009 (www.unu.edu)
by Timmermann, Martina & Kruesmann, Monika

2009 Performance and Congestion Analysis of the Portuguese Hospital Services
by Simões, Pedro & Cunha Marques, Rui

2009 Regulating a monopolist with unknown bureaucratic tendencies
by Ana Pinto Borges & João Correia-da-Silva & Didier Laussel

2009 A Mathematical Model for Estimating the Number of Health Workers Required for Universal Antiretroviral Treatment
by Till Bärnighausen & David E. Bloom & Salal Humair

2009 Investments in Pharmaceuticals Before and After TRIPS
by Margaret Kyle & Anita McGahan

2009 Paying a Premium on Your Premium? Consolidation in the U.S. Health Insurance Industry
by Leemore Dafny & Mark Duggan & Subramaniam Ramanarayanan

2009 Regulation of private health insurance markets: Lessons from enrollment, plan type choice, and adverse selection in Medicare Part D
by Florian Heiss & Daniel McFadden & Joachim Winter

2009 Genetic Adverse Selection: Evidence from Long-Term Care Insurance and Huntington Disease
by Emily Oster & Ira Shoulson & Kimberly Quaid & E. Ray Dorsey

2009 Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
by David M. Cutler & Robert S. Huckman & Jonathan T. Kolstad

2009 Dynamic Cost-offsets of Prescription Drug Expenditures: Panel Data Analysis Using a Copula-based Hurdle Model
by Partha Deb & Pravin K. Trivedi & David M. Zimmer

2009 A Quality-Adjusted Price Index for Colorectal Cancer Drugs
by Claudio Lucarelli & Sean Nicholson

2009 Selection Stories: Understanding Movement Across Health Plans
by David M. Cutler & Bryan Lincoln & Richard J. Zeckhauser

2009 A Bargain at Twice the Price? California Hospital Prices in the New Millennium
by Yaa Akosa Antwi & Martin Gaynor & William B. Vogt

2009 The Effects of Consumer-Directed Health Plans on Health Care Spending
by Anthony T. Lo Sasso & Lorens A. Helmchen & Robert Kaestner

2009 Equilibrium effects of public goods: The impact of community water fluoridation on dentists
by Katherine Ho & Matthew Neidell

2009 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
by Anupam Jena & Tomas Philipson

2009 What's the "Interest" in FDA Drug Advisory Committee Conflicts of Interest?
by Joseph Golec & John Vernon

2009 Employer-Sponsored Health Insurance and the Promise of Health Insurance Reform
by Thomas C. Buchmueller & Alan C. Monheit

2009 Choice Inconsistencies Among the Elderly: Evidence from Plan Choice in the Medicare Part D Program
by Jason T. Abaluck & Jonathan Gruber

2009 Towards an Efficient Mechanism for Prescription Drug Procurement
by Kyna Fong & Michael Schwarz

2009 Who Pays What for Primary Health Care? Patterns and Determinants of the Fees Paid by Patients in a Mixed Public-Private Financing Model
by Jackie Cumming & Steven Stillman & Michelle Poland

2009 Visiting and Office Home Care Workers’ Occupational Health: An Analysis of Workplace Flexibility and Worker Insecurity Measures Associated with Emotional and Physical Health
by Isik U. Zeytinoglu & Margaret Denton & Sharon Davies & M. Bianca Seaton & Jennifer Millen

2009 Universal Health Insurance Coverage: Progress and Issues. Twenty-first Annual Herbert Lourie Memorial Lecture on Health Policy
by Jonathan Gruber

2009 Physician dispensing and antibiotic prescriptions
by Massimo Filippini & Giuliano Masiero & Karine Moschetti

2009 Copayments for doctor visits in Germany and the probability of visiting a physician - Evidence from a natural experiment
by Farbmacher, Helmut

2009 The Convergence of Health Care Financing Structures: Empirical Evidence from OECD-Countries
by Andrea Leiter & Engelbert Theurl

2009 Racial Differences in Fringe Benefits and Compensation
by Mok, Wallace & Siddique, Zahra

2009 Racial Differences in Fringe Benefits and Compensation
by Mok, Wallace & Siddique, Zahra

2009 Self-Employment and the Role of Health Insurance
by Gumus, Gulcin & Regan, Tracy L.

2009 Self-Employment and the Role of Health Insurance
by Gumus, Gulcin & Regan, Tracy L.

2009 Monopolistic Competition and Costs in the Health Care Sector
by Ingmar Kumpmann

2009 The Welfare Impact of Reducing Choice in Medicare Part D: A Comparison of Two Regulation Strategies
by Claudio Lucarelli & Jeffrey T. Prince & Kosali Simon

2009 Income and the Demand for Complementary Health Insurance in France
by Michel Grignon & Bidénam Kambia-Chopin

2009 Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom
by Nathalie Grandfils & Catherine Sermet

2009 Horizontal inequity in access to health care in four South American cities
by Ana I. Balsa & Máximo Rossi & Patricia Triunfo

2009 The Convergence of Health Care Financing Structures: Empirical Evidence from OECD-Countries
by Andrea M. Leiter & Engelbert Theurl

2009 Effects of fiscal decentralisation and electoral accountability efficiency evidence from the Italian health care sector
by Francesco Porcelli

2009 A Moving Target: Universal Access to Healthcare Services in Latin America and the Caribbean
by William Savedoff

2009 Hospital Markets and the Effect of Competition on Quality
by Alfons Palangkaraya & Jongsay Yong

2009 Hospital Competition, Technical Efficiency, and Quality
by C. L. Chua & Alfons Palangkaraya & Jongsay Yong

2009 Supplier Density and At-home Care Use in Japan: Evidence from a Micro-level Survey on Long Term Care Receivers
by Noguchi, Haruko & Shimizutani, Satoshi

2009 A Model of Hierarchical Professionals: Cooperation and Conflict between Anesthesiologists and CRNAs
by Park, Jee-Hyeong & Spurr, Stephen J. & Chang, Sheng-Kai

2009 Price and welfare effects of a pharmaceutical substitution reform
by Granlund, David

2009 Er der brug for fem milliarder mere i sundhedsvæsenet? Hvad kan de bruges til?
by Møller Pedersen, Kjeld

2009 Market Conditions and General Practitioners’ Referrals
by Iversen, Tor & Ma, Albert

2009 Four Empirical Essays on the Market for General Practitioners' Services
by Godager, Geir

2009 Helsetjenester uten grenser? Om internasjonal handel med helsetjenester og mulige virkninger av internasjonal konkurranse for det norske helsevesenet
by Godager, Geir & Iversen, Tor

2009 Birds of a Feather Flock Together: A Study of Doctor-Patient Matching
by Godager, Geir

2009 Patient switching in a list patient system
by Iversen, Tor & Lurås, Hilde

2009 Does quality influence choice of general practitioner? An analysis of matched doctor-patient panel data
by Biørn, Erik & Godager, Geir

2009 Fastlegeordningen - Utvikling i bruk, tilgjengelighet og fornøydhet
by Godager, Geir & Iversen, Tor & Lurås, Hilde

2009 Laboratorie- og røntgen-virksomheten i kjølvannet av sykehus-reformen: Mer privatisering og lavere kostnader?
by Hagen, Terje P. & Iversen, Tor & Kittelsen, Sverre A.C.

2009 A study of income-motivated behavior among general practitioners in the Norwegian list patient system
by Iversen, Tor

2009 Regulation versus practice - The impact of accessibility on the use of specialist health care in Norway
by Iversen, Tor & Kopperud, Gry Stine

2009 Choosing a GP - Experiences from the implementation of a list patient system in Norway
by Lurås, Hilde

2009 General Practice: Four Empirical Essays on GP Behaviour and Individuals’ Preferences for GPs
by Lurås, Hilde

2009 Economies of scope in Norwegian hospital production - A DEA analysis
by Kittelsen, Sverre A.C. & Magnussen, Jon

2009 The effect of patient shortage on general practitioners’ future income and list of patients
by Iversen, Tor

2009 Fysioterapitjenesten i Asker og Bærum - Kvalitet, tilgjengelighet og effektivitet
by Kittelsen, Sverre A.C. & Roseng, Erik H.

2009 Deductibles in Health Insurance: Pay or Pain?
by Asheim, Geir B. & Nilssen, Tore & Emblem, Anne Wenche

2009 Genetic testing and repulsion from chance
by Hoel, Michael & Nilssen, Tore & Vislie, Jon & Iversen, Tor

2009 The effect of activity-based financing on hospital efficiency: A panel data analysis of DEA efficiency scores 1992-2000
by Biørn, Erik & Hagen, Terje P. & Iversen, Tor & Magnussen, Jon

2009 Reforming decentralized integrated health care systems: Theory and the case of the Norwegian reform
by Pedersen, Kjeld Møller

2009 Designing Competition in Health Care Markets
by Dalen, Dag Morten & Moen, Espen R & Riis, Christian

2009 Health Insurance: Treatment vs. Compensation
by Asheim, Geir & Nilssen, Tore & Emblem, Anne Wenche

2009 Private health care as a supplement to a public health system with waiting time for treatment
by Hoel, Michael & Sæther, Erik Magnus

2009 Betalingsvillighet for behandlingsgaranti -analyse av en befolkningsundersøkelse
by Kopperud, Gry Stine

2009 The interaction between patient shortage and patients waiting time
by Iversen, Tor & Lurås, Hilde

2009 Impact of the public/private mix of health insurance on genetic testing
by Hoel, Michael & Iversen, Tor

2009 The Gate is Open: Primary Care Physicians as Social Security Gatekeepers
by Carlsen, Benedicte & Nyborg, Karine

2009 Towards common European health policies: what are the implications for the Nordic countries?
by Blomqvist, Paula & Larsson, Jakob

2009 Effects of informal eldercare on female labor supply in different European welfare states
by Kotsadam, Andreas

2009 Norwegian priority guidelines: Estimating the distributional implications across age, gender and SES
by Carlsen, Fredrik & Kaarbøe, Oddvar

2009 Prioritization and patients' rights: Analysing the effect of a reform in the Norwegian Hospital Sector
by Askildsen, Jan Erik & Holmås, Tor Helge & Kaarbøe, Oddvar

2009 Inequity in the use of physician services in Norway. Changing patterns over time
by Grasdal, Astrid & Monstad, Karin

2009 Versorgung von HIV-Patienten in Deutschland: Herausforderungen der Zukunft
by Claes, Christa & Mittendorf, Thomas & Stoll, Matthias

2009 Improving Risk Adjustment in the Czech Republic
by Radovan Chalupka

2009 Nuove politiche per l'innovazione nel settore delle scienze della vita
by Laura Magazzini & Fabio Pammolli & Massimo Riccaboni

2009 La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio
by Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno

2009 I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini
by Davide Integlia & Fabio Pammolli

2009 Taming the Deficit: Saving Our Children from Themselves
by Dean Baker & David Rosnick

2009 Free Trade in Health Care: The Gains from Globalized Medicare and Medicaid
by Dean Baker & Hye-Jin Rho

2009 Adverse Selection and Private Health Insurance Coverage in India - A Rational Behaviour Model of Insurance Agents under Asymmetric Information
by Sukumar Vellakkal

2009 L'hôpital et l'économie : le mariage impossible ?
by Fermon, Béatrice

2009 Les dépenses de santé : une augmentation salutaire ?
by Dormont, Brigitte

2009 Démographie médicale et carrières des médecins généralistes : les inégalités entre générations
by Samson, Anne-Laure & Dormont, Brigitte

2009 The influence of supplementary health insurance on switching behaviour : evidence from Swiss data
by Dormont, Brigitte & Geoffard, Pierre-Yves & Lamiraud, Karine

2009 Pharmaco-économie et analyse d’impact budgétaire : les recommandations du CES
by Lévy, Pierre

2009 Taux de perte en vaccins et efficience du Programme élargi de vaccination : où en est-on dans les districts sanitaires africains ?
by Guezo-Mevo, B & Lévy, Pierre & Kora, G & Abdou Garda, M & Barry, A & Agossa, A

2009 Selective contracting and foreclosure in health care markets
by Bijlsma, Michiel & Boone, Jan & Zwart, Gijsbert

2009 Technological adoption in health care
by Barros, Pedro Luis Pita & Martinez-Giralt, Xavier

2009 Waiting-time targets in healthcare markets: How long are we waiting?
by Dixon, Huw David & Siciliani, Luigi

2009 Evaluación De Costo-Efectividad De La Adición De La Resonancia Magnética A La Radiografía Convencional En La Evaluación De Pacientes Con Pie Diabético
by Liliana Chicaíza & Oscar Gamboa & Mario García Molina

2009 Small-area variation in health care affecting the choice of cesarean delivery: the case of a colombian health insurer
by Vecino Ortiz, Andrés Ignacio & Bardey, David & Castano-Yepes, Ramón

2009 Competition among health plans: a two-sided market approach
by David Bardey & Jean-Charles Rochet

2009 Effects of Colombia's Social Protection System on Workers' Choice between Formal and Informal Employment
by Adriana Camacho & Emily Conover & Alejandro Hoyos

2009 Portrait des conditions de pratique et de la pénurie des effectifs infirmiers au Québec
by Mathieu Laberge & Claude Montmarquette

2009 Supplementary Private Health Insurance in Selected Countries: Lessons for EU Governments?
by Sebastian Gechert

2009 Hospital Competition and Quality with Regulated Prices
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2009 Gatekeeping – Open Door to Effective Medical Care Utilisation?
by Eva Hromadkova

2009 Tort Reform and the Demand for Medical Care: Evidence from State-by-State Variation in Non-Economic Damages Caps
by Anca Cotet

2009 How Payment Systems Affect Physicians´ Provision Behaviour – An Experimental Investigation
by Heike Hennig-Schmidt & Reinhard Selten & Daniel Wiesen

2009 Technological adoption in health care
by Pedro Pita Barros & Xavier Martinez-Giralt

2009 Technological adoption in health care
by Pedro Pita Barros & Xavier Martinez-Giralt

2009 Monitoring of Socio-Economic Spreading of drug addiction
by Inessa Gurban

2009 Assurabilité et développement de l'assurance dépendance
by Plisson, Manuel

2009 Incentives in statutory health insurance bonus schemes - Communication as an underrated precondition of success
by Viviane Scherenberg & Gerd Glaeske

2009 Using Qualitative Research to Inform the Development of a Comprehensive Outcomes Assessment for Asthma
by Diane M. Turner-Bowker & Renee N. Saris-Baglama & Michael A. DeRosa & Christine A. Paulsen & Christopher P. Bransfield

2009 How do People with Different Levels of Activation Self-Manage their Chronic Conditions?
by Anna Dixon & Judith Hibbard & Martin Tusler

2009 Patients' Preferences for Generic and Branded Over-the-Counter Medicines: An Adaptive Conjoint Analysis Approach
by Merja Halme & Kari Linden & Kimmo Kri

2009 Using the Pediatric Asthma Therapy Assessment Questionnaire to Measure Asthma Control and Healthcare Utilization in Children
by Gregory B. Diette & Shiva G. Sajjan & Elizabeth A. Skinner & Thomas W. Weiss & Albert W. Wu & Leona E. Markson

2009 First Things First: Difficulty with Current Medications is Associated with Patient Willingness to Add New Ones
by Brian J. Zikmund-Fisher & Timothy P. Hofer & Mandi L. Klamerus & Eve A. Kerr

2009 Using Self-Regulation Theory to Examine Patient Goals, Barriers, and Facilitators for Taking Medication
by Suzan N. Kucukarslan & Sheena Thomas & Abraham Bazzi & Deborah Virant-Young

2009 Gender Differences in the Selection of an Action Plan for Patients with Type 2 Diabetes Mellitus
by Jim Nuovo & Thomas Balsbaugh & Bridget Levich

2009 Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention
by Lauren McCormack & Pamela Williams-Piehota & Carla Bann

2009 Public Involvement in Setting a National Research Agenda: A Mixed Methods Evaluation
by Sandy Oliver & David G. Armes & Gill Gyte

2009 Development and Validation of a Functional Health Literacy Test
by Xu-Hao Zhang & Julian Thumboo & Kok-Yong Fong & Shu-Chuen Li

2009 Using the Health Utilities Index in Routine Clinical Care: Process, Feasibility, and Acceptability: A Randomized Controlled Trial
by Maria-Jose Santana & David H. Feeny

2009 Use of, Satisfaction with, and Willingness to Switch Prescription and Over-The-Counter Treatments for Chronic Urticaria: An Online Survey
by Donald E. Stull & Sonia Gavriel

2009 A Model of Patient Choice with Mid-Therapy Information
by William C. Grant & Teresa L. Kauf

2009 Paying for Enhanced Service: Comparing Patients' Experiences in a Concierge and General Medicine Practice
by Justin M. Ko & David G. Fairchild & Dana G. Safran

2009 Upper Gastrointestinal Symptoms Experienced by Users of Low-Dose Aspirin (Acetylsalicylic Acid) [75-325 mg/day] for Primary and Secondary Coronary Artery Disease Prevention: Perspectives from Patient Focus Groups
by Mary Kay. Margolis & Elisabeth Srstadius & J�rgen N�sdal & Stephanie Manson & Karin Coyne

2009 The Impact on Patient Health Outcomes of Interventions Targeting the Patient-Physician Relationship
by Stephen M. Auerbach

2009 Jordan Louviere, PhD: Honoring a Pioneer in the Study of Patient and Citizen Choice
by Terry Flynn

2009 Personal Health Budgets for the UK NHS: A Revolution for the Patient?
by Peter Beresford

2009 The Effect of Item Screeners on the Quality of Patient Survey Data: A Randomized Experiment of Ambulatory Care Experience Measures
by Hector P. Rodriguez & Ted von. Glahn & Angela Li & William H. Rogers & Dana Gelb. Safran

2009 Health-Related Quality of Life and Quality of Life in Type 2 Diabetes: Relationships in a Cross-Sectional Study
by Murali Sundaram & Jan Kavookjian & Julie Hicks. Patrick

2009 Healthcare Experiences of Limited English-Proficient Asian American Patients: A Cross-Sectional Mail Survey
by Quyen Ngo-Metzger & Dara H. Sorkin & Russell S. Phillips

2009 Impact of Natalizumab on Patient-Reported Outcomes in a Clinical Practice Setting: A Cross-Sectional Survey
by Siddhesh A. Kamat & Krithika Rajagopalan & Judith J. Stephenson & Sonalee Agarwal

2009 Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
by Ronald R. White & Greg Lenhart & Puneet K. Singhal & Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier & Arthur W. Segraves

2009 Utilities of the EQ-5D: Transferable or Not?
by Saskia Knies & Silvia M.A.A. Evers & Math J.J.M. Candel & Johan L. Severens & Andr J.H.A. Ament

2009 The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
by Daniel Polsky & Daria Eremina & Gregory Hess & Jerrold Hill & Scott Hulnick & Adam Roumm & Joanna L. Whyte & Joel Kallich

2009 Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
by Petra Menn & Rolf Holle

2009 A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
by Sandra L. Tunis

2009 Methods for Measuring Temporary Health States for Cost-Utility Analyses
by Davene R. Wright & Eve Wittenberg & J. Shannon. Swan & Rebecca A. Miksad & Lisa A. Prosser

2009 The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?
by John E. Brazier & Simon Dixon & Julie Ratcliffe

2009 Determinants of Willingness to Pay for a New Therapy in a Sample of Menopausal-Aged Women
by Andrej Rasch & Jan-Marc Hodek & Claus Runge & Wolfgang Greiner

2009 The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US
by Jasmina I. Ivanova & Howard G. Birnbaum & Seth Samuels & Matthew Davis & Amy L. Phillips & Dennis Meletiche

2009 Economic Burden of Follicular Non-Hodgkin's Lymphoma
by Talia Foster & Jeffrey D. Miller & Mark E. Boye & Mason W. Russell

2009 A Decision-Theoretic Framework for the Application of Cost-Effectiveness Analysis in Regulatory Processes
by Gianluca Baio & Pierluigi Russo

2009 Estimating Drug Costs in Economic Evaluations in Ireland and the UK: An Analysis of Practice and Research Recommendations
by Dyfrig A. Hughes & Lesley Tilson & Michael Drummond

2009 Case-Control Studies in Pharmacoeconomic Research: An Overview
by J. Jaime. Caro & Krista F. Huybrechts

2009 Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers
by Paul E. Kalb & Paul E. Greenberg

2009 Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease
by Andrew P. Yu & Scott Johnson & Si-Tien Wang & Pavel Atanasov & Jackson Tang & Eric Wu & Jingdong Chao & Parvez M. Mulani

2009 Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracil/l-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan
by Takeru Shiroiwa & Takashi Fukuda & Kojiro Shimozuma & Yasuo Ohashi & Kiichiro Tsutani

2009 Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome
by Jaime Latour-Perez & Eva de-Miguel-Balsa

2009 Costs of Illness in a Russian Cohort of Patients with Parkinson's Disease
by Yaroslav Winter & Sonja von Campenhausen & Georgy Popov & Jens P. Reese & Jens Klotsche & Kai Btzel & Eugene Gusev & Wolfgang H. Oertel & Richard Dodel & Alla Guekht

2009 Economic Evaluations in the EURONHEED: A Comparative Analysis
by Florencia Hutter & Fernando Antoanzas

2009 Societal and Patient Burden of Fibromyalgia Syndrome
by Lieven Annemans & Katell Le Lay & Charles Taeb

2009 Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
by Natasha K. Stout & Amy B. Knudsen & Chung Yin. Kong & Pamela M. McMahon & G. Scott. Gazelle

2009 Is it Time for Reporting Guidelines for Calibration Methods?
by Scott B. Cantor

2009 How to Deal with Cost Differences at Baseline
by Antoinette D.I. van Asselt & Ghislaine A.P.G. van Mastrigt & Carmen D. Dirksen & Arnoud Arntz & Johan L. Severens & Alfons G.H. Kessels

2009 Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants
by Howard G. Birnbaum & Rym Ben-Hamadi & Paul E. Greenberg & Matthew Hsieh & Jackson Tang & Camille Reygrobellet

2009 Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies
by Ling-Hsiang Chuang & Paul Kind

2009 Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis
by Elise M. Pelletier & Boyung Shim & Rami Ben-Joseph & J. Jaime. Caro

2009 Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease
by Maureen P.M.H. Rutten-van Mlken & Martine Hoogendoorn & Leida M. Lamers

2009 Pharmacoeconomic Considerations in Treating Actinic Keratosis
by Marjorie V. Neidecker & Mary Lynn. Davis-Ajami & Rajesh Balkrishnan & Steven R. Feldman

2009 Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group
by Anthony T. Newall & Heath Kelly & Stuart Harsley & Paul A. Scuffham

2009 Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs
by Brian Godman & Ulrich Schwabe & Gisbert Selke & Bjrn Wettermark

2009 Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
by Irina Cleemput & Nancy Thiry

2009 The Author's Reply
by Lieven Annemans, on behalf of the authors

2009 Pharmaceutical Risk-Sharing Agreements
by Afschin Gandjour

2009 Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
by Kamal M.F. Itani & Kasem S. Akhras & Robert Stellhorn & Alvaro Quintana & David Budd & Sanjay Merchant

2009 Utility Assessment in Patients with Mental Disorders: Validity and Discriminative Ability of the Time Trade-Off Method
by Hans-Helmut Knig & Oliver H. Gnther & Matthias C. Angermeyer & Christiane Roick

2009 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations
by Linus Jnsson & Anders Wimo

2009 Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A
by Jeroen Luyten & Philippe Beutels

2009 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature
by Alyssa B. Schultz & Chin-Yu Chen & Dee W. Edington

2009 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
by Joseph Cook & Graeme Hunter & John A. Vernon

2009 Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines
by Uwe Siebert & Gaby Sroczynski & Pamela Aidelsburger & Siegbert Rossol & Jurgen Wasem & Michael P. Manns & John G. McHutchison & John B. Wong

2009 Impact of Transdermal Oxybutynin on Work Productivity in Patients with Overactive Bladder: Results from the MATRIX Study
by Laura T. Pizzi & Amy Talati & Eric Gemmen & Naomi V. Dahl & Thomas J. Bunz & Peter K. Sand

2009 Cost Effectiveness of Drug-Eluting Stents In Belgian Practice: Healthcare Payer Perspective
by Mattias Neyt & Chris De Laet & Annemieke De Ridder & Hans Van Brabandt

2009 Willingness to Pay for Cancer Prevention
by Timothy L. Hunt & Bryan R. Luce & Matthew J. Page & Robin Pokrzywinski

2009 Reviewing the Cost Effectiveness of Rotavirus Vaccination: The Importance of Uncertainty in the Choice of Data Sources
by Joke Bilcke & Philippe Beutels

2009 Economic and Human Costs of Restless Legs Syndrome
by Thomas Reinhold & Falk Mller-Riemenschneider & Stefan N. Willich & Bernd Brggenjrgen

2009 Cost Effectiveness of Herpes Zoster Vaccine in Canada
by Mehdi Najafzadeh & Carlo A. Marra & Eleni Galanis & David M. Patrick & David M. Patrick

2009 Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected
by Allan Wailoo & Aki Tsuchiya & Christopher McCabe

2009 Swimming Upstream: Comparative Effectiveness Research in the US
by Jeremy A. Greene

2009 Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK
by Jeroen P. Jansen & Ritesh Kumar & Yehuda Carmeli

2009 Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
by David R. Rappange & Werner B.F. Brouwer & Rudolf T. Hoogenveen & Pieter H.M. Van Baal

2009 Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
by Aline Gauthier & Andrea Manca & Susan Anton

2009 Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster
by Tracy A. Lieu & G. Thomas. Ray & Ismael R. Ortega-Sanchez & Ken Kleinman & Donna Rusinak & Lisa A. Prosser

2009 Cost Effectiveness of Facility-Based Care, Home-Based Care and Mobile Clinics for Provision of Antiretroviral Therapy in Uganda
by Joseph B. Babigumira & Ajay K. Sethi & Kathleen A. Smyth & Mendel E. Singer

2009 Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries: An Observational Study of Breast Cancer Chemotherapy in Taiwan
by Ya-Chen Tina. Shih & I-Wen Pan & Yi-Wen Tsai

2009 Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program
by Sripen Tantivess & Yot Teerawattananon & Anne Mills

2009 Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region
by Federico Augustovski & Cynthia Iglesias & Andrea Manca & Michael Drummond & Adolfo Rubinstein & Sebastin Garca. Mart

2009 Cost Effectiveness in Low- and Middle-Income Countries: A Review of the Debates Surrounding Decision Rules
by Samuel D. Shillcutt & Damian G. Walker & Catherine A. Goodman & Anne J. Mills

2009 The Future of Health Technology Assessment in Healthcare Decision Making in Asia
by Bong-Min Yang

2009 Developing Nations Special Issue
by Mendel E. Singer

2009 Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
by Peng Liubao & Wan Xiaomin & Tan Chongqing & Jon Karnon & Chen Gannong & Li Jianhe & Cui Wei & Luo Xia & Cao Junhua

2009 30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
by Peter J. Neumann & Chi-Hui Fang & Joshua T. Cohen

2009 A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting
by Laura McCullagh & Lesley Tilson & Cathal Walsh & Michael Barry

2009 Budget-Impact Analyses: A Critical Review of Published Studies
by Ewa Orlewska & Laszlo Gulcsi

2009 Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
by John A. Vernon & Robert Goldberg & Joseph Golec

2009 New Anticoagulants for the Prevention of Deep Venous Thrombosis: Time to Consider Cost Effectiveness?
by Stavros Apostolakis & Eduard Shantsila & Gregory Y.H. Lip

2009 Demand for Outpatient Healthcare: Empirical Findings from Rural India
by Sisira Sarma

2009 Cost Savings Associated with Filling a 3-Month Supply of Prescription Medicines
by Atonu Rabbani & G. Caleb. Alexander

2009 A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine
by Derek Misurski & Maureen J. Lage & Rosalind Fabunmi & Kristina S. Boye

2009 The Cost Effectiveness of Home-Based Provision of Antiretroviral Therapy in Rural Uganda
by Elliot Marseille & James G. Kahn & Christian Pitter & Rebecca Bunnell & William Epalatai & Emmanuel Jawe & Willy Were & Jonathan Mermin

2009 Cost Effectiveness of Antiretrovirals - Long Term or Short Term?
by Steffen Flessa

2009 Assessing Comparative Effectiveness Research in the US
by Joshua P. Cohen & John F.P. Bridges

2009 Which Barriers Prevent the Efficient Use of Resources in Medical Device Sectors?
by Steven Simoens

2009 The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
by Zhimei Liu & Quan V. Doan & Jennifer Malin & Robert Leonard

2009 Economic Evaluation of Sinfrontal in the Treatment of Acute Maxillary Sinusitis in Adults
by Kyra C. Kneis & Afschin Gandjour

2009 Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study
by Ivar Snb. Kristiansen & Dag Nyholm & Dag Isacson

2009 Financial Risk of the Biotech Industry versus the Pharmaceutical Industry
by Joseph Golec

2009 Value-Based Insurance Design in Medicare
by William E. Encinosa

2009 Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences
by Bjrn Wettermark & Brian Godman & Bengt Jacobsson & Flora M. Haaijer-Ruskamp

2009 Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
by Stephanie R. Earnshaw & Jonathan Graham & MerriKay Oleen-Burkey & Jane Castelli-Haley & Kenneth Johnson

2009 Implementing Differential Pricing for Essential Medicines via Country-Specific Bilateral Negotiated Discounts
by Ebenezer Kwabena. Tetteh

2009 Aversion to Geographic Inequality and Geographic Variation in Preferences in the Context of Healthcare
by Carlota Quintal

2009 Comparative Utility of Aripiprazole and Haloperidol in Schizophrenia: Post Hoc Analysis of Two 52-Week, Randomized, Controlled Trials
by John M. Kane & Edward Kim & Hong J. Kan & Zhenchao Guo & John A. Bates & Richard Whitehead & Andrei Pikalov

2009 Development of a Budget-Impact Model to Quantify Potential Cost Savings from Prescription Opioids Designed to Deter Abuse or Ease of Extraction
by Alan G. White & Howard G. Birnbaum & Dov B. Rothman & Nathaniel Katz

2009 Oral Therapies for the Treatment of Pulmonary Arterial Hypertension: A Population-Based Cost-Minimization Analysis
by George Dranitsaris & Sanjay Mehta

2009 Direct Economic Burden of High-Risk and Metastatic Melanoma in the Elderly: Evidence from the SEER-Medicare Linked Database
by Keith L. Davis & Debanjali Mitra & Srividya Kotapati & Ramy Ibrahim & Jedd D. Wolchok

2009 Cost Effectiveness of Sirolimus-Eluting Stents Compared with Bare Metal Stents in Acute Myocardial Infarction: Insights from the TYPHOON Trial
by Florence Canoui-Poitrine & Grgoire Jeanblanc & Corinne Alberti & Priscilla Armoogum & Ana Cebrian & Didier Carri & Patrick Henry & Emmanuel Teiger & Michel Slama & Christian Spaulding & Isabelle Durand-Zaleski

2009 Health-Promoting Schools: Evidence for a Holistic Approach to Promoting Health and Improving Health Literacy
by Albert Lee

2009 Informing Disinvestment through Cost-Effectiveness Modelling: Is Lack of Data a Surmountable Barrier?
by Jonathan Karnon & Jill Carlton & Carolyn Czoski-Murray & Kevin Smith

2009 Planes Mínimos Obligatorios en Mercados de Seguros de Salud Segmentados
by Edmundo Beteta & Manuel Willington

2009 Entrepreneurial Development In The Health Care Industry And Spa Industry In The Northeast Of Thailand
by Suranart Khamanarong & Kimaporn Khamanarong & Yahin Khamanarong

2009 Reasons for Use of Out-of-County Health Care Facilities in the Mississippi Delta
by Wynveen, Brooklynn J.

2009 Spatial Model Specification for Contractual Arrangements between Rural Hospitals and Physicians
by Fannin, J. Matthew & Barnes, James N.

2009 Factors Affecting Hospital Choice for Rural Iowa Residents
by Jintanakul, Kanlaya & Otto, Daniel

2009 Provision of Employer-Sponsored Health Insurance in Small Businesses: Does Rural Location Matter?
by Shields, Martin & Mushinski, David & Davis, Lisa

2009 Does Demolition Of Slums Affects On Pre-School Children’S Health In Mumbai?
by Sanjay RODE

2009 Health care system – concept and importance
by BUSU Cristian

2009 The e-health concept
by Sofia Elena COLESCA & Liliana DOBRICA

2009 Relationships of education and health in the context of economic development
by Helena Vychová & Jan Mertl

2009 Consumer Satisfaction in Social Security Hospital: A Case Study of Punjab Employees Social Security Institution Hospital, Rawalpindi
by Nasir Ayat & Mahmood Khalid

2009 Demand for Public Health Care in Pakistan
by Ather H. Akbari & Wimal Rankaduwa & Adiqa K. Kiani

2009 Relationship And Causality Between Economic Growth Rate And Certain Diseases In The European Union
by UNITA Lucian & STRACIUC Oreste & MAGHIAR T. Traian & BORZA Ciprian Tudor

2009 Role of Quality Management in Pharmaceutical Development: Evidence from Islamabad and Lahore
by Tariq Mehmood & M. Rashid Salaria & M.A. Qureshi

2009 Equidad en el Acceso, Desigualdad y Utilización de los Servicios de Salud. Una Aplicación al Caso Argentino en 2001
by Mariana De Santis & Verónica Herrero

2009 Provisión de cuidados informales y enfermedad de Alzheimer: valoración económica y estudio de la variabilidad del tiempo
by Berta Rivera & Bruno Casal & Luis Currais

2009 Who’s going broke? Comparing growth in Public healthcare expenditure in Ten OECD Countries
by Christian Hagist & Laurence J. Kotlikoff

2009 The Effect of Patient's Asymmetric Information Problem on Medical Care Utilization with Consideration of a Patient's Ex-ante Health Status
by Lim, Jae-Young & Jo, Changik

2009 Comparison of health care financing schemes before and after market reforms in China¡¯s urban areas
by WANG Nuo & SUN Huixin & Christian GERICKE

2009 A theoretical investigation of the reformed public health insurance in urban China
by DING Jihong & ZHU Minglai

2009 Is Health Care demand rationed by income and other determinants? An empirical assessment for Italy
by Rossella Bardazzi

2009 Demografische Entwicklung in Ostdeutschland: Tendenzen und Implikationen
by Joachim Ragnitz

2009 Pourquoi les systèmes de santé sont-ils organisés différemment ?
by Michel Grignon

2009 « Patient » ou « personne malade » ?. Les nouvelles figures du consommateur de soins
by Claude Le Pen

2009 Economias de escala na oferta de serviços públicos de saúde: um estudo para os municípios paulistas
by Enlinson Mattos & Fabiana Rocha & Lucas Novaes & Paulo Arvate & Verônica Orellano

2009 China’s Healthcare Reform And Resources Redistribution: Lessons For Emerging Nations
by Jia CUI & Shaomin HUANG & Gerald RAMEY

2009 Cost Analysis of Good Practice – a Case Study for Dentistry Services in Romania
by Dutescu Adriana & Ponorîca Andreea Gabriela & Stanila Georgiana Oana

2009 Responsiveness of Health Systems: a Barometer of the Quality of Health Services
by Ana-Lucia Ristea & Ion Stegaroiu & Valeriu Ioan-Franc & Vasile Dinu

2009 Health Insurance Status and Physician Behavior in Germany
by Hendrik Jürges

2009 The Evolution of Medical Spending Risk
by Jonathan Gruber & Helen Levy

2009 One Chance in a Million: Altruism and the Bone Marrow Registry
by Theodore C. Bergstrom & Rodney J. Garratt & Damien Sheehan-Connor

2009 Insurer-Provider Networks in the Medical Care Market
by Katherine Ho

2008 Health Insurance or Food for the Family? An Examination into Unintended Consequences
by Olufunke A. Alaba & Steven F. Koch

2008 La rentabilité collective des soins de santé
by Le Pen, Claude

2008 Cost-effectiveness of etanercept and efalizumab In the management of moderate and severe plaque psoriasis
by Feneron, D. & Daures, JP. & Ollivier, AL. & Thiriet, C. & Maurel, F. & Ortonne, JP. & Le Pen, Claude

2008 Lien entre durée de séjour et réadmissions en chirurgie et en obstétrique : étude de deux procédures à partir des données du PMSI
by Bahrami, Stéphane & Holstein, J. & Chatellier, G. & Le Roux, Y. E. & Dormont, Brigitte

2008 Medical demography and intergenerational inequalities in general practitioners' earnings
by Samson, Anne-Laure & Dormont, Brigitte

2008 Socioeconomic Inequalities in Health in 22 European Countries
by Jusot, Florence & Kunst, Anton E. & Leinsalu, Mall & Menvielle, Gwenn & Schaap, Maartje M. & Roskam, Albert-Jan R. & Stirbu, Irina & Mackenbach, Johan P.

2008 Premiers résultats d’une enquête pilote sur l’interaction médecin–patient et son rôle dans la formation des inégalités sociales de santé (Intermède)
by Afrite, A. & Dourgnon, Paul & Pascal, J. & Jusot, Florence & Lang, T. & Lombrail, P.

2008 Run for Cover Now or Later? The impact of premiums, threats and deadlines on supplementary private health insurance in Australia
by Randall P. Ellis & Elizabeth Savage

2008 Incentives and Choice in Health Care
by

2008 Will Competitive Bidding Decrease Medicare Prices
by Brett Katzman & Kerry Anne McGeary

2008 Building a national Health System: Learning From Other Countries' Mistakes
by Brian Ferguson

2008 A Physician Fee that Applies to Acute but not to Preventive Care: Evidence from a German Deductible Program
by Stefan Felder & Andreas Werblow

2008 Qualitative und quantitative Risikoverteilung und die Lösung von Schnittstellenproblemen bei der Umstrukturierung von Kliniken mit Hilfe von PPP
by Jacob, Dieter & Neunzehn, Dirk & Uhlig, Tilo

2008 DRG prospective payment system: refine or not refine?
by Luigi Siciliani & Elín J. G. Hafsteinsdóttir

2008 Bargaining and the Provision of Health Services
by Luigi Siciliani & Anderson Stanciol

2008 Measuring and testing for gender discrimination in professions: the case of English family doctors
by H Gravelle & A Risa Hole

2008 Multitasking, quality and pay for performance
by Oddvar Martin Kaarboe & Luigi Siciliani

2008 Competition and quality in regulated markets: a differential-game approach
by Kurt R. Brekke & Roberto Cellini & Luigi Siciliani & Odd Rune Straume

2008 Do waiting times reduce hospital costs?
by Luigi Siciliani & Anderson Stanciole & Rowena Jacobs

2008 Testing For Asymmetric Information In Insurance Markets With Unobservable Types
by Dardanoni, V & Li Donni, P

2008 The Effects of Financial Incentives on Quality of Care: The Case of Diabetes
by Scott, A & Schurer, S & Jensen, P H & Sivey, P

2008 Salaries, Recruitment, and Retention for CRNA Faculty-Part 1
by Steven Stern & Elizabeth Merwin & Lorraine Jordan & Lorraine Jordan

2008 The E¤ect of Rurality on Mental and Physical Health
by Steven Stern & Elizabeth Merwin & Emily Hauenstein & Ivora Hinton & Virgina Rovnyak & Melvin Wilson & Ishan Williams & Irma Mahone

2008 Clinical Faculty: Major Contributors to the Education of New CRNAs
by Steven Stern, PhD & Elizabeth Merwin, RN & Lorraine Jordan

2008 Selection Effects in Regulated Markets
by Maarten C.W. Janssen & Alexei Parakhonyak

2008 The Price Elasticity of Demand for Pharmaceuticals amongst High Income Older People in Australia: A Natural Experiment
by Siminski, Peter

2008 Adverse selection in the U.S. health insurance markets: Evidence from the MEPS
by Di Novi, Cinzia

2008 Managed Care Konzepte und Lösungsansätze– Ein internationaler Vergleich aus schweizerischer Sicht
by Johannes Schoder & Peter Zweifel

2008 Estimating Welfare in Insurance Markets Using Variation in Prices
by Mark Cullen & Liran Einav & Amy Finkelstein

2008 Feminization of Ageing and Long Term Care Financing in Singapore
by Chia Ngee Choon & Shawna Lim Shi en & Angelique Chan

2008 Do Optional Deductibles Reduce the Number of Doctor Visits? – Empirical Evidence with German Data
by Hendrik Schmitz

2008 Smoking in Germany: Stylized Facts, Behavioral Models, and Health Policy
by Silja Göhlmann & Christoph M. Schmidt

2008 Pharmaceutical industry, drug quality and regulation. Evidence from US and Italy
by Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari

2008 The German Socio-Economic Panel as Reference Data Set
by Thomas Siedler & Jürgen Schupp & C. Katharina Spiess & Gert G. Wagner

2008 New Market Power Models and Sex Differences in Pay
by Michael R. Ransom & Ronald L. Oaxaca

2008 Is There Monopsony In The Labor Market? Evidence From A Natural Experiment
by Douglas Staiger & Joanne Spetz & Ciaran Phibbs

2008 Recruitment Restrictions and labor markets: evidence from the post-bellum U.S. south
by Suresh Naidu

2008 Estimating the Firm’s Labor Supply Curve in a “New Monopsony” Framework: School Teachers in Missouri
by Michael R. Ransom & David P. Sims

2008 The Health Care Crisis in the United States: The Issues and Proposed Solutions by the 2008 Presidential Candidates
by Pareto, Marcos Pompeu

2008 Does quality influence choice of general practitioner? An analysis of matched doctor-patient panel data
by Biorn, Erik & Godager, Geir

2008 Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration
by Ching, Andrew

2008 Una introducción al análisis multinivel: ¿La demanda individual de salud es afectada por el médico de cabecera?
by Herrera Gómez, Marcos

2008 Measuring regional public health provision
by Halkos, George & Tzeremes, Nickolaos

2008 Incidencia del Auge en la salud privada
by Fernández Montt, René

2008 Fishy Gifts: Bribing with Shame and Guilt
by Ong, David

2008 Does better information about hospital quality affect patients’ choice? Empirical findings from Germany
by Wübker, Ansgar & Sauerland, Dirk & Wübker, Achim

2008 Using Cost Observation to Regulate Bureaucratic Firms
by Ana Pinto Borges & João Correia-da-Silva

2008 Worker Sorting, Health Insurance and Wages: Further Evidence from Displaced Workers in the United States
by Steven F. Lehrer & Nuno Sousa Pereira

2008 Pharmaceutical Pricing and Reimbursement Policies in Germany
by Valérie Paris & Elizabeth Docteur

2008 Pharmaceutical Pricing and Reimbursement Policies in Slovakia
by Zoltán Kaló & Elizabeth Docteur & Pierre Moïse

2008 Moving Towards more Sustainable Healthcare Financing in Germany
by Nicola Brandt

2008 Competition and quality in regulated markets: a differential-game approach
by Kurt R. Brekke & Roberto Cellini & Luigi Siciliani & Odd Rune Straume

2008 Hospital competition and quality with regulated prices
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2008 Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment
by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume

2008 Hospitals As Hotels: The Role of Patient Amenities in Hospital Demand
by Dana Goldman & John A. Romley

2008 Re-examining the Effects of Medicaid Expansions for Pregnant Women
by Dhaval M. Dave & Sandra Decker & Robert Kaestner & Kosali I. Simon

2008 Mental Health Parity Legislation, Cost-Sharing and Substance Abuse Treatment Admissions
by Dhaval M. Dave & Swati Mukerjee

2008 Unhealthy Insurance Markets: Search Frictions and the Cost and Quality of Health Insurance
by Randall D. Cebul & James B. Rebitzer & Lowell J. Taylor & Mark E. Votruba

2008 Estimating Welfare in Insurance Markets Using Variation in Prices
by Liran Einav & Amy Finkelstein & Mark R. Cullen

2008 The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures
by Anirban Basu & Wesley Yin & G. Caleb Alexander

2008 Forecasting the Cost of U.S. Health Care in 2040
by Robert W. Fogel

2008 Demanding Customers: Consumerist Patients and Quality of Care
by Hai Fang & Nolan H. Miller & John A. Rizzo & Richard J. Zeckhauser

2008 Simple Humans, Complex Insurance, Subtle Subsidies
by Jeffrey Liebman & Richard Zeckhauser

2008 Medicare Part D's Effects on Elderly Drug Costs and Utilization
by Jonathan D. Ketcham & Kosali Simon

2008 The Welfare Impact of Reducing Choice in Medicare Part D: A Comparison of Two Regulation Strategies
by Claudio Lucarelli & Jeffrey Prince & Kosali Simon

2008 Is American Health Care Uniquely Inefficient?
by Alan M. Garber & Jonathan Skinner

2008 The Effect of Soft Budget Constraints on Access and Quality in Hospital Care
by Yu-Chu Shen & Karen Eggleston

2008 Information, Learning, and Drug Diffusion: the Case of Cox-2 Inhibitors
by Pradeep Chintadunta & Renna Jiang & Ginger Z. Jin

2008 Organizational Fragmentation and Care Quality in the U.S. Health Care System
by Randall D. Cebul & James B. Rebitzer & Lowell J. Taylor & Mark Votruba

2008 Has Public Health Insurance for Older Children Reduced Disparities in Access to Care and Health Outcomes?
by Janet Currie & Sandra Decker & Wanchuan Lin

2008 Pricing and Welfare in Health Plan Choice
by M. Kate Bundorf & Jonathan D. Levin & Neale Mahoney

2008 State and Federal Approaches to Health Reform: What Works for the Working Poor?
by Ellen Meara & Meredith Rosenthal & Anna Sinaiko & Katherine Baicker

2008 Utilisation of Physician Services in the 50+ Population. The Relative Importance of Individual versus Institutional Factors in 10 European Countries
by Kristian Bolin & Anna Lindgren & Bjorn Lindgren & Petter Lundborg

2008 Is There a Market for Voluntary Health Insurance in Developing Countries?
by Mark Pauly & Fredric E. Blavin & Sudha Meghan

2008 Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
by Patricia M. Danzon & Andrew J. Epstein

2008 The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
by Mark Duggan & Fiona Scott Morton

2008 Do Markets Respond to Quality Information? The Case of Fertility Clinics
by M. Kate Bundorf & Natalie Chun & Gopi Shah Goda & Daniel P. Kessler

2008 After Midnight: A Regression Discontinuity Design in Length of Postpartum Hospital Stays
by Douglas Almond & Joseph J. Doyle, Jr.

2008 Choice, Price Competition and Complexity in Markets for Health Insurance
by Richard Frank & Karine Lamiraud

2008 The Changing Effect of HMO Market Structure: An Analysis of Penetration, Concentration, and Ownership Between 1994-2005
by Yu-Chu Shen & Vivian Wu & Glenn Melnick

2008 Managed Care and Medical Expenditures of Medicare Beneficiaries
by Michael Chernew & Philip DeCicca & Robert Town

2008 Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance
by David M. Cutler & Amy Finkelstein & Kathleen McGarry

2008 How Costly Is Hospital Quality? A Revealed-Preference Approach
by John A. Romley & Dana Goldman

2008 Visiting and Office Home Care Workers’ Occupational Health: An Analysis of Workplace Flexibility and Worker Insecurity Measures Associated with Emotional and Physical Health
by Isik U. Zeytinoglu & Margaret Denton & Sharon Davies & M. Bianca Seaton & Jennifer Millen

2008 An Application of Price and Quantity Indexes in the Analysis of Changes in Expenditures on Physician Services
by Frank T. Denton & Christine H. Feaver & Byron G. Spencer

2008 An Application of Price and Quantity Indexes in the Analysis of Changes in Expenditures on Physician Services
by Frank T. Denton & Christine H. Feaver & Byron G. Spencer

2008 Adverse Selection and Career Outcomes in the Ethiopian Physician Labor Market
by Joost de Laat & William Jack

2008 Dispensing practices and antibiotic use
by Massimo Filippini & Giuliano Masiero & Karine Moschetti

2008 Economies of scale and efficiency measurement in Switzerland's Nursing homes
by Medhi Farsi & Massimo Filippini & Diego Lunati

2008 The Chinese Health Care System: Structure, Problems and Challenges
by Jens Leth Hougaard & Lars Peter Østerdal & Yi Yu

2008 A Dynamic Analysis of the Demand for Health Insurance and Health Care
by Bolhaar, Jonneke & Lindeboom, Maarten & van der Klaauw, Bas

2008 A Dynamic Analysis of the Demand for Health Insurance and Health Care
by Bolhaar, Jonneke & Lindeboom, Maarten & van der Klaauw, Bas

2008 Wage Effects of Recruitment Methods: The Case of the Italian Social Service Sector
by Mosca, Michele & Pastore, Francesco

2008 Wage Effects of Recruitment Methods: The Case of the Italian Social Service Sector
by Mosca, Michele & Pastore, Francesco

2008 The Health Returns to Education: What Can We Learn from Twins?
by Lundborg, Petter

2008 The Health Returns to Education: What Can We Learn from Twins?
by Lundborg, Petter

2008 Grenzen des Wettbewerbs im Gesundheitswesen
by Ingmar Kumpmann

2008 La qualité des soins en France : comment la mesurer pour l'améliorer ?
by Zeynep Or & Laure Com-Ruelle

2008 Comparability of Health Care Responsiveness in Europe using anchoring vignettes from SHARE
by Nicolas Sirven & Brigitte Santos-Eggimann & Jacques Spagnoli

2008 Role of private hospitals in Kerala: An Exploration
by T.R. Dilip

2008 Collusion in the Private Health Insurance Market: Empirical Evidence for Chile
by Claudio Agostini & Eduardo Saavedra & Manuel Willington

2008 Consumer Loyalty in the Swedish Pharmaceuticals Market
by Granlund, David & Rudholm, Niklas

2008 Does physicians' compensation affect the probability of their vetoing generic substitution?
by Granlund, David

2008 Hospitalers omkostninger, struktur og effektivitet. En undersøgelse af stordrifts- og samdriftsfordele i det danske sygehusvæsen
by Kristensen, Troels & Møller Pedersen, Kjeld & Rose Olsen, Kim

2008 Nurses Wanted: Is the Job Too Hars or is the Wage Too Low
by Di Tommaso, M. L. & Strøm, Steinar & Sæther, Erik Magnus

2008 Consumer Loyalty in the Swedish Pharmaceuticals Market
by Granlund, David & Rudholm, Niklas

2008 Does Physicians' Compensation Affect the Probability of their Vetoing Generic Substitution?
by Granlund, David

2008 Does a mandatory telemedicine call prior to visiting a physician reduce costs or simply attract good risks?
by Chantal Grandchamp & Lucien Gardiol

2008 Nutzen und Kosten der derzeitigen Regulierung des Apothekenmarktes in Deutschland
by von der Schulenburg, J.-Matthias & Hodek, Jan-Marc

2008 The Intergenerational Content of Social Spending: Health Care and Sustainable Growth in China
by Jean-Paul Fitoussi & Francesco Saraceno

2008 Strategic interaction between general practitioners and specialists: implications for gatekeeping
by Catherine SCHAUMANS

2008 Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale
by Roberto Cicciomessere & Fabio Pammolli & Nicola Carmine Salerno

2008 La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche
by Fabio Pammolli & Nicola Carmine Salerno

2008 The Impact of the Medicare Drug Benefit on Health Care Spending by Older Households
by Dean Baker & Ben Zipperer

2008 Asignación de trasplantes renales en México: estimación de un sistema de puntajes
by Alexander Elbittar & Gabriela Calderón

2008 The Production of Child Health in Kenya: A Structural Model of Birth Weight
by Germano Mwabu

2008 Demanding Customers: Consumerist Patients and Quality of Care
by Fang, Hai & Miller, Nolan & Rizzo, John A. & Zeckhauser, Richard

2008 The Status of the Millennium Development Goals in the UNECE Region
by Patrice Robineau

2008 Feminization of Ageing and Long Term Care Financing in Singapore
by Chia Ngee Choon & Shawna Lim Shi’en & Angelique Chan

2008 The German Socio-Economic Panel as a Reference Data Set
by Thomas Siedler & Jürgen Schupp & C. Katharina Spieß & Gert G. Wagner

2008 Do Optional Deductibles Reduce the Number of Doctor Visits?: Empirical Evidence with German Data
by Hendrik Schmitz

2008 Les contrats d’assurance dépendance sur le marché français en 2006
by Dufour-Kippelen, Sandrine

2008 Assurance dépendance, effets de sélection et antisélection
by Legal, Renaud & Plisson, Manuel

2008 Commentaire sur l’article de G. Menvielle et al. «Evolution temporelle des inégalités sociales de mortalité en France entre 1968 et 1996. Etude en fonction du niveau d’études par cause de décès », RESP 2007 ; 55 : 97-105
by Grignon, Michel & Jusot, Florence

2008 Investigating Generic and Brand Name Pharmaceutical’s Market Shares and Prices in Tunisia
by Chebbi, Houssem Eddine & Boujelbene, Younes & Ayadi, Inès

2008 La complémentaire santé : un bien normal ?
by Jusot, Florence & Legal, Anne & Wittwer, Jérôme

2008 A Dynamic Analysis of the Demand for Health Insurance and Health Care
by Bolhaar, Jonneke & Lindeboom, Maarten & van der Klaauw, Bas

2008 Competition and quality in regulated markets with sluggish demand
by Brekke, Kurt Richard & Cellini, Roberto & Siciliani, Luigi & Straume, Odd Rune

2008 Multitasking, Quality and Pay for Performance
by Kaarboe, Oddvar Martin & Siciliani, Luigi

2008 Can We Measure Hospital Quality from Physicians' Choices?
by Machado, Matilde Pinto & Mora, Ricardo & Romero-Medina, Antonio

2008 Competition and Quality in Regulated Markets: a Differential-Game Approach
by Brekke, Kurt Richard & Cellini, Roberto & Siciliani, Luigi & Straume, Odd Rune

2008 Upcoding and Optimal Auditing in Health Care (or The economics of DRG creep)
by Kuhn, Michael & Siciliani, Luigi

2008 Vertical relationships between health insurers and healthcare providers
by Michiel Bijlsma & Arno Meijer & Victoria Shestalova

2008 Rising health spending, new medical technology and the Baumol effect
by Marc Pomp & Suncica Vujic

2008 Bondades y Limitaciones de la Focalización con Proxy Means Tests: El Caso del Sisben en Colombia
by Martha Bottia & Lina Cardona & Carlos Medina

2008 Price Adjustment in the Hospital Sector
by Marisa Miraldo & Luigi Siciliani & Andrew Street

2008 Optimal Contracts and Contractual Arrangements Within the Hospital: Bargaining vs. Take-it-or-leave-it Offers
by Matteo M Galizzi & Marisa Miraldo

2008 Determinants of General Practitioners' Wages in England
by Stephen Morris & Matt Sutton & Hugh Gravelle & Bob Elliott & Arne Hole & Ada Ma & Bonnie Sibbald & Diane Skatun

2008 Pharmaceutical Patents: Incentives for R&D or Marketing?
by Kurt R. Brekke & Odd Rune Straume

2008 The impact of upcoding, cream skimming and readmissions on hospitals’ efficiency: the case of Lombardy
by Paolo Berta & Giuditta Callea & Gianmaria Martini & Giorgio Vittadini

2008 Technical efficiency of Italian public hospitals
by Alessandro Schiavone

2008 The Italian hospital system
by Maurizio Lozzi

2008 Re-visiting the Health Care Luxury Good Hypothesis: Aggregation, Precision, and Publication Biases?
by Joan Costa-Font & Marin Gemmill & Gloria Rubert

2008 What is the Impact of Duplicate Coverage on the Demand for Health Care in Germany?
by Martin H. Vargas & Majed Elhewaihi

2008 A Future of Good Jobs? America's Challenge in the Global Economy
by

2008 Les déterminants de la demande individuelle de couverture complémentaire santé en France
by Legal, Renaud

2008 Society Change or Organisational Evolution? Global or Local e-Pharmacies?
by Bruno SALGUES & Kalyan BOLLAMPALLY

2008 Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study
by Kavita Gajria & Mark Kosinski & Jeff Schein & Shane Kavanagh & Dominique Dubois

2008 How Much Time Do Patients Spend on Outpatient Visits?: The American Time Use Survey
by Louise B. Russell & Yoko Ibuka & Deborah Carr

2008 The Burden of Restless Legs Syndrome: An Assessment of Work Productivity, Sleep, Psychological Distress, and Health Status Among Diagnosed and Undiagnosed Individuals in an Internet-Based Panel
by Sheri Fehnel & Laurie Zografos & Tammy Curtice & Hemal Shah & Lori McLeod

2008 Association of Pre-Existing Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients
by Steven B. Zeliadt & Scott D. Ramsey & Arnold L. Potosky & Neeraj K. Arora & David K. Blough & Ingrid Oakley-Girvan & Ann S. Hamilton & Stephen K. Van Den Eeden & David F. Penson

2008 Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy
by Candida M. Mastroianni & Caterina Viscomi & Silvia Ceniti & Rosanna De Simone & Aldo Filice & Gennaro Gadaleta Caldarola & Stefania Infusino & Caterina Manfredi & Antonio Rea & Claudia Sandomenico & Salvatore Turano & Francesco Serrano & Giovanni Condemi & Carla Cortese & Tullia Prantera & Salvatore Palazzo

2008 Hormonal Contraceptive Users' Self-Reported Benefits, Adverse Reactions, and Fears in 2001 and 2007
by Miia Tiihonen & Hanna-Mari Leppanen & Anna-Mari Heikkinen & Riitta Ahonen

2008 Obesity and Symptom Burden in Family Medicine Patients
by James E. Rohrer & Norman H. Rasmussen & Margaret S. Houston & Kurt B. Angstman

2008 Understanding and Assessing the Impact of Alcoholism on Quality of Life: A Systematic Review of the Content Validity of Instruments Used to Assess Health-Related Quality of Life in Alcoholism
by Matthew D. Reaney & Colin Martin & Jane Speight

2008 Erik Rifkin, PhD: Writer, Researcher, Patient, and Citizen Advocate
by Jennifer Chang

2008 Association Between Measures of Fatigue and Health-Related Quality of Life in Rheumatoid Arthritis and Osteoarthritis
by Marita Cross & Helen Lapsley & Annica Barcenilla & Peter Brooks & Lyn March

2008 The Relationship Between Physician Friendliness and Caring, and Patient Satisfaction: Findings from an Internet-Based Survey
by Adam A. Uhas & Fabian T. Camacho & Steven R. Feldman & Rajesh Balkrishnan

2008 Does Behavioral Bootstrapping Boost Weight Control Confidence?: A Pilot Study
by James E. Rohrer & Kristin S. Vickers-Douglas & Robert J. Stroebel

2008 Making Patient-Centered Care More Visible: Planetree's Vision
by Carrie Brady

2008 Honoring the Life of a Pioneer in Patient-Centered Care: Harvey Picker, PhD (1915-2008)
by Susan B. Frampton & Sara Guastello

2008 Translation and Validation of the Chinese Diabetic Foot Ulcer Scale - Short Form
by Lan Fong Hui & Daniel Yee-Tak Fong & Michael Yam & Wing Yuk Ip

2008 The Use of Multi-Criteria Decision Analysis Weight Elicitation Techniques in Patients with Mild Cognitive Impairment: A Pilot Study
by Janine A. van Til & James G. Dolan & Anne M. Stiggelbout & Karin C.G.M. Groothuis & Maarten J. IJzerman

2008 Psychometric Performance of the National Eye Institute 25-Item Visual Function Questionnaire: In Turkish Diabetic Retinopathy Patients
by Akinci Fevzi & Yildirim Aysegul

2008 A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer
by Alistair E. Ring & Kerry A. Cheong & Claire L. Watkins & David Meddis & David Cella & Peter G. Harper

2008 Lillie Shockney: Breast Cancer Survivor, Advocate, and Researcher
by John F.P. Bridges

2008 When Time is Not on Your Side: Patient Experiences with Waiting for Home Care and Admission to a Nursing or Residential Home
by N. Job A. van Exel & Marion de Ruiter & Werner B.F. Brouwer

2008 Honoring Pioneers in Patient-Centered Outcomes Research
by John F.P. Bridges & Christopher I. Carswell

2008 Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study
by Maribel Salas & Catarina I. Kiefe & Pamela J. Schreiner & Yongin Kim & Lucia Juarez & Sharina D. Person & O. Dale Williams

2008 Age and Choice in Health Insurance: Evidence from a Discrete Choice Experiment
by Karolin Becker & Peter Zweifel

2008 If You Want Patients with Knee Osteoarthritis to Exercise, Tell Them about NSAIDs
by Liana Fraenkel & Terri Fried

2008 Concordance of Couples' Prostate Cancer Screening Recommendations from a Decision Analysis
by Scott B. Cantor & Robert J. Volk & Murray D. Krahn & Alvah R. Cass & Jawaria Gilani & Susan C. Weller & Stephen J. Spann

2008 The Role of The Patient in Promoting Patient-Centered Outcomes Research
by Michael J. Klag & Ellen J. MacKenzie & Christopher I. Carswell & John F.P. Bridges

2008 Subgroups and Heterogeneity in Cost-Effectiveness Analysis
by Mark Sculpher

2008 Exploring Uncertainty in Cost-Effectiveness Analysis
by Karl Claxton

2008 Valuing Health States for Use in Cost-Effectiveness Analysis
by John Brazier

2008 Use of Indirect and Mixed Treatment Comparisons for Technology Assessment
by Alex Sutton & A.E. Ades & Nicola Cooper & Keith Abrams

2008 Estimating `Costs' for Cost-Effectiveness Analysis
by Alec Miners

2008 The NICE Cost-Effectiveness Threshold: What it is and What that Means
by Christopher McCabe & Karl Claxton & Anthony J. Culyer

2008 NICE Methodology for Technology Appraisals: Cutting Edge or Tried and Trusted?
by Louise Longworth & Carole Longson

2008 NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
by Julia Earnshaw & Gavin Lewis

2008 NICE's 2008 Methods Guide: Sensible Consolidation or Opportunities Missed?
by Mark Sculpher

2008 Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer
by Kate McKeage & Katherine A. Lyseng-Williamson

2008 Demand Forecasting for Preventive AIDS Vaccines: Economic and Policy Dimensions
by Robert Hecht & Gian Gandhi

2008 Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User's Guide
by Emily Lancsar & Jordan Louviere

2008 Assessing the Impact of Global Price Interdependencies
by Anke Richter

2008 Modelling Approaches: The Case of Schizophrenia
by Bart M.S. Heeg & Joep Damen & Erik Buskens & Sue Caleo & Frank de Charro & Ben A. van Hout

2008 Waiting for Reimbursement of New Medicines in Canada: It's Time for a Rethink
by Brett J. Skinner

2008 Cost-Effectiveness Analyses of Natalizumab (Tysabri(R)) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK
by Ray Gani & Gavin Giovannoni & David Bates & Belinda Kemball & Steve Hughes & John Kerrigan

2008 Generic Entry, Reformulations and Promotion of SSRIs in the US
by Haiden A. Huskamp & Julie M. Donohue & Catherine Koss & Ernst R. Berndt & Richard G. Frank

2008 Future Drug Prices and Cost-Effectiveness Analyses
by Martin Hoyle

2008 Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes: A Systematic Review on Content and Adherence to Guidelines
by Stefan Vegter & Cornelis Boersma & Mark Rozenbaum & Bob Wilffert & GerJan Navis & Maarten J. Postma

2008 The Author's Reply
by Adam E. Block

2008 Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
by Jon Jureidini & Barbara Mintzes & Melissa Raven

2008 Pharmaceutical Risk-Sharing Agreements
by Joseph P. Cook & John A. Vernon & Richard Manning

2008 Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe
by Bjorn Wettermark & Brian Godman & Karolina Andersson & Lars L. Gustafsson & Alan Haycox & Vittorio Bertele'

2008 Cost Effectiveness of the German Screen-and-Treat Strategy for Postmenopausal Osteoporosis
by Dirk Mueller & Eva Weyler & Afschin Gandjour

2008 Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model: Application to a Population of US Adult Smokers
by Paul Howard & Christopher Knight & Annabel Boler & Christine Baker

2008 Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada
by Deborah A. Marshall & Patrick R. Douglas & Michael F. Drummond & George W. Torrance & Stuart MacLeod & Orlando Manti & Lokanadha Cheruvu & Ron Corvari

2008 Cost of Epilepsy: A Systematic Review
by Adam Strzelczyk & Jens Peter Reese & Richard Dodel & Hajo M. Hamer

2008 Economic Burden of Heart Failure in the Elderly
by Lawrence Liao & Larry A. Allen & David J. Whellan

2008 Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-alpha Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia
by Shelby D. Reed & Kevin J. Anstrom & Yanhong Li & Kevin A. Schulman

2008 A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
by Ana M.C. Sogayar & Flavia R. Machado & Alvaro Rea-Neto & Amselmo Dornas & Cintia M.C. Grion & Suzana M.A. Lobo & Bernardo R. Tura & Carla L.O. Silva & Ruy G.R. Cal & Idal Beer & Vilto Michels & Jorge Safi & Marcia Kayath & Eliezer Silva

2008 Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making
by Lieven Annemans

2008 Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States
by Nick Bansback & Roberta Ara & Jonathan Karnon & Aslam Anis

2008 Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence
by Christopher M. Doran

2008 Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment
by Nancy Kline Leidy & Margaret Vernon

2008 Cost-Effectiveness Analysis: Developing Nations Left Behind
by Mendel E. Singer

2008 Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
by Martin Knapp & Frank Windmeijer & Jacqueline Brown & Stathis Kontodimas & Spyridon Tzivelekis & Josep Maria Haro & Mark Ratcliffe & Jihyung Hong & Diego Novick

2008 An Economic Evaluation of Atorvastatin for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
by Scott D. Ramsey & Lauren D. Clarke & Craig S. Roberts & Sean D. Sullivan & Scott J. Johnson & Larry Z. Liu

2008 Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model
by Simon Kreck & Jochen Klaus & Reiner Leidl & Christian von Tirpitz & Alexander Konnopka & Herbert Matschinger & Hans-Helmut Konig

2008 The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4
by Paul A. Scuffham & Jennifer A. Whitty & Andrew Mitchell & Rosalie Viney

2008 Making a Case for Employing a Societal Perspective in the Evaluation of Medicaid Prescription Drug Interventions
by Sanjoy Roy & S. Suresh Madhavan

2008 An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare
by Marc A. Koopmanschap & N. Job A. van Exel & Bernard van den Berg & Werner B.F. Brouwer

2008 Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases
by Kate McKeage & Greg L. Plosker

2008 Community and Patient Values for Preventing Herpes Zoster
by Tracy A. Lieu & Ismael Ortega-Sanchez & G. Thomas Ray & Donna Rusinak & W. Katherine Yih & Peter W. Choo & Irene Shui & Ken Kleinman & Rafael Harpaz & Lisa A. Prosser

2008 Preferences of Patients with Diabetes Mellitus for Inhaled versus Injectable Insulin Regimens
by Jeremy Chancellor & Samuel Aballea & Alison Lawrence & Rob Sheldon & Sandrine Cure & Juliette Plun-Favreau & Nick Marchant

2008 Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches
by Sun-Young Kim & Sue J. Goldie

2008 Projecting Vaccine Efficacy: Accounting for Geographic Strain Variations
by Johnie Rose & Mendel E. Singer

2008 Transparency of Economic Evaluations of Health Technologies
by Joan Rovira

2008 Meandering Down the Road to Transparency
by Christopher I. Carswell & Joseph A. Paladino

2008 Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents
by Mei Sheng Duh & Jennifer R. Weiner & Leigh Ann White & Patrick Lefebvre & Paul E. Greenberg

2008 Having Your Cake and Eating It: Office of Fair Trading Proposal for Funding New Drugs to Benefit Patients and Innovative Companies
by Brian Godman & Alan Haycox & Ulrich Schwabe & Roberta Joppi & Silvio Garattini

2008 Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness
by Lisa A. Prosser & Megan A. O'Brien & Noelle-Angelique M. Molinari & Katherine H. Hohman & Kristin L. Nichol & Mark L. Messonnier & Tracy A. Lieu

2008 The Burden of Schizophrenia on Caregivers: A Review
by A. George Awad & Lakshmi N.P. Voruganti

2008 Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide
by James E. Stahl

2008 Economic Burden of Psoriatic Arthritis
by Christoph Ackermann & Arthur Kavanaugh

2008 Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections
by Robin de Vries & Simon Daenen & Keith Tolley & Axel Glasmacher & Archie Prentice & Sarah Howells & Hariette Christopherson & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma

2008 Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration: Multi-Country Observational Study
by Alan F. Cruess & Gergana Zlateva & Xiao Xu & Gisele Soubrane & Daniel Pauleikhoff & Andrew Lotery & Jordi Mones & Ronald Buggage & Caroline Schaefer & Tyler Knight & Thomas F. Goss

2008 The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
by Giovanni Fattore & Claudio Jommi

2008 Dynamic Modelling of Infectious Diseases: An Application to the Economic Evaluation of Influenza Vaccination
by Roberto Pradas-Velasco & Fernando Antonanzas-Villar & Maria Puy Martinez-Zarate

2008 Carmustine Implants for the Treatment of Newly Diagnosed High-Grade Gliomas: A Cost-Utility Analysis
by Gabriel Rogers & Ruth Garside & Stuart Mealing & Martin Pitt & Rob Anderson & Matthew Dyer & Ken Stein & Margaret Somerville

2008 Cost-Effectiveness Analyses of Hepatitis A Vaccine: A Systematic Review to Explore the Effect of Methodological Quality on the Economic Attractiveness of Vaccination Strategies
by Andrea M. Anonychuk & Andrea C. Tricco & Chris T. Bauch & Ba' Pham & Vladimir Gilca & Bernard Duval & Ava John-Baptiste & Gloria Woo & Murray Krahn

2008 The New Myth: The Social Value of the QALY
by Werner Brouwer & Job van Exel & Rachel Baker & Cam Donaldson

2008 Modelling Downstream Effects in the Presence of Technological Change
by Duncan Mortimer

2008 Does `NICE blight' exist, and if so, why?
by Alan Haycox

2008 Acknowledgement
by Adis International Limited

2008 Book Review
by Adis International Limited

2008 A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic Neuropathy
by Alec B. O'Connor & Katia Noyes & Robert G. Holloway

2008 Single Technology Appraisals by NICE: Are They Delivering Faster Guidance to the NHS?
by Leela Barham

2008 Management and Prevention of Diabetic Foot Ulcers and Infections: A Health Economic Review
by Ivy Chow & Elkin V. Lemos & Thomas R. Einarson

2008 Measuring US Pharmaceutical Industry R&D Spending
by Joseph Golec & John Vernon

2008 Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data
by Alan G. Wade & Jose-Luis Fernandez & Clement Francois & Karina Hansen & Natalya Danchenko & Nicolas Despiegel

2008 Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients
by Gerardo Machnicki & Jean-Francois Ricci & Daniel C. Brennan & Mark A. Schnitzler

2008 A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
by D. Eldon Spackman & David L. Veenstra

2008 A Review of Health-Utility Data for Osteoarthritis: Implications for Clinical Trial-Based Evaluation
by Hirsch S. Ruchlin & Ralph P. Insinga

2008 The Impact of Influenza on Working Days Lost: A Review of the Literature
by Martin Keech & Paul Beardsworth

2008 Methods for the Meta-Analysis of Willingness-to-Pay Data: An Overview
by George Van Houtven

2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes: Whose Aversion Counts Anyway?
by Johan L. Severens

2008 Loss Aversion and Cost Effectiveness of Healthcare Programmes
by Afschin Gandjour

2008 The Authors
by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman

2008 Assessing the Value of a Future Study
by Afschin Gandjour

2008 Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model
by Guiqing Yao & Nick Freemantle & Marcus Flather & Puvan Tharmanathan & Andrew Coats & Philip A. Poole-Wilson

2008 Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients
by W. Ken Redekop & Ewa Orlewska & Pawel Maciejewski & Frans F.H. Rutten & Louis W. Niessen

2008 Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
by Paul McCrone & Margaret Heslin & Martin Knapp & Paul Bull & Alan Thompson

2008 Quality-of-Life Assessment in Rheumatoid Arthritis
by Anthony S. Russell

2008 Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
by David R. Rappange & Pieter H.M. van Baal & N. Job A. van Exel & Talitha L. Feenstra & Frans F.H. Rutten & Werner B.F. Brouwer

2008 Funding a Clinical Trial: The Perspective of a Medicines Funder
by Peter Alsop & Scott Metcalfe & Jackie Evans

2008 Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing
by Steven Simoens

2008 Effectiveness of a Structured Intensive Weight Loss Program Using Health Educators
by James E. Rohrer & Harvey D. Cassidy & Diane Dressel & Barbara Cramer

2008 Relationship between the Change in Mental Health and Indicators of Medical Costs in the Prevention of Lifestyle-Related Disease
by Reiko Ishihara & Chihoko Kame & Akira Babazono

2008 An Economic Evaluation of Quantitative Ultrasonometry as Pre-Screening Test for the Identification of Patients with Osteoporosis
by Mickael Hiligsmann & Olivier Ethgen & Olivier Bruyere & Jean-Yves Reginster

2008 Assessing the Barriers to Engaging Challenging Populations in Disease Management Programs: The Medicaid Experience
by Dylan H. Roby & Gerald F. Kominski & Nadereh Pourat

2008 Health Beliefs and Culture: Essential Considerations for Outcome Measurement
by Kamaldeep Bhui & Sokratis Dinos

2008 Antimicrobial Stewardship Programs: Role in Optimizing Infectious Disease Outcomes
by Christine J. Kubin

2008 Information Technology to Support Self-Management in Chronic Care: A Systematic Review
by Michael R. Solomon

2008 Use of Collaboration to Improve Outcomes in Chronic Disease: An Overview
by Monica Gilbert & Carole Staley & Sharryn Lydall-Smith & David J. Castle

2008 Is the Rate of Generic Drug Prescribing a Fair Measure for Pay for Performance?
by Stephen Buetow & Linda Bryant

2008 Acknowledgment
by Adis International Limited

2008 Evaluation Methods in Disease Management Studies: 2004-07
by Thomas Wilson & Martin MacDowell & Patricia Salber & Gary Montrose & Carolyn Hamm

2008 Symptom Perspectives: Patient-Professional Differences and Communication
by Cathy Michaels & Suzanne C. Lareau

2008 Patients with Chronic Obstructive Pulmonary Disease: Between Reality and Expectations - A Patient
by Wlodzimierz Vlady Rozenbaum

2008 Patients with Alpha-1 Antitrypsin Deficiency: Disease Management Considerations
by Rick Carter & Brian L. Tiep

2008 Successful Smoking Cessation
by Gary L. Huber & Vijay K. Mahajan

2008 Clinical Decision Processes and Patient Engagement in Self-Management
by Jean Bourbeau

2008 Disease Management of Chronic Obstructive Pulmonary Disease from a Disease Management Organization Perspective: Providing Technology and Time to Address Gaps in Care
by Christobel E. Selecky

2008 Integrated Chronic Obstructive Pulmonary Disease Management in Primary Care
by Niels H. Chavannes

2008 Disease Management for Chronic Obstructive Pulmonary Disease: A Clinical Strategy
by Brian L. Tiep & Mary C. Barnett

2008 Asthma as a Model for Chronic Disease Management Programs: The Interplay between Pulmonary Function and Quality of Life
by Aris C. Garro & Robert B. Klein

2008 Optimizing Disease Management of Chronic Obstructive Pulmonary Disease
by Philip Corsello & David Tinkelman

2008 Approaches to Chronic Disease and Chronic Care: From Oxymoron to Modern Zeitgeist
by Anna M. Tacon

2008 The Emerging Chronic Obstructive Pulmonary Disease Epidemic: Clinical Impact, Economic Burden, and Opportunities for Disease Management
by Rick Carter & Brian L. Tiep & Rebecca E. Tiep

2008 Chronic Obstructive Pulmonary Disease: The Challenge and the Solution
by Thomas L. Petty

2008 Delivering Diabetes Self-Management Education (DSME) in Primary Care: The Pittsburgh Regional Initiative For Diabetes Education (PRIDE)
by Linda M. Siminerio & Kristine Ruppert & Sharlene Emerson & Francis X. Solano & Gretchen A. Piatt

2008 Disease Management Programs Targeting Obesity in Children: Setting the Scene for Wellness in the Future
by Adrienne R. Hughes & John J. Reilly

2008 Community Pharmacy, Disease State Management, and Adherence to Medication: A Review
by Carol Lyn Armour & Lorraine Smith & Ines Krass

2008 Clinical Pharmacy Services in the Home
by Linda D. MacKeigan & Lisa M. Nissen

2008 Launch of a National Mandatory Chronic Disease Prevention Program in Japan
by Atsushi Kobayashi

2008 Measuring Quality in Pay-for-Performance Programs: From `One-Size-Fits-All' Measures to Individual Patient Risk-Reduction Scores
by Jennifer A. Meddings & Laurence F. McMahon

2008 Pharmacy Continuity of Care: What do Community Pharmacists Need from an Acute Care Hospital to Improve Continuity of Pharmaceutical Care?
by Cherokee Layson-Wolf & Jill A. Morgan

2008 An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol
by Alessandro Menotti & Mariapaola Lanti

2008 Clinical and Economic Effects of a Therapeutic Substitution Policy for Proton Pump Inhibitors in Aboriginal Patients in Northern Communities in Canada's Northwest Territories
by Kathryn Gaebel & Neda Toeg & Mitchell Levine

2008 Why it Pays for Hospitals to Initiate a Heart Failure Disease Management Program
by Mauricio Velez & Bethany Westerfeldt & Peter S. Rahko

2008 Creating the Virtual Team: Application to Diabetes Mellitus Disease Management
by Roger Mazze

2008 Pharmacist-Led Interventions for the Management of Cardiovascular Disease: Opportunities and Obstacles
by Karen J. McConnell & Anne M. Denham & Kari L. Olson

2008 Considerations in Culturally Directed Asthma Disease Management Programs
by Michelle M. Cloutier

2008 Employee Disease Management in US and Global Workplaces: Integrating Strategies and Expanding their Scope
by Robin C. Rager & Joseph A. Leutzinger & Jeff A. Hochberg & Wolf Kirsten & David H. Chenoweth

2008 The Potential and Pitfalls of Medicine Management: What Have We Learned So Far?
by Alison Blenkinsopp & Christine M. Bond

2008 Lessons from Early Experience with Pay for Performance
by Tim Doran

2008 Disease Management Update
by Adis International Limited

2008 Intensified Diabetes Care Monitoring and Physician Education: Impact on Outcomes and Costs of Care
by Ann Donnelly & Prasad Kommareddi & Michael James & Jerry Van Horn & Christopher Zacker & Dan Belletti

2008 Cost Analysis of a Maternity Disease Management Program
by Gary Stanziano & Niki Istwan

2008 Interdisciplinary Coordination for Breast Healthcare: A Rational Approach to Detection, Diagnosis, and Treatment
by Benjamin O. Anderson & Cary S. Kaufman & Krystyna D. Kiel & Robert W. Carlson

2008 Disease Management Update
by Adis International Limited

2008 Nursing Workload Associated with Hospital Patient Care
by Nicole Mittmann & Soo Jin Seung & Luca F. Pisterzi & Pierre K. Isogai & Donna Michaels

2008 General Pain and Frequency of Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
by James E. Rohrer & Stephen P. Merry & Steven C. Adamson & Darryl E. Barnes

2008 Challenges and Applications of the Transtheoretical Model in Patients with Diabetes Mellitus
by Ana Andres & Juana Gomez & Carmina Saldana

2008 Poor Adherence to Medication in Adults with Rheumatoid Arthritis: Reasons and Solutions
by Rachel A. Elliott

2008 Challenges Facing Nurse-Led Disease Management for Heart Failure
by Paul L. Hebert & Jane E. Sisk

2008 Cost-Effectiveness Analysis of Entecavir versus Lamivudine in the First-Line Treatment of Australian Patients with Chronic Hepatitis B
by Elizabeth Arnold & Yong Yuan & Uchenna Iloeje & Greg Cook

2008 Does Extending Health Insurance Coverage to the Uninsured Improve Population Health Outcomes?
by James A. Thornton & Jennifer L. Rice

2008 Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France
by Baudouin Standaert & Nathalie Parez & Bertrand Tehard & Xavier Colin & Bruno Detournay

2008 A Pharmacoeconomic Analysis of Compliance Gains on Antipsychotic Medications
by Joep Damen & Per-Olof Thuresson & Bart Heeg & Mickael Lothgren

2008 Community-Based Interventions to Promote Increased Physical Activity: A Primer
by Melissa Bopp & Elizabeth Fallon

2008 The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand
by Edward Norey & Tessa M. Simone & Shaker A. Mousa

2008 The Impact of Banning Smoking in Workplaces: What are the Early Effects?
by Shane Allwright

2008 Cost Analysis of Amlodipine versus Enalapril in Patients with Coronary Artery Disease and Normal Blood Pressure: Findings from the CAMELOT Economic Substudy
by Joseph Menzin & Luke Boulanger & Simon Tang & Kamlesh Thakker & Steven E. Nissen

2008 The Association of Adherence to Antiretroviral Therapy with Healthcare Utilization and Costs for Medical Care
by Edward M. Gardner & Moises E. Maravi & Cornelis Rietmeijer & Arthur J. Davidson & William J. Burman

2008 Households' Willingness to Pay for a Motorcycle Helmet in Hanoi, Vietnam
by Khanh H. Pham & Quynh X. Le Thi & Dennis J. Petrie & Jon Adams & Christopher M. Doran

2008 Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women
by Dirk Mueller & Afschin Gandjour

2008 Direct Medical Costs for Type 2 Diabetes Mellitus Complications in the US Commercial Payer Setting: A Resource for Economic Research
by Elise M. Pelletier & Paula J. Smith & Kristina S. Boye & Derek A. Misurski & Sandra L. Tunis & Michael E. Minshall

2008 Cost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context
by Mattias Neyt & Nancy Thiry & Dirk Ramaekers & Hans Van Brabandt

2008 The Lifetime Cost of Hepatocellular Carcinoma: A Claims Data Analysis from a Medical Centre in Taiwan
by Hui-Chu Lang & Jaw-Ching Wu & Sang-Hue Yen & Chung-Fu Lan & Shi-Liang Wu

2008 Cost-Effectiveness Analysis of Switching Antipsychotic Medication to Long-Acting Injectable Risperidone in Patients with Schizophrenia: A 12- and 24-Month Follow-Up from the e-STAR Database in Spain
by Jose M. Olivares & Alfonso Rodriguez-Martinez & Jose A. Buron & David Alonso-Escolano & Alexander Rodriguez-Morales

2008 Wealth Status and Risky Sexual Behaviour in Ghana and Kenya
by Kofi Awusabo-Asare & Samuel K. Annim

2008 Differences in Generic Drug Prices between the US and Canada
by Malcolm Gooi & Chaim M. Bell

2008 Cost Effectiveness of Screen-and-Treat Strategies for Low Bone Mineral Density: How Do We Screen, Who Do We Screen and Who Do We Treat?
by John T. Schousboe

2008 The Contribution of Managed Care to the Performance of Healthcare Systems - Evidence from Three Countries
by Johannes Schoder & Peter Zweifel

2008 Economies of Scale and Efficiency Measurement in Switzerland's Nursing Homes
by Mehdi Farsi & Massimo Filippini & Diego Lunati

2008 What Drives Individual Health Expenditure in Switzerland?
by Marcel Bilger & Jean-Paul Chaze

2008 The Evolution of Physician Density in Switzerland
by Gabrielle Wanzenried & Sandra Nocera

2008 The Productive Efficiency of the Health Care Sector of China
by Ng, Ying Chu

2008 Caracterizing The Public Health System Reform Using The Statistical Survey Approach
by Andrei Tudorel & Calin Catalina & Tusa Erika & Stancu Stelian & Stancu Stelian

2008 Equity in the Use of Health Care Services by Immigrants in the Spanish National Health Care System
by JIMÉNEZ RUBIO, DOLORES

2008 The Demand for Health Insurance and Use of Medical Services in Colombia: Differences Between Workers and the Self-Employed Workers
by Juan Miguel Gallego

2008 An analysis of income-related inequalities in the health care use by dynamic models
by Mª Luz González Alvarez & Antonio Clavero Barranquero

2008 Measuring Intra-Hospital Clinic Efficiency and Productivity: Application to a Greek University General Hospital
by N. Maniadakis & N. Kotsopoulos & P. Prezerakos & J. Yfantopoulos

2008 Zahl der Pflegefälle wird deutlich steigen
by Erika Schulz

2008 Estimación de los determinantes del acceso a los servicios de salud en la region Caribe
by Sandra Rodríguez & Paola Roldán

2008 Demanda por seguro de salud y uso de servicios médicos en Colombia: diferencias entre trabajadores dependientes e independientes
by Juan Miguel Gallego

2008 Risk Adjustment Systems in Health Insurance Markets in the US, Germany, Netherlands and Switzerland
by Udo Schneider & Volker Ulrich & Eberhard Wille

2008 External Audit In Nhs Trusts
by Iulian Dobra

2008 The Efficiency Of Resource Usage In The Social Health Insurance System
by Cumpanasu Ecaterina & Vaidean Viorela-Ligia

2008 Horizons and Perspectives eHealth
by Luminita VIZITEU

2008 Organizational Fragmentation and Care Quality in the U.S. Healthcare System
by Randall D. Cebul & James B. Rebitzer & Lowell J. Taylor & Mark E. Votruba

2008 Is American Health Care Uniquely Inefficient?
by Alan M. Garber & Jonathan Skinner

2008 The Quality of Medical Advice in Low-Income Countries
by Jishnu Das & Jeffrey Hammer & Kenneth Leonard

2008 The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare
by David Card & Carlos Dobkin & Nicole Maestas

2007 Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: The MESSAGE study
by Giret d'Orsay, Geneviève & Mazières, Bernard & Bard, Hervé & Ligierc, Marie & Brud, Isabelle & Le Pen, Claude

2007 Assurance maladie et aléa de moralité ex-ante : la franchise cautionnée est-elle efficace ?
by Bien, Franck & Alary, David

2007 Ampleur, tendance et causes des inégalités sociales de santé et de mortalité en Europe : une revue des études comparatives
by Cambois, Emmanuelle & Jusot, Florence

2007 Healthy Working Life Expectancies at age 50 in Europe : a new indicator
by Forette, Françoise & Brieu, Marie-Anne & Robine, Jean-Marie & Jusot, Florence & Sermet, Catherine & Barnay, Thomas & Brouard, Nicolas & Lièvre, Agnès

2007 Health expenditures, longevity and growth
by Suhrcke, Marc & Pelgrin, Florian & Oliveira Martins, Joaquim & Dormont, Brigitte

2007 Cross-Country Measures for Monitoring Epilepsy Care by ILAE Commission on Healthcare Policy
by Donaldson, Karen Lee & Wiebe, Samuel & Langfitt, John T. & Lévy, Pierre & Butler, James & Chisholm, Daniel & Pachlatko, Christoph & Beghi, Ettore & Baker, Gus A. & Begley, Charles E.

2007 The Comparative Effects of Bariatric Surgery on Weight and Type 2 Diabetes
by Lévy, Pierre & Finer, Nick & Santini, Ferruccio & Fried, Martin

2007 Étude médicoéconomique d'un acide hyaluronique dans l'arthrose du genou en pratique rhumatologique courante : étude MESSAGE
by Mazières, Bernard & Bard, Hervé & Ligier, Marie Ligier & Bru, Isabelle & Giret d'Orsay, Geneviève & Le Pen, Claude

2007 La concurrence en économie de la santé : une liaison difficile mais légitime
by Guillaume, Marc

2007 Does service-level spending show evidence of selection across health plan types?
by Shenyi Jiang & Randall P. Ellis & Tzu-chun Kuo

2007 The Choice of Employment Arrangement in the Market for Hospitalist Services
by Guy David & Lorens A. Helmchen

2007 The Diffusion of a Medical Innovation: Is Success in the Stars?
by Mary A. Burke & Gary M. Fournier & Kislaya Prasad

2007 The Effect of Reimbursement on the Intensity of Hospital Services
by Richard C. Lindrooth & Gloria J. Bazzoli & Jan Clement

2007 Sağlık kurumlarında finansal performans ölçümü: Kamu hastanelerinin veri madenciliği ile sınıflandırılması
by Nermin ÖZGÜLBAŞ & Ali Serhan KOYUNCUGİL

2007 Multivariate Cointegration Technique Estimation of Health Demand Function: The Case of Croatia
by Josip Tica & Šime Smolić

2007 Paying for performance with altruistic or motivated providers
by Luigi Siciliani

2007 An Incentive Mechanism for Using Risk Adjuster to Reimburse Health Care Providers
by Bipasa Datta & Qianhui Yan

2007 Modelling the Dynamics of a Public Health Care System: Evidence from Time-Series Data
by Fabrizio Iacone & Steve Martin & Luigi Siciliani & Peter C Smith

2007 Third degree waiting time discrimination: optimal allocation of a public sector health care treatment under rationing by waiting
by Hugh Gravelle & Luigi Siciliani

2007 Ramsey Waits: Allocating Public Health Service Resources when there is Rationing by Waiting
by Hugh Gravelle & Luigi Siciliani

2007 Optimal Waits and Charges in Health Insurance
by Hugh Gravelle & Luigi Siciliani

2007 Nurses Wanted. Is the job too harsh or is the wage too low?
by Maria Laura Di Tommaso & S. Strøm & E. M. Sæther

2007 Market Structure and Hospital-Insurer bargaining in the Netherlands
by Halbersma, R.S. & Mikkers, M.C. & Motchenkova, E.

2007 Generic entry into a regulated pharmaceutical market
by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué

2007 Generic entry into a regulated pharmaceutical market
by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué

2007 Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques
by Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff

2007 Market Structure and Hospital-Insurer Bargaining in the Netherlands
by Halbersma, R.S. & Mikkers, M.C. & Motchenkova, E. & Seinen, I.

2007 Costs and prospects for home based Long Term Care in Northern Italy: the Galca survey
by Bettio, Francesca & Mazzotta, Fernanda & Solinas, Giovanni

2007 Cost and Technical Efficiency of German Hospitals – A Stochastic Frontier Analysis
by Annika Frohloff

2007 The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry
by Barros, Pedro Pita

2007 The Effect of Newer Drugs on Health Spending: Do They Really Increase the Costs?
by Civan, Abdülkadir & Koksal, Bulent

2007 What is the impact of duplicate coverage on the demand for health care in Germany?
by Vargas, MH & Elhewaihi, M

2007 A Structural Misclassifcation Model to Estimate the Impact of Physician Incentives on Healthcare Utilization
by Arrieta, Alejandro

2007 An Assessment of OECD Health Care System Using Panel Data Analysis
by Mohan, Ramesh & Mirmirani, Sam

2007 Nachfrage nach Gesundheitsleistungen – Einkommensrisiken und Einkommenschancen
by Stolze, Henning

2007 The Effects of Detailing on Prescribing Decisions under Two-Sided Learning
by Ching, Andrew & Ishihara, Masakazu

2007 The advantages and disadvantages of needs-based resource allocation in integrated health systems and market systems of health care provider reimbursement
by Gugushvili, Alexi

2007 A Random Parameter Logit model for modeling Health Care Provider Choice in Bolivia
by Canaviri, Jose

2007 Exit from the Hospital Industry
by Ciliberto, Federico & Lindrooth, Richard

2007 Incentive Compatibility and Efficiency in the contractual Insurer-Provider Relationship: Economic Theory and practical Implications: The Case of North Carolina
by Schmid, Andreas

2007 Financing of health services and alternative methods: some suggestions
by Isik, A.Kadir & Bolukbasi, Okan & Isik, Hayriye

2007 Health Care Services and Government Spending in Pakistan
by Muhammad Akram & Faheem Jehangir Khan

2007 Investment decisions in hospital technology when physicians are devoted workers
by Rossella Levaggi & Michele Moretto & Vincenzo Rebba

2007 Investment in hospital care technology under different purchasing rules: a real option approach
by Rossella Levaggi & Michele Moretto

2007 Pharmaceutical Pricing and Reimbursement Policies in Sweden
by Pierre Moïse & Elizabeth Docteur

2007 Pharmaceutical Pricing and Reimbursement Policies in Switzerland
by Valérie Paris & Elizabeth Docteur

2007 Pharmaceutical Pricing and Reimbursement Policies in Mexico
by Pierre Moïse & Elizabeth Docteur

2007 Improving the Efficiency of Health Care Spending: Selected Evidence on Hospital Performance
by Espen Erlandsen

2007 Healthcare Reform in Russia: Problems and Prospects
by William Tompson

2007 Competition and Waiting Times in Hospital Markets
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2007 Does Medicare Save Lives?
by David Card & Carlos Dobkin & Nicole Maestas

2007 Is the Food and Drug Administration Safe and Effective?
by Tomas J. Philipson & Eric Sun

2007 The Welfare Effects of Public Drug Insurance
by Darius Lakdawalla & Neeraj Sood

2007 The Lifetime Costs and Benefits of Medical Technology
by David M. Cutler

2007 Social Networks and Access to Health Care Among Mexican-Americans
by Carole Roan Gresenz & Jeannette Rogowski & José J. Escarce

2007 Custom Made Versus Ready to Wear Treatments; Behavioral Propensities in Physician's Choices
by Richard G. Frank & Richard J. Zeckhauser

2007 Health Status, Health Care and Inequality: Canada vs. the U.S
by June E. O'Neill & Dave M. O'Neill

2007 The Value of Life Near its End and Terminal Care
by Gary Becker & Kevin Murphy & Tomas Philipson

2007 End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing
by Avi Dor & Mark V. Pauly & Margaret A. Eichleay & Philip J. Held

2007 Information and Communications Technology in Chronic Disease Care: Why is Adoption So Slow and Is Slower Better?
by Michael C. Christensen & Dahlia Remler

2007 Worker Sorting, Taxes and Health Insurance Coverage
by Kevin Lang & Hong Kang

2007 Value Based Cost Sharing Meets the Theory of Moral Hazard: Medical Effectiveness in Insurance Benefits Design
by Mark V. Pauly & Fredric E. Blavin

2007 Are You Sure You're Saving Enough for Retirement?
by Jonathan Skinner

2007 Worker Sorting, Compensating Differentials and Health Insurance: Evidence from Displaced Workers
by Steven F. Lehrer & Nuno Sousa Pereira

2007 Mergers and Barriers to Entry In Pharmaceutical Markets
by Granier, L. & Trinquard, S.

2007 Generic entry, price competition, and market segmentation in the prescription drug market
by Tracy L. Regan

2007 Self-Employment and the Role of Health Insurance
by Gulcin Gumus & Tracy Regan

2007 Effects of 'Authorized-Generics' on Canadian Drug Prices
by Paul Grootendorst

2007 Health-Care Utilization in Canada: 25 Years of Evidence
by Lori J. Curtis & William J. MacMinn

2007 Public and Private Health Care Financing with Alternate Public Rationing
by Katherine Cuff & Jeremiath Hurley & Stuart Mestelman & Andrew Muller & Robert Nuscheler

2007 Is It Time to Redesign Hospice? End-of-Life Care at the User Interface. Syracuse Seminar on Aging
by David J. Casarett

2007 Nachfrage nach Gesundheitsleistungen – Einkommensrisiken und Einkommenschancen
by Henning Stolze

2007 The National Regulation of Pharmaceutical Markets and the Timing of New Drug Launches in Europe
by Alexander Heuer & Malwina Mejer & Jennifer Neuhaus

2007 Diffusion and Competition of Innovative Cardiological Technologies
by Thomas Grebel & Tom Wilfer

2007 Bounding ATE with ITT
by Ito, Seiro

2007 Tax Incentives as a Solution to the Uninsured: Evidence from the Self-Employed
by Gumus, Gulcin & Regan, Tracy L.

2007 Tax Incentives as a Solution to the Uninsured: Evidence from the Self-Employed
by Gulcin Gumus & Tracy L. Regan

2007 An Analysis of Hospital Efficiency and Productivity Growth Using the Luenberger Productivity Indicator
by Carlos Pestana Barros & António Gomes de Menezes & José Cabral Vieira & Nicolas Peypoch & Bernardin Solonandrasana

2007 An Analysis of Hospital Efficiency and Productivity Growth Using the Luenberger Productivity Indicator
by Barros, Carlos Pestana & Menezes, Antonio & Vieira, José António Cabral & Peypoch, Nicolas & Solonandrasana, Bernardin

2007 Health Insurance and Life Style Choices: Identifying the Ex Ante Moral Hazard
by Stanciole, Anderson

2007 Barometre des pratiques en medecine liberale Resultats de l'enquete 2006 "L'organisation du travail et la pratique de groupe des medecins generalistes bretons
by Julien Beaute & Yann Bourgueil & Julien Mousques & Remy Bataillon & Jean-Louis Samzun & Lise Rochaix

2007 Impact of Preventive Health Care on Indian Industry and Economy
by Alka Chadha & Ali Mehdi & Garima Malik

2007 Impact of Preventive Health Care on Indian Industry and Economy
by Alka Chadha & Ali Mehdi & Garima Malik

2007 Impact of Preventive Health Care on Indian Industry and Economy
by Alka Chadha & Ali Mehdi & Garima Malik

2007 Planes Mínimos Obligatorios en Mercados de Seguros de Salud Segmentados
by Edmundo Beteta & Manuel Willington

2007 Collusion in a One-Period Insurance Market with Adverse Selection
by Alexander Alegria & Manuel Willington

2007 Colusión en el Mercado de Isapres: Modelación y Evidencia Empírica
by Claudio Agostini & Eduardo Saavedra & Manuel Willington

2007 Public and Private Health Care Financing with Alternate Public Rationing Rules
by Katherine Cuff & Jeremiah Hurley & Stuart Mestelman & Andrew Muller & Robert Nuscheler

2007 Publicly Funded Medical Savings Accounts: Expenditures and Distributional Impacts
by Jeremiah Hurley & G. Emmanuel Guindon & Vicky Rynard & Steve Morgan

2007 Physician Labour Supply in Canada: a Cohort Analysis
by Thomas F. Crossley & Jeremiah Hurley & Sung-Hee Jeon

2007 Regional Variations in Medical Expenditure and Hospitalization Days for Heart Attack Patients in Japan: Evidence from the Tokai Acute Myocardial Study (TAMIS)
by Noguchi, Haruko & Shimizutani, Satoshi & Masuda, Yuichiro

2007 Ekonomisk analys av Fallskärmsprojektet Sammanfattande rapport
by Niklasson, Harald & Tomsmark, Lars

2007 Economic Policy in Health Care: Sickness Absence and Pharmaceutical Cost
by Granlund, David

2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence
by Granlund, David & Rudholm, Niklas

2007 Does Competition Increase Economic Efficiency in Swedish County Councils?
by Rudholm, Niklas & Nordmark, Arvid & Marklund, Per-Olov

2007 Swedish Health Care Performance – Quantity versus Quality
by Janlöv, Nils

2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence
by Granlund, David & Rudholm, Niklas

2007 Deregulating the Norwegian Pharmaceuticals Market - Consequences for Costs and Availability
by Rudholm, Niklas

2007 Agent model with a monopoly power : physicians
by Béatrice Desquins & Alberto Holly & Lise Rochaix

2007 Ethnicity And Equity In The Use Of Health Care Services In The Spanish National Health Care System
by Dolores Jiménez-Rubio

2007 Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico
by Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno

2007 La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale
by Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno

2007 Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica
by Chiara Bonassi & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno

2007 La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato
by Fabio Pammolli & Nicola Carmine Salerno

2007 Medicines in parallel trade in the European Union: a gravity specification
by Joan Costa-i-Font & Panos Kanavos

2007 Direct payments in England: factors linked to variations in local provision
by José-Luis Fernández & Jeremy Kendall & Vanessa Davey & Martin Knapp

2007 Health Economics for Low-Income Countries
by Germano Mwabu

2007 Health Economics for Low-Income Countries
by Germano Mwabu

2007 Evolution comparée de la consommation de médicaments dans les 5 pays européens entre 2000 et 2004 : analyse de 7 classes pharmaco-thérapeutiques
by Viens, Gérard & Levesque, Karine & Chahwakilian, Pierre & El Hasnaoui, Abdelkader & Gaudillat, Anne & Nicol, Guénolé & Crouzier, Caroline

2007 Health Care Services and Government Spending in Pakistan
by Muhammad Akram & Faheem Jehangir Khan

2007 Impact of Preventive Health Care on Indian Industry and Economy
by Alka Chadha & Ali Mehdi & Garima Malik

2007 Choice of Contracts in the British National Health Service: An Empirical Study
by Martin Chalkley & Duncan McVicar

2007 Health Insurance Status and Physician-Induced Demand for Medical Services in Germany: New Evidence from Combined District and Individual Level Data
by Hendrik Jürges

2007 Health Insurance Status and Physician-Induced Demand for Medical Services in Germany: New Evidence from Combined District and Individual Level Data
by Hendrik Jürges

2007 Moral hazard and health insurance: an evaluation based on Rubins causal framework
by V. ALBOUY & B. CRÉPON

2007 Paying for Performance with Altruistic or Motivated Providers
by Siciliani, Luigi

2007 Competition and Waiting Times in Hospital Markets
by Brekke, Kurt Richard & Siciliani, Luigi & Straume, Odd Rune

2007 Performance Indicators for Quality with Adverse Selection, Gaming and Inequality Aversion
by Kuhn, Michael & Siciliani, Luigi

2007 Measuring annual price elasticities in Dutch health insurance; a new method
by Rudy Douven & Marco Ligthart & H. Lieverdink & I. Vermeulen

2007 Cream-Skimming And Risk Adjustment in Colombian Health Insurance System:: The Public Insurer Case
by Ronald Eduardo Gómez Suárez

2007 Modelling the Dynamics of a Public Health Care System: Evidence from Time-Series Data
by Fabrizio Iacone & Steve Martin & Luigi Siciliani & Peter C Smith

2007 Hospital Financing and the Development and Adoption of New Technologies
by Marisa Miraldo

2007 Reference Pricing Versus Co-Payment in the Pharmaceutical Industry: Price, Quality and Market Coverage
by Marisa Miraldo

2007 Competition and Waiting Times in Hospital Markets
by Kurt R. Brekke & Luigi Siciliani & Odd Rune Straume

2007 Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?
by Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås

2007 Distribuição da rede de oferta de serviços de saúde na região norte: uma análise espacial multivariada
by Cristina Guimarães Rodrigues & Rodrigo Ferreira Simões & Pedro Vasconcelos Amaral

2007 The Origins and the Evolution of Health Economics: a discipline by itself? Led by economists, practitioners or politics?
by Luís Pina Rebelo

2007 Double Moral Hazard and Outcome-based Remuneration of Physicians
by Udo Schneider

2007 Biased Risk Perceptions of Longevity and Disability in Old Age
by Joan Costa Font

2007 Transitions In Latin America And In Poland And Syria
by

2007 The Authors' Reply
by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos

2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
by Philip Home & Adrian Bagust & Matthew Taylor & Philip Ambery & Samara Mendes da Costa

2007 Reliability of Medicaid Claims Versus Medical Record Data: In a Cost Analysis of Palivizumab
by Julie Jacobson Vann & John Feaganes & Steven Wegner

2007 Preferences of Community Pharmacists for Extended Roles in Primary Care: A Survey and Discrete Choice Experiment
by Anthony Scott & Christine Bond & Jackie Inch & Aileen Grant

2007 Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention
by Bart M.S. Heeg & Ron J.G. Peters & Marc Botteman & Ben A. van Hout

2007 Epidemiology and Economic Impact of Meticillin-Resistant Staphylococcus aureus: Review and Analysis of the Literature
by Andrew F. Shorr

2007 Modelling Disease Progression in Alzheimer's Disease: A Review of Modelling Methods used for Cost-Effectiveness Analysis
by Colin Green

2007 The Increasingly Complex Fourth Hurdle for Pharmaceuticals
by Joshua Cohen & Elly Stolk & Maartje Niezen

2007 Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations
by Lisa A. Prosser & James K. Hammitt & Ron Keren

2007 A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease
by Maureen P.M.H. Rutten-van Molken & Floortje E. van Nooten & Marion Lindemann & Manfred Caeser & Peter M.A. Calverley

2007 A Stated Preference Binary Choice Experiment to Explore NICE Decision Making
by Paul Tappenden & John Brazier & Julie Ratcliffe & James Chilcott

2007 Direct Costs in Patients Hospitalised with Community-Acquired Pneumonia After Non-Response to Outpatient Treatment with Macrolide Antibacterials in the US
by Joseph A. Paladino & Martin H. Adelman & Jerome J. Schentag & Paul B. Iannini

2007 Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study
by Roberto Dal Negro & Peter Piskorz & Roberto Vives & Magda Guilera & Vasilisa Sazonov Kocevar & Xavier Badia

2007 The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis
by Grant H. Skrepnek

2007 Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature
by Jaume Puig-Junoy & Ivan Moreno-Torres

2007 When Drugs Don't Work: Economic Assessment of Enhancing Compliance with Interventions Supported by Electronic Monitoring Devices
by Dyfrig Hughes

2007 Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries
by Liu Bao Peng & Chong Qing Tan & Xiao Min Wan & Wei Cui

2007 Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
by Alexander Konnopka & Hans-Helmut Konig

2007 The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale
by Leida M. Lamers & Carin A. Uyl-de Groot & Ivonne Buijt

2007 A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma
by Ya-Chen Tina Shih & Josephine Mauskopf & Rohit Borker

2007 Retrospective Economic and Outcomes Analyses Using Non-US Databases: A Review
by Lizheng Shi & Eric Q Wu & Meredith Hodges & Andrew Yu & Howard Birnbaum

2007 Cost Considerations in the Treatment of Colorectal Cancer
by Frank G.A. Jansman & Maarten J. Postma & Jacobus R.B.J. Brouwers

2007 Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia
by John A. Vernon

2007 Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads
by Ron Goeree & Daria O'Reilly & Jean-Eric Tarride & Jim Bowen & Gord Blackhouse & Kaitryn Campbell & Rob Hopkins & Morgan Lim & Lisa Patterson

2007 Building Bridges Between Academic Research and Policy Formulation: When Costing Less Means Costing More
by Amiram Gafni & Stephen Birch

2007 Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression
by Adam E. Block

2007 Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands
by Maarten J. Postma & Annoesjka Novak & Huib W.K.F.H. Scheijbeler & Marlene Gyldmark & Marianne L.L. van Genugten & Jan C. Wilschut

2007 Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia
by Theodore Darkow & Henry J. Henk & Simu K. Thomas & Weiwei Feng & Jean-Francois Baladi & George A. Goldberg & Alan Hatfield & Jorge Cortes

2007 A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers?
by Yot Teerawattananon & Steve Russell & Miranda Mugford

2007 Estimation, Power and Sample Size Calculations for Stochastic Cost and Effectiveness Analysis
by S.D. Walter & Amiram Gafni & Stephen Birch

2007 Reform of Prescription Drug Reimbursement and Pricing in the German Social Health Insurance Market: A Comparison of Three Scenarios
by Stefan Gress & Dea Niebuhr & Uwe May & Jurgen Wasem

2007 Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer: A Lifetime Model
by J. Alasdair Millar & Michael J. Millward

2007 Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study
by Kanlaya Teerawattananon & Saniorn Iewsakul & Chawewan Yenjitr & Somsanguan Ausayakhun & Watanee Yenjitr & Miranda Mugford & Yot Teerawattananon

2007 Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England: Healthcare System and Patient Perspectives
by Anthony Scott & Michela Tinelli & Christine Bond

2007 The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation
by Peter Wahlqvist & Gordon H. Guyatt & David Armstrong & Alessio Degl'Innocenti & Diane Heels-Ansdell & Samer El-Dika & Ingela Wiklund & Carlo A. Fallone & Lisa Tanser & Sander Veldhuyzen van Zanten & Peggy Austin & Alan N. Barkun & Naoki Chiba & Holger J. Schunemann

2007 Health Utilities Using the EQ-5D in Studies of Cancer
by A. Simon Pickard & Caitlyn T. Wilke & Hsiang-Wen Lin & Andrew Lloyd

2007 Replace Pharmaceutical Patents Now
by Earl L. Grinols & James W. Henderson

2007 Book Review
by Adis International Limited

2007 Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective
by Leon E. Cosler & Adi Eldar-Lissai & Eva Culakova & Nicole M. Kuderer & David Dale & Jeffrey Crawford & Gary H. Lyman

2007 Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective
by Thomas E. Delea & Oleg Sofrygin & Simu K. Thomas & Jean-Francois Baladi & Pradyumna D. Phatak & Thomas D. Coates

2007 Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
by Steven B. Zeliadt & David F. Penson

2007 The Economic Implications of Glaucoma: A Literature Review
by Jordana K. Schmier & Michael T. Halpern & Mechelle L. Jones

2007 Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date
by Irina Cleemput & Fabienne Dobbels

2007 Letter From the Commissioner's Office at the US FDA
by John A. Vernon

2007 Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada
by Daniel T. Grima & Melissa F. Thompson & Luc Sauriol

2007 Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients
by Danielle E.M. Brunenberg & Gwenn E.C. Wetzels & Patricia J. Nelemans & Carmen D. Dirksen & Johan L. Severens & Henri E.J.H. Stoffers & Jan S.A.G. Schouten & Martin H. Prins & Peter W. de Leeuw & Manuela A. Joore

2007 Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods
by Diego F. Ossa & Andrew Briggs & Emma McIntosh & Warren Cowell & Tim Littlewood & Mark Sculpher

2007 Do Drugs Reduce Utilisation of Other Healthcare Resources?
by Pierre-Yves Cremieux & Pierre Ouellette & Patrick Petit

2007 Enzyme Replacement Therapy in Orphan and Ultra-Orphan Diseases: The Limitations of Standard Economic Metrics as Exemplified by Fabry-Anderson Disease
by David F. Moore & Markus Ries & Evelyn L. Forget & Raphael Schiffmann

2007 Economic Evaluations of Cholesterol-Lowering Drugs: A Critical and Systematic Review
by Pearl D. Gumbs & Monique W.M. Verschuren & Aukje K. Mantel-Teeuwisse & Ardine G. de Wit & Anthonius de Boer & Olaf H. Klungel

2007 Economic Evaluation and Decision Making: Reimbursing Trastuzumab in Early-Stage Breast Cancer
by Steven Simoens

2007 Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making
by Christine M. McDonough & Anna N.A. Tosteson

2007 Is Medication Review by Pharmacists of Any Use?
by Arnold G. Zermansky & Nick Freemantle

2007 Letter From the Commissioner's Office at the US FDA
by John A. Vernon

2007 Home-Based Medication Review in Older People: Is it Cost Effective?
by Margaret Pacini & Richard D. Smith & Edward C.F. Wilson & Richard Holland

2007 Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans
by Ralph P. Insinga & Robbin F. Itzler & James M. Pellissier

2007 Conjoint Analysis of French and German Parents' Willingness to Pay for Meningococcal Vaccine
by David Bishai & Roger Brice & Isabelle Girod & Aneta Saleh & Jenifer Ehreth

2007 Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments
by Ramandeep Basra & Con Kelleher

2007 A `League Table' of Contingent Valuation Results for Pharmaceutical Interventions: A Hard Pill to Swallow?
by Tracey H. Sach & Richard D. Smith & David K. Whynes

2007 Time Preferences for Health in Northern Tanzania: An Empirical Analysis of Alternative Discounting Models
by Bjarne Robberstad & John Cairns

2007 Reducing the Societal Burden of Depression: A Review of Economic Costs, Quality of Care and Effects of Treatment
by Julie M. Donohue & Harold Alan Pincus

2007 Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis
by Mark J.C. Nuijten & Wolfgang Wittenberg & Maximilian Lebmeier

2007 A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
by Dominic P. Tilden & Segundo Mariz & Gillies O'Bryan-Tear & Julia Bottomley & Alexander Diamantopoulos

2007 Rates and Probabilities in Economic Modelling: Transformation, Translation and Appropriate Application
by Rachael L. Fleurence & Christopher S. Hollenbeak

2007 Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants
by Judith E. Bosmans & Oscar H. Brook & Hein P.J. van Hout & Martine C. de Bruijne & Hugo Nieuwenhuyse & Lex M. Bouter & Wim A.B. Stalman & Maurits W. van Tulder

2007 Letter From the Commissioner's Office at the US FDA
by John A. Vernon

2007 NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used?
by Denis Getsios & Kristen Migliaccio-Walle & Jaime J. Caro

2007 When NICE Says No!
by Alan Haycox

2007 Acknowledgement
by Adis International Limited

2007 Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective
by Bart Heeg & Joep Damen & Ben Van Hout

2007 Economic Evidence at the Local Level: Options for Making it More Useful
by Kees van Gool & Gisselle Gallego & Marion Haas & Rosalie Viney & Jane Hall & Robyn Ward

2007 Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events
by Greg L. Plosker & Katherine A. Lyseng-Williamson

2007 Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2007 The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses
by Marcio Machado & Michael Iskedjian & Ines A. Ruiz & Thomas R. Einarson

2007 Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B
by David L. Veenstra & Sean D. Sullivan & Lauren Clarke & Uche H. Iloeje & Eskinder Tafesse & Adrian Di Bisceglie & Kris V. Kowdley & Robert G. Gish

2007 Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis
by Amanda R. Patrick & Wolfgang C. Winkelmayer & Jerry Avorn & Michael A. Fischer

2007 Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation: A Literature Review
by Alec H. Miners & Guiqing Yao & James Raftery & Rod S. Taylor

2007 The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature
by Rachael L. Fleurence & Cynthia P. Iglesias & Jeanene M. Johnson

2007 It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies
by Oren Shavit & Moshe Leshno & Assaf Goldberger & Amir Shmueli & Amnon Hoffman

2007 Warfarin Pharmacogenetics: Economic Considerations
by Dyfrig A. Hughes & Munir Pirmohamed

2007 Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia
by Neale Cohen & Michael E. Minshall & Lyn Sharon-Nash & Katerina Zakrzewska & William J. Valentine & Andrew J. Palmer

2007 Cost Effectiveness of Pegaptanib for the Treatment of Age-Related Macular Degeneration in the UK
by Sorrel E. Wolowacz & Neil Roskell & Steven Kelly & Fiona M. Maciver & Chris S. Brand

2007 Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients
by Ya-Chen Tina Shih & Nebiyou B. Bekele & Ying Xu

2007 A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD
by Laura Bojke & Edward Hornby & Mark Sculpher

2007 Valuing Children's Health: A Comparison of Cost-Utility Analyses for Adult and Paediatric Health Interventions in the US
by Joseph A. Ladapo & Peter J. Neumann & Ron Keren & Lisa A. Prosser

2007 Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters
by Jeffrey S. Hoch & Carolyn S. Dewa

2007 Ninth Annual Disease Management Leadership Forum and First Disease Management Association of America-National Association of Manufacturers Integrated Care Summit: Las Vegas, Nevada, 16-19 September 2007
by Ginny-Louise MacKay

2007 Cost-Effectiveness Analysis of a Pharmacy Asthma Care Program in Australia
by Adam Gordois & Carol Armour & Martha Brillant & Sinthia Bosnic-Anticevich & Deborah Burton & Lynne Emmerton & Ines Krass & Bandana Saini & Lorraine Smith & Kay Stewart

2007 Nurse Practitioner-Based Diabetes Care Management: Impact of Telehealth or Telephone Intervention on Glycemic Control
by Karen Chang & Rita Davis & Judy Birt & Pete Castelluccio & Peter Woodbridge & David Marrero

2007 Patient and Physician Factors Contributing to Poor Outcomes in Patients with Asthma and COPD
by Adrian Gillissen & Hubertus Wirtz & Uwe Juergens

2007 Health Support of People with Disabilities in South Australia: Innovations in Policy and Practice
by David Caudrey & Marguerite Dissinger

2007 Disease Management of Chronic Heart Failure in the Elderly: Issues and Options
by Ken McDonald

2007 Acknowledgment
by Adis International Limited

2007 Disease Management Update
by Adis International Limited

2007 Consensus Development and Application of ICD-9-CM Codes for Defining Chronic Illnesses and their Complications
by Ariel Linden & Thomas J. Biuso & Gopal Allada & Alan F. Barker & Joaquin Cigarroa & Sai Praveen Haranath & Diana Rinkevich & Karl Stajduhar

2007 Obesity and Medical Visits in Family Medicine: A Retrospective Analysis of Medical Records
by James E. Rohrer & Steven C. Adamson & Joseph W. Furst

2007 Health Coaching as an Intervention in Health Management Programs
by Susan W. Butterworth & Ariel Linden & Wende McClay

2007 Selection of Proton Pump Inhibitors for Formulary Inclusion: Making Decisions Based on Appropriate Criteria
by Stephen W. Nissen & Keith M. Olsen

2007 Health Plan Employer Data and Information Set (HEDIS(R)) Criteria to Determine the Quality of Asthma Care in Children: What Are the Limitations?
by Harold J. Farber & Michael Schatz

2007 Perspectives on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: Outcomes From a Meeting of the Latin America Experts Group
by Luis Bahamondes & Santiago Cordova-Eguez & Jose Enrique Pons & Lee Shulman

2007 Disease Management Update
by Adis International Limited

2007 The Role of Medication Adherence as a Determinant of Blood Pressure Control in a Managed Care Population
by Nilay D. Shah & MaryAnn E. Steiner & Lee C. Vermeulen & Lawrence A. Fleming & Patrick R. Cory

2007 Consumer-Directed Health Plans and the Chronically Ill
by Stephen T. Parente & Jon B. Christianson & Roger Feldman

2007 Measuring the Quality of Healthcare: The Connection between Structure, Process, and Outcomes of Care, Using the Example of Myocardial Infarction Treatment in Germany
by Ansgar Wubker

2007 Evaluation of an Online Relapse Prevention Program for Bipolar Disorder: An Overview of the Aims and Methodology of a Randomized Controlled Trial
by Caryl Barnes & Robin Harvey & Philip Mitchell & Michael Smith & Kay Wilhelm

2007 Physician-Patient e-Visit Programs: Implementation and Appropriateness
by Pamela Whitten & Lorraine Buis & Brad Love

2007 Disease Management Programs for Glaucoma: Has the Vision Become a Reality?
by Lawrence D. Goldberg

2007 Disease Management Update
by Adis International Limited

2007 Psychoeducational Approaches to Medication Adherence in Patients with Bipolar Disorder
by Martha Sajatovic & Peijun Chen & Philipp Dines & Edwin R. Shirley

2007 Treating Allergic Asthma with Omalizumab
by Paul P. Belliveau & Monina R. Lahoz

2007 Design, Measurement, and Evaluation of an Education Strategy in the Hospital Setting to Combat Antimicrobial Resistance: Theoretical Considerations and a Practical Example
by Celine Pulcini & Sally Crofts & Diane Campbell & Peter Davey

2007 Implementation of an HPV-Vaccination Program: Key Factors for Success
by Shalini L. Kulasingam

2007 Disease Management and the Medical Home Model: Competing or Complementary?
by Vincent Kuraitis

2007 Abandoning the UK NHS?
by Tony Clive Hockley

2007 The Role of Spirometry in Evaluating Therapeutic Responses in Advanced COPD
by Pierantonio Laveneziana & Denis E. O'Donnell

2007 The Rise of Specialty Pharmacy Costs: Issues for Providers, Payers, and Patients
by Steve B. Miller & Tracy A. Hoffman & Jonah C. Houts & Jane L. Miller & Britton L. Pim & Andrew Behm

2007 Exploring Disease Management Programs for Diabetes Mellitus: Proposal of a Novel Hybrid Model
by Kerri L. Cavanaugh & Richard O. White & Russell L. Rothman

2007 Physician Prescribing and Medicare Part D: Closing the Gaps
by William H. Shrank

2007 Disease Management Update
by Adis International Limited

2007 Patient-Motivated Prevention of Lifestyle-Related Disease in Japan: A Randomized, Controlled Clinical Trial
by Akira Babazono & Chihoko Kame & Reiko Ishihara & Eiji Yamamoto & Alan L. Hillman

2007 Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings: Advantages and Limitations
by Jay Hawkshead & Marie A. Krousel-Wood

2007 Initiatives to Promote Effective Self-Care Skills in Children and Adolescents with Diabetes Mellitus
by Barbara J. Anderson & Britta Svoren & Lori Laffel

2007 Estimating the Effect of Regression to the Mean in Health Management Programs
by Ariel Linden

2007 Disease Management Update
by Adis International Limited

2007 Spotlight on the Pharmacoeconomics of Candesartan Cilexetil in Chronic Heart Failure and Hypertension
by Greg L. Plosker & Susan J. Keam

2007 The Impact of Nebulized Levalbuterol on Health Care Payments for Elderly Asthma and Chronic Obstructive Pulmonary Disease Patients in Medicaid Plans
by Ronald J. Ozminkowski & Shaohung Wang & Stacey R. Long

2007 Estimating the Impact of a Congestive Heart Failure Disease Management Program on Prescription Drug Use: A State Medicaid Program
by Anthony C. Moscoso & Matthew J. Strand & Gregory D. Berg & Gary K. Grunwald

2007 Hypertension Home Telemonitoring: Current Evidence and Recommendations for Future Studies
by Mirou Jaana & Guy Pare & Claude Sicotte

2007 Use of the Pre-Post Method to Measure Cost Savings in Disease Management: Issues and Implications
by Ariel Linden

2007 Initiatives and Barriers to Adopting Health Information Technology: A US Perspective
by Henry A. DePhillips

2007 La integración vertical en el sistema de salud colombiano
by Jairo Humberto Restrepo & John Fernando Lopera & Sandra Milena Rodríguez

2007 Valoración global de la discapacidad, propuesta de un índice y su aplicación a la población española recogida en la EDDES/Global Measure of the Disability. A Proposal of an Index and its Application to the Spanish Population Reflected in the Survey on Disabilities, Impairments and Health Status
by ALBARRÁN LOZANO, IRENE & ALONSO GONZÁLEZ, PABLO & FAJARDO CALDERA, MIGUEL ÁNGEL

2007 Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák
by Gulácsi, László & Kovács, Erzsébet & Oesterle, August & Boncz, Imre

2007 Die Ausgestaltung von Versorgungsvertraegen: Eine vertragstheoretische Analyse
by Axel Muehlbacher

2007 Medizinische Versorgungszentren
by Volker Amelung & Felix Cornelius

2007 Bestimmungsgruende fuer den medizinischen Fortschritt
by Robert Arnold

2007 Preisbildung bei ambulant und stationaer erbrachten Gesundheitsleistungen
by Guenter Neubauer & Florian Pfister

2007 Zur Dualitaet von GKV und PKV, The Future of Private and Public Health Insurance in Germany
by Klaus Dirk Henke

2007 Vertragswettbewerb im Gesundheitswesen
by Axel Boersch-Supan

2007 Beitragssatz, Kassenwettbewerb und Gesundheitsreform, Eine empirische Analyse
by Hanfried H. Andersen & Markus M. Grabka & Johannes Schwarze

2007 Measuring Across Hospital Efficiency and Productivity: The Case of Second Regional Health Authority of Attica
by P. Prezerakos & N. Maniadakis & D. Kaitelidou & N. Kotsopoulos & J. Yfantopoulos

2007 El mutualismo de previsión social en España
by Mª Teresa Sánchez Martínez

2006 The Timing of New Technology Adoption: The Case of MRI
by Philipp Schmidt-Dengler

2006 On the characteristics of a mixed system of provision of a private good. An application to health care
by Simona GRASSI

2006 Les mesures de la santé et de l’activité sont-elles comparables dans les enquêtes européennes ?
by Sermet, Catherine & Rochereau, Thierry & Barnay, Thomas & Jusot, Florence

2006 Health expenditure growth : reassessing the threat of ageing
by Huber, Hélène & Grignon, Michel & Dormont, Brigitte

2006 Prescription Drug Expenditures in the United States: The Effects of Obesity, Demographics, and New Pharmaceutical Products
by Donald Vandegrift & Anusua Datta

2006 Assessing Consumer Gains from a Drug Price Control Policy in the United States
by Rexford E. Santerre & John A. Vernon

2006 Differentielle Mortalität in Deutschland
by Rembrandt Scholz

2006 Zum Einfluss von Demographie und medizinisch-technischem Fortschritt auf die Gesundheitsausgaben
by Henke, Klaus-Dirk & Reimers, Lutz

2006 Is Waiting-time Prioritisation Welfare Improving?
by Hugh Gravelle & Luigi Siciliani

2006 Rationing the Public Provision of Health Care in the Presence of Private Supplements: Evidence from the Italian NHS
by Daniele Fabbri & Chiara Monfardini

2006 Why do patients bypass the nearest hospital? An empirical analysis for orthopaedics care and neurosurgery in the Netherlands
by Marco Varkevisser & Stéphanie van der Geest

2006 Are Hospitals Seasonally Inefficient? Evidence from Washington State Hospitals
by Daniel Friesner & Matthew McPherson & Robert Rosenman

2006 Efficiency of Thai provincial public hospitals after the introduction of National Health Insurance Program
by R. Amy Puenpatom & Robert Rosenman

2006 Rationing The Public Provision Of Healthcare In The Presence Of Private Supplements: Evidence From The Italian Nhs
by Daniele Fabbri & Chiara Monfardini

2006 Style of practice and assortative mating: a recursive probit analysis of cesarean section scheduling in Italy
by Daniele Fabbri & Chiara Monfardini

2006 Supply, Demand, and Equilibrium in the Market for CRNAs
by Steven Stern & Elizabeth Merwin & Lorraine Jordan

2006 Does Medical Diagnosis Data Clarify the Relation Between Prenatal Care and Delivery Outcomes?
by Sankar Mukhopadhyay & Jeanne Wendel

2006 Measuring Selection Incentives in Managed Care: Evidence from the Massachusetts State Employee Insurance Program
by Anupa Bir & Karen Eggleston

2006 Health Care Provider Choice
by Christelle Swanepoel & Ian Stuart

2006 Who gets the Credit? Determinants of the Probability of Default in the German Hospital Sector
by Boris Augurzky & Dirk Engel & Christoph Schwierz

2006 The Effects of Reference Pricing on Ex-factory Prices of Rx Drugs in Germany – A Panel Data Approach
by Boris Augurzky & Silja Göhlmann & Stefan Gress & Jürgen Wasem

2006 Copayments in the German Health System – Do They Work?
by Boris Augurzky & Thomas Bauer & Sandra Schaffner

2006 Adaption of New Technologies and Costs of Health Care
by Kulvik, Martti & Linnosmaa, Ismo & Hermans, Raine

2006 Price Variation in Markets with Homogeneous Goods: The Case of Medigap
by Nicole Maestas & Mathis Schroeder & Dana P. Goldman

2006 Elección de planes de salud mediante técnicas de clasificación fuzzy (Health plans selection using fuzzy classification techniques)
by Lowenthal-Quastler, Sonia K. & Garcia-Fronti, Javier & Casparri, María Teresa

2006 Evaluating the Effect of a Policy Change to Hospital Productivity: 80 Hours Work Restriction on Medical Residents
by Fernandez, Jose

2006 Cost of inpatient rehabilitation care in the Department of Veterans Affairs
by Wagner, Todd H. & Richardson, Samuel S. & Vogel, Bruce & Wing, Kristen & Smith, Mark W.

2006 Moonlighting: Public Service and Private Practice
by Gary Biglaiser & Ching-to Albert Ma

2006 Pharmaceutical Pricing and Reimbursement Policies in Canada
by Valérie Paris & Elizabeth Docteur

2006 Balancing Health Care Quality and Cost Containment: The Case of Norway
by Alexandra Bibbee & Flavio Padrini

2006 Investigating Health Technology Diffusion in New Zealand – How Does it Spread and Who Stands to Gain?
by Louise Allsopp

2006 Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels
by Allan Begosh & John Goldsmith & Ed Hass & Randall W. Lutter & Clark Nardinelli & John A. Vernon

2006 Repugnance as a Constraint on Markets
by Alvin E. Roth

2006 Health Insurance as a Two-Part Pricing Contract
by Darius Lakdawalla & Neeraj Sood

2006 European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
by Joseph H. Golec & John A. Vernon

2006 What Drove First Year Premiums in Stand-Alone Medicare Drug Plans?
by Kosali I. Simon & Claudio Lucarelli

2006 Intellectual Property and Marketing
by Darius Lakdawalla & Tomas Philipson & Y. Richard Wang

2006 The Effect of State Community Rating Regulations on Premiums and Coverage in the Individual Health Insurance Market
by Bradley Herring & Mark V. Pauly

2006 Moral Hazard, Adverse Selection and Health Expenditures: A Semiparametric Analysis
by Patrick Bajari & Han Hong & Ahmed Khwaja

2006 Regulatory Exploitation and the Market for Corporate Controls
by Leemore Dafny & David Dranove

2006 The Effects of HMO and Its For-Profit Expansion on the Survival of Specialized Hospital Services
by Yu-Chu Shen

2006 Nursing Home Quality as a Public Good
by David C. Grabowski & Jonathan Gruber & Joseph J. Angelelli

2006 The Boskin Commission Report: A Retrospective One Decade Later
by Robert J. Gordon

2006 Sources of Advantageous Selection: Evidence from the Medigap Insurance Market
by Hanming Fang & Michael P. Keane & Dan Silverman

2006 The Welfare Consequences of Hospital Mergers
by Robert Town & Douglas Wholey & Roger Feldman & Lawton R. Burns

2006 The Health Care Safety Net and Crowd-Out of Private Health Insurance
by Anthony T. Lo Sasso & Bruce D. Meyer

2006 Health Insurance Take-up by the Near Elderly
by Thomas C. Buchmueller & Sabina Ohri

2006 Demande induite par l’offre ambulatoire : un survol de la littérature théorique et empirique
by Trinquard, S.

2006 Pseudo-Generic Products and Mergers in Pharmaceutical Markets
by Granier, L. & Trinquard, S.

2006 Tax Incentives as a Solution to the Uninsured: Evidence from the Self-Employed
by Gulcin Gumus & Tracy Regan

2006 Tax Incentives as a Solution to the Uninsured: Evidence from the Self-Employed
by Tracy L. Regan & Gulcin Gumus

2006 Contrasting Inequalities: Comparing Correlates of Health in Canada and the United States
by Hugh Armstrong & Wallace Clement & Zhiqiu Lin & Steven Prus

2006 Satisfied Workers, Retained Workers: Effects of Work and Work Environment on Homecare Workers' Job Satisfaction, Stress, Physical Health, and Retention
by Isik U. Zeytinoglu & Margaret Denton

2006 Physician Labour Supply in Canada: a Cohort Analysis
by Thomas F. Crossley & Jeremiah Hurley & Sung-Hee Jeon

2006 Satisfied Workers, Retained Workers: Effects of Work and Work Environment on Homecare Workers' Job Satisfaction, Stress, Physical Health, and Retention
by Isik U. Zeytinoglu & Margaret Denton

2006 Physician Labour Supply in Canada: a Cohort Analysis
by Thomas F. Crossley & Jeremiah Hurley & Sung-Hee Jeon

2006 Physician Labour Supply in Canada: a Cohort Analysis
by Thomas F. Crossley, Jeremiah Hurley, and Sung-Hee Jeon

2006 Variations Among Regions and Hospitals in Managing Chronic Illness: How Much Care Is Enough? Seventeenth Annual Herbert Lourie Memorial Lecture on Health Policy
by John E. Wennberg

2006 Changing Economic Incentives in Long-Term Care
by R. Tamara Konetzka

2006 The Distributional Impact of Healthcare Financing in Nigeria: A Case Study of Enugu State
by Hyacinth Ementa Ichoku & William Munpuibeyi Fonta

2006 Indian Patent Policy and Publich Health : implications from the Japanese Experience
by Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko

2006 Relative Efficiency, Scale Effect, and Scope Effect of Public Hospitals: Evidence from Australia
by Jian Wang & Zhong Zhao & Amir Mahmood

2006 Conjugal Bereavement Effects on Health and Mortality at Advanced Ages
by van den Berg, Gerard J. & Lindeboom, Maarten & Portrait, France

2006 Conjugal Bereavement Effects on Health and Mortality at Advanced Ages
by Gerard J. van den Berg & Maarten Lindeboom & France Portrait

2006 Copayments in the German Health System: Does It Work?
by Boris Augurzky & Thomas K. Bauer & Sandra Schaffner

2006 Copayments in the German Health System: Does It Work?
by Augurzky, Boris & Bauer, Thomas K. & Schaffner, Sandra

2006 Relative Efficiency of Health Provision: a DEA Approach with Non-discretionary Inputs
by António Afonso & Miguel St. Aubyn

2006 (M)oral Hazard?
by Grönqvist, Erik

2006 Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?
by Brekke, Kurt R. & Grasdal, Astrid L. & Holmås, Tor Helge

2006 Wages and work conditions as determinants for physicians’ work decisions
by Askildsen, Jan Erik & Holmås, Tor Helge

2006 Is There a Demand Response by Patients in Primary Care?
by Holmås, Tor Helge & Kaarbøe, Oddvar

2006 Centralized or decentralized? A case study of Norwegian hospital reform
by Magnussen, Jon & Hagen, Terje P. & Kaarbøe, Oddvar M.

2006 Catastrophic insurance: Impact of the Australian Medicare Safety Net on fees, service use and out-of-pocket costs, CHERE Working Paper 2006/9
by Kees van Gool & Elizabeth Savage & Rosalie viney & Marion Haas & Rob Anderson

2006 Who?s getting caught? An analysis of the Australian Medicare Safety Net, CHERE Working Paper 2006/8
by Kees van Gool & Elizabeth Savage & Rosalie viney & Marion Haas & Rob Anderson

2006 Decision making by patients: An application of naturalistic decision making theory to cervical screening and chronic renal failure, Working Paper 2006/5
by Marion Haas

2006 Genetic testing, income distribution and insurance markets, CHERE Working Paper 2006/3
by Ray Rees & Patricia Apps

2006 Healthy, wealthy and insured? The role of self-assessed health in the demand for private health insurance, CHERE Working Paper 2006/2
by Denise Doiron & Glenn Jones & Elizabeth Savage

2006 Horizontal inequities in Australia?s mixed public/private health care system, CHERE Working Paper 2006/13
by Eddy van Doorslaer & Philip Clarke & Elizabeth Savage & Jane Hall

2006 Do financial incentives for supplementary private health insurance reduce pressure on the public system? Evidence from Australia, CHERE Working Paper 2006/11
by Mingshan Lu & Elizabeth Savage

2006 Does the reason for buying health insurance influence behaviour? CHERE Working Paper 2006/1
by Denzil Fiebig & Elizabeth Savage & Rosalie Viney

2006 Integrierte Versorgung in Deutschland - ein empirisches Schlaglicht
by Mittendorf, Thomas & Schmidt, Frank

2006 Eliciting the Demand for Long Term Care Coverage: A Discrete Choice Modelling Analysis
by Rinaldo Brau & Matteo Lippi Bruni

2006 Physician Quality and Health Care for the Poor and Uninsured
by Lara Bryant & Sharmila Vishwasrao

2006 La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica
by Laura Magazzini & Fabio Pammolli & Nicola Carmine Salerno

2006 Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine
by Fabio Pammolli & Nicola Carmine Salerno

2006 THE UNQUALIFIED MEDICAL PRACTITIONERS - Methods of Practice and Nexus with the Qualified Doctors
by K.V. Narayana

2006 Decomposing the causes of health care use inequalities: a micro-simulations approach
by Hélène Huber

2006 Adverse selection and moral hazard in health insurance
by Bien, Franck & Alary, David

2006 Opening the black box of group dynamics : the participation/reification duality as generative mechanism
by Dameron, Stéphanie & Josserand, Emmanuel

2006 Moral Hazard and the Demand for Health Services: A Matching Estimator Approach
by Barros, Pedro Luis Pita & Machado, Matilde Pinto & Sanz-de-Galdeano, Anna

2006 Entry and Regulation - Evidence from Health Care Professions
by Schaumans, Catherine & Verboven, Frank

2006 Health plan pricing behaviour and managed competition
by Rudy Douven & E. Schut

2006 Consumer price sensitivity in health insurance
by Machiel van Dijk & Marc Pomp & Rudy Douven

2006 Hospital’s activity-based financing system and manager-physician interaction
by CRAINICH, David & LELEU, Hervé & MAULEON, Ana

2006 Integración vertical en el sistema de salud colombiano: Aproximaciones empíricas y análisis de doble marginalización
by Jairo Humberto Restrepo & Sandra Rodríguez & John Fernando Lopera

2006 Integración vertical en el sistema de salud colombiano: Aproximaciones empíricas y análisis de doble marginalización
by Jairo Humberto Restrepo Zea & John Fernando Lopera Sierra & Sandra Rodríguez Acosta

2006 Propuesta Para El Diseño De Un Sistema De Protección Social Para Colombia
by Jairo Núñez Méndez & Laura Cuesta

2006 Evaluating The Impact Of Health Care Reform In Colombia: From Theory To Practice
by Alejandro Gaviria & Carlos Medina & Carolina Mejía

2006 R&D In The Pharmaceutical Industry: A World Of Small Innovation
by Beatriz Dominguez & Juan-José Ganuza & Gerard Llobet

2006 Advance Market Commitments for Vaccines Working Paper and Spread Sheet
by Ruth Levine & Ernst R. Berndt & Rachel Glennerster & Michael R. Kremer & Jean Lee & Georg Weizsacker & Heidi Williams

2006 Reference Pricing of Pharmaceuticals
by Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume

2006 What Do We know About Competition and Quality in Health Care Markets?
by Martin Gaynor

2006 Contractual design and public-private parternships for hospitals
by Pedro Pita Barros & Xavier Martinez-Giralt

2006 Bargaining Over Labor: Do Patients have any Power?
by Joshua S. Gans & Andrew Leigh

2006 The Authors' Reply
by Adrian A. Bagust & Marc Evans & Sophie Beale & Philip Home & Andrew Perry & Murray Stewart & Arran Shearer & Alan Martin & Lisa Hulme & Andreas Liebl & Oliver Schoeffski & Anita Goertz & Javier Ampudia-Blasco & Belen Martinez-Lage & Isabel Perez Escolano & Gonzalo Paris

2006 Modelling Lifetime Metabolic Progression and Cost Effectiveness of Treatment Strategies for Type 2 Diabetes
by Andrew J. Palmer & Craig J. Currie

2006 Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF
by Ting Hsiang Lin

2006 Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia: Cost Effectiveness and Risk Sharing
by John H. Wlodarczyk & Leslie G. Cleland & Anne M. Keogh & Keith D. McNeil & Kate Perl & Robert G. Weintraub & Trevor J. Williams

2006 Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003
by Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen

2006 Cost-of-Illness Studies: A Review of Current Methods
by Ebere Akobundu & Jing Ju & Lisa Blatt & C. Daniel Mullins

2006 Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework: Some Considerations
by Emma McIntosh

2006 The Value of Thinly Spread QALYs
by Duncan Mortimer

2006 Accuracy versus Transparency in Pharmacoeconomic Modelling: Finding the Right Balance
by David M. Eddy

2006 US FDA Guidance: Apropos of PROs
by Paul Kind

2006 National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
by Slobodan M. Jankovic & Nebojsa Milivojevic

2006 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
by Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette

2006 Costs of Inflammatory Bowel Disease in Germany
by Renee Stark & Hans-Helmut Konig & Reiner Leidl

2006 A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction
by Mark Lamotte & Lieven Annemans & Pawel Kawalec & York Zoellner

2006 Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease
by Virginia L. Priest & Evan J. Begg & Sharon J. Gardiner & Christopher M.A. Frampton & Richard B. Gearry & Murray L. Barclay & David W.J. Clark & Paul Hansen

2006 A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials
by Darren J. Clayson & Diane J. Wild & Paul Quarterman & Isabelle Duprat-Lomon & Maria Kubin & Stephen Joel Coons

2006 Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence
by Michelle Orme & Annabel Boler

2006 Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
by Pamela C. Heaton

2006 Clopidogrel: A Pharmacoeconomic Review of its Use in Patients with Non-ST Elevation Acute Coronary Syndromes
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2006 Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma
by Gunnar Johansson & Emma B. Andreasson & Per E. Larsson & Claus F. Vogelmeier

2006 Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation
by Richard C. Oude Voshaar & Paul F.M. Krabbe & Wim J.M.J. Gorgels & Eddy M.M. Adang & Anton J.L.M. van Balkom & Eloy H. van de Lisdonk & Frans G. Zitman

2006 Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country
by Hwee-Lin Wee & Chee-Eng Tan & Su-Yen Goh & Shu-Chuen Li

2006 Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies
by John B. Wong

2006 Cost of Lung Cancer: A Methodological Review
by Laurent Molinier & Christophe Combescure & Cristos Chouaid & Jean-Pierre Daures & Bruno Housset & Didier Fabre & Alain Grand & Alain Vergnenegre

2006 Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues
by Yin Bun Cheung & Julian Thumboo

2006 Economic Models of Antiretroviral Therapy: Searching for the Optimal Strategy
by Fred J. Hellinger

2006 NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
by Nick Freemantle

2006 The Authors' Reply
by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg

2006 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
by Nick Bosanquet & Andrew Yeates

2006 Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore
by Lee-Yee Chong & Oh-Moh Chay & Li Shu-Chuen

2006 Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients: A Pharmacoeconomic Analysis
by George Dranitsaris & Mark Vincent & Mark Crowther

2006 Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germany
by Peter K. Schadlich & Michael Kentsch & Manfred Weber & Wolfgang Kammerer & Josef Georg Brecht & Vijay Nadipelli & Eduard Huppertz

2006 The Effects of Type 1 Diabetes and its Long-Term Complications on Physical and Mental Health Status
by Jarmo Hahl & Helena Hamalainen & Tuula Simell & Olli Simell

2006 The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
by George W. Carides & Shahnaz Shahinfar & Erik J. Dasbach & William F. Keane & William C. Gerth & Charles M. Alexander & William H. Herman & Barry M. Brenner & the RENAAL Investigators

2006 Healthcare Rationing in Spain: Framework, Descriptive Analysis and Consequences
by Rosa Rodriguez-Monguio & Fernando Antonanzas Villar

2006 Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy: Implications for Decision Making
by Cornelis Boersma & Jarir Atthobari & Ron T. Gansevoort & Lolkje T.W. de Jong-Van den Berg & Paul E. de Jong & Dick de Zeeuw & Lieven J.P. Annemans & Maarten J. Postma

2006 The Authors' Reply
by Lawrence D. Goldberg & John G. Walt

2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
by Javier Soto

2006 Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer
by Christopher Dunn & Susan J. Keam

2006 Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial
by Shelby D. Reed & Jasmina I. Radeva & Davey B. Daniel & Samir H. Mody & Jamie B. Forlenza & R. Scott McKenzie & Kevin A. Schulman

2006 Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers
by Cynthia P. Iglesias & Karl Claxton

2006 Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment
by Janneke Kaper & Edwin J. Wagena & Constant P. van Schayck & Johan L. Severens

2006 Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial
by Laura Bojke & Mark Sculpher & Richard Stephens & Wendi Qian & Nick Thatcher & David Girling

2006 Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review
by Sylvia M.C. Vijgen & Mirjam Hoogendoorn & Caroline A. Baan & G. Ardine de Wit & Wien Limburg & Talitha L. Feenstra

2006 Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare
by Florian Vogt & David L.B. Schwappach & John F.P. Bridges

2006 The Authors' Reply
by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt

2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
by Stephanie Land

2006 Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?
by Marieke Krol & Werner Brouwer & Pedram Sendi

2006 A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
by Aslam H. Anis & Huiying Sun & Sonia Singh & John Woolcott & Bohdan Nosyk & Marc Brisson

2006 Post-Exposure Influenza Prophylaxis with Oseltamivir: Cost Effectiveness and Cost Utility in Families in the UK
by Beate Sander & Frederick G. Hayden & Marlene Gyldmark & Louis P. Garrison

2006 Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment
by Zoe Philips & Laura Bojke & Mark Sculpher & Karl Claxton & Su Golder

2006 Optimal Assignment of Treatments to Health States Using a Markov Decision Model: An Introduction to Basic Concepts
by Mohan V. Bala & Josephine A. Mauskopf

2006 Economic and Developmental Considerations for Pharmacogenomic Technology
by John A. Vernon & Scott J. Johnson & W. Keener Hughen & Antonio Trujillo

2006 The Burden of Age-Related Macular Degeneration
by Jordana K. Schmier & Mechelle L. Jones & Michael T. Halpern

2006 Bernard S. Bloom, PhD
by Henry A. Glick

2006 Rationing of Drugs for Rare Diseases
by Dyfrig Hughes

2006 Bimatoprost: A Pharmacoeconomic Review of its Use in Open-Angle Glaucoma and Ocular Hypertension
by Greg L. Plosker & Susan J. Keam

2006 The Authors' Reply
by Paul Kind & Sue Macran

2006 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
by A. Simon Pickard & Deborah Dobrez & David Cella

2006 Quality-of-Life Valuations of Advanced Breast Cancer by New Zealand Women
by Richard J. Milne & Kathy H. Heaton-Brown & Paul Hansen & David Thomas & Vernon Harvey & Alison Cubitt

2006 Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer's Disease and Other Dementias
by Jerrold Hill & Howard Fillit & Simu K. Thomas & Sobin Chang

2006 Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
by Lawrence D. Goldberg & John Walt

2006 Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen Therapy: The UK Perspective
by Jonathan Karnon & Thomas Delea & Stephen R.D. Johnston & Robert Smith & Jane Brandman & Jennifer Sung & Paul E. Goss

2006 Trends in Outpatient Prescription Drug Use and Related Costs in the US: 1998-2003
by Diane K. Wysowski & Laura A. Governale & Joslyn Swann

2006 Aromatase Inhibitors in Breast Cancer: A Review of Cost Considerations and Cost Effectiveness
by Jonathan Karnon

2006 Less is More: Medicines that Require Less Frequent Administration Improve Adherence, but Are They Better?
by Dyfrig Hughes

2006 How Much is the Cost of Visual Impairment: the Author's Reply
by Antoine Lafuma

2006 How Much is the Cost of Visual Impairment: Caveat Emptor
by Catherine Meads & Chris Hyde

2006 Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK
by Antoine Lafuma & Antoine Brezin & Stefania Lopatriello & Klaus Hieke & Julia Hutchinson & Viviane Mimaud & Gilles Berdeaux

2006 The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
by Rachael L. DiSantostefano & Andrea K. Biddle & John P. Lavelle

2006 A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
by Mark Lamotte & Lieven Annemans & Thomas Evers & Maria Kubin

2006 Combination Vaccine Against Invasive Meningococcal B and Pneumococcal Infections: Potential Epidemiological and Economic Impact in The Netherlands
by Jasper M. Bos & Hans C. Rumke & Robert Welte & Lodewijk Spanjaard & Loek van Alphen & Maarten J. Postma

2006 Differential Effects of Atypical versus Typical Antipsychotic Medication on Earnings of Schizophrenia Patients: Estimates from a Prospective Naturalistic Study
by David Salkever & Eric Slade & Mustafa Karakus

2006 Sociodemographic Differences in Quality of Life in Rheumatoid Arthritis
by Erik J. Groessl & Theodore G. Ganiats & Andrew J. Sarkin

2006 Better Analysis for Better Decisions: Has Pharmacoeconomics Come of Age?
by Michael Drummond & Mark Sculpher

2006 Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia
by Andrew R. Willan & Ron Goeree & Eleanor M. Pullenayegum & Christopher McBurney & Gordon Blackhouse

2006 Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis
by Antonio Gomez-Outes & Eduardo Rocha & Javier Martinez-Gonzalez & Vijay V. Kakkar

2006 Evaluation of the Cost Effectiveness of Sirolimus versus Tacrolimus for Immunosuppression Following Renal Transplantation in the UK
by Phil McEwan & Simon Dixon & Keshwar Baboolal & Pete Conway & Craig J. Currie

2006 Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population
by Eric Q. Wu & Howard Birnbaum & Milena Mareva & Andrew Parece & Zihong Huang & David Mallett & Haya Taitel

2006 Incorporating Carer Effects into Economic Evaluation
by Simon Dixon & Mel Walker & Sam Salek

2006 Too Important to Ignore: Informal Caregivers and Other Significant Others
by Werner B.F. Brouwer

2006 Costs of Irritable Bowel Syndrome in the UK and US
by Stefanie Maxion-Bergemann & Frank Thielecke & Florian Abel & Rito Bergemann

2006 Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis
by A.E. Ades & Mark Sculpher & Alex Sutton & Keith Abrams & Nicola Cooper & Nicky Welton & Guobing Lu

2006 The Authors' Reply
by J.M. Bos & M.J. Postma & L. Annemans

2006 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
by Stuart Birks

2006 Candesartan Cilexetil: A Pharmacoeconomic Review of its Use in Chronic Heart Failure and Hypertension
by Greg L. Plosker & Susan J. Keam

2006 Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia
by Wei Yu & Xinhua S. Ren & Austin F. Lee & Lawrence Herz & Yu-Hui Huang & Lewis E. Kazis

2006 Cost Effectiveness of Tumour Necrosis Factor-alpha Inhibitors as First-Line Agents in Rheumatoid Arthritis
by James R. Spalding & Joel Hay

2006 Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations
by Ulrike Ravens-Sieberer & Michael Erhart & Nora Wille & Ralf Wetzel & Jennifer Nickel & Monika Bullinger

2006 Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis
by Hege Urdahl & Andrea Manca & Mark J. Sculpher

2006 Letter From the Commissioner's Office at the US FDA
by John A. Vernon

2006 Do Pharmacogenomic Tests Provide Value to Policy Makers?
by Ya-Chen Tina Shih & Lajos Pusztai

2006 Acknowledgement
by Adis International Limited

2006 Economic Evaluation in the US: What is the Missing Link?
by Peter J. Neumann & Sean D. Sullivan

2006 Economic Evaluations in the Canadian Common Drug Review
by Andreas Laupacis

2006 Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario's Evidence-Based HTPA Process
by Ron Goeree & Leslie Levin

2006 Economic Evaluation and Decision Making in the UK
by Martin J. Buxton

2006 Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers
by Stephen Birch & Amiram Gafni

2006 `Lost in Translation': Accounting for Between-Country Differences in the Analysis of Multinational Cost-Effectiveness Data
by Andrea Manca & Andrew R. Willan

2006 Analysis Sans Frontieres: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?
by Mark J. Sculpher & Michael F. Drummond

2006 Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven?
by Andrew H. Briggs & Adrian R. Levy

2006 Utility Measurement in Healthcare: The Things I Never Got To
by George W. Torrance

2006 Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience
by Karl P. Claxton & Mark J. Sculpher

2006 Recent Developments in Decision-Analytic Modelling for Economic Evaluation
by Milton C. Weinstein

2006 Better Analysis for Better Decisions: Facing Up to the Challenges
by Michael F. Drummond & Mark J. Sculpher

2006 Hospitalisation Costs of Cystic Fibrosis
by Jonas Schreyogg & Helge Hollmeyer & Miriam Bluemel & Doris Staab & Reinhard Busse

2006 Disability and Quality of Life in Post-Traumatic Stress Disorder: Impact of Drug Treatment
by Soraya Seedat & Christine Lochner & Bavanisha Vythilingum & Dan J. Stein

2006 Single-Inhaler Combination Therapy for Asthma: A Review of Cost Effectiveness
by Manabu Akazawa & David A. Stempel

2006 Therapeutic Options for the Prevention and Treatment of Postoperative Nausea and Vomiting: A Pharmacoeconomic Review
by Jean Lachaine

2006 Should We Abandon QALYs as a Resource Allocation Tool?
by Sandeep Vijan

2006 QALYs: Are They Helpful to Decision Makers?
by Maurice McGregor & J. Jaime Caro

2006 The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead
by James M. Mason & Anne R. Mason

2006 Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit?
by Eduard Shantsila & Timothy Watson & Gregory Y.H. Lip

2006 The Cost Effectiveness of Anticoagulation Management Services for Patients with Atrial Fibrillation and at High Risk of Stroke in the US
by Patrick W. Sullivan & Thomas W. Arant & Samuel L. Ellis & Heather Ulrich

2006 The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis
by Paco M.J. Welsing & Johan L. Severens & Margriet Hartman & Anke M. van Gestel & Piet L.C.M. van Riel & Roland F.J.M. Laan

2006 2006 Disease Management Leadership Forum Meeting Report: Denver, Colorado, 2-5 December 2006
by Julie A. Meek

2006 Economic Analysis of a Telemedicine Intervention to Improve Glycemic Control in Patients with Diabetes Mellitus: Illustration of a Novel Analytic Method
by James M. Mason & Robert J. Young & John P. New & J. Martin Gibson & Andrew F. Long & Tina Gambling & Tim Friede

2006 Psychiatric Drug Use Among Patients of a Community Mental Health Service: Patterns and Implications
by Natasa Gisev & J. Simon Bell & Andrew J. McLachlan & Manoranjenni Chetty & Timothy F. Chen

2006 Combination Therapy for Asthma: Perspectives of the Patient, Provider, and Payer
by Harold J. Farber & James Glauber

2006 Targeted Screening and Treatment of Chronic Kidney Disease: Lessons Learned from the Kidney Early Evaluation Program
by Joseph A. Vassalotti & Leslie Gracz-Weinstein & Monica R. Gannon & Wendy Weinstock Brown

2006 Using Nicotine Replacement Therapy to Assist in Reducing Cigarette Consumption before Quitting: Another Strategy for Smoking Cessation?
by Hayden McRobbie & Robyn Whittaker & Christopher Bullen

2006 Putting a Public Health Face on Clinical Practice: Potential for Using an Infectious Disease Management Model for Chronic Disease Prevention
by Donald O. Fedder & Harsha Desai & Migle Maciunskaite

2006 Acknowledgment
by Adis International Limited

2006 Disease Management Update
by Adis International Limited

2006 The Role of Peginterferon alpha-2a (40kD) Plus Ribavirin in the Management of Chronic Hepatitis C Mono-Infection
by Dene Simpson & Monique P. Curran

2006 The Impact of Open Access to Atypical Antipsychotics on Treatment Costs for Medi-Cal Patients with Bipolar Disorder
by Sangeeta Narayan & Kimberly L. Sterling & Jeffrey S. McCombs

2006 Internet-Based Smoking Cessation Initiatives: Availability, Varieties, and Likely Effects on Outcomes
by Anna M. McDaniel & Renee M. Stratton

2006 Preparing for and Responding to Bioterrorist Attacks: The Role of Disease Management Initiatives
by R. Gregory Evans & Steven J. Lawrence

2006 Disease Management and Its Implications for Outpatient Physician Practice: A Memo for Physicians
by Jaan Sidorov

2006 Disease Management Update
by Adis International Limited

2006 Impact of a Diabetes Disease Management Program by Race and Ethnicity
by Verna L. Welch & Natalia Vukshich Oster & Julie A. Gazmararian & Kimberly Rask & Laura Schild & Charles Cutler & Claire Spettell & Michael Reardon

2006 Disease Management of the Frail Elderly Population
by Stuart Levine & Judy Y. Reyes & Randy Schwartz & Dave Schmidt & Tim Schwab & Moon Leung

2006 Poor Adherence to Anti-inflammatory Medication in Asthma: Reasons, Challenges, and Strategies for Improved Disease Management
by Rachel A. Elliott

2006 Developing a Specialist Patient Program for Migraine
by Ann Turner

2006 Adherence to Antipsychotic Treatment in Schizophrenia: What Role Does Cognitive Behavioral Therapy Play in Improving Outcomes?
by Gary Donohoe

2006 Measuring the Economic Value of Disease Management Programs
by Don Fetterolf

2006 In Search of Financial Savings from Disease Management: Applying the Number-Needed-to-Decrease Analysis to a Diabetic Population
by Ariel Linden & Thomas J. Biuso

2006 Disease Management Update
by Adis International Limited

2006 Community Direct Access Service for Early Detection and Treatment of Clinical Deterioration: Effectiveness and Impact on the Workload Pattern of a Hospital-Based Heart Failure Unit
by Carmel Conlon & Christina O'Loughlin & Mark Ledwidge & Kenneth McDonald

2006 Analysis of Factors Affecting Patient Satisfaction: Focus on Asthma Patients
by Bayram Sahin & Mehtap Tatar

2006 Impact of Telehealth on Healthcare Utilization by Congestive Heart Failure Patients
by Craig A. Lehmann & Nancy Mintz & Jean Marie Giacini

2006 Evaluation of an Asthma Disease Management Program in a Medicaid Population
by Alice Lind & Louise Kaplan & Gregory D. Berg

2006 Telemedicine for Diabetes Care
by Toree H. Malasanos

2006 Removing Prescription Charges for Patients with Mental Health Disorders: Would it Improve Patient Outcomes in the UK?
by Ellen I. Schafheutle

2006 Physician Voluntary Reporting Program
by David W. Plocher

2006 The Economic Burden of End-Stage Renal Disease with Hyperphosphatemia: A Study of Florida Medicaid
by Annesha White & Folakemi Odedina & Hong Xiao & Ellen Campbell & Richard Segal

2006 Process Optimization by Means of a Computerized Process Simulation Model in Cardiac Surgery
by Richard Feyrer & Udo Kunzmann & Michael Weyand & Robert Cesnjevar

2006 Promoting the Implementation of Best-Practice Guidelines Using a Matrix Tool: Focus on Cancer Care
by Karen Luxford & David Hill & Richard Bell

2006 Type 2 Diabetes Mellitus Treatment Patterns and Healthcare Costs in the Elderly Population
by Gary Erwin & Shrividya Iyer & Rukmini Rajagopalan & James Astuto & Patricia Wilson & Justin Schaneman & Nathan Kleinman

2006 Prescription to Over-the-Counter Switch of Second-Generation Antihistamines (Loratadine): A Review of Its Impact on Healthcare Costs and Resource Utilization
by Kavita V. Nair

2006 Disease Management Update
by Adis International Limited

2006 Management of Schizophrenia: Defining the Role of Long-Acting Injectable Risperidone
by Monique P. Curran & Gillian M. Keating

2006 The Cost of Lung Cancer Management in France from the Payor's Perspective
by Alain Vergnenegre & Laurent Molinier & Christophe Combescure & Jean-Pierre Daures & Bruno Housset & Christos Chouaid

2006 Population-Based Disease Management in the German Statutory Health Insurance: Implementation and Preliminary Results
by Stephanie A.K. Stock & Marcus Redaelli & Karl W. Lauterbach

2006 Clinical and Behavioral Impact of Implementing Community-Based Diabetes Disease Management in Japan
by Hiroyuki Sakamaki & Shunya Ikeda & Naoki Ikegami & Michiko Norimoto & Shigemitsu Moriwaki

2006 An Evaluation of the Factors Associated with Statin Dose Management and Low-Density Lipoprotein-Cholesterol Goal Attainment
by Caron Ory & Christina Fontes & Setareh A. Williams & Gerald M. Borok & Kenneth McDonough & Eunice Chang

2006 Disease Management for Hypertension: A Pilot Cluster Randomized Trial of 67 Australian General Practices
by Deborah A. Turnbull & Justin J. Beilby & Tahereh Ziaian & Farooq Qureshi & Mark Nelson & Anne L. Tonkin & John E. Marley

2006 Worksite Disease Management Programs for Depression: Potential Employer Benefits
by Diane E. Steffick & John C. Fortney & Jeffrey L. Smith & Jeffrey M. Pyne

2006 Access to Prescription Drugs: The Case of Medicaid
by Peter J. Cunningham

2006 The Author's Reply
by Joshua Cohen

2006 Comparing Patient Access to Pharmaceuticals in the UK and US
by Joel W. Hay

2006 Comparison of Individual and Group Valuation of Health State Scenarios across Communities in West Africa
by Anayo Fidelis Akunne & John F.P. Bridges & Mamadou Sanon & Rainer Sauerborn

2006 Maximising Responses to Discrete Choice Experiments: A Randomised Trial
by Joanna Coast & Terry N. Flynn & Chris Salisbury & Jordan Louviere & Tim J. Peters

2006 Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers' Pricing Strategies and Price Regulation
by Tom Stargardt & Jonas Schreyogg

2006 Analysis of Healthcare Financing, Supply and Utilisation Trends in the New EU Countries
by Jane E. Ruseski

2006 Handling Value Added Tax (VAT) in Economic Evaluations: Should Prices Include VAT?
by Mickael Bech & Terkel Christiansen & Dorte Gyrd-Hansen

2006 Quality and Cost in Healthcare: A Relationship Worth Examining
by Craig Mitton & Francois Dionne & Stuart Peacock & Sam Sheps

2006 Acknowledgement
by Adis International Limited

2006 Patients' Preferences for Healthcare System Reforms in Hungary: A Conjoint Analysis
by Baktygul Akkazieva & Laszlo Gulacsi & Agnes Brandtmuller & Marta Pentek & John F.P. Bridges

2006 Comparing Patient Access to Pharmaceuticals in the UK and US
by Joshua Cohen & Catherine Cairns & Cherie Paquette & Laura Faden

2006 Community-Based Youth Tobacco Control Interventions: Cost Effectiveness of the Full Court Press Project
by Hana Ross & Lisa M. Powell & Joseph E. Bauer & David T. Levy & Richard M. Peck & Hye-Ryeon Lee

2006 Modelling the Costs and Outcomes of Changing Rates of Screening for Alcohol Misuse by GPs in the Australian Context
by Marian Shanahan & Anthony Shakeshaft & Richard P. Mattick

2006 To Retain or Remove User Fees?: Reflections on the Current Debate in Low- and Middle-Income Countries
by Chris D. James & Kara Hanson & Barbara McPake & Dina Balabanova & Davidson Gwatkin & Ian Hopwood & Christina Kirunga & Rudolph Knippenberg & Bruno Meessen & Saul S. Morris & Alexander Preker & Yves Souteyrand & Abdelmajid Tibouti & Pascal Villeneuve & Ke Xu

2006 Estimating Technical Efficiency in the Hospital Sector with Panel Data: A Comparison of Parametric and Non-Parametric Techniques
by Luigi Siciliani

2006 Supplier-Induced Demand: Reconsidering the Theories and New Australian Evidence
by Jeffrey R.J. Richardson & Stuart J. Peacock

2006 How Cost-of-Illness Studies Can be Made More Useful for Illicit Drug Policy Analysis
by Timothy J. Moore & Jonathan P. Caulkins

2006 Centralising Drug Review to Improve Coverage Decisions: Economic Lessons From (and For) Canada
by Steve Morgan & Meghan McMahon & Craig Mitton

2006 Factors Associated with Physicians' Choice of Working Sector: A National Longitudinal Survey in Finland
by Terhi Kankaanranta & Jari Vainiomaki & Ville Autio & Hannu Halila & Harri Hyppola & Mauri Isokoski & Santero Kujala & Esko Kumpusalo & Kari Mattila & Irma Virjo & Jukka Vanska & Pekka Rissanen

2006 Australian General Practice: Where Have the GP Services Gone?
by Ian McRae

2006 A Macroeconomic Approach to Evaluating Policies to Contain Antimicrobial Resistance: A Case Study of Methicillin-Resistant Staphylococcus aureus (MRSA)
by Richard D. Smith & Milton Yago & Michael Millar & Joanna Coast

2006 Recycling Blood: Sharing the Benefits of Cell Salvage
by Bernard Crotty

2006 Using Economic Analyses for Local Priority Setting: The Population Cost-Impact Approach
by Richard F. Heller & Islay Gemmell & Edward C.F. Wilson & Richard Fordham & Richard D. Smith

2006 The Relationship between Ex Ante Mortality Risk and End-of-Life Medical Costs
by David H. Howard & Steven D. Culler & Benjamin G. Druss & Kenneth E. Thorpe

2006 Genetic Health Technology and Economic Evaluation: A Critical Review
by James Jarrett & Miranda Mugford

2006 Methodological Aspects in the Assessment of Treatment Effects in Observational Health Outcomes Studies
by Josep Maria Haro & Stathis Kontodimas & Miguel Angel Negrin & Mark Ratcliffe & David Suarez & Frank Windmeijer

2006 Health Reform, Equity and Primary Healthcare: Taking Off the Make-Up
by Stephen Thomas & Okore Okorafor & Sandi Mbatsha

2006 How to Measure Government Productivity: A Review Article on 'Measurement of Government Output and Productivity for the National Accounts' (The Atkinson Report)
by Aled ab Iorwerth

2006 La equidad del mecanismo de pago por uso de servicios en el sistema de aseguramiento en salud de Colombia
by Liliana Chicaíza & Fredy Rodríguez & Mario García

2006 Una aproximación de los precios hedónicos al seguro privado de enfermedad en España = A Hedonic Price Approach to the Health Private Insurance in Spain
by Ordaz Sanz, José Antonio & Murillo Fort, Carles

2006 Health Care, Insurance, and the Contract Choice Effect
by Richard Dusansky & �agatay Koç

2006 El entorno regional y la percepción del estado de salud en Colombia, 2003
by Luís Miguel Tovar Cuevas & Gustavo Adolfo García Cruz

2006 Assessing Health Reform in Colombia: From Theory to Practice
by Alejandro Gaviria & Carlos Medina & Carolina Mejia

2006 El entorno regional y la percepción del estado de salud en Colombia, 2003
by Tovar, Luís & García, Gustavo

2006 Determinantes dos Gastos das Famílias com Saúde no Brasil
by Mônica Viegas Andrade & Kenya Valeria Micaela de Souza Noronha & Thiago Barros de Oliveira

2005 Worker Sorting and Health Insurance Coverage: Evidence from Displaced Workers
by Steven F. Lehrer & Nuno Sousa Pereira

2005 Intervención del gobierno en los mercados de servicio de salud
by Janice Seinfeld

2005 Otras características del sector salud
by Janice Seinfeld

2005 Herramientas de evaluación económica
by Janice Seinfeld

2005 Herramientas microeconómicas para analizar el sector salud
by Janice Seinfeld

2005 Análisis económico de la salud
by

2005 Health-Specific Moral Hazard Effects
by Çaatay Koç

2005 Competition and Disclosure Incentives: An Empirical Study of HMOs
by Ginger Zhe Jin

2005 Bewertung der Immobilien von Akutkrankenhäusern der Regelversorgung unter Beachtung des neuen DRG-orientierten Vergütungssystems für stationäre Leistungen
by Jacob, Dieter & Uhlig, Tilo & Stuhr, Constanze

2005 Social health insurance: The major driver of unsustainable fiscal policy?
by Hagist, Christian & Klusen, Norbert & Plate, Andreas & Raffelhüschen, Bernd

2005 Social Health Insurance: the major driver of unsustainable fiscal policy?
by Hagist, Christian & Klusen, Norbert & Plate, Andreas & Raffelhüschen, Bernd

2005 Deductibles in social health insurance systems: Findings from Germany
by Hagist, Christian & Holldorf, Inken & Pütz, Claudia

2005 Health Insurance and Demography : The Russian Case
by Fetzer, Stefan & Hagist, Christian & Hahn, Nargiza

2005 (Teil-)Privatisierung mit sozialer Flankierung: Ein geeignetes Mittel zur langfristigen Sicherung der Gesundheits- und Pflegevorsorge?
by Fetzer, Stefan & Häcker, Jasmin & Hagist, Christian

2005 Panel data analysis of dentists’ activity under global budgeting in the presence of activityrelated non-response
by Miaw-Chwen Lee & Andrew M Jones

2005 Modelling The Health Sector Policy Reforms For Nigeria:A Phased Project Study
by DR. GODWIN CHUKWUDUM NWAOBI

2005 Modelling The Health Sector Modelling The Health Sector:Nigeria
by DR. GODWIN CHUKWUDUM NWAOBI

2005 The Physician-Patient Relationship Revisited - the Patient's View
by Udo Schneider & Volker Ulrich

2005 Asymmetric Information and Outcome-based Compensation in Health Care – Theoretical Implications
by Udo Schneider

2005 Dirichlet-Multinomial Regression
by Paulo Guimaraes & Richard Lindrooth

2005 La evaluación del gasto sanitario en España en sus niveles y determinantes
by Guillem López

2005 R&D in the pharmaceutical industry: A world of small innovations
by Beatriz Domínguez & Juan José Ganuza & Gerard Llobet

2005 La evaluación del gasto sanitario en España en sus niveles y determinantes
by Guillem López

2005 Drug innovation, prices and health
by Vicente Ortún & Jaume Puig & María Callejón

2005 Comportamiento médico: una aplicación a las cesáreas en el Uruguay
by Leonel Muinelo & Máximo Rossi & Patricia Triunfo

2005 Doctors’ Fees in Ireland Following the Change in Reimbursement - Did They Jump?
by David Madden

2005 It takes three to tango: Soft budget constraint and cream skimming in the hospital care market
by Levaggi, Rosella & Montefiori, Marcello

2005 Cost Sharing in Health Insurance: An Instrument for Risk Selection?
by Karolin Becker & Peter Zweifel

2005 The Purpose and Limits of Social Health Insurance
by Peter Zweifel

2005 Consumer Resistance Against Regulation: The Case of Health Care
by Peter Zweifel & Harry Telser & Stephan Vaterlaus

2005 The Impact of Health Insurance Status on Treatment Intensity and Health Outcomes
by David Card & Carlos Dobkin & Nicole Maestas

2005 La Reforma al Sector Salud en Colombia
by Loaiza Quintero, Osmar Leandro

2005 Supplier Discretion over Provision: Theory and an Application to Medical Care
by James Malcomson

2005 Getting Better Value for Money from Sweden's Healthcare System
by David Rae

2005 The Future of Drug Development: The Economics of Pharmacogenomics
by John A. Vernon & W. Keener Hughen

2005 Who's Going Broke? Comparing Growth in Healthcare Costs in Ten OECD Countries
by Christian Hagist & Laurence Kotlikoff

2005 Moral Hazard in Nursing Home Use
by David C. Grabowski & Jonathan Gruber

2005 Does the Profit Motive Make Jack Nimble? Ownership Form and the Evolution of the U.S. Hospital Industry
by Sujoy Chakravarty & Martin Gaynor & Steven Klepper & William B. Vogt

2005 Hospital Ownership and Financial Performance: A Quantitative Research Review
by Yu-Chu Shen & Karen Eggleston & Joseph Lau & Christopher Schmid

2005 The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare
by Amy Finkelstein

2005 What Did Medicare Do (And Was It Worth It)?
by Amy Finkelstein & Robin McKnight

2005 The Formation and Evolution of Physician Treatment Styles: An Application to Cesarean Sections
by Andrew Epstein & Sean Nicholson

2005 Information and Consumer Choice: The Value of Publicized Health Plan Ratings
by Ginger Zhe Jin & Alan T. Sorensen

2005 Generic Scrip Share and the Price of Brand-Name Drugs: The Role of the Consumer
by John A. Rizzo & Richard Zeckhauser

2005 Price and the Health Plan Choices of Retirees
by Thomas C. Buchmueller

2005 Changes in the Physiology of Aging during the Twentieth Century
by Robert W. Fogel

2005 Health Insurance, Treatment and Outcomes: Using Auto Accidents as Health Shocks
by Joseph J. Doyle Jr.

2005 Did the HMO Revolution Cause Hospital Consolidation?
by Robert Town & Douglas Wholey & Roger Feldman & Lawton R. Burns

2005 Dynamic Inefficiencies in Insurance Markets: Evidence from long-term care insurance
by Amy Finkelstein & Kathleen McGarry & Amir Sufi

2005 Users and Suppliers of Physician Services: A Tale of Two Populations
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2005 Survey Results of the New Health Care Worker Study: Implications of Changing Employment Patterns
by Isik Urla Zeytinoglu & Margaret Denton & Sharon Davies & Andrea Baumann & Jennifer Blythe & Ann Higgins

2005 Where Have All The Home Care Workers Gone?
by Margaret Denton & Isik Urla Zeytinoglu & Sharon Davies & Danielle Hunter

2005 Users and Suppliers of Physician Services: A Tale of Two Populations
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2005 Survey Results of the New Health Care Worker Study: Implications of Changing Employment Patterns
by Isik Urla Zeytinoglu & Margaret Denton & Sharon Davies & Andrea Baumann & Jennifer Blythe & Ann Higgins

2005 Where Have All The Home Care Workers Gone?
by Margaret Denton & Isik Urla Zeytinoglu & Sharon Davies & Danielle Hunter

2005 Aging, Health and Aggregate Medical Care Spending in France
by Michel Grignon

2005 Risikoselektion und Risikoausgleich am Beispiel der gesetzlichen Krankenkassen in Deutschland
by Dieterich, Felix

2005 Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate: Reforming the Drug Approval Process According to Market Principles
by Corinne Sauer & Robert Sauer

2005 Risk Adjustment and Primary Health Care in Chile
by Verónica Vargas & Juergen Wasem

2005 Do Non-Profit Operators Provide Higher Quality of Care? Evidence from Micro-Level Data for Japan's Long-term Care Industry
by Haruko Noguchi & Satoshi Shimizutani

2005 Nonprofit/For-Profit Status and Earning Differentials in the Japanese At-home Elderly Care Industry: Evidence from Micro-level Data on Home Helpers and Staff Nurses
by Haruko Noguchi & Satoshi Shimizutani

2005 Reference Pricing of Pharmaceuticals
by Brekke, Kurt R & Königbauer, Ingrid & Straume, Odd Rune

2005 Access to Primary Health Care and Health Outcomes: The Relationships between GP Characteristics and Mortality Rates
by Aakvik, Arild & Holmås, Tor Helge

2005 Patents: Incentives for R&D or Marketing?
by Brekke, Kurt R. & Straume, Odd Rune

2005 Medical indemnity: Crisis and response, CHERE Discussion Paper No 56
by Sandy Fowler

2005 Gesundheitsprämie versus Bürgerversicherung – Beschäftigungseffekte der Finanzierungsreform im Gesundheitswesen
by Martin Distelkamp & Prof. Dr. Bernd Meyer & Marc Ingo Wolter

2005 Poverty, Inequality and Health: А case study of Armenia
by Tamara Tonoyan

2005 The demand for health insurance in a multirisk context
by Mohamed Anouar Razgallah

2005 Cadaveric vs. Live-Donor Kidney Transplants: The Interaction of Institutions and Inequality
by Nejat Anbarci & Mustafa Caglayan

2005 Productivity and its Drivers in Finnish Primary Care 1988-2003
by Maija-Liisa Järviö & Juho Aaltonen & Tarmo Räty & Kalevi Luoma

2005 Quality and Investment Decisions in Hospital Care when Physicians are Devoted Workers
by Michele Moretto & Rosella Levaggi & Vincenzo Rebba

2005 Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN
by Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno

2005 Separate When Equal? Racial Inequality and Residential Segregation
by Bayer, Patrick & Fang, Hanming & McMillan, Robert

2005 Die Einführung der Praxisgebühr und ihre Wirkung auf die Zahl der Arztkontakte und die Kontaktfrequenz: eine empirische Analyse
by Markus M. Grabka & Jonas Schreyögg & Reinhard Busse

2005 Innovation diffusion under budget constraints : Microeconometric evidence on heart attack in France
by Dormont, Brigitte & Milcent, Carine

2005 Une analyse microéconomique de la cessation d'activité : l'effet de l'état de santé
by Barnay, Thomas

2005 Viabilité financière et efficience des stratégies vaccinales dans les pays en développement : des approches substituables ou complémentaires ? Une réponse fondée sur la littérature grise
by Lévy, Pierre

2005 L’évaluation économique des maladies chroniques
by Lévy, Pierre

2005 Separating Selection and Incentive Effects in Health Insurance
by Gardiol, Lucien & Geoffard, Pierre-Yves & Grandchamp, Chantal

2005 Extending Choice In English Health Care: The implications of the economic evidence
by Burgess, Simon & Propper, Carol & Wilson, Deborah

2005 Race and ethnic inequality in health and health care in Colombia
by Raquel Bernal & Mauricio Cárdenas Santa María

2005 Análisis de eficiencia técnica de la red Pública de prestadores de servicios dentro del Sistema General de Seguridad Social en Salud
by Alfredo SARMIENTO GOMEZ & Wilma CASTELLANOS ARANGUREN & Angélica Cecilia NIETO ROCHA & Carlos Eduardo ALONSO MALAVER

2005 Una aproximación a la salud en Colombia a partir de las Encuestas de Calidad de Vida
by Manuel Ramirez & Andrés Zambrano & Francisco José Yepes & Jóse Guerra

2005 Biased selection within the social health insurance market in Colombia
by Ramón Abel Castaño & Andrés Zambrano

2005 Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry
by Jean O. Lanjouw

2005 Addressing the Challenge of HIV/AIDS: Macroeconomic, Fiscal and Institutional Issues
by Maureen Lewis

2005 Primary Health Care in Practice: Is It Effective?
by Maureen Lewis & Gunnar Eskeland & Ximena Traa-Valerezo

2005 Extending Choice In English Health Care: The implications of the economic evidence
by Carol Propper & Deborah Wilson & Simon Burgess

2005 Bargaining and idle public sector capacity in health care
by Pedro Pita Barros & Xavier Martinez-Giralt

2005 Book Review
by Adis International Limited

2005 Linezolid: A Pharmacoeconomic Review of its Use in Serious Gram-Positive Infections
by Greg L. Plosker & David P. Figgitt

2005 Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
by Adrienne Heerey & Sanjeev Suri

2005 Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops
by Guillaume Desjeux & Laurent Galoisy-Guibal & Cyrille Colin

2005 A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults
by Emily Beth Devine & Zafar Hakim & Jesse Green

2005 Economic Implications of Biological Therapies for Crohn's Disease: Review of Infliximab
by Keith Bodger

2005 The Role of Economic Evaluation in Vaccine Decision Making: Focus on Meningococcal Group C Conjugate Vaccine
by Robert Welte & Caroline L. Trotter & W. John Edmunds & Maarten J. Postma & Philippe Beutels

2005 The Authors' Reply
by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan

2005 Incorporation of Uncertainty in Health Economic Modelling Studies
by Mark Nuijten

2005 An Economic Evaluation of Rizatriptan in the Treatment of Migraine
by Melissa Thompson & Marek Gawel & Brigitte Desjardins & Nicole Ferko & Daniel Grima

2005 Cost of Illness and its Predictors for Parkinson's Disease in Germany
by Annika E. Spottke & Martin Reuter & Olaf Machat & Bernhard Bornschein & Sonja von Campenhausen & Karin Berger & Rudolf Koehne-Volland & Jurgen Rieke & Alexander Simonow & Dirk Brandstaedter & Uwe Siebert & Wolfgang H. Oertel & Gudrun Ulm & Richard Dodel

2005 Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme
by Janne A. Martikainen & Akseli Kivioja & Taru Hallinen & Pia Vihinen

2005 Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy
by Suzanne Polinder & Willem Jan Meerding & Job van Exel & Werner Brouwer

2005 Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK
by Louis S. Matza & Kristina Secnik & Sally Mannix & F. Randy Sallee

2005 Granulocyte Colony-Stimulating Factor for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited
by Elizabeth A. Calhoun & Glen T. Schumock & June M. McKoy & Simon Pickard & Karen A. Fitzner & Elizabeth A. Heckinger & Eowyn F. Powell & Kathyrn R. McCaffrey & Charles L. Bennett

2005 Pharmaceutical Policy regarding Generic Drugs in Belgium
by Steven Simoens & Kristien De Bruyn & Marc Bogaert & Gert Laekeman

2005 Real-World Trials to Answer Real-World Questions
by Nick Freemantle & Lawrence Blonde & Bjorn Bolinder & Robert A. Gerber & F.D. Richard Hobbs & Luc Martinez & Stuart Ross

2005 The Authors' Reply
by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi

2005 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
by Eduardo Carracedo-Martinez

2005 Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease
by Kristen Migliaccio-Walle & J. Jaime Caro & Khajak J. Ishak & Judith A. O'Brien

2005 Economic Assessment of Adjustable Maintenance Treatment with Budesonide/Formoterol in a Single Inhaler versus Fixed Treatment in Asthma
by Bernd Bruggenjurgen & Dagmar Selim & Peter Kardos & Kai Richter & Claus Vogelmeier & Stephanie Roll & Wolfgang Meyer-Sabellek & Roland Buhl & Stefan N Willich

2005 Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations
by Kun-Sei Lee & Werner B.F. Brouwer & Sang-Il Lee & Hye-Won Koo

2005 The State of Patient-Reported Outcomes in Atrial Fibrillation: A Review of Current Measures
by Karin Coyne & Mary Kay Margolis & Susan Grandy & Peter Zimetbaum

2005 Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications
by Mirella De Civita & Dean Regier & Abul H. Alamgir & Aslam H. Anis & Mark J. FitzGerald & Carlo A. Marra

2005 Price Differentiation and Transparency in the Global Pharmaceutical Marketplace
by David B. Ridley

2005 Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies
by J.M. Bos & Maarten J. Postma & Lieven Annemans

2005 Development of an Economic Model to Assess the Cost Effectiveness of Treatment Interventions for Chronic Obstructive Pulmonary Disease
by Michael Spencer & Andrew H. Briggs & Ronald F. Grossman & Laureen Rance

2005 The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK
by Marco Barbieri & John B. Wong & Michael Drummond

2005 Pharmacoeconomic Evaluation of Antidepressants: A Critical Appraisal of Methods
by Sheikh Usman Iqbal & Mark Prashker

2005 Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials
by Dennis A. Revicki & Louis S. Matza & Emuella Flood & Andrew Lloyd

2005 Remission from Depression: A Review of Venlafaxine Clinical and Economic Evidence
by Donald Han & Edward C.Y. Wang

2005 The Economics of Topical Immunomodulators for the Treatment of Atopic Dermatitis
by William Abramovits & Mark Boguniewicz & Amy S. Paller & Diane L. Whitaker-Worth & Mary M. Prendergast & Michael Tokar & Kuo B. Tong

2005 Health Utilities in Alzheimer's Disease and Implications for Cost-Effectiveness Analysis
by Peter J. Neumann

2005 Incorporation of Uncertainty in Health Economic Modelling Studies
by Anthony O'Hagan & Christopher McCabe & Ron Akehurst & Alan Brennan & Andrew Briggs & Karl Claxton & Elisabeth Fenwick & Dennis Fryback & Mark Sculpher & David Spiegelhalter & Andrew Willan

2005 On Pharmacogenomics and Cost-Effectiveness Analysis at the Individual Level
by Mohan V. Bala & Gary A. Zarkin

2005 Cost Effectiveness of Imatinib Compared with Interferon-alpha or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia
by Kim Dalziel & Ali Round & Ruth Garside & Ken Stein

2005 Reductions in Anaemia and Fatigue are Associated with Improvements in Productivity in Cancer Patients Receiving Chemotherapy
by Ernst Berndt & Joel Kallich & Anne McDermott & Xiao Xu & Howard Lee & John Glaspy

2005 Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy
by Lucie Blais & Odile Sheehy & Jean-Marc Saint-Hilaire & Gilles-Pierre Bernier & Philippe Godfroid & Jacques LeLorier

2005 Economic Considerations in the Prescribing of Third-Generation Antidepressants
by Stuart Montgomery & John J. Doyle & Lee Stern & Christopher R. McBurney

2005 The Health-Related Quality of Life and Economic Burden of Constipation
by Cheryl Dennison & Manishi Prasad & Andrew Lloyd & Samir K. Bhattacharyya & Ravinder Dhawan & Karin Coyne

2005 Valuing Patient and Caregiver Time: A Review of the Literature
by Jennifer E. Tranmer & Denise N. Guerriere & Wendy J. Ungar & Peter C. Coyte

2005 Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?
by Adam La Caze

2005 Effects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder
by Ellen W. Freeman

2005 Willingness to Pay for a QALY: Theoretical and Methodological Issues
by Dorte Gyrd-Hansen

2005 Quality Control in the Regulation of Pharmaceuticals
by Alan Maynard

2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide for Rheumatoid Arthritis in Germany: II. The Contribution of Leflunomide to Efficiency
by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz

2005 Modelling Cost Effectiveness and Cost Utility of Sequential DMARD Therapy Including Leflunomide in Rheumatoid Arthritis in Germany: I. Selected DMARDs and Patient-Related Costs
by Peter K. Schadlich & Henning Zeidler & Angela Zink & Erika Gromnica-Ihle & Matthias Schneider & Christoph Straub & Josef G. Brecht & Eduard Huppertz

2005 Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone
by Claes-Goran Lofdahl & Asa Ericsson & Klas Svensson & Emma Andreasson

2005 Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature
by Helen Doll & Marc Miravitlles

2005 Review of the Cost Effectiveness of Immunisation Strategies for the Control of Epidemic Meningococcal Meningitis
by Mark A. Miller & Cathryn K. Shahab

2005 Pharmacoeconomic Analyses Using Discrete Event Simulation
by J. Jaime Caro

2005 Future Challenges for the Economic Evaluation of Healthcare: Patient Preferences, Risk Attitudes and Beyond
by John F.P. Bridges

2005 Meningococcal Vaccination: Cui Bono?
by Thomas D. Szucs

2005 Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
by Natalie C. Edwards & Marcia F.T. Rupnow & Chris L. Pashos & Marc F. Botteman & Ronald J. Diamond

2005 The Case of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Rheumatoid Arthritis: A Budget Impact Analysis
by Jan Sorensen & Lis S. Andersen

2005 A Pharmacoeconomic Evaluation of Statins in the Treatment of Hypercholesterolaemia in the Primary Care Setting in Spain
by Pedro J. Tarraga-Lopez & Angel Celada-Rodriguez & Miguel Cerdan-Oliver & Juan Solera-Albero & Jose M Ocana-Lopez & Mateo A. Lopez-Cara & Jaime De Miguel-Clave

2005 Oral Serotonin Receptor Agonists: A Review of Their Cost Effectiveness in Migraine
by Jennifer H. Lofland & David B. Nash

2005 International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis: A Systematic Literature Review
by Hubertus Rosery & Rito Bergemann & Stefanie Maxion-Bergemann

2005 The Economic Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: Can Drugs Ease the Burden?
by Daniel L. Murman & Christopher C. Colenda

2005 Penny and Pound Wise: Pharmacoeconomics from a Governmental Perspective
by Mike F. van Oostenbruggen & Ronald B. Jansen & Katja Mur & Huib Kooijman

2005 The Relationship between Productivity and Health-Related QOL: An Exploration
by Werner B.F. Brouwer & Willem-Jan Meerding & Leida M. Lamers & Johan L. Severens

2005 EMEA: For Patients or For Industry?
by Silvio Garattini

2005 Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease
by Greg L. Plosker & Katherine A. Lyseng-Williamson

2005 The Impact of Anaemia and its Treatment on Employee Disability and Medical Costs
by Ernst Berndt & William Crown & Joel Kallich & Stacey Long & Xue Song & Gary H. Lyman

2005 Cost-Minimisation Analysis of Sivelestat for Acute Lung Injury Associated with Systemic Inflammatory Response Syndrome
by Naoki Aikawa & Seitaro Fujishima & Makoto Kobayashi & Shozo Matsuoka & Taira Abiru

2005 Evaluation of the Cost Effectiveness of Escitalopram versus Venlafaxine XR in Major Depressive Disorder
by Jose-Luis Fernandez & Stuart Montgomery & Clement Francois

2005 Providing Systematic Guidance in Pharmacoeconomic Guidelines for Analysing Costs
by Philip Jacobs & Arto Ohinmaa & Bruce Brady

2005 Cost Effectiveness of Treating Low HDL-Cholesterol in the Primary Prevention of Coronary Heart Disease
by Joel W. Hay & Kimberly L. Sterling

2005 The Case for Stratified Cost-Effectiveness Analysis by Baseline Health-Related QOL: Theory and Sensitivity Analysis
by Joseph Schaafsma

2005 The Diffusion of Health Economics Knowledge in Europe: The EURONHEED (European Network of Health Economics Evaluation Database) Project
by Gerard de Pouvourville & Philippe Ulmann & John Nixon & Stephanie Boulenger & Julie Glanville & Michael Drummond

2005 The Friction-Cost Method: Replacement for Nothing and Leisure for Free?
by Werner B.F. Brouwer & Marc A. Koopmanschap

2005 Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs
by Howard Birnbaum

2005 Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
by Kristina Secnik & Andrine Swensen & Maureen J. Lage

2005 A Randomised Trial of the Cost Effectiveness of Buprenorphine as an Alternative to Methadone Maintenance Treatment for Heroin Dependence in a Primary Care Setting
by Anthony H. Harris & Elena Gospodarevskaya & Alison J. Ritter

2005 Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer
by Davide Radice & Alberto Redaelli

2005 Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study
by Maria Pisu & Martin I. Meltzer & Eugene S. Hurwitz & Michael Haber

2005 Measuring Productivity Changes in Economic Evaluation: Setting the Research Agenda
by Marc Koopmanschap & Alex Burdorf & Karin Jacob & Willem Jan Meerding & Werner Brouwer & Hans Severens

2005 A Review of the Costs of Managing Childhood Epilepsy
by Ettore Beghi & Barbara Frigeni & Massimiliano Beghi & Paola De Compadri & Livio Garattini

2005 Pharmacoeconomic Impact of Non-Compliance with Statins
by Andrew M. Peterson & William F. McGhan

2005 Role of Pharmacoeconomic Analysis in R&D Decision Making: When, Where, How?
by Paul Miller

2005 Rizatriptan: A Pharmacoeconomic Review of its Use in the Acute Treatment of Migraine
by Paul L. McCormack & Rachel H. Foster

2005 Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease
by Colin Green & Joanna Picot & Emma Loveman & Andrea Takeda & Jo Kirby & Andrew Clegg

2005 Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness
by Katia Noyes & Andrew W. Dick & Robert G. Holloway & The Parkinson Study Group

2005 A Willingness-To-Pay Assessment of Parents' Preference for Shorter Duration Treatment of Acute Otitis Media in Children
by Delphine Gueylard Chenevier & Jacques LeLorier

2005 Estimating Mean Total Costs in the Presence of Censoring: A Comparative Assessment of Methods
by Tracey A. Young

2005 Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach
by Hamid Sadri & Linda D. MacKeigan & Lawrence A. Leiter & Thomas R. Einarson

2005 Cost-Effectiveness Acceptability Curves and a Reluctance to Lose
by Johan L. Severens & Danielle E.M. Brunenberg & Elisabeth A.L. Fenwick & Bernie O'Brien & Manuela A. Joore

2005 No Room for Kinkiness in a Public Healthcare System
by Jack Dowie

2005 The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development - The Authors' Reply
by Joseph A. DiMasi & Cherie Paquette

2005 Comment on _The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development_
by Aidan Hollis

2005 Acknowledgement
by Adis International Limited

2005 The Importance of Drug Adverse Effects Compared with Seizure Control for People with Epilepsy: A Discrete Choice Experiment
by Andrew Lloyd & Emma McIntosh & Martin Price

2005 Economic Evaluation of Three Two-Drug Chemotherapy Regimens in Advanced Non-Small-Cell Lung Cancer
by Niels Neymark & Pilar Lianes & Egbert F. Smit & Jan P. van Meerbeeck

2005 Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States
by Paul Kind & Susan Macran

2005 Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy
by Patricia Brown & Moran Ki & Betsy Foxman

2005 Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature
by Ralph P. Insinga & Erik J. Dasbach & Elamin H. Elbasha

2005 Antiviral Agents for Influenza: A Comparison of Cost-Effectiveness Data
by Larry D. Lynd & Ron Goeree & Bernie J. O'Brien

2005 Economic Evaluations of Healthcare Programmes and Decision Making: The Influence of Economic Evaluations on Different Healthcare Decision-Making Levels
by Marieke E. van Velden & Johan L. Severens & Annoesjka Novak

2005 Reporting Pharmacoeconomic Evaluations
by C.I. Carswell & J.A. Paladino

2005 Pharmacological Management of Overactive Bladder: A Systematic and Critical Review of Published Economic Evaluations
by Denis Getsios & Wissam El-Hadi & Ingrid Caro & J. Jaime Caro

2005 Measuring Health-Related Quality of Life in Older Patient Populations: A Review of Current Approaches
by Anne Hickey & Maja Barker & Hannah McGee & Ciaran O'Boyle

2005 Transparency in Economic Evaluations
by Suzanne Hill

2005 Eplerenone: A Pharmacoeconomic Review of its Use in Patients with Post-Myocardial Infarction Heart Failure
by Katherine F. Croom & Greg L. Plosker

2005 Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-alpha-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1
by Maria Buti & Miguel A. Casado & Leslie Fosbrook & Rafael Esteban

2005 Economic Analysis of On-Demand Maintenance Therapy with Proton Pump Inhibitors in Patients with Non-Erosive Reflux Disease
by Dyfrig A. Hughes & Keith Bodger & Peter Bytzer & Dirk de Herdt & Dominique Dubois

2005 Using Policy Simulation to Predict Drug Plan Expenditure when Planning Reimbursement Changes
by Colin R. Dormuth & Sean Burnett & Sebastian Schneeweiss

2005 The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach
by Peter Hertzman

2005 Cost Effectiveness of a Clinical Decision Support System Based on the Recommendations of the European Society of Cardiology and Other Societies for the Management of Hypercholesterolemia: Report of a Cluster-Randomized Trial
by Albert Cobos & Jordi Vilaseca & Cesar Asenjo & Juan Pedro-Botet & Emilia Sanchez & Alicia Val & Eva Torremade & Cristina Espinosa & Salvador Bergonon

2005 Consumer Knowledge of the Impact of a Change in Prescription Drug Benefit Design
by Roger Feldman & Jean Abraham & Linda Davis & Caroline Carlin

2005 Utilization and Medical Care Expenditures in Patients with Chronic Obstructive Pulmonary Disease: A Managed Care Claims Data Analysis
by Kristina S. Yu-Isenberg & Ann Vanderplas & Eunice Y. Chang & Hemal Shah

2005 Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis: Effects on Calcium Intake, Exercise Frequency, and Medication Use
by John T. Schousboe & Rowan C. DeBold & Linda S. Kuno & Thomas W. Weiss & Ya-Ting Chen & Thomas A. Abbott

2005 Efficiency of Interventions in HIV Infection, 1994-2004
by Guy Harling & Robin Wood & Eduard J. Beck

2005 How Should Functionally Equivalent Drugs be Reimbursed?: A Retrospective Analysis of Reimbursement for Epoetin-alpha and Darbepoetin-alpha in 2001-3 and the Cost Implications for CMS
by Panos G. Kanavos & Omer R. Saka

2005 Acknowledgment
by Adis International Limited

2005 US FDA Drug Classification System
by Alan J. Johnson & Edward Fleegler & Gregory D. Berg

2005 Management of Hormone-Responsive Postmenopausal Breast Cancer: Defining the Role of Anastrozole
by Lynda R. Wiseman & Lesley J. Scott

2005 Clinical and Utilization Outcomes for a Heart Failure Care Support Program: A Matched-Cohort Study
by Alan Johnson & Gregory Berg & Edward Fleegler & Jeanne Lehn

2005 Predicted Effects of a New Combination Vaccine on Childhood Immunization Coverage Rates and Vaccination Activities
by Allen S. Meyerhoff & David P. Greenberg & R. Jake Jacobs

2005 Evaluation and Treatment of Depression in Managed Care (Part II): Quality Improvement Programs
by Christy L. Beaudin & Teresa L. Kramer

2005 Evaluation and Treatment of Depression (Part I): Benefits for Patients, Providers, and Payors
by Teresa L. Kramer & Christy L. Beaudin & Carol R. Thrush

2005 Using the Internet in Asthma Management: Current Concepts and Challenges
by Ashok M. Patel

2005 Cost of Acute Myocardial Infarction in Hong Kong
by Vivian W.Y. Lee & Wai Kwong Chan & Nelson L.C. Lam & Kenneth K.C. Lee

2005 Impact of Bipolar Disorder on Employers: Rationale for Workplace Interventions
by Leslie B. Montejano & Ron Z. Goetzel & Ronald J. Ozminkowski

2005 The Performance Gap between Clinical Trials and Patient Treatment for Dyslipidemia: A Comprehensive Review
by Joseph J. Saseen & Setareh A. Williams & Robert J. Valuck & John C. O'Donnell & Kenneth McDonough

2005 The Challenge of Suicide Prevention: An Overview of National Strategies
by Martin Anderson & Rachel Jenkins

2005 Impact of Coaching Patients on Coronary Risk Factors: Lessons from The COACH Program
by Margarite J. Vale & Michael V. Jelinek & James D. Best

2005 Use of Short-Acting Insulin Secretagogues for Type 2 Diabetes Mellitus: Considerations for National Health Systems
by Maribel Salas & Jamie Banks

2005 Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program
by Hartmut B Krentz & M. John Gill

2005 Work Loss, Healthcare Utilization, and Costs among US Employees with Chronic Pain
by Laura T. Pizzi & Chureen T. Carter & Jamie B. Howell & Susan M. Vallow & Albert G. Crawford & Evan D. Frank

2005 Psychoeducational Programs for Patients with Epilepsy
by Theodor W. May & Margarete Pfafflin

2005 Economic, Patient Preference, and Health-Related Quality of Life Considerations for Intranasal Corticosteroids in Allergic Rhinitis: Implications for Managed Care
by Gireesh V. Gupchup & Matthew E. Borrego & Richard Santos & Bijal M. Shah

2005 Evaluating Disease Management Program Effectiveness: An Introduction to the Bootstrap Technique
by Ariel Linden & John L. Adams & Nancy Roberts

2005 Impact of Insurance Coverage on the Use and Effects of Smoking Cessation Medications
by Leif I. Solberg

2005 Consultation-Liaison Psychiatry: Advantages for Healthcare Systems
by James A. Bourgeois & Donald M. Hilty & Mark E. Servis & Robert E. Hales

2005 Prescription to Over-the-Counter Switching of Drugs: Methodological Issues and Implications for Non-Sedating Antihistamines
by John A. Rizzo & Ronald J. Ozminkowski & Ron Z. Goetzel

2005 Effectiveness of Interventions to Increase Adherence to Statin Therapy
by Jacqueline Muller-Nordhorn & Stefan N. Willich

2005 Management of Metastatic Colorectal Cancer: Defining the Role of Capecitabine
by Lynda R. Wiseman & Katherine A. Lyseng-Williamson

2005 Examining the Association Between Preventive Screenings and Subsequent Health Services Utilization by Patients with Type 2 Diabetes Mellitus
by Fevzi Akinci & Joseph S. Coyne & Joni Minear & Kenn Daratha & Dan Simonson

2005 Identifying Future High-Healthcare Users: Exploring the Value of Diagnostic and Prior Utilization Information
by Amy K. Rosen & Fei Wang & Maria E. Montez & Carter C. Rakovski & Dan R. Berlowitz & Jaime C. Lucove

2005 Using Propensity Scores to Construct Comparable Control Groups for Disease Management Program Evaluation
by Ariel Linden & John L. Adams & Nancy Roberts

2005 Walking for the Management of Obesity
by Mikael Fogelholm

2005 Impact of a Clinical Decision Support System on the Management of Patients with Hypercholesterolemia in the Primary Healthcare Setting
by Alex Bassa & Miguel del Val & Albert Cobos & Eva Torremade & Salvador Bergonon & Carlos Crespo & Max Brosa & Silvia Munio & Cristina Espinosa

2005 Early Intervention in Psychosis: Rationale and Evidence for Effectiveness
by Bethan Reading & Max Birchwood

2005 Telemanagement in Chronic Heart Failure: A Review
by Ruth M. Kleinpell & Boaz Avitall

2005 Clinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia: A Review
by L. Brian Cross & Andrea S. Franks

2005 Non-Pharmacological Treatments for Chronic Pain: A Disease Management Context
by Dennis C. Turk & Bill McCarberg

2005 Drug-Eluting Stents in the Management of Coronary Artery Disease: Implications for Payors and Hospitals
by James B. Hermiller

2005 The Incremental Cost Effectiveness of Withdrawing Pulmonary Artery Catheters from Routine Use in Critical Care
by Katherine Stevens & Christopher McCabe & Carys Jones & Joanne Ashcroft & Sheila Harvey & Kathy Rowan

2005 Determining Priority for Liver Transplantation: A Comparison of Cost per QALY and Discrete Choice Experiment-Generated Public Preferences
by Julie Ratcliffe & Martin Buxton & Tracey Young & Louise Longworth

2005 The Cost Effectiveness of Universal versus Selective Newborn Screening for Sickle Cell Disease in the US and the UK: A Critique
by Scott D. Grosse & Richard S. Olney & Mary Ann Baily

2005 The Australian Health Policy Changes of 1999 and 2000: An Evaluation
by Sandra Hopkins & Peter Zweifel

2005 What Value Health?: A Review of Health State Values Used in Early Technology Assessments for NICE
by Ken Stein & Alison Fry & Ali Round & Ruairidh Milne & John Brazier

2005 How to Present the Business Case for Healthcare Quality to Employers
by Sean Nicholson & Mark V. Pauly & Daniel Polsky & Catherine M. Baase & Gary M. Billotti & Ronald J. Ozminkowski & Marc L. Berger & Claire E. Sharda

2005 Should Patients Have a Greater Role in Valuing Health States?
by John Brazier & Ron Akehurst & Alan Brennan & Paul Dolan & Karl Claxton & Chris McCabe & Mark Sculpher & Aki Tsuchyia

2005 Acknowledgement
by Stuart Birks & Gary Buurman

2005 Book Review
by Adis International Limited

2005 Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine: A Study Conducted for the Netherlands
by Cornelis Boersma & Rogier M. Klok & Jasper M. Bos & Mark Naunton & Paul B. van den Berg & Lolkje T.W. de Jong-van den Berg & Maarten J. Postma

2005 Barriers to the Equitable Funding of Primary Healthcare in South Africa
by Stephen Thomas & Okore A. Okorafor & Sandi Mbatsha

2005 Methodological Challenges Posed by Economic Evaluations of Early Childhood Intervention Programmes
by Stavros Petrou & Ron Gray

2005 Can We Use Contingent Valuation to Assess the Demand for Childhood Immunisation in Developing Countries?: A Systematic Review of the Literature
by Raymond Y.T. Yeung & Richard D. Smith

2005 Prisoner Healthcare Co-Payment Policy: A Cost-Cutting Measure that Might Threaten Inmates' Health
by Niyi Awofeso

2005 Can Privatising Selected Services Benefit the Public Healthcare System?: The Greek Case
by Dimitris Niakas & Mamas Theodorou & Lycurgus Liaropoulos

2005 The Chinese Pharmaceutical Market at the Crossroads: Pro-Competition Solutions to Improve Access, Quality and Affordability
by Y. Richard Wang

2005 The Infrastructure of Obesity and the Obesity Epidemic: Implications for Public Policy
by Kenneth R. Stanton & Zoltan J. Acs

2005 The Impact of Deficit Reduction on the Nursing Labour Market in Canada: Unintended Consequences of Fiscal Reform
by Marko Vujicic & Robert G. Evans

2005 What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
by Jaume Puig-Junoy

2005 Using Contingent Choice Methods to Assess Consumer Preferences About Health Plan Design
by M. Susan Marquis & Melinda Beeuwkes Buntin & Kanika Kapur & Jill M. Yegian

2005 Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials
by Andrea Manca & Stephen Palmer

2005 Comparing the Preferences of Health Professionals and Members of the Public for Setting Healthcare Priorities: Experiences from Australia
by Virginia Wiseman

2005 Procedural Justice in Public Healthcare Resource Allocation
by Aki Tsuchiya & Luis Silva Miguel & Richard Edlin & Allan Wailoo & Paul Dolan

2005 Prescribing Incentive Schemes: A Useful Approach?
by Anne R. Mason & Michael F. Drummond & Jane A. Hunter & Adrian K. Towse & Jonathan Cooke

2005 Medicare Coverage and Reimbursement of Outpatient Prescription Drugs in the US: History, Recent Changes and Outlook for the Future
by Sharon Forrest & Mireille M Goetghebeur & Joel Hay

2005 A Wolf Dressed in Sheep's Clothing: Perhaps Quality Measures are Just Unmeasured Severity
by John F.P. Bridges & Avi Dor & Michael Grossman

2005 Untangling the Debate Surrounding Strategies for Achieving Sustainable High Coverage of Insecticide-Treated Nets
by Warren Stevens

2005 Decentralisation Strategies and Provider Incentives in Healthcare: Evidence from the English National Health Service
by Russell Mannion & Maria Goddard & Michael Kuhn & Angela Bate

2005 Using Value of Information Analysis to Inform Publicly Funded Research Priorities
by Laura Ginnelly & Karl Claxton & Mark J. Sculpher & Sue Golder

2005 Affordability of Medicines and Patients' Cost-Reducing Behaviour: Empirical Evidence Based on SUR Estimates from Italy and the UK
by Vincenzo Atella & Ellen Schafheutle & Peter Noyce & Karen Hassell

2005 Key Performance Indicators for the Implementation of Social Health Insurance
by Guy Carrin & Chris James

2005 Impact of Demographic Changes on Healthcare Expenditures and Funding in the EU
by Afschin Gandjour & Juliette Greb & Eckart Bomsdorf & Karl Wilhelm Lauterbach

2005 Emerging health isues in Asia and the Pacific: implications for public health policy
by Amarakoon Bandara

2005 Cost Accounting Implications of Surgical Learning in the DRG Era – Data Evidence from a German Hospital –
by Christian Ernst & Andrea Szczesny

2005 Formas de contratación de los servicios de urgencias: una aproximación desde la economía de los costos de transacción
by Sergio Torres Valdivieso & Rafael Guillermo García Cáceres & John Jairo Quintero

2005 Fallas del mercado de la salud en Colombia: el caso de la insuficiencia renal crónica
by Liliana Chicaíza

2005 Social Health Insurance and Its Failures in the Czech Republic and Slovakia: The Role of the State
by Jozef Medveď & Juraj Nemec & Leoš Vítek

2005 A Semi-Parametric Model for Asymmetric Information in Health Plan Markets
by Ralph Bradley

2005 Análisis empírico de la demanda de seguro privado de enfermedad en España/An empirical analysis of the demand for private health insurance in Spain
by ORDAZ SANZ, J.A. & GUERRERO CASAS, F.M. & MURILLO FORT, C.

2005 Risk Signaling in the Health Insurance Market
by Chu-Shiu Li

2005 A survey of econometric models to analyze the demand and utilisation of health care
by Antonio Clavero Barranquero & Mª. Luz González Alvarez

2004 Is Health Care a Necessity or a Luxury? Evidence from Local Quantile Regressions
by Chiu-Kuei Chang & Mei-Yuan Chen

2004 Is the French health insurance an efficient instrument for intragenerational income redistribution ?
by Jusot, Florence

2004 Assurance maladie et risque moral ex ante. L'incidence du type de risque sanitaire
by Bien, Franck

2004 Asymmetric Information and the Demand for Health Care – the Case of Double Moral Hazard
by Udo Schneider

2004 Deutsche Finanzpolitik zwischen Konsolidierung und Wachstum
by Heise, Arne

2004 Behavioral Differences Between Public and Private Not-For-Profit Hospitals in the Italian National Health Service
by Gian Paolo Barbetta & Gilberto Turati & Angelo Zago

2004 Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency
by Drusilla K. Brown & George Norman

2004 Hospital Competition under Regulated Prices: Application to Urban Health Sector Reforms in China
by Karen Eggleston & Winnie Yip

2004 Validity and Reliability of Willingness-to-Pay Estimates: Evidence from Two Overlapping Discrete-Choice Experiments
by Harry Telser & Karolin Becker & Peter Zweifel

2004 Age and Choice in Health Insurance: Evidence from Switzerland
by Karolin Becker & Peter Zweifel

2004 The payment of hospital services: a waiting lists model
by Alessandra Ferrari

2004 The payment of hospital services: a waiting lists model
by Alessandra Ferrari

2004 Erfolg und Erfolgsfaktoren freiberuflich tätiger Ärzte Ergebnisse der FFB-Ärzteumfrage für Niedersachsen
by Ackermann, Dagmar & Merz, Joachim & Stolze, Henning

2004 Modeling Health Insurance Choice Using the Heterogeneous Logit Model
by Keane, Michael

2004 Modeling Health Insurance Choices in “Competitive” Markets
by Keane, Michael

2004 Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure
by Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo

2004 Private Health Insurance in the Netherlands: A Case Study
by Nicole Tapay & Francesca Colombo

2004 Income-Related Inequality in the Use of Medical Care in 21 OECD Countries
by Eddy van Doorslaer & Cristina Masseria

2004 Private Health Insurance in France
by Thomas C. Buchmueller & Agnes Couffinhal

2004 The Slovak Health Insurance System and The Potential Role for Private Health Insurance: Policy Challenges
by Francesca Colombo & Nicole Tapay

2004 Private Health Insurance in Ireland: A Case Study
by Francesca Colombo & Nicole Tapay

2004 The Reform of the Health Care System in Portugal
by Stéphanie Guichard

2004 The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market
by Jeffrey R. Brown & Amy Finkelstein

2004 The Economic Theory of Illegal Goods: The Case of Drugs
by Gary S. Becker & Kevin M. Murphy & Michael Grossman

2004 The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing
by Mark Duggan & Fiona Scott Morton

2004 Aged-Care Support in Japan: Perspectives and Challenges
by Olivia S. Mitchell & John Piggott & Satoshi Shimizutani

2004 Compensating Wage Differentials and AIDS Risk
by Jeff DeSimone & Edward J. Schumacher

2004 Supply or Demand: Why is the Market for Long-Term Care Insurance So Small?
by Jeffrey R. Brown & Amy Finkelstein

2004 How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs
by Avi Dor & William Encinosa

2004 How Far to the Hospital? The Effect of Hospital Closures on Access to Care
by Thomas C. Buchmueller & Mireille Jacobson & Cheryl Wold

2004 Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
by Patricia M. Danzon & Andrew Epstein & Sean Nicholson

2004 Death Spiral or Euthanasia? The Demise of Generous Group Health Insurance Coverage
by Mark V. Pauly & Olivia Mitchell & Yuhui Zeng

2004 Managed Care Discounting: Evidence from the MarketScan Database
by Avi Dor & Siran M. Koroukian & Michael Grossman

2004 Competition in Imperfect Markets: Does it Help California's Medicaid Mothers?
by Anna Aizer & Janet Currie & Enrico Moretti

2004 How Much is Post-Acute Care Use Affected by Its Availability?
by Melinda Beeuwkes Buntin & Anita Datar Garten & Susan Paddock & Debra Saliba & Mark Totten & Jose J. Escarce

2004 Managed Care, Drug Benefits and Mortality: An Analysis of the Elderly
by Gautam Gowrisankaran & Robert J. Town

2004 Competition in Health Care Markets and Vertical Restraints
by Baranes, E. & Bardey, D.

2004 Competition in Health Care Markets and Vertical Restraints
by Baranes, E. & Bardey, D.

2004 Social Interaction and the Health Insurance Choices of the Elderly
by Eldar Beiseitov & Jeffrey D. Kubik & John R. Moran

2004 Erfolg und Erfolgsfaktoren freiberuflich tätiger Ärzte Ergebnisse der FFB-Ärzteumfrage für Niedersachsen
by Dagmar Ackermann & Joachim Merz & Henning Stolze

2004 Der Preis des "Grünen Goldes" - Informationen und Informationsdefizite über den Marktwert genetischer Ressourcen
by Oliver Deke

2004 Die Erstellung medizinischer Leistungen - entscheidungstheoretische Grundlagen und gesundheitspolitischer Handlungsbedarf
by Michael Stolpe

2004 The Chicken or the Egg? Endogeneity in Labour Market Participation of Informal Carers in England
by Heitmueller, Axel

2004 The Chicken or the Egg? Endogeneity in Labour Market Participation of Informal Carers in England
by Heitmueller, Axel

2004 Waiting lists, waiting times and admissions: an empirical analysis at hospital and general practice level
by Frank Windmeijer & Hugh Gravell & Pierre Hoonhout

2004 The Relationship between Physician Labour Supply, Service Volume and Service Intensity
by Sung-Hee Jeon & Jeremiah Hurley

2004 Fixed Budgets as a Cost Containment Measure for Pharmaceuticals
by Granlund, David & Rudholm, Niklas & Wikström, Magnus

2004 Testing for Price Leadership and for Reputation Goods Effects: Swedish Dental Services
by Eriksson, Rickard

2004 Competence in Health Care - An Industrial Systems Analysis Using Competence Bloc Theory to Compare European and US Health Care
by Eliasson, Gunnar & Eliasson, Åsa

2004 Parallel Import and the Pricing of Pharmaceutical Products: Evidence from the European Union
by Ganslandt, Mattias & Maskus, Keith E.

2004 Information Updating and Insurance Dropout: Evidence from Dental Insurance
by Grönqvist, Erik

2004 Does Adverse Selection Matter? Evidence from a Natural Experiment
by Grönqvist, Erik

2004 Insurance and monopoly power in a mixed private/public hospital system, CHERE Discussion Paper No 55
by Donald J Wright

2004 Specialist payment schemes and patient selection in private and public hospitals, CHERE Discussion Paper No 54
by Donald J Wright

2004 Can we design a market for competitive health insurance? CHERE Discussion Paper No 53
by Jane Hall

2004 Nurses' retention and hospital characteristics in New South Wales, CHERE Discussion Paper No 52
by Denise Doiron & Glenn Jones

2004 Empirische Erfahrungen, Versichertenverhalten zu steuern
by Osmers, Henning & Vauth, Christoph

2004 Optimal risk adjustment in a model with adverse selection and spatial competition
by William Jack(Georgetown University)

2004 La demande de soins curatifs, l'auto-protection et l'auto-assurance
by Mohammed Anouar Razgallah

2004 Investment in Hospital Care Technology under Different Purchasing Rules: A Real Option Approach
by Michele Moretto & Rosella Levaggi

2004 Il pendolo delle riforme nei sistemi sanitari europei
by Antonio Nicita

2004 In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale
by Marianna Madia & Fabio Pammolli & Nicola Carmine Salerno

2004 Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria
by Fabio Pammolli & Nicola Carmine Salerno

2004 Panel Data Sample Selection Model: an Application to Employee Choice of Health Plan Type and Medical Cost Estimation
by Jeonghoon Ahn

2004 The impact of liability for malpractice on the optimal reimbursement schemes for health services
by Sonja Ossig & Eberhard Feess

2004 Tarification des hôpitaux : la prise en compte des hétérogénéités
by Dormont, Brigitte & Milcent, Carine

2004 Prospective payment system : consequences for hospital-physician interactions in the private sector
by Ana, MAULEON & Laurent, COUDEVILLE & Benoit, DERVAUX

2004 Working for God?
by Reinikka, Ritva & Svensson, Jakob

2004 Risk adjustment in the Netherlands; an analysis of insurers' health care expenditures
by Rudy Douven

2004 The determinants of the health status in a developing country: results form the colombian case
by Ramirez Manuel & Juan Miguel Gallego & Carlos Sepulveda

2004 Public vs private demand for covering long term care expenditures
by R. Brau & M. Lippi Bruni & AM. Pinna

2004 Genetic Testing and Repulsion from Chance
by Michael Hoel & Tor Iversen & Tore Nilssen & Jon Vislie

2004 Mapping choice in the NHS: Analysis of routine data
by Mike Damiani & Jennifer Dixon & Carol Propper

2004 Willigness to Pay for Long-Term Care Coverage: the Role of Private Information and Self-Insurance
by Joan Costa Font & Juan Rovira Forns

2004 The Economics of a Two Tier Health System: A Fairer Medicare?
by Patricia Apps & Ray Rees & Elizabeth Savage

2004 O Risco Moral No Sistema De Saúde Suplementar Brasileiro
by Ana Carolina Maia & Mônica Viegas Andrade & Ana Maria Hermeto Camilo de Oliveira

2004 Estimando Seleção Adversa Em Planos De Saúde
by Sandro Leal Alves

2004 A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery
by Sean D. Sullivan & Bruce L. Davidson & Susan R. Kahn & James E. Muntz & Gerry Oster & Gary Raskob

2004 The Burden of Migraine in Spain: Beyond Direct Costs
by Xavier Badia & Sol Magaz & Laura Gutierrez & Jordi Galvan

2004 A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer
by Jeremy Holmes & David Dunlop & Lindsay Hemmett & Peter Sharplin & Uday Bose

2004 Cost Effectiveness and Cost Utility of Adjuvant Interferon alpha in Cutaneous Melanoma: A Review
by Ralph Crott

2004 Global Registries for Measuring Pharmacoeconomic and Quality-of-Life Outcomes: Focus on Design and Data Collection, Analysis and Interpretation
by Lisa Kennedy & Ann-Marie Craig

2004 Outcome Measures for Pharmacoeconomics Education
by Vittorio Maio & Jennifer H. Lofland

2004 Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level
by Agota Szende & Klas Svensson & Elisabeth Stahl & Agnes Meszaros & Gyula Y. Berta

2004 An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK
by Paul A. Scuffham & Stephen Chaplin

2004 Growth Hormone Therapy and Quality of Life in Adults and Children
by Deborah J. Radcliffe & Joseph S. Pliskin & J.B. Silvers & Leona Cuttler

2004 Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?
by Mohan V. Bala & Gary A. Zarkin

2004 The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics
by Christopher R. Flowers & David Veenstra

2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply
by Sean D. Sullivan & Kavita Patel & Jesse Green

2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive
by Miguel Arguedas

2004 Drotrecogin Alfa (Activated): A Pharmacoeconomic Review of its Use in Severe Sepsis
by James E. Frampton & Rachel H. Foster

2004 Management and Costs of Treating Lung Cancer Patients in a University Hospital
by Konstantin J. Dedes & Thomas D. Szucs & Stephan Bodis & Markus Joerger & Adam Lowy & Erich W. Russi & Hans C. Steinert & Walter Weder & Rolf A. Stahel

2004 Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature
by Simon Dixon & Emma McKeen & Margaret Tabberer & Suzy Paisley

2004 Adherence to Guidelines for Community-Acquired Pneumonia: Does it Decrease Cost of Care?
by Patricia D. Brown

2004 Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus
by Greg L. Plosker & David P. Figgitt

2004 Measuring Treatment Preferences and Willingness to Pay for Docetaxel in Advanced Ovarian Cancer
by George Dranitsaris & Julia Elia-Pacitti & Wayne Cottrell

2004 Economic Implications of Treatment-Resistant Depression Among Employees
by Paul Greenberg & Patricia K. Corey-Lisle & Howard Birnbaum & Maryna Marynchenko & Ami Claxton

2004 The Economic Burden of Allergic Rhinitis: A Critical Evaluation of the Literature
by Shelby D. Reed & Todd A. Lee & Douglas C. McCrory

2004 Bernard J. O'Brien, BA, MSc, PhD
by Deborah A. Freund

2004 Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective
by Kurt Neeser & Georg Lubben & Uwe Siebert & Wendelin Schramm

2004 Cost Effectiveness of Representatives of Three Classes of Antidepressants Used in Major Depression in the UK
by Alan Lenox-Smith & Pete Conway & Chris Knight

2004 Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections
by Joseph L. Kuti & Srividya Kotapati & Peter Williams & Blair Capitano & Charles H. Nightingale & David P. Nicolau

2004 How Often Do Sensitivity Analyses for Economic Parameters Change Cost-Utility Analysis Conclusions?
by Bruce R. Schackman & Heather Taffet Gold & Patricia W. Stone & Peter J. Neumann

2004 Longitudinal versus Cross-Sectional Methodology for Estimating the Economic Burden of Breast Cancer: A Pilot Study
by C. Daniel Mullins & Junling Wang & Jesse L. Cooke & Lisa Blatt & Claudia R. Baquet

2004 Economic Impact of Respiratory Syncytial Virus-Related Illness in the US: An Analysis of National Databases
by L. Clark Paramore & Vincent Ciuryla & Gabrielle Ciesla & Larry Liu

2004 The NICE Reference Case Requirement: More Pain for What, if Any, Gain?
by Amiram Gafni & Stephen Birch

2004 The NICE Reference Case Requirement: Implications for Drug Manufacturers and Health Systems
by Paul C. Langley

2004 Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
by Sean D. Sullivan & Antonio Craxi & Alfredo Alberti & Giovanni Giuliani & Claudio De Carli & Neil Wintfeld & Kavita K. Patel & Jesse Green

2004 Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing(R)
by Annoesjka Novak & Christine de la Loge & Linda Abetz

2004 A
by Manishi Prasad & Peter Wahlqvist & Rich Shikiar & Ya-Chen Tina Shih

2004 Aggressive Non-Hodgkin
by Stephen M. Beard & Lucy Wall & Louise Gaffney & Fiona Sampson

2004 Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French Version: In a Population of Patients Treated for Ocular Hypertension and Glaucoma
by Jean-Phillipe Nordmann & Muriel Viala & Kate Sullivan & Benoit Arnould & Gilles Berdeaux

2004 Cost Effectiveness of Interventions for Lateral Epicondylitis: Results from a Randomised Controlled Trial in Primary Care
by Ingeborg B.C. Korthals-de Bos & Nynke Smidt & Maurits W. van Tulder & Maureen P.M.H. Rutten-van Molken & Herman J. Ader & Danielle A.W.M. van der Windt & Willem J.J. Assendelft & Lex M. Bouter

2004 A Review of Health-Related Workplace Productivity Loss Instruments
by Jennifer H. Lofland & Laura Pizzi & Kevin D. Frick

2004 Cost-of-Illness Studies in Diabetes Mellitus
by Lorraine Ettaro & Thomas J. Songer & Ping Zhang & Michael M. Engelgau

2004 Education in Pharmacoeconomics: An International Multidisciplinary View
by Karen L. Rascati & Michael F. Drummond & Lieven Annemans & Peter G. Davey

2004 Cost of Stress Urinary Incontinence: A Claims Data Analysis
by Howard G. Birnbaum & Stephanie A. Leong & Emily F. Oster & Kraig Kinchen & Peter Sun

2004 Health Economic Evaluation of Non-Melanoma Skin Cancer and Actinic Keratosis
by Mitchell K. Higashi & David L. Veenstra & Paul C. Langley

2004 The Generation Gap: Differences Between Children and Adults Pertinent to Economic Evaluations of Health Interventions
by Ron Keren & Susmita Pati & Chris Feudtner

2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors' Reply
by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer

2004 Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature
by Thomas Hammerschmidt & Kurt Banz & Stefan Wagenpfeil & Albrecht Neiss & Peter Wutzler

2004 Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
by Katherine A. Lyseng-Williamson & Rachel H. Foster

2004 Cost-Effective Strategies in the Prevention of Diabetic Nephropathy
by Jonathan D. Rippin & Anthony H. Barnett & Stephen C. Bain

2004 Allocation of Resources Between Smoking Cessation Methods and Lovastatin Treatment of Hypercholesterolaemia: Based on Cost Effectiveness and the Social Welfare Function
by Pedro Plans-Rubio

2004 A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care: Among Patients with AIDS in Northern Italy
by Andrea Tramarin & Stefano Campostrini & Maarten J. Postma & Guido Calleri & Keith Tolley & Nicoletta Parise & Fausto de Lalla

2004 Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data
by Ulf-G. Gerdtham & Douglas Lundin

2004 Assessing the Value of Antipsychotics for Treating Schizophrenia: The Importance of Evaluating and Interpreting the Clinical Significance of Individual Service Costs
by Sandra L. Tunis & Haya Ascher-Svanum & Michael Stensland & Bruce J. Kinon

2004 The Economic Implications of Non-Adherence after Renal Transplantation
by Irina Cleemput & Katrien Kesteloot & Yves Vanrenterghem & Sabina De Geest

2004 The Effect of Cost Construction Based on Either DRG or ICD-9 Codes or Risk Group Stratification on the Resulting Cost-Effectiveness Ratios
by Elinor C.G. Chumney & Andrea K. Biddle & Kit N. Simpson & Morris Weinberger & Kathryn M. Magruder & William N. Zelman

2004 Discrete Choice Experiment to Derive Willingness To Pay for Methyl Aminolevulinate Photodynamic Therapy Versus Simple Excision Surgery in Basal Cell Carcinoma
by Adele Weston & Patrick FitzGerald

2004 Economic Costs to Business of the HIV/AIDS Epidemic
by Gordon G. Liu & Jeff J. Guo & Scott R. Smith

2004 Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases
by Jasper M. Bos & Philippe Beutels & Lieven Annemans & Maarten J. Postma

2004 Acknowledgement
by Adis International Limited

2004 Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study
by Fredrik Borgstrom & Olof Johnell & John A. Kanis & Anders Oden & David Sykes & Bengt Jonsson

2004 Relative Cost Effectiveness of Depo-Provera(R), Implanon(R), and Mirena(R) in Reversible Long-Term Hormonal Contraception in the UK
by Susan J. Varney & Julian F. Guest

2004 Validation of the Work and Health Interview
by Walter F. Stewart & Judith A. Ricci & Carol Leotta & Elsbeth Chee

2004 Measurement of Health-Related QOL in Diabetes Mellitus
by Ken Watkins & Cathleen M. Connell

2004 Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall
by Elly A. Stolk & Gijs van Donselaar & Werner B.F. Brouwer & Jan J.V. Busschbach

2004 Etanercept: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2004 Use and Cost of Antiretrovirals in France 1995-2000: An Analysis Based on the Medical Dossier on Human Immunodeficiency (release 2) Database
by Yves A. Flori & Marc le Vaillant

2004 Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence
by Dyfrig A. Hughes & Dominique Dubois

2004 Clinical and Economic Impact of Epoetins in Cancer Care
by Monia Marchetti & Giovanni Barosi

2004 Economic Impact of Migraine and Other Episodic Headaches in France: Data from the GRIM2000 Study
by Andre Pradalier & Jean-Paul Auray & Abdelkader El Hasnaoui & Kazem Alzahouri & Jean-Francois Dartigues & Gerard Duru & Patrick Henry & Michel Lanteri-Minet & Christian Lucas & Guy Chazot & Anne-Francois Gaudin

2004 Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?
by Akira Babazono & Motonobu Miyazaki & Hiroshi Une & Eiji Yamamoto & Toshihide Tsuda & Yoshio Mino & Alan L. Hillman

2004 Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective
by Peter K. Schadlich & Josef G. Brecht & Badrudin Rangoonwala & Eduard Huppertz

2004 Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus
by Frederick B. Dong & Stephen W. Sorensen & Diane L. Manninen & Theodore J. Thompson & Venkat Narayan & Carlyn E. Orians & Edward W. Gregg & Richard C. Eastman & Erik J. Dasbach & William H. Herman & Jeffrey M. Newman & Andrew S. Narva & David J. Ballard & Michael M. Engelgau

2004 Comparisons of Hypertension-Related Costs from Multinational Clinical Studies
by C. Daniel Mullins & Mirko Sikirica & Viran Seneviratne & Jeonghoon Ahn & Kasem S. Akhras

2004 The Costs and Benefits of Community Thrombolysis for Acute Myocardial Infarction: A Decision-Analytic Model
by Luke Vale & Harvey Steffens & Cam Donaldson

2004 Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis
by Patrick W. Sullivan & Sheryl L. Follin & Michael B. Nichol

2004 Pharmacoeconomic Burden of Undertreating Hypertension
by Luca Degli Esposti & Giorgia Valpiani

2004 Pharmacoeconomic Implications of New Therapies in Sepsis
by Kelly A. Wood & Derek C. Angus

2004 Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery
by Jesus Honorato & Antonio Gomez-Outes & Antonio Navarro-Quilis & Javier Martinez-Gonzalez & Eduardo Rocha & Andre Planes

2004 Cost Effectiveness of Ibutilide With Prophylactic Magnesium in the Treatment of Atrial Fibrillation
by Craig I. Coleman & James S. Kalus & C. Michael White & Anne P. Spencer & James P. Tsikouris & Jenny O. Chung & Kenneth W. Kenyon & Martin Ziska & Jeffrey Kluger & Prabashni Reddy

2004 A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries
by Robert Welte & Talitha Feenstra & Hans Jager & Reiner Leidl

2004 Varicella Vaccination in Italy: An Economic Evaluation of Different Scenarios
by Laurent Coudeville & Alain Brunot & Carlo Giaquinto & Carlo Lucioni & Benoit Dervaux

2004 Acute Rhinosinusitis: A Pharmacoeconomic Review of Antibacterial Use
by Jean-Blaise Wasserfallen & Francoise Livio & Giorgio Zanetti

2004 Transferability of Economic Evaluation Results
by Fernando Antonanzas

2004 Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma
by Richard D. OConnor & Harold Nelson & Rohit Borker & Amanda Emmett & Priti Jhingran & Kathleen Rickard & Paul Dorinsky

2004 Economic Aspects of Severe Sepsis: A Review of Intensive Care Unit Costs, Cost of Illness and Cost Effectiveness of Therapy
by Hilmar Burchardi & Heinz Schneider

2004 Assessing the Use of Retrospective Databases in Conducting Economic Evaluations of Drugs: The Case of Asthma
by Fredrik Berggren

2004 Incorporation of Statistical Uncertainty in Health Economic Modelling Studies Using Second-Order Monte Carlo Simulations
by Mark J.C. Nuijten

2004 Resource Use and Cost of Care for Patients Hospitalised with Community Acquired Pneumonia: Impact of Adherence to Infectious Diseases Society of America Guidelines
by Joanne J. Orrick & Richard Segal & Thomas E. Johns & Wayne Russell & Feng Wang & Donald D. Yin

2004 Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD)
by Mitchell Friedman & Shailendra S. Menjoge & Susan F. Anton & Steven Kesten

2004 Economic Aspects of Pneumococcal Pneumonia: A Review of the Literature
by Diana De Graeve & Philippe Beutels

2004 Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia: An Economic Perspective
by Mauro Percudani & Corrado Barbui & Michele Tansella

2004 The Measurement of Contingent Valuation for Health Economics
by Ahmed M. Bayoumi

2004 On Cost Effectiveness and Sample Size in Clinical Trials. The Author's Reply
by Martin E. Backhouse

2004 On Cost Effectiveness and Sample Size in Clinical Trials
by Augustinus A.M. Hart & Marcel G.W. Dijkgraaf

2004 Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation: Impact of Bioavailability on Costs and Outcomes
by Nicole Mittmann & Paul I. Oh & Scott E. Walker & William R. Bartle

2004 Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox(R)/Asasantin(R)) in France
by Jean-Pierre Marissal & Bernard Selke

2004 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
by Andrew Moore & Ceri Phillips & Elke Hunsche & James Pellissier & Simone Crespi

2004 From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer
by Samuel Limat & Marie-Christine Woronoff-Lemsi & Celine Menat & Anne Madroszyk-Flandin & Yacine Merrouche

2004 An Economic Model of 2-Hour Post-Dose Ciclosporin Monitoring in Renal Transplantation
by Paul A. Keown & Bryce Kiberd & Robert Balshaw & Shideh Khorasheh & Carlo Marra & Philip Belitsky & Zoltan Kalo

2004 Effectiveness, Quality of Life, and Cost of Caring for Children in France with Recurrent Acute Rhinopharyngitis Managed by Homeopathic or Non-Homeopathic General Practitioners: A Pragmatic, Prospective Observational Study
by Melanie Trichard & Gilles Chaufferin & Christian Dubreuil & Nicolas Nicoloyannis & Gerard Duru

2004 The Burden of Osteoporosis and the Case for Disease Management
by William D. Fraser

2004 Long-Term Drug Treatment of GERD: Economic Issues for Formulary Decision Makers
by James Chan & Theodore R. Levin

2004 Development of a Regionalized, Comprehensive Care Network for Pediatric Sickle Cell Disease to Improve Access to Care in a Rural State
by Lee M. Hilliard & Mary H. Maddox & Shenghui Tang & Thomas H. Howard

2004 Socioeconomic Implications of Long-Term Warfarin Use
by Joseph Menzin & Talia Foster & Rebecca Audette

2004 Improving Treatment Regimen Adherence in Coronary Heart Disease by Targeting Patient Types
by Robin S. Turpin & Jeffrey B. Simmons & Janice F. Lew & Charles M. Alexander & Marie A. Dupee & Patricia Kavanagh & Ellen R. Cameron

2004 Thiazolidinediones for Diabetes Mellitus: Considerations for Reimbursements by Third-Party Payors
by Andrew J. Palmer & William J. Valentine & Joshua A. Ray

2004 Barrett
by Deepak V. Gopal & Mark Reichelderfer & Eric A. Gaumnitz & Josephine Harter & Blair A. Jobe

2004 Acknowledgments
by Adis International Limited

2004 Management of Benign Prostatic Hyperplasia: Defining the Role of Tamsulosin
by Katherine F. Croom & Antona J. Wagstaff

2004 Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE): A Naturalistic Design and Rationale for the Study of Patterns of Care in Hypertension
by Jaime J. Caro & Norman Hollenberg & Joseph D Jackson & Krista A Payne & Gil LItalien

2004 Overview of Disease Management Approaches: Implications for Corporate-Sponsored Programs
by Shirley A. Musich & Alyssa B. Schultz & Wayne N. Burton & Dee W. Edington

2004 National Performance Measures for Diabetes Mellitus Care: Implications for Health Care Providers
by Fevzi Akinci & Joseph Coyne & Bernard Healey & Joni Minear

2004 Pulmonary Rehabilitation Programs: Improving Outcomes in Elderly Patients with COPD
by Jorg D. Leuppi & Roland M. Bingisser

2004 Impact of a Migraine Disease Management Program: Humanistic Outcomes
by Henry X. Hu & Glen D. Solomon & Kathleen Conboy & Lisa Deml & Leona E. Markson

2004 Economic Benefits of Including Environmental Issues as a Component of Comprehensive Asthma Care: A Managed Care Perspective
by Doug Brugge & James Hyde & Bonnie H. Weinbach & Jonathan I. Levy & Suzanne Steinbach

2004 Reducing the Incidence of Type 2 Diabetes Mellitus: A Healthcare Plan and Program Implementation Perspective
by Nicolaas P. Pronk & Jackie Boucher & Robert W. Jeffery & Nancy E. Sherwood & Raymond Boyle

2004 Opportunities for Pharmacists to Aid in the Management of Acid-Peptic Disorders
by C. Wayne Weart & Harry Leider

2004 Specialist and Generalist Care for Type 1 Diabetes Mellitus: Differential Impact on Processes and Outcomes
by Janice C. Zgibor & Trevor J. Orchard

2004 Short-Term Aggressive Disease Management Programs for Heart Failure: Effect on Drug Utilization, Clinical Outcomes, and Costs
by Kwame O. Akosah & Stephanie Carothers

2004 Performance Measurement of Disease Management Programs: Examination of Recent Guidelines
by Barry M. Zajac

2004 Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
by Greg L. Plosker & Tim Ibbotson

2004 A Surveillance System for the Real-Time Reporting of Influenza Activity
by Helmut Uphoff & Irena Groniewicz & Marc Soriano & Isabel Burckhardt-Batista

2004 Dosing Patterns of Anti-TNF Therapy in Patients with Rheumatoid Arthritis in a Managed Care Setting
by Karen Stockl & Manal Jarrar & Neeta Tandon

2004 The Costs of Non-Adherence to Oral Antihyperglycemic Medication in Individuals with Diabetes Mellitus and Concomitant Diabetes Mellitus and Cardiovascular Disease in a Managed Care Environment
by T. Jeffrey White & Ann Vanderplas & Eunice Chang & Christopher M. Dezii & Geoffrey D. Abrams

2004 Atypical Antipsychotics as First-Line Treatments for Schizophrenia: Advantages for Stakeholders in the UK Healthcare System
by Ann M. Mortimer

2004 Optimizing Drug Prescribing in Managed Care Populations: Improving Clinical and Economic Outcomes
by Rachel Czubak & Jasmine Tucker & Barbara J. Zarowitz

2004 The Department of Health (England) Action Plan for Improving Services for People with Epilepsy: Will It Improve Quality of Care?
by Frank M.C. Besag

2004 Improvements in Asthma Pharmacotherapy and Self-Management: An Example of a Population-Based Disease Management Program
by Richard A. Feifer & Robert R. Verbrugge & Mona Khalid & Rebecca Levin & Gwendolyn B. OKeefe & Ronald E. Aubert

2004 Impact of Three-Tier Pharmacy Benefit Structures on Consumer Attitudes, Pharmacy, Medical Utilization and Costs: A Critical Review
by Kavita V. Nair & Robert J. Valuck

2004 Impact of Guidelines on Healthcare from the Patient and Payor Perspective: Example of the American Pain Society Guidelines
by Bill McCarberg

2004 Management of Overactive Bladder: Defining the Role of Extended-Release Tolterodine
by Susan J. Keam & Caroline M. Perry

2004 Management of Genital Herpes: Defining the Role of Valaciclovir
by Antona J. Wagstaff & Susan J. Keam & David P. Figgitt

2004 Employer-Based Disease Management Programs in Cancer: Experience to Date
by Frederick C. Lee

2004 Management of Mild to Moderate Alzheimer Disease: Defining the Role of Rivastigmine
by Greg L. Plosker & Gillian M. Keating

2004 Management of Parkinson Disease: Defining the Role of Ropinirole
by David Murdoch & Susan M. Cheer & Antona J. Wagstaff

2004 Prevention and Treatment of Osteoporosis in Postmenopausal Women: Defining the Role of Alendronate
by Susan J. Keam & Greg L. Plosker

2004 Adalimumab for Rheumatoid Arthritis: Considerations for Reimbursement by Third-Party Payors
by Leo van de Putte & Michael B. Nichol

2004 Nurses
by Erik Magnus Saether

2004 Burning a Hole in the Budget: Tobacco Spending and its Crowd-Out of Other Goods
by Susan H. Busch & Mireia Jofre-Bonet & Tracy A. Falba & Jody L. Sindelar

2004 Income-Related Inequality in the Use of Dental Services in Finland
by Lien Nguyen & Unto Hakkinen

2004 Tackling Regional Health Inequalities in France by Resource Allocation: A Case for Complementary Instrumental and Process-Based Approaches?
by Martine M. Bellanger & Alain Jourdain

2004 Consumer Mobility in Social Health Insurance Markets: A Five-Country Comparison
by Trea Laske-Aldershof & Erik Schut & Konstantin Beck & Stefan Gress & Amir Shmueli & Carine Van de Voorde

2004 Senior Citizens and the Burden of Prescription Drug Outlays: What Lessons for the Medicare Prescription Drug Benefit?
by Panos Kanavos & Marin Gemmill

2004 How Much Might Universal Health Insurance Reduce Socioeconomic Disparities in Health?: A Comparison of the US and Canada
by Sandra L. Decker & Dahlia K. Remler

2004 Is Patient Choice an Effective Mechanism to Reduce Waiting Times?
by Diane Dawson & Rowena Jacobs & Steve Martin & Peter Smith

2004 Do Patients Always Prefer Quicker Treatment?: A Discrete Choice Analysis of Patients
by Peter Burge & Nancy Devlin & John Appleby & Charlene Rohr & Jonathan Grant

2004 Guest Editorial
by Adam Oliver

2004 Aggregating Public Preferences for Healthcare: Putting Theory into Practice
by Virginia Wiseman

2004 Examining Within-Country Variation of Maternity Costs in the Context of a Multicountry, Multicentre Randomised Controlled Trial
by Guy Hutton & Julia Fox-Rushby & Miranda Mugford & Jadsada Thinkhamrop & Bandit Thinkhamrop & Ana Maria Galvez & Manuel Alvarez

2004 Medicare Payment Policy and the Controversy over Hospital Cost Shifting
by Rick Mayes & Jason S. Lee

2004 Listening to the Decision Makers: Sustainability of PBMA in Alberta
by Craig Mitton & San Patten & Cam Donaldson

2004 Productivity Research and Healthcare Delivery Innovation
by Karen Eggleston & Jerome Grossman & David Cutler

2004 Observations on Health Financing Reform in the Republic of Georgia, 1996-2002
by Kees Schaapveld & Grant Rhodes

2004 Calculating Society
by Jeff Richardson & Richard D. Smith

2004 Healthcare Expenditure and Ageing: A Comment
by J. Francois Outreville

2004 EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group
by Karen Gerard & Tricia Nicholson & Mark Mullee & Raj Mehta & Paul Roderick

2004 The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement
by Andrew Briggs & Mark Sculpher & Jill Dawson & Ray Fitzpatrick & David Murray & Henrik Malchau

2004 Improving Road Safety and Residential Quality of Life: Evaluating the Automated Wayside Horn System
by Roy E. Lucke & Richard A. Raub & Thomas E. Thunder

2004 The Economics of Prevention in a Post-Managed-Care Environment
by Cyril F. Chang & Teresa M. Waters & David M. Mirvis

2004 Should We Maximise QALYs?: A Debate with Respect to Peak-End Evaluation
by Adam Oliver

2004 Do Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?
by Anne Ludbrook & Kathy Porter

2004 Modelling the Ability of Risk Adjusters to Reduce Adverse Selection in Managed Care
by Randall S. Stafford & Donglin Li & Roger B. Davis & Lisa I. Iezzoni

2004 Comparing Utility Scores Before and After Hearing-Aid Provision: Results According to the EQ-5D, HUI3 and SF-6D
by Garry R. Barton & John Bankart & Adrian C. Davis & Quentin A. Summerfield

2004 Driver Perception Response Time During the Signal Change Interval
by Pin-Kai Goh & Yiik-Diew Wong

2004 A Tribute to the Life and Work of Bernie O
by John F.P. Bridges

2004 The Value of Life and Accident Costing: A Willingness-to-Pay Study Amongst Motorcyclists in Malaysia
by Mohd Y. Mohd Fauzi & Mohd N. Nor Ghani & Radin S. Radin Umar & Hashim Ahmad Hariza

2004 Healthcare Payment Incentives: A Comparative Analysis of Reforms in Taiwan, South Korea and China
by Karen Eggleston & Chee-Ruey Hsieh

2004 The Impact of Physician Payment Methods on Raising the Efficiency of the Healthcare System: An International Comparison
by Steven Simoens & Antonio Giuffrida

2004 The Reliability of Willingness to Pay for Changes in Health Status
by Richard D. Smith

2004 Road Safety and Accident Prevention
by Richard Tay

2004 An Alternative Approach to Resource Allocation: Weighted Capacity to Benefit Plus MESH Infrastructure
by Gavin Mooney & Shane Houston

2004 Self-Reported Effectiveness of Double-Fine Zones as a Speed Control Measure
by Barnie Jones & Kevin Haas & Alan Kirk & Andrew Griffith

2004 Editorial Foreword
by Adis International Limited

2004 Licensing Doctors: Do Economists Agree?
by Shirley Svorny

2004 How to Get Real About Organs
by Alexander Tabarrok

2004 Does the National Health Service Corps Improve Physician Supply in Underserved Locations?
by George M. Holmes

2004 The Relationship between the Supply of Primary Care Physicians and Measures of Health
by John Robst & Glenn G. Graham

2004 Comportement individuel en matière de vaccination. Une approche bayésienne
by Laurent Coudeville

2004 Concept Model of Internet Based Strategy and Management System of the Bulgarian Healthcare
by Jan Andersson

2004 Estimando Seleção Adversa em Planos de Saúde
by Sandro Leal Alves

2003 Les TIC restructurent-elles ? Péripéties de deux réseaux de télémédecine en périnatalité
by Moisdon, Jean-Claude & Midy, Fabienne & David, Albert

2003 Les personnes âgées en institution
by Mesrine, Annie & Dufour-Kippelen, Sandrine

2003 El gasto en cuidados médicos de las familias uruguayas
by Pereyra, Andrés & Rossi, Máximo & Triunfo, Patricia

2003 Monopoly pricing with negative network effects: the case of vaccines
by Kessing, Sebastian & Nuscheler, Robert

2003 Optimale Verschuldung, Konsolidierungstrajektorien und Makroeffekte
by Heise, Arne

2003 Measuring and comparing the (in)efficiency of German and Swiss hospitals
by Steinmann, Lukas & Dittrich, Gunnar & Karmann, Alexander & Zweifel, Peter

2003 Shortages of Rural Mental Health Professionals
by Steven Stern & Elizabeth Merwin & Ivory Hinton

2003 Demand for pharmaceutical drugs: A choice modelling experiment
by Anna Merino

2003 Demand for pharmaceutical drugs: A choice modelling experiment
by Anna Merino

2003 Hotelling competition on quality in the health care market
by Montefiori, Marcello

2003 Optimal Intellectual Property Rights Exhaustion and Humanitarian Assistance during a National Health Emergency
by Drusilla K. Brown & George Norman

2003 How Did the German Health Care Reform of 1997 Change the Distribution of the Demand for Health Services?
by Rainer Winkelmann

2003 Re-evaluating an Evaluation Study: The Case of the German Health Care Reform of 1997
by Rainer Winkelmann

2003 Co-Payments for Prescription Drugs and the Demand for Doctor Visits - Evidence from a Natural Experiment
by Rainer Winkelmann

2003 Cost to the Patient or Cost to the Healthcare System? Which one Matters the Most for GP Prescribing Decisions? A UK-Italy Comparison
by Vincenzo Atella & Karen Hassell & Ellen Schafheutle & Marjorie C. Weiss & Peter R. Noyce

2003 Health Service Gatekeepers
by James Malcomson

2003 Self-regulation and the Certification of the European Information Economy The Case of e-Healthcare Information Provision
by Marcus Alexander & Matthew C. Harding

2003 Health-Care Systems: Lessons from the Reform Experience
by Elizabeth Docteur & Howard Oxley

2003 Private Health Insurance in Australia: A Case Study
by Francesca Colombo & Nicole Tapay

2003 Tackling Excessive Waiting Times for Elective Surgery: A Comparison of Policies in Twelve OECD Countries
by Jeremy Hurst & Luigi Siciliani

2003 Survey of Pharmacoeconomic Assessment Activity in Eleven Countries
by Michael Dickson & Jeremy Hurst & Stéphane Jacobzone

2003 Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke: A Study of 12 OECD Countries
by Michael Dickson & Stéphane Jacobzone

2003 Health-Care Systems: Lessons from the Reform Experience
by Elizabeth Docteur & Howard Oxley

2003 The US Health System: An Assessment and Prospective Directions for Reform
by Elizabeth Docteur & Hannes Suppanz & Jaejoon Woo

2003 The Magnitude and Nature of Risk Selection in Employer-Sponsored Health Plans
by Sean Nicholson & Kate Bundorf & Rebecca M. Stein & Daniel Polsky

2003 Who Gets Health Care?
by Robert W. Fogel & Chulhee Lee

2003 Quality and Employers' Choice of Health Plan
by Michael Chernew & Gautam Gowrisankaran & Catherine McLaughlin & Teresa Gibson

2003 The Effects of Private Insurance on Measures of Health: Evidence from the Health and Retirement Study
by Avi Dor & Joseph Sudano & David W. Baker

2003 Barriers to Entering Medical Specialties
by Sean Nicholson

2003 Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
by Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira

2003 Cut to the Bone? Hospital Takeovers and Nurse Employment Contracts
by Janet Currie & Mehdi Farsi & W. Bentley MacLeod

2003 Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter?
by William H. Crown & Ernst R. Berndt & Onur Baser & Stan N. Finkelstein & Whitney P. Witt

2003 Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand
by Patricia M. Danzon & Jonathan D. Ketcham

2003 Kidney Exchange
by Alvin E. Roth & Tayfun Sonmez & M. Utku Unver

2003 The Changing American Hospital in the Twenty-first Century 14th Annual Herbert Lourie Memorial Lecture on Health Policy
by Ralph W. Muller

2003 Ressourcen und Ergebnisse der globalen Gesundheitsökonomie, Einführung und Überblick
by Michael Stolpe

2003 Famine and Reform in North Korea
by Marcus Noland

2003 Issues in Japanese Health Policy and Medical Expenditure
by Iwamoto, Yasushi

2003 Uncertainty in the Generic Versus Brand Name Prescription Decision
by Hellström, Jörgen & Rudholm, Niklas

2003 Titanium Implants – A Comparison of a Swedish and an Ohio Firm
by Fridh, Ann-Charlotte

2003 Genetic testing and repulsion from chance
by Hoel, Michael & Iversen, Tor & Nilssen, Tore & Vislie, Jon

2003 Deductibles in Health Insurances: Pay or Pain?
by Asheim, Geir B. & Emblem, Anne Wenche & Nilssen, Tore

2003 Gatekeeping in health care
by Brekke, Kurt R. & Nuscheler, Robert

2003 Direct-to-Consumer Advertising in Pharmaceutical Markets
by Brekke, Kurt R. & Kuhn, Michael

2003 Internationales Benchmarking von Gesundheitssystemen - Ansatz zur Problemlösung?
by Wente, Tobias & Vauth, Christoph

2003 An analysis of the significant variation in psychostimulant use across the U.S
by Farasat A.S. Bokhari & Rick Mayes & Richard M. Scheffler

2003 Working Paper 11-03 - The AGIR project: Ageing, Health and Retirement in Europe - Use of health care and nursing care by the elderly: Data for Belgium
by Micheline Lambrecht & Julie Mestdagh

2003 Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica
by Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni

2003 Private Versus Public Health Care in a National Health Service
by Brekke, Kurt R & Lars Sorgard

2003 Moving beyond a drug budget mentality : the french case
by Le Pen, Claude

2003 La disponibilità a pagare per la copertura del rischio di non autosufficienza: analisi econometrica e valutazioni di policy
by R. Brau & G. Fiorentini & M. Lippi Bruni & AM. Pinna

2003 Entry and Competition in Local Hospital Markets
by Jean Marie Abraham & Martin Gaynor & William B Vogt

2003 Competition among Hospitals
by Martin Gaynor & William B Vogt

2003 The Effects of Budgets on Doctors Behaviour: Evidence from a Natural Experiment
by Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter Smith

2003 Negotiation Advantages of Professional Associations in Health Care
by Pedro Pita Barros & Xavier Martinez-Giralt

2003 Ausgliederung von Leistungen fuer Zahnersatz aus der gesetzlichen Krankenversicherung - Eigenverantwortung der Versicherten und Folgen fuer die GKV -
by Axel Olaf Kern

2003 Rescuing Patients from the Rule of Efficiency: A Need to Debate the
by Sophia Kessabi & Richard de Abreu Lourenco & Michael Wonder

2003 Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France
by Anne-Chantal Braud & Christine Levy-Piedbois & Pascal Piedbois & Youri Piedbois & Alain Livartovski & Beatrice Le Vu & Jean Tredaniel & Francois Reboul & Yvelise Brewer & Said Talbi & Francois Blanchon & Britta Paschen & Isabelle Durand-Zaleski

2003 Economic Evaluation of Norethisterone Acetate/Ethinylestradiol (FemHRT(R)) for Women with Menopausal Symptoms
by Douglas Coyle & Ann Cranney & Peter Tugwell

2003 The Comparative Medical Costs of Atherothrombotic Disease in European Countries
by Emile Levy & Sylvie Gabriel & Jerome Dinet

2003 Assessing the Economic Impact of Adverse Drug Effects
by Rosa Rodriguez-Monguio & Maria Jose Otero & Joan Rovira

2003 Costs of Bipolar Disorder
by Leah S. Kleinman & Ana Lowin & Emuella Flood & Gian Gandhi & Eric Edgell & Dennis A. Revicki

2003 Cost Effectiveness of Pneumococcal Vaccination for Infants and Children with the Conjugate Vaccine PnC-7 in Germany
by Christa Claes & Johann-Matthias Graf von der Schulenburg

2003 The Cost Effectiveness of ACE Inhibitors as First-Line Antihypertensive Therapy
by Alain J. Nordmann & Murray Krahn & Alexander G. Logan & Gary Naglie & Allan S. Detsky

2003 Labour Force Participation Among Individuals with Hepatitis C in the US
by Philip Jacobs & Ying Chu Ng & Tania Stafinski & Roger Dodd & Bryce Larke & Winnie Wong

2003 The Economics of Screening and Treatment in Type 2 Diabetes Mellitus
by Maria Raikou & Alistair McGuire

2003 Quality of Life and Economic Considerations in the Management of Prostate Cancer
by Marco Turini & Alberto Redaelli & Paola Gramegna & Davide Radice

2003 A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal Therapy: For Advanced Breast Cancer in Postmenopausal Patients
by Jon Karnon & Trefor Jones

2003 Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
by Andreas Maetzel & Jorg Ruof & Melva Covington & Anne Wolf

2003 Using Gross National Product to Calculate Acceptable Immunisation Costs: Deploying Cost-Effectiveness Calculations in Reverse
by Vineet Tyagi & Saroj K. Singh & Ashu Sawhney & Vikas Taneja & Jacob M. Puliyel

2003 Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery
by Sean D. Sullivan & Susan R. Kahn & Bruce L. Davidson & Lars Borris & Patrick Bossuyt & Gary Raskob

2003 Cytomegalovirus Infection in Solid Organ Transplantation: Economic Implications
by Ananya Das

2003 Pharmaceutical Care Programmes for the Elderly: Economic Issues
by Grainne E. Crealey & Ian K. Sturgess & James C. McElnay & Carmel M. Hughes

2003 Factors Affecting UK Primary-Care Costs of Managing Patients with Asthma over 5 Years
by Roben Das Gupta & Julian F. Guest

2003 Cost Effectiveness of Nasal Budesonide versus Surgical Treatment for Nasal Polyps
by Fredrik Berggren & Leif Johansson

2003 Peginterferon alpha-2a (40kD) [Pegasys(R)] Improves HR-QOL Outcomes Compared with Unmodified Interferon alpha-2a [Roferon(R)-A]: In Patients with Chronic Hepatitis C
by Jens Rasenack & Stefan Zeuzem & S. Victor Feinman & E. Jenny Heathcote & Michael Manns & Eric M. Yoshida & Mark G. Swain & Edward Gane & Moises Diago & Dennis A. Revicki & Amy Lin & Neil Wintfeld & Jesse Green

2003 Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease
by Anders Wimo & Bengt Winblad & Albrecht Stoffler & Yvonne Wirth & Hansjorg Mobius

2003 The Cost Effectiveness of Two New Antiepileptic Therapies in the Absence of Direct Comparative Data: A First Approximation
by Ben A. van Hout & Dennis D. Gagnon & Pauline Mcnulty & Anthony O'Hagan

2003 Cost Effectiveness of Alendronate (Fosamax(R)) for the Treatment of Osteoporosis and Prevention of Fractures
by Olof Johnell & Bengt Jonsson & Linus Jonsson & Dennis Black

2003 A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention
by Jarmo Hahl & Tuula Simell & Antti Kupila & Paivi Keskinen & Mikael Knip & Jorma Ilonen & Olli Simell

2003 Ontario's Formulary Committee: How Recommendations Are Made
by Anne M. PausJenssen & Peter A. Singer & Allan S. Detsky

2003 A Study of Influenza and Influenza-Related Complications among Children in a Large US Health Insurance Plan Database
by Jeanne Loughlin & Nick Poulios & Pavel Napalkov & Yann Wegmuller & Arnold S. Monto

2003 Unit Costs of Inpatient Hospital Days
by Jan B. Oostenbrink & Tineke Buijs-Van der Woude & Michel van Agthoven & Marc A. Koopmanschap & Frans F.H. Rutten

2003 Cost Comparisons of Pharmacological Strategies in Open-Heart Surgery
by Prabashni Reddy & Jessica Song

2003 Health-Related Quality-of-Life Assessments in Patients with Advanced Cancer of the Prostate
by Jan Adolfsson

2003 Specialist Nurse Management Programmes: Economic Benefits in the Management of Heart Failure
by Simon Stewart & John D. Horowitz

2003 Bedside Rapid Flu Test and Zanamivir Prescription in Healthy Working Adults: A Cost-Benefit Analysis
by Michael Schwarzinger & Bruno Housset & Fabrice Carrat

2003 Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma: In Four European Countries
by Jeanfrancois Rouland & Claude Lepen & Carlos Gouveiapinto & Patrizia Berto & Gilles Berdeaux

2003 A Meta-Analysis of Quality-of-Life Estimates for Stroke
by Tammy O. Tengs & Ting H. Lin

2003 The Burden of Age-Related Macular Degeneration: Results of a Cohort Study in Two French Referral Centres
by Julia Bonastre & Claude Le Pen & Gisele Soubrane & Gabriel Quentel

2003 Treatment of Atopic Dermatitis and Impact on Quality of Life: A Review with Emphasis on Topical Non-Corticosteroids
by Roman Schiffner & Julia Schiffner-Rohe & Michael Landthaler & Wilhelm Stolz

2003 NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales
by Amiram Gafni & Stephen Birch

2003 European Healthcare Policies for Controlling Drug Expenditure
by Silvia M. Ess & Sebastian Schneeweiss & Thomas D. Szucs

2003 Discounting in Cost-Utility Analysis of Healthcare Interventions: Reassessing Current Practice
by Brian J. Cohen

2003 Cost Effectiveness and Cost Utility of Acetylcysteine versus Dimethyl Sulfoxide for Reflex Sympathetic Dystrophy
by Hiske E.M. van Dieten & Roberto S.G.M. Perez & Maurits W. van Tulder & Jaap J. de Lange & Wouter W.A. Zuurmond & Herman J. Ader & Hindrik Vondeling & Maarten Boers

2003 Economic Implications of the Use of Basiliximab in Addition to Triple Immunosuppressive Therapy in Renal Allograft Recipients: A UK Perspective
by Stephen J. Walters & Malcolm Whitfield & Ronald L. Akehurst & James B. Chilcott

2003 Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson's Disease
by Michael Iskedjian & Thomas R. Einarson

2003 Cost of Illness of Atopic Dermatitis in Children: A Societal Perspective
by Andrew S. Kemp

2003 Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting: Olmesartan Medoxomil Compared with Losartan, Valsartan, and Irbesartan
by W. Robert Simons

2003 Potential Costs and Effects of the National Service Framework for Coronary Heart Disease in the UK
by Venanzio Vella

2003 Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
by Niklas Zethraeus & Magnus Johannesson & Bengt Jonsson & Mickael Lothgren & Magnus Tambour

2003 Economic Evaluations of Varicella Vaccination Programmes: A Review of the Literature
by Nancy Thiry & Philippe Beutels & Pierre Van Damme & Eddy Van Doorslaer

2003 Generic Clozapine: A Cost-Saving Alternative to Brand Name Clozapine?
by Gordon Tse & Deborah Thompson & Ric M. Procyshyn

2003 An Evaluation of the Cost Effectiveness of Drotrecogin Alfa (Activated) Relative to the Number of Organ System Failures
by Madeline Betancourt & Peggy S. McKinnon & R. Michael Massanari & Salmaan Kanji & David Bach & John W. Devlin

2003 The Health Economics of Bladder Cancer: A Comprehensive Review of the Published Literature
by Marc F. Botteman & Chris L. Pashos & Alberto Redaelli & Benjamin Laskin & Robert Hauser

2003 Economic Evaluations of Granulocyte Colony-Stimulating Factor: In the Prevention and Treatment of Chemotherapy-Induced Neutropenia
by Marc Esser & Helmut Brunner

2003 Development and Validation of the Diabetic Foot Ulcer Scale-Short Form (DFS-SF)
by Carla M. Bann & Sheri E. Fehnel & Dennis D. Gagnon

2003 The Cost Effectiveness of Tacrolimus versus Microemulsified Cyclosporin: A 10-Year Model of Renal Transplantation Outcomes
by Michelle E. Orme & Wieslaw A. Jurewicz & Nagappan Kumar & Tracy L. McKechnie

2003 Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems
by Cynthia L. Leibson & Kirsten Hall Long

2003 Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer
by Alberto Redaelli & Carole W. Cranor & Gary J. Okano & Pat Ray Reese

2003 Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain
by Josep Darba

2003 Escitalopram: A Pharmacoeconomic Review of its Use in Depression
by Katherine F. Croom & Greg L. Plosker

2003 The Cost Effectiveness of Apligraf(R) Treatment of Diabetic Foot Ulcers
by W. Ken Redekop & Joseph McDonnell & Paul Verboom & Kornelia Lovas & Zoltan Kalo

2003 Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer
by Silas C. Martin & Dennis D. Gagnon & Lucy Zhang & Carsten Bokemeyer & Marinus Van Marwijk Kooy & Ben van Hout

2003 Costs and Cost Effectiveness of Low Molecular Weight Heparins and Platelet Glycoprotein IIb/IIIa Inhibitors: In the Management of Acute Coronary Syndromes
by Nick Bosanquet & Bengt Jonsson & Keith A.A. Fox

2003 Reductions in Individual Work Productivity Associated with Type 2 Diabetes Mellitus
by Jill E. Lavigne & Charles E. Phelps & Alvin Mushlin & Wayne M. Lednar

2003 Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study
by Juan Oliva & Cesar Roa & Juan del Llano

2003 Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting
by Jan B. Oostenbrink & Maiwenn J. Al & Maureen P.M.H. Rutten-van Molken

2003 Heartburn in Patients with Gastro-Oesophageal Reflux Disease in Germany and Sweden: A Study on Patients
by Roger Jones & Silke Horbach & Peter Sander & Tina Ryden-Bergsten

2003 Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes: In Patients with Bipolar I Disorder in France
by Marie de Zelicourt & Roland Dardennes & Helene Verdoux & Gian Gandhi & Babak Khoshnood & Eric Chomette & Marie-Laure Papatheodorou & Eric T. Edgell & Christian Even & Francis Fagnani

2003 Evaluating Minimal Clinically Important Differences for the Acne-Specific Quality of Life Questionnaire
by Lori D. McLeod & Sheri E. Fehnel & Jane Brandman & Tara Symonds

2003 Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?
by Josephine Mauskopf & Frans Rutten & Warren Schonfeld

2003 Prevention of Recurrent Rhinopharyngitis in At-Risk Children in France: A Cost-Effectiveness Model for a Nonspecific Immunostimulating Bacterial Extract (OM-85 BV)
by Jean-Jacques Pessey & Francoise Megas & Benoit Arnould & Florence Baron-Papillon

2003 A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
by Jean A. Maroun & Carl Asche & Francoise Romeyer & Jayanti Mukherjee & Christine Cripps & Amit Oza & Jamie R. Skillings & Jacques Letarte

2003 Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer
by Linus Jonsson

2003 Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
by Christian Krauth & Noushin Jalilvand & Tobias Welte & Reinhard Busse

2003 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2003 The Incorporation of Potential Confounding Variables in Markov Models
by Mark J.C. Nuijten & Frans Rutten

2003 Quality of Life in Patients with Rheumatoid Arthritis: Which Drugs Might Make a Difference?
by Barbara Blumenauer & Ann Cranney & Jennifer Clinch & Peter Tugwell

2003 Practical Aspects of Designing and Conducting Pharmacoeconomic Studies in Japan
by Jim Doherty & Keiko Sato

2003 Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes
by Greg L. Plosker & Tim Ibbotson

2003 Validation of Expert Opinion in Identifying Comorbidities Associated with Atopic Dermatitis/Eczema
by Charles N. Ellis & Lynn A. Drake & Mary M. Prendergast & William Abramovits & Mark Boguniewicz & C. Ralph Daniel & Mark Lebwohl & Seth R. Stevens & Diane L. Whitaker-Worth & Kuo B. Tong

2003 Defining Monetary Values for Quality of Life Improvements: An Exploratory Study
by Jean Lachaine & Claudine Laurier & Andre-Pierre Contandriopoulos

2003 Recurrent Genital Herpes Treatments and Their Impact on Quality of Life
by Mathijs H. Brentjens & Kimberly A. Yeung-Yue & Patricia C. Lee & Stephen K. Tyring

2003 Integer/Linear Mathematical Programming Models: A Tool for Allocating Healthcare Resources
by Stephanie R. Earnshaw & Susan L. Dennett

2003 Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus
by Joe W. Ramsdell & Seth N. Braunstein & Jennifer M. Stephens & Christopher F. Bell & Marc F. Botteman & Scott T. Devine

2003 Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer
by Patricia Marino & Anne-Gaelle Le Corroller & Thao Palangie & Maud Janvier & Michel Fabbro & Laurent Molinier & Thierry Delozier & Alain Livartowski & Jean-Paul Moatti & Patrice Viens

2003 Cost Evaluation of Basiliximab Treatment for Renal Transplant Patients in Japan
by Tomonori Hasegawa & Hidehiko Imai & Sunao Miki

2003 The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of Life: A Literature Review
by Manishi Prasad & Anne M. Rentz & Dennis A. Revicki

2003 A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?
by Suzanne Hill & Nick Freemantle

2003 Lower Respiratory Tract Infections: Impact on the Workplace
by Howard G. Birnbaum & Melissa Morley & Stephanie Leong & Paul Greenberg & Gene L. Colice

2003 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective
by Ewa Orlewska & Andrzej Budaj & Dariusz Tereszkowski-Kaminski

2003 Consumer Preference for Dinoprostone Vaginal Gel Using Stated Preference Discrete Choice Modelling
by Susan J. Taylor & Carol L. Armour

2003 Cost Effectiveness of Adding Folinic Acid to Fluorouracil Plus Levamisole as Adjuvant Chemotherapy in Patients with Colon Cancer in Germany
by Brigitta U.M. Monz & Hans-Helmut Konig & Reiner Leidl & Ludger Staib & Karl-Heinrich Link

2003 Determinants of Drug Costs in Hospitalised Patients with Haemophilia: Impact of Recombinant Activated Factor VII
by Jean Philippe Galanaud & Nathalie Pelletier-Fleury & Helene Logerot-Lebrun & Thierry Lambert

2003 Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients
by Karen L. Rascati & Michael T. Johnsrud & M. Lynn Crismon & Maureen J. Lage & Beth L. Barber

2003 Disease Management Update
by Adis International Limited

2003 Validation of the Pneumonia Severity Index Among Patients Treated at Home or in the Hospital
by Brian S. Armour & Stephen R. Pitts & M. Melinda Pitts & Jennifer Wike & Linda Alley & Jeff Etchason

2003 School-Based Prevention Programs for Eating Disorders: Achievements and Opportunities
by Riccardo Dalle Grave

2003 Comprehensive Case Management Models For Pulmonary Tuberculosis
by Patrick Chaulk & Vahe A. Kazandjian

2003 What is the Return on Investment Associated with Diabetes Disease Management?: A Report from One Managed Care Organization in Pennsylvania, USA
by Jaan Sidorov & Peter Paulick & Lila Sobel

2003 A Review of Telemedicine and Asthma
by Claire Wainwright & Richard Wootton

2003 The MELD System for Liver Allocation: Implications for Patients and Payors
by Richard B. Freeman

2003 Certification for Disease-Specific Care Programs
by Charles A. Mowll

2003 Disease Management Update
by Adis International Limited

2003 New Biochemical Tools for Diagnosing Acute Coronary Syndromes: Impact on Patient Outcomes and Resource Utilization in Hospitals
by W. Frank Peacock & Fred Wilson

2003 Acute Care for Elders Units: Practical Considerations for Optimizing Health Outcomes
by Robert M. Palmer & Steven R. Counsell & Seth C. Landefeld

2003 Supporting Herbal Resource Needs for Health Plan Members: Complementary and Alternative Medicine by Telephone
by Jodi A. Chaffin & Jolene J. Thoennes & Jackie L. Boucher & Nicolaas P. Pronk

2003 Improving the Health Status of US Working Adults with Type 2 Diabetes Mellitus: A Review
by Fevzi Akinci & Bernard J. Healey & Joseph S. Coyne

2003 Chronic Disease Management: A Definition And Systematic Approach To Component Interventions
by Susan L. Norris & Russell E. Glasgow & Michael M. Engelgau & Patrick J. OConnor & David McCulloch

2003 Disease Management Update
by Adis International Limited

2003 Utilization and Financial Outcomes of an Asthma Disease Management Program Delivered to Medicaid Members: Results of a Three-Group Comparison Study
by Alan E. Johnson & Ming Yin & Gregory Berg

2003 Cost Effectiveness of Diabetes Mellitus Management Programs: A Health Plan Perspective
by Todd Gilmer & Patrick J. OConnor

2003 The Role of Evidence-Based Medicine in Disease Management
by Paul H. Keckley

2003 Diabetes Self-Management Education Research: An International Review of Intervention Methods, Theories, Community Partnerships and Outcomes
by Leonard Jack, Jr

2003 How Can Social Workers Improve Outcomes and Costs in Disease Management?
by Nancy Claiborne & Henry Vandenburgh

2003 Disease Management Update
by Adis International Limited

2003 Identifying Future High-Cost Cases Through Predictive Modeling
by Yang Zhao & Arlene S. Ash & John Haughton & Benjamin McMillan

2003 Disease Management of Migraine and the Importance of Stratified Care
by Richard B. Lipton & Marcelo E. Bigal & Wsalter F. Stewart

2003 Screening for Depression in Patients with Chronic Illness: Why and How?
by Jeffrey M. Davis & Christine M. Gershtein

2003 Disease Management Programs in the Geriatric Setting: Practical Considerations
by Kenneth J. Steinman & Michael A. Steinman & Theodore I. Steinman

2003 Medicaid Disease Management Programs: Findings from Three Leading US State Programs
by Jeann L. Gillespie & Louis F. Rossiter

2003 Disease Management Update
by Adis International Limited

2003 A Comparative Cost Analysis of Participating versus Non-Participating Somatizing Patients Referred to a Behavioral Medicine Group in a Health Maintenance Organization
by Steven E. Locke & Patricia Ford & Thomas McLaughlin

2003 Educating the Public About Stroke: Role in Improving Outcomes
by Richard N. Bradley

2003 Disease-Specific Self-Management Programs in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Comprehensive and Critical Evaluation
by Jean Bourbeau

2003 Health Screening and Health Promotion Programs for the Elderly
by Adam Drewnowski & Elaine Monsen & Diana Birkett & Susan Gunther & Susan Vendeland & Jeff Su & Gillian Marshall

2003 Telemedicine from the Payor Perspective: Considerations for Reimbursement Decisions
by Pamela Whitten & Emily Kuwahara

2003 Can Genomics Deliver on the Promise of Improved Outcomes and Reduced Costs?: Background and Recommendations for Health Insurers
by Marc S. Williams

2003 Disease Management Update
by Adis International Limited

2003 Estimating Influenza-Related Hospital Admissions in Children and Adults: A Time Series Analysis
by Paul A. Scuffham

2003 Active Management of Patients with Chronic Renal Insufficiency: The Effect on Hospital Days During the Initial Hemodialysis Period
by Ilan Zawadzki & Moshe Fridman & Wing Chan & Seonyoung Ryu

2003 Importance of Cultural Sensitivity in Therapeutic Transactions: Considerations for Healthcare Providers
by Oyedeji Ayonrinde

2003 The Effectiveness of Asthma Nurse Intervention: The Need for Change
by Christine Wrench & Alyn H. Morice

2003 Structured Outpatient Education and Treatment Programs for Patients with Diabetes Mellitus and/or Hypertension: The German Experience
by Monika Gruesser & Karola Hoffstadt & Viktor Joergens

2003 Teledermatology Can Produce High-Quality Care at Low Cost
by Keng Chen & Stephen Shumack & Richard Wootton

2003 Disease Management Update
by Adis International Limited

2003 Spotlight on Insulin Lispro in Diabetes Mellitus This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (14): 989-1025
by Christopher J. Dunn & Greg L. Plosker

2003 Results of a Men's Urological Health Screening Program at Lockheed Martin Aeronautical Systems
by Pamella Thomas & Ron Z. Goetzel & Ronald J. Ozminkowski & Vahan S. Kassabian & David C. Schutt

2003 Antidepressant Treatment Patterns and Success Rates in a Managed Care Organization
by Edward P. Armstrong

2003 Electronic Management Systems in Diabetes Mellitus: Impact on Patient Outcomes
by Riccardo Bellazzi

2003 Designing and Evaluating Health Promotion Programs: Simple Rules for a Complex Issue
by Nicolaas P. Pronk

2003 Physician Financial Incentives in Managed Care: Resource Use, Quality and Cost Implications
by Brian S. Armour & Mmelinda Pitts

2003 An Overview of Community Pharmacist Interventions: Assessing Cost-Effectiveness and Patients' Willingness To Pay
by Shu Chuen Li

2003 Interdisciplinary Team-Based Disease Management of Heart Failure
by Thomas G. Di Salvo & Lynne Warner Stevenson

2003 Assessment Methods for Patient-Reported Outcomes
by Michael R. Hufford & Saul Shiffman

2003 Ethical Considerations in Disease Management: A Managed Care Perspective
by Robert A. Baldor

2003 Disease Management Update
by Adis International Limited

2003 Spotlight on Galantamine in Alzheimer's Disease This Spotlight is derived from abstract and summary text of an Adis Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (13): 919-942
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2003 Assessing Beneficiary Health Outcomes and Disease Management Initiatives in Medicare
by Samuel C. Haffer & Sonya E. Bowen & Erin Dowd Shannon & Brenda M. Fowler

2003 Economic Impact of Patient Adherence with Antidepressant Therapy Within a Managed Care Organization
by T. Jeffrey White & Ann Vanderplas & Caron Ory & Christopher M. Dezii & Eunice Chang

2003 Determinants of Quality of In-Hospital Care for Patients with Acute Coronary Syndromes
by Ian A. Scott

2003 Reducing Racial and Ethnic Disparities in Disease Management to Improve Health Outcomes
by Dennis P. Andrulis

2003 Predictive Modeling in Health Plans
by Randy C. Axelrod & David Vogel

2003 Long-Term Care Insurance in Japan: Its Frameworks, Issues and Roles
by Kiyomi Asahara & Yumiko Momose & Sachiyo Murashima

2003 Acknowledgment
by Adis International Limited

2003 Management of Rheumatoid Arthritis: Defining the Role of Leflunomide
by Christopher I. Carswell & Caroline M. Perry & Tim Ibbotson

2003 Clinical and Utilization Outcomes for a Pediatric and Adolescent Telephonic Asthma Care Support Program: A Propensity Score-Matched Cohort Study
by Gregory D. Berg & Alan Johnson & Edward Fleegler

2003 Impact of Antimicrobial Control Programs on Patient Outcomes: Pharmacy Perspective
by David T. Bearden & George P. Allen

2003 Health Outcomes Assessment in Cancer: Current Measurement Strategies and Recommendations for Improvement
by William F. Lawrence & Carolyn M. Clancy

2003 The Approaches to Schizophrenia Communication (ASC) Tool: Including the Patient Perspective in Treatment
by Albana M. Dassori & Alexander L. Miller & Peter J. Weiden

2003 Specialist Nurse-Led Intervention in Outpatients with Congestive Heart Failure: Impact on Clinical and Economic Outcomes
by Nicholas D. Palmer & Barbara Appleton & Erwin A. Rodrigues

2003 Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene
by Keri Wellington & Greg L. Plosker

2003 Antibacterials for Viral Respiratory Infections: Results of a Physician-Based Intervention in a Predominantly Preferred Provider Organization Setting
by John Berthiaume & Helen O. Chernicoff & Jaok J. Kim & Richard S. Chung & Roberta C. Pang & Antonio P. Legorreta

2003 Global Efforts for Reducing the Burden of Smoking
by Frank J. Chaloupka & Prabhat Jha & Marlo A. Corrao & Vera Luiza da Costa e Silva & Hana Ross & Christina C. Ciecierski & Derek Yach

2003 Provider Training and Education in Disease Management: Current and Innovative Technology
by Myra L. Muramoto & Jean Campbell & Zenen Salazar

2003 Long-Term Effects of Second-Generation Cholinesterase Inhibitors on Clinical Outcomes and Costs of Alzheimer
by J. Jaime Caro & Denis Getsios

2003 A Schema for Effective Osteoporosis Management: Outcomes of the Geisinger Health System Osteoporosis Program
by Eric D. Newman

2003 Capital Budgeting and Entrepreneurial Organizations: A Survey of Hospital Practices
by Shih-Jen Kathy Ho & Lilian Chan & Daniel L. Tompkins

2003 Physician Reimbursement, Time-Consistency and the Quality of Care
by Robert Nuscheler

2003 Public vs. Private Health Care Services Demand in Italy
by Daniele Fabbri & Chiara Monfardini

2003 The Effect of Public Policies on Nursing Home Care in the United States
by O. David Gulley & Rexford E. Santerre

2003 La Salud En Colombia: ¿Qué Tan Meritorio Y Público Es Este Bien O Servicio?
by CARLOS ARTURO MEZA CARVAJALINO

2002 Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
by Lévy, Emile & Lévy, Pierre

2002 Incomplete risk adjustment and adverse selection in the German public health insurance system
by Knaus, Thomas & Nuscheler, Robert

2002 Physician reimbursement, time-consistency and the quality of care
by Nuscheler, Robert

2002 Moral Hazard, Market Power, and Second Best Health Insurance
by Wigger, Berthold U. & Anlauf, Markus

2002 Managed Care, Physician Incentives, and Norms of Medical
by David J. Cooper & James B. Rebitzer

2002 The Productivity of Pharmaceuticals in Improving Health: An Analysis of the OECD Health Data
by James W. Shaw & William C. Horrace & Ronald J. Vogel

2002 Libertàdi scelta e contratti prospettici: l'asimmetria informativa nel mercato delle cure sanitarie ospedaliere
by Montefiori, Marcello

2002 On the Dynamics of Physician Density; Theory and Empirical Evidence for Switzerland
by Sandra Nocera & Gabrielle Wanzenried

2002 Managed Health Care and Provider Integration: a Theory of Bilateral Market Power
by Karen Eggleston & George Norman & Lynne Pepall

2002 The demand for health care in South Africa
by Roy Havemann & Servaas van der Berg

2002 Willingness to Pay for Dental Fear Treatment. Is Supplying Fear Treatment Socially Beneficial?
by Bente Halvorsen & Tiril Willumsen

2002 Health Care Reform and the Number of Doctor Visits – An Econometric Analysis
by Rainer Winkelmann

2002 The Effect of Activity-Based Financing on Hospital Efficiency: A Panel Data Analysis of DEA Efficiency Scores 1992-2000
by Biorn, Erik & Hagen, Terje P. & Iversen, Tor & Magnussen, Jon

2002 Demand for Curative Health Care in Rural India: Choosing between Private, Public and No Care
by Gupta, Indrani & Dasgupta, Puranmita

2002 Access to Physician Services: Does Supplemental Insurance Matter? Evidence from France
by Thomas C. Buchmueller & Agnès Couffinhal & Michel Grignon & Marc Perronin

2002 Competition, Payer, and Hospital Quality
by Gautam Gowrisankaran & Robert Town

2002 Did Blue Cross and Blue Shield Suffer from Adverse Selection? Evidence from the 1950s
by Melissa A. Thomasson

2002 Does Managerial 'Outsourcing' Reduce Expense Preference Behavior? A Comparison of Adopters and Non-Adopters of Contract-Management in US Hospitals
by Kathleen Carey & Avi Dor

2002 Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
by Sean Nicholson & Patricia M. Danzon & Jeffrey S. McCullough

2002 Minimum Standards and Insurance Regulation: Evidence from the Medigap Market
by Amy Finkelstein

2002 Medicaid Managed Care: Effects on Children's Medicaid Coverage and Utilization
by Janet Currie & John Fahr

2002 Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy
by Patricia M. Danzon & Stephen B. Soumerai

2002 Parallel Private Health Insurance in Australia: A Cautionary Tale and Lessons for Canada
by Hurley, Jeremiah & Vaithianathan, Rhema & Crossley, Thomas F. & Cobb-Clark, Deborah

2002 Parallel Private Health Insurance in Australia: A Cautionary Tale and Lessons for Canada
by Hurley, Jeremiah & Vaithianathan, Rhema & Crossley, Thomas F. & Cobb-Clark, Deborah A.

2002 Regulation of Cost and Quality under Yardstick Competition
by Tangerås, Thomas P.

2002 Nya läkemedel i Sverige: Innovationshöjd, prissättning och marknadsframgång
by Jönsson, Bengt & Lundkvist, Jonas & Persson, Björn

2002 Hälsoekonomiska utvärderingar som underlag för beslut om pris och subventionering. Riktlinjer och beslutskriterier
by Jönsson, Bengt & Lundkvist, Jonas

2002 Kostnadseffektivitet hos nya läkemedel. En systematisk genomgång av publicerade studier för NCEs registrerade i Sverige 1987-2000
by Jönsson, Bengt & Lundkvist, Jonas

2002 The drug bargaining game: Pharmaceutical regulation in Australia, CHERE Discussion Paper No 51
by Donald J Wright

2002 Deriving welfare measures from stated preference discrete choice modelling experiments, CHERE Discussion Paper No 48
by Emily Lancsar

2002 Acerca de la magnitud de la inequidad en salud en el Perú
by Martín Valdivia

2002 Assurance-maladie, accès aux soins et redistribution des revenus
by Le Pen, Claude

2002 Reforming Incentive Schemes Under Political Constraints: The Physician Agency
by Demange, Gabrielle & Geoffard, Pierre-Yves

2002 Incentives in HMO's
by Martin Gaynor & James B Rebitzer & Lowell J Taylor

2002 Arztinduzierte Nachfrage in der ambulanten Versorgung - Bedeutung fuer eine Privatisierung von Leistungen der Gesetzlichen Krankenversicherung -
by Axel Olaf Kern

2002 Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden
by Frances B. Garfield & Denis Getsios & J. Jaime Caro & Anders Wimo & Bengt Winblad

2002 Cost Effectiveness of Treatment of Parkinson's Disease with Entacapone in the United States
by Cynthia S. Palmer & Mark J.C. Nuijten & Jordana K. Schmier & Prasun Subedi & Edward H. Snyder

2002 Direct Medical Cost of Managing Deep Vein Thrombosis According to the Occurrence of Complications
by Judith A. O'Brien & Jaime J. Caro

2002 Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis
by J. Jaime Caro & Denis Getsios & Ingrid Caro & Judith A. O'Brien

2002 Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes
by Lisa L. Ioannides-Demos & Joseph E. Ibrahim & John J. McNeil

2002 On-Demand and Intermittent Therapy for Gastro-Oesophageal Reflux Disease: Economic Considerations
by John M. Inadomi

2002 Economic Benefits of Amlodipine Treatment in Patients with Coronary Artery Disease
by Roman Casciano & John J. Doyle & John Chen & Steve Arikian & Julian Casciano & Heather Kugel & Raul Arocho

2002 Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care: An Overview and Cost Analysis
by Craig Anderson & Cliona Ni Mhurchu & Paul M. Brown & Kristie Carter

2002 Ready-to-Use Injection Preparations versus Conventional Reconstituted Admixtures: Economic Evaluation in a Real-Life Setting
by Phillipe van der Linden & Jacques Douchamps & Claude Schmitt & Dominique Forget

2002 Cost-Effective Approaches to the Treatment of Community-Acquired Pneumonia in the Era of Resistance
by Joseph L. Kuti & Blair Capitano & David P. Nicolau

2002 Methods for Claims-Based Pharmacoeconomic Studies in Psychosis
by Frank Gianfrancesco & Ruey-Hua Wang & Ramy Mahmoud & Richard White

2002 Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium
by Niels Neymark & Thierry Gorlia & Ines Adriaenssen & Benoit Baron & Martine Piccart

2002 A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac(R) in the UK Use of the tradename is for product identification purposes only and does not imply endorsement
by Roben Das Gupta & Julian F. Guest

2002 Limitations of the Methods Used for Calculating Quality-Adjusted Life-Year Values
by Gerard Duru & Jean Paul Auray & Ariel Beresniak & Michel Lamure & Abby Paine & Nicolas Nicoloyannis

2002 Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting
by Ron L. Akehurst & John E. Brazier & Nigel Mathers & Caroline O'Keefe & Eva Kaltenthaler & Anne Morgan & Maria Platts & Stephen J. Walters

2002 Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations
by Jan B. Oostenbrink & Marc A. Koopmanschap & Frans F.H. Rutten

2002 Homocyst(e)ine and Coronary Heart Disease: Pharmacoeconomic Support for Interventions to Lower Hyperhomocyst(e)inaemia
by Brahmajee K. Nallamothu & A. Mark Fendrick & Gilbert S. Omenn

2002 Use of Healthcare Services by Patients Treated with Risperidone Versus Conventional Antipsychotic Agents
by Frank Gianfrancesco & Michael B. Durkin & Ramy Mahmoud & Ruey-Hua Wang

2002 Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life
by Amir Shmueli

2002 Estimating the Effect of Changes in Body Mass Index on Health State Preferences
by Zafar Hakim & Anne Wolf & Louis P. Garrison

2002 A Fair Innings for NICE?
by Nick Freemantle & Karen Bloor & Joanne Eastaugh

2002 Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature
by Gary Ginsberg & Serena Lowe

2002 Sickle Cell Anaemia: Epidemiology and Cost of Illness
by Paul J. Nietert & Marc D. Silverstein & Miguel R. Abboud

2002 The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden
by Lars Agreus & Lars Borgquist

2002 The Practice of Splitting Tablets: Cost and Therapeutic Aspects
by John Bachynsky & Cheryl Wiens & Krystal Melnychuk

2002 Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer
by M. Lees & M. Aristides & N. Maniadakis & J. McKendrick & N. Botwood & D. Stephenson

2002 Cost Effectiveness of Oral Terbinafine (Lamisil(R)) Compared with Oral Fluconazole (Diflucan(R)) in the Treatment of Patients with Toenail Onychomycosis
by Heini Salo & Markku Pekurinen

2002 Economic Considerations Related to Providing Adequate Pain Relief for Women in Labour: Comparison of Epidural and Intravenous Analgesia
by Cecil Huang & Alex Macario

2002 Quality-of-Life Assessment in Osteoporosis: Health-Status and Preference-Based Measures
by Anna N.A. Tosteson & Cristina S. Hammond

2002 Cost Effectiveness of Esomeprazole Compared with Omeprazole in the Acute Treatment of Patients with Reflux Oesophagitis in the UK
by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green

2002 Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis: Comparison of On-Demand Esomeprazole with Conventional Omeprazole Strategies
by Peter Wahlqvist & Ola Junghard & Andy Higgins & Jonathan Green

2002 Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma
by Alan J. Zillich & Karen Blumenschein & Magnus Johannesson & Patricia Freeman

2002 Putting Your Money Where Your Mouth Is: Willingness to Pay for Dental Gel
by Debora Matthews & Angela Rocchi & Amiram Gafni

2002 Enoxaparin: A Pharmacoeconomic Review of its Use in the Prevention and Treatment of Venous Thromboembolism and in Acute Coronary Syndromes
by David Bergqvist

2002 A Monte Carlo Simulation for Modelling Outcomes of AIDS Treatment Regimens
by Anke Richter & Brett Hauber & Kit Simpson & Josephine A. Mauskopf & Dongping Yin

2002 Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion
by Stephan H. Duda & Gunnar Tepe & Mohan Bala & Oliver Luz & Gerhard Ziemer & Kenneth Ouriel & Benjamin Pusich & Jakub Wiskirchen & Claus D. Claussen & Kurt Banz

2002 Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction
by Josep Darba & Inaki Izquierdo & Caridad Pontes & Carlos Navas & Joan Rovira

2002 Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies
by Martin J. Price & Andrew H. Briggs

2002 Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment
by Gregorio Brevetti & Roberta Annecchini & Roxanna Bucur

2002 Acute Exacerbations of Chronic Bronchitis: A Pharmacoeconomic Review of Antibacterial Use
by Stephen Morris & Pippa Anderson & Debra E. Irwin

2002 Optimising Drug Utilisation in Long Term Care
by Kate L. Lapane & Carmel M. Hughes

2002 Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine: The Disability in Strategies for Care (DISC) Study
by Mark Sculpher & David Millson & David Meddis & Lynne Poole

2002 Design, Analysis and Presentation of Multinational Economic Studies: The Need for Guidance
by Francis Pang

2002 Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation
by Jonathan Karnon & Jackie Brown

2002 Health-Related Quality of Life in a UK-Based Population of Men with Erectile Dysfunction
by Julian F. Guest & Roben Das Gupta

2002 Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer: A Model for Europe and Australia
by Peter Lindgren & Bengt Jonsson & Alberto Redaelli & Davide Radice

2002 Pharmacy Benefit Management: Enhancing the Applicability of Pharmacoeconomics for Optimal Decision Making
by C. Daniel Mullins & Junling Wang

2002 Economic Comparison of Leflunomide and Methotrexate in Patients with Rheumatoid Arthritis: An Evaluation Based on a 1-Year Randomised Controlled Trial
by Andreas Maetzel & Vibeke Strand & Peter Tugwell & George Wells & Claire Bombardier

2002 Economic Impact of Low Dose Polyethylene Glycol 3350 Plus Electrolytes Compared with Lactulose in the Management of Idiopathic Constipation in the UK
by Angela H. Christie & Pearl Culbert & Julian F. Guest

2002 Antihypertensive Treatment with and without Benazepril in Patients with Chronic Renal Insufficiency: A US Economic Evaluation
by Thomas J. Hogan & William J. Elliott & Arnold H. Seto & George L. Bakris

2002 Onychomycosis: Health-Related Quality of Life Considerations
by James W. Shaw & Vijay N. Joish & Stephen Joel Coons

2002 Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis
by Philippe Beutels & W. John Edmunds & Fernando Antonanzas & G. Ardine de Wit & David Evans & Rachel Feilden & A. Mark Fendrick & Gary M. Ginsberg & Henry A. Glick & Eric Mast & Marc Pechevis & Eddy K.A. Van Doorslaer & Ben A. van Hout

2002 Health State Preference Assessment in Diabetic Peripheral Neuropathy
by Sean D. Sullivan & Doris P. Lew & E. Beth Devine & Zafar Hakim & Gayle E. Reiber & David L. Veenstra

2002 Use of Randomised Controlled Trials for Producing Cost-Effectiveness Evidence: Potential Impact of Design Choices on Sample Size and Study Duration
by Martin E. Backhouse

2002 Quality of Life in Patients with Epilepsy and Impact of Treatments
by Patrizia Berto

2002 Developing the Revised NICE Appraisal Technical Guidance to Manufacturers and Sponsors: Opportunity or Threat?
by Rod S. Taylor & John Hutton & Anthony J. Culyer

2002 Insulin Lispro: A Pharmacoeconomic Review of its Use in Diabetes Mellitus
by Christopher J. Dunn & Greg L. Plosker

2002 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome
by Max Brosa & Carlos Rubio-Terres & Ibrahim Farr & Vijay Nadipelli & Jenaro Froufe

2002 Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies
by Emile Levy & Pierre Levy

2002 Theoretical Arguments for the Discounting of Health Consequences: Where Do We Go from Here?
by Angelina Lazaro

2002 Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2002 Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
by Ketan Sheth & Rohit Borker & Amanda Emmett & Kathleen Rickard & Paul Dorinsky

2002 The Annual Societal Cost of Alcohol Misuse in Scotland
by Susan J. Varney & Julian F. Guest

2002 The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions
by Edward C.F. Wilson & Emma S. McKeen & Paul A. Scuffham & Martin C.J. Brown & Kevan Wylie & Geoff Hackett

2002 The Economic Costs of Early Stage Prostate Cancer
by Christopher S. Saigal & Mark S. Litwin

2002 Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
by Mark J.C. Nuijten & Frans Rutten

2002 Costs and Effectiveness of Using Coumarins Before, During and After Coronary Angioplasty
by Jurrien M. ten Berg & Johannas C. Kelder & Thys H.W. Plokker & Ben A. van Hout

2002 UK Department of Health Guidance on Prescribing for Impotence Following the Introduction of Sildenafil: Potential to Contain Costs in the Average Health Authority District
by Martin Ashton-Key & Michael Sadler & Byron Walmsley & Simon Holmes & Sarah Randall & Michael H. Cummings

2002 Cost-Effectiveness Comparison of Tizanidine and Baclofen in the Management of Spasticity
by David N. Rushton & Adam C. Lloyd & Pippa M. Anderson

2002 Long Term Cost-of-Illness in Stroke: An International Review
by Krista A. Payne & Krista F. Huybrechts & Jjaime Caro & Traci J. Craig Green & Wendy S. Klittich

2002 Vision-Specific Instruments for the Assessment of Health-Related Quality of Life and Visual Functioning: A Literature Review
by Mary Kay Margolis & Karin Coyne & Tessa Kennedy-Martin & Timothy Baker & Oliver Schein & Dennis A. Revicki

2002 Cost Effectiveness of Asthma Management Strategies
by Mike Thomas & John Haughney & David Price

2002 The Impact of Health Economics on Healthcare Delivery: A Health Economist's Perspective: A Primary Care Response
by David Kernick

2002 Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer
by Mike Aristides & Jack Chen & Mark Schulz & Eve Williamson & Stephen Clarke & Kaye Grant

2002 Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia
by Alexander H. Miners & Caroline A. Sabin & Keith H. Tolley & Christine A. Lee

2002 Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria
by Xavier Badia & Fermin Mearin & Agustin Balboa & Eva Baro & Ellen Caldwell & Mercedes Cucala & Manuel Diaz-Rubio & Arturo Fueyo & Julio Ponce & Mentse Roset & Nicholas J. Talley

2002 Valuation of Symptomatic Hepatitis A in Adults: Estimates Based on Time Trade-Off and Willingness-To-Pay Measurement
by R Jake Jacobs & Ronald J. Moleski & Allen S. Meyerhoff

2002 Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death
by Marian A. Spath & Bernie J. O'Brien

2002 Prospective Study Designs in Outcomes Research: The Case of Migraine
by Elizabeth A. Rothermich & Meryl I. Brod & Warren H. Schonfeld & Clayton R. Rowland & Baltazar Gomez-Mancilla

2002 Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation
by Melissa Young & Greg L. Plosker

2002 Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK: A Comparison of Collection Methods of Resource Use Data
by Bo Standaert & Janet Goldstone & Z. John Lu & Moshe Haim Erder & John Liu Yin

2002 The Cost Effectiveness of Chlorofluorocarbon-Free Beclomethasone Dipropionate in the Treatment of Chronic Asthma: A Cost Model Based on a 1-Year Pragmatic, Randomised Clinical Study
by David Price & John Haughney & Martin Duerden & Charles Nicholls & Charlotte Moseley

2002 Cost of Illness of Crohn's Disease
by Keith Bodger

2002 Disease Management Update
by Adis International Limited

2002 Cost-Benefit Analysis of Vaccination Against Influenza of Employees from an Academic Medical Centre
by Wilma Parlevliet & Corianne de Borgie & Gerard Frijstein & Henk-Jan Guchelaar

2002 An Independent Practice Association-Supported Disease Management Program: Impact on Patients with Coronary Artery Disease
by Miriam Cannon-Wagner & Diane S. Soule & David R. Walker & Richard P. Vance

2002 The Influence of Socioeconomic and Psychological Factors on Patient Adherence to Self-Management Strategies: Lessons Learned in Asthma
by John Kolbe

2002 Disease Management and the Application of Privacy Guidelines
by Marybeth Regan

2002 Pulmonary Rehabilitation Programs: Outcomes in Patients with Chronic Obstructive Pulmonary Disease
by Nicolino Ambrosino

2002 National Service Framework for Older People: Will Access to Health Services for Elderly Patients Improve?
by Sumeet Chadha & John Young

2002 Disease Management Update
by Adis International Limited

2002 Prevalence and Management of Anemia Among Patients with Chronic Kidney Disease in a Health Maintenance Organization
by Annamaria T. Kausz & Earl P. Steinberg & Allen R. Nissenson & Brian J.G. Pereira

2002 Methods Aimed at Improving Asthma Care and Outcomes Management: A Case Study
by Felicia C. Allen-Ramey & Gregory B. Diette & Robert C. McDonald & Elizabeth A. Skinner & Donald M. Steinwachs & Albert W. Wu

2002 Migraine Prophylaxis in Managed Care Organizations: Unclear Role in Disease Management Programs
by Jennifer H. Lofland & Purna K. Lakhia

2002 Supporting Patient Care by Using Innovative Information Technology: A Case Study from Clinical Psychiatry
by Elske Ammenwerth & Frauke Ehlers & Ulrike Kutscha & Ansgar Kutscha & Ronald Eichstadter & Franz Resch

2002 Building the Outcomes-Based Formulary
by Brian T. Sweet & Marcus D. Wilson & William J. Waugh & Andrea D. Hess & Joshua J. Spooner

2002 Managed Drug Use in Assisted Living and Home Care Settings: Who Benefits?
by Stephen M. Setter & David Alexander Sclar & Brian J. Gates

2002 Disease Management Programs: The Second Generation
by Paul S. Shelton

2002 Disease Management Update
by Adis International Limited

2002 Management of Erectile Dysfunction: Defining the Role of Sildenafil
by Katherine A. Lyseng-Williamson & Antona J. Wagstaff

2002 The Role of Different Types of Health Insurance on Access and Utilization of Antihypertensive Drugs: An Empirical Study in a US Hypertensive Population
by Christine Huttin

2002 Community Mental Health Services for Individuals with Intellectual Disabilities: Issues and Approaches to Optimizing Outcomes
by Angela Hassiotis

2002 Preventing Relapse of Psychotic Illness: Role of Self-Monitoring of Prodromal Symptoms
by Lisa Hewitt & Max Birchwood

2002 Disease Management Update
by Adis International Limited

2002 Management of Type 2 Diabetes Mellitus: Defining the Role of Nateglinide
by Christopher I. Carswell & Christine R. Culy & Caroline M. Perry

2002 A Formulary Analysis of Angiotensin II Antagonists in a UK Teaching Hospital
by Andrew P. Moore & Nigel M. Wheeldon & Mike Jennings

2002 Models of Palliative Care Service Delivery: What is Most Cost Effective?
by Nick Bosanquet

2002 Lymphedema After Surgery for Cancer: The Role of Patient Support Groups in Patient Therapy
by Stanley G. Rockson

2002 Health Promotion for Individuals with Disabilities: The Need for a Transitional Model in Service Delivery
by James H. Rimmer

2002 Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
by Alan Chock & Vera Gong & Christopher J. Destache

2002 Disease Management Update
by Adis International Limited

2002 Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon-beta-1a (Rebif(R)) Use of a tradename is for product identification purposes only, and does not imply endorsement
by Katherine A. Lyseng-Williamson & Greg L. Plosker

2002 New Trends in Patient Monitoring
by Senen Barro & Jesus Presedo & Paulo Felix & Daniel Castro & Jose Antonio Vila

2002 Integration of Case and Disease Management: Why and How?
by Margaret A. Radzwill

2002 Telemedicine, Outcomes and Policy Decisions
by Arto Ohinmaa & David Hailey

2002 Disease Management Update
by Adis International Limited

2002 Spotlight on Paclitaxel in Ovarian Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (12): 1227-1259
by Melissa Young & Greg L. Plosker

2002 Excess Healthcare Costs Associated with Excess Health Risks in Diseased and Non-Diseased Health Risk Appraisal Participants
by Shirley Musich & Timothy McDonald & David Hirschland & Dee W. Edington

2002 Standardized Telephonic Case Management in a Hispanic Heart Failure Population: An Effective Intervention
by Barbara Riegel & Beverly Carlson & Dale Glaser & Zoe Kopp & Tomas E. Romero

2002 The Potential Impact of Measuring Healthcare Quality on Pharmaceutical-Related Costs and Outcomes
by William L. Roper & R. Tamara Hodlewsky & Hugh Tilson & Kathleen N. Lohr & William H. Campbell

2002 The Emerging Role of the Consumer in Pharmaceutical Pricing Decisions
by Elinor C. Chumney & Kit N. Simpson

2002 Pharmacy Benefit Managers' Role in Facilitating Medicare Beneficiary Access to Pharmaceutical Care
by Joshua Cohen & Jennifer Chee

2002 Risks and Benefits of the Use of Capitation Formulae in Primary Care
by Azeem Majeed

2002 Pharmaceutical Company Websites as Sources of Information for Consumers: How Appropriate and Informative Are They?
by Kathleen M. Griffiths & Helen Christensen & Kimberley Evans

2002 Disease Management Update
by Adis International Limited

2002 Piperacillin/Tazobactam in Moderate to Severe Bacterial Infections The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1135-1175
by Melissa Young & Greg L. Plosker

2002 Use of the Internet by Patients with Chronic Illness
by Richard W. Millard & Patricia A. Fintak

2002 Employer Role in Integrative Workplace Health Management: A New Model in Progress
by Cordia Chu & Sophie Dwyer

2002 Development of a Migraine Disease Management Initiative in a Managed Care Plan
by Glen D. Solomon & Henry X. Hu & Rick Simmons & Kathleen Conboy & Rob Jeddeloh & Marie Eastburn

2002 The Fifth Vital Sign: Cornerstone of a New Pain Management Strategy
by Hildegarde J. Berdine

2002 Utilizing an Intranet in Disease Management
by Marybeth Regan

2002 Role of Family Physicians in Implementing Asthma Self-Management Programs
by Bart P.A. Thoonen & Chris van Weel

2002 Outcomes Associated with a Disease Management Program for End-Stage Renal Disease
by Allen R. Nissenson

2002 Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection
by Alissa Scalera & Ahmed M. Bayoumi & Paul Oh & Nancy Risebrough & Neil Shear & Alice Lin-in Tseng

2002 Integrating Healthcare Standards and Performance Measurement
by Richard G. Koss & Linda S. Hanold & Jerod M. Loeb

2002 Effective Utilization of Pharmacoeconomics for Decision Makers
by Judith D. Bentkover & Ron Corey

2002 Disease Management Update
by Adis International Limited

2002 Spotlight on Paclitaxel in Non-Small Cell Lung Cancer The full text of this article was published in PharmacoEconomics 2001; 19 (11): 1111-1134
by Greg L. Plosker & Miriam Hurst

2002 The Development of a Tool to Assess Quality of Cost Estimates
by Philip Jacobs & Greg Finlayson & Ben Faienza & Murray Brown & Betty Newson & Nadine MacLean

2002 Role of Parent Training in the Effective Management of Attention-Deficit/Hyperactivity Disorder
by Thomas J. Power & Heather F. Russell & Stephen L. Soffer & Jessica Blom-Hoffman & Suzanne M. Grim

2002 Practical Considerations for the Design and Evaluation of Disease Education and Management Programs in the Workplace
by Seth Serxner & David Anderson

2002 Worksite Health Promotion: A Critical Investment
by Bruce Sherman

2002 An HMO-Sponsored Primary Care-Based Disease Management and Case Management Initiative: Economic and Selected Clinical Outcomes
by Jaan Sidorov & Franz Joseph Fisher & Sabrina Girolami & Otto Wolke

2002 Disease Management Update: From the World Literature
by Adis International Limited

2002 Management of Acute Bacterial Exacerbations of Chronic Bronchitis: Defining the Role of Moxifloxacin
by Harinder S. Malhotra & Caroline M. Perry & Douglas Ormrod

2002 Management of Alzheimer's Disease: Defining the Role of Donepezil
by Tim Ibbotson & Karen L. Goa

2002 Management of Rheumatoid Arthritis: Defining the Role of Etanercept
by Gillian M. Keating & Blair Jarvis

2002 Improved Diabetes Control Through a Provider-Based Disease Management Program
by Rose Maljanian & Neil Grey & Ilene Staff & Marisol Cruz-Marino-Aponte

2002 Disease Management Update
by Adis International Limited

2002 Spotlight on Mycophenolate Mofetil in Solid Organ Transplantation This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (10): 675-713
by Melissa Young & Greg L. Plosker

2002 Strategies for Pharmacists in the Implementation of Diabetes Mellitus Management Programs: New Roles in Primary and Collaborative Care
by Gloria J. Nichols-English & Melanie Provost & Dayin Koompalum & Hua Chen & Masood Athar

2002 Rural Psychiatry: Special Issues and Models of Service Delivery
by Fiona Judd & Caitlin Fraser & Margaret Grigg & Joseph Scopelliti & Gene Hodgins & Adrian Donoghue & John Humphreys

2002 On the Evaluation of Drug Benefits Policy Changes with Longitudinal Claims Data: Concepts of Income-Based Deductibles and Issues Related to Causal Inference
by Sebastian Schneeweiss & Malcolm Maclure & Colin Dormuth

2002 Point of Care Testing: Potential for Tracking Disease Management Outcomes
by Christopher P. Price

2002 Clinical Guidelines in Disease Management
by Albert I. Wertheimer & Nicole M. Chaney

2002 Disease Management Update
by Adis International Limited

2002 An Empirical Model for the Development of Disease Management Programs in General Practice: A Case Study Using Hypertension
by Deborah A. Turnbull & Helen Mensforth & Justin J. Beilby & John E. Marley & Farooq Qureshi & Anne L. Tonkin

2002 Patients Diagnosed with Irritable Bowel Syndrome: Medical Record Validation of a Claims-Based Identification Algorithm
by Antonio P. Legorreta & Jean-Francois Ricci & Mike Markowitz & Priti Jhingran

2002 The Relationship of Diabetes Mellitus Performance Indicators with Self-Reported Health and Patient Satisfaction
by David P. Nau & Ritesh N. Kumar

2002 Guidelines and Care Management Issues for People with Alzheimer's Disease and Other Dementias
by Katie Maslow & John Selstad & Susan J. Denman

2002 The Effects of the Internet on Pharmaceutical Consumers and Providers
by Francois M.H.M. Dupuits

2002 Telemedicine Screening for Diabetic Retinopathy: Improving Patient Access to Care
by Kanagasingam Yogesan & Ian J. Constable & Ian Chan

2002 Disease Management Update
by Adis International Limited

2002 Management of Parkinson's Disease: Defining the Role of Entacapone
by Tim Ibbotson & Karen L. Goa

2002 Improving Patient Outcomes with Tools for Asthma Self-Monitoring: A Review of the Literature
by Timothy R. Myers

2002 A Complex System Perspective on Medication Compliance: Information for Healthcare Providers
by Simon Rietveld & Jos M. Koomen

2002 Evaluating Disease Management Programs
by David R. Walker & Byron K. McKinney & Miriam Cannon-Wagner & Richard P. Vance

2002 The Developing Role of Pharmacists in Patient Access to Emergency Contraception
by Judith A. Soon & Marc Levine & Mary H.H. Ensom & Jacqueline S. Gardner & Hilary M. Edmondson & David W. Fielding

2002 Optimal facility placement and discriminatory congestion pricing in neighborhoods with different time costs
by H. Shelton Brown

2002 Aplicación de la Programación Compromiso a la gestión de listas de espera quirúrgicas de un hospital público
by MAR ARENAS PARRA & AMELIA BILBAO TEROL & BLANCA PÉREZ GLADISH & Mª VICTORIA RODRÍGUEZ URÍA

2002 Freiwillige Versicherung in einer mit Pauschalbeiträgen finanzierten GKV: Ein Kommentar zu einem Vorschlag des Sachverständigenrats
by Matthias Wrede

2002 Choosing Health Insurance in a Dual Health Care System: The Chilean Case
by Ricardo Sanhueza & Jaime Ruiz-Tagle

2002 L'assurabilité de la dépendance et sa prise en charge par le secteur privé. Une mise en perspective internationale
by Laurence Assous & Ronan Mahieu

2001 Cost Sharing in Health Service Provision: An Empirical Assessment of Cost Savings
by Chalkley, M. & Malcomson, J.M.

2001 The Canadian Health Care System: Lessons for Malaysia
by Wilson, L.S.

2001 The Impact of Public Testing for Human Immunodiciency Virus
by Boozer, M.A. Philipson, T.J.

2001 Parallel Imports of Pharmaceutical Products in the European Union
by Granslandt, M. & Maskus, K.E.

2001 The World Trade Organization and Publicly Funded Healthcare in Canada
by Ostry, A.

2001 Heare, There and All Over the Place: Defining and Measuring Continuity of Health Care
by Haggerty, J. & Reid, R. & McGrail, K.M. & McKendry, R.

2001 Pricing Life: Why It's Time for Health Care Rationing
by Peter A. Ubel, M. D.

2001 Ökonomische Analyse der Arzt-Patient-Beziehung: Theoretische Modellierung und empirische Ergebnisse
by Schneider, Udo

2001 Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catheterization
by Farasat A.S. Bokhari

2001 Das Konzept einer nachhaltigen Finanzpolitik aus heterodoxer Sicht - ein Diskussionsbeitrag
by Arne Heise

2001 Testing the descriptive performance of the rank-dependent utility in the domain of health profiles
by José Mª Abellán & José Luis Pinto

2001 Quality safeguards and regulation of online pharmacies
by Benito Arruñada

2001 Testing the descriptive performance of the rank-dependent utility in the domain of health profiles
by José Mª Abellán & José Luis Pinto

2001 Cost Sharing in Health Service Provision: An Empirical Assessment of Cost Savings
by James Malcomson & Martin Chalkley

2001 Payer Type and the Returns to Bypass Surgery: Evidence from Hospital Entry Behavior
by Michael Chernew & Gautam Gowrisankaran & A. Mark Fendrick

2001 Area Differences in Utilization of Medical Care and Mortality Among U.S. Elderly
by Victor R. Fuchs & Mark McClellan & Jonathan Skinner

2001 Hospitals, Managed Care, and the Charity Caseload in California
by Janet Currie & John Fahr

2001 Learning and the Value of Information: Evidence From Health Plan Report Cards
by Michael Chernew & Gautam Gowrisankaran & Dennis P. Scanlon

2001 Incentives in HMOs
by Martin Gaynor & James B. Rebitzer & Lowell J. Taylor

2001 Tax Credits, the Distribution of Subsidized Health Insurance Premiums, and the Uninsured
by Mark V. Pauly & Bradley Herring & David Song

2001 Measuring the Relative Performance of Providers of a Health Service
by Daniel A. Ackerberg & Matilde P. Machado & Michael H. Riordan

2001 Exploring the Effects of Population Change on the Costs of Physician Services
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2001 Exploring the Effects of Population Change on the Costs of Physician Services
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2001 Health Care Reform and the Number of Doctor Visits - An Econometric Analysis
by Winkelmann, Rainer

2001 Health Care Reform and the Number of Doctor Visits - An Econometric Analysis
by Winkelmann, Rainer

2001 Self Selection and Moral Hazard in Chilean Health Insurance
by Claudio Sapelli & Bernardita Vial

2001 Parallel Imports of Pharmaceutical Products in the European Union
by Ganslandt, Mattias & Maskus, Keith E.

2001 The Impact of Physician Preferences and Patient Habits on the Diffusion of New Drugs
by Johannesson, Magnus & Lundin, Douglas

2001 It's what's expected: genetic testing for inherited conditions, CHERE Discussion Paper No 46
by Marion Haas & Jane Hall & Richard De Abreu Lourenco

2001 The public view of private health insurance, CHERE Discussion Paper No 45
by Jane Hall

2001 Health insurance and health care utilization: Theory and evidence from Australia 1989-90, CHERE Discussion Paper No 44
by Elizabeth Savage

2001 Kassenwechsel in der gesetzlichen Krankenversicherung: welche Rolle spielt der Beitragssatz?
by Johannes Schwarze & Hanfried H. Andersen

2001 Wettbewerb aller Krankenversicherungen kann Qualität verbessern und Kosten des Gesundheitswesens senken
by Wolfgang Buchholz & Birgit Edener & Markus Grabka & Klaus-Dirk Henke & Monika Huber & Hermann Ribhegge & Andreas Ryll & Hans-Jürgen Wagener & Gert G. Wagner

2001 Optionen der Weiterentwicklung des Risikostrukturausgleichs in der GKV
by Friedrich Breyer & Mathias Kifmann

2001 The Demand for Physician Services. Evidence from a Natural Experiment
by Bart COCKX & Carine BRASSEUR

2001 Health Care Reform and the Number of Doctor Visits - An Econometric Analysis
by Winkelmann, Rainer

2001 Games of Capacity Manipulation in Hospital-Intern Markets
by Hideo Konishi & M. Utku Unver

2001 Moral Hazard, Insurance, and Some Collusion
by Ingela Alger & Ching-to Albert Ma

2001 The Political Economy of Health Care Reforms
by

2001 A Multinational Study to Measure the Value that Patients with Cancer Place on Improved Emesis Control Following Cisplatin Chemotherapy
by George Dranitsaris & Pauline Leung & Renoto Ciotti & Ana Ortega & Maria Spinthouri & Lycurgus Liaropoulos & Roberto Labianca & Antonello Quadri

2001 The Cost of Palliative Care for Hepatocellular Carcinoma in Hong Kong
by Anthony T.C. Chan & Philip Jacobs & Winnie Yeo & Maria Lai & Clarke B. Hazlett & Tony S.K. Mok & Thomas W.T. Leung & Wan Y. Lau & Philip J. Johnson

2001 The Economics of HIV Vaccines: Projecting the Impact of HIV Vaccination of Infants in Sub-Saharan Africa
by Jasper M. Bos & Maarten J. Postma

2001 Cost-Utility Analysis of Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke: A Canadian Healthcare Perspective
by Shannon E. Sinclair & Luciana Frighetto & Peter S. Loewen & Rubina Sunderji & Philip Teal & Susan C. Fagan & Carlo A. Marra

2001 Different Approaches To Valuing the Lost Productivity of Patients with Migraine
by Jennifer H. Lofland & Julie C. Locklear & Kevin D. Frick

2001 Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden: Analysis Using Data from the Cardiac Insufficiency Bisoprolol Study II Trial
by Mattias Ekman & Niklas Zethraeus & Bengt Jonsson

2001 Impact of Allergic Rhinitis Treatment on Quality of Life
by Anju Tripathi & Roy Patterson

2001 Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan
by Takuro Shimbo & Kenji Hira & Manabu Takemura & Tsuguya Fukui

2001 Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma
by Rogelio Menendez & Richard H. Stanford & Lisa Edwards & Christopher Kalberg & Kathleen Rickard

2001 Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer
by Sabrina Trippoli & Monica Vaiani & Carlo Lucioni & Andrea Messori

2001 Incremental Cost Analysis of Ambulatory Clinic and Home-Based Intravenous Therapy for Patients with Multiple Myeloma
by Peter C. Coyte & Mark J. Dobrow & Larry Broadfield

2001 Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC(R)) Use of tradenames is for product identification only and does not imply endorsement. for Helicobacter pylori Eradication
by Karen Agro & Gordon Blackhouse & Ron Goeree & Andrew R. Willan & Jia-Qing Huang & Richard H. Hunt & Bernie J. O'Brien

2001 The Cost Effectiveness of Stratified Care in the Management of Migraine
by Paul Williams & Andrew J. Dowson & Alan M. Rapoport & James Sawyer

2001 A Review of the Direct Costs of Rheumatoid Arthritis: Managed Care versus Fee-for-Service Settings
by Deborah P. Lubeck

2001 The Impact of Health Economics on Healthcare Delivery: The Health Economists' Perspective
by Ruth McDonald & Alan Haycox & Tom Walley

2001 Pharmacoeconomic Fellowships: The Need for Outcome Measures
by Vittorio Maio & Tammy K. Girts & Jennifer H. Lofland & David B. Nash

2001 Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs
by Francesc Peris & Eduard Martinez & Xavier Badia & Max Brosa

2001 Cost Effectiveness of Becaplermin in the Treatment of Diabetic Foot Ulcers in Four European Countries
by Ola Ghatnekar & Ulf Persson & Michael Willis & Knut Odegaard

2001 Emerging Role of Pharmacoeconomics in the Research and Development Decision-Making Process
by Joseph A. Dimasi & Erol Caglarcan & Maria Wood-Armany

2001 Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson's Disease
by Linda M. Rubenstein & Andrea DeLeo & Elizabeth A. Chrischilles

2001 A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
by Sherine E. Gabriel & Douglas Coyle & Larry W. Moreland

2001 Highly Active Antiretroviral Therapy: Pharmacoeconomic Issues in the Management of HIV Infection
by Pedram Sendi & Andrew J. Palmer & Amiram Gafni & Manuel Battegay

2001 Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure
by Melissa Young & Greg L. Plosker

2001 International Validation of the CLAU-S Quality-of-Life Questionnaire for Use in Patients with Intermittent Claudication
by Patrick Marquis & Sylvie Comte & Philippe Lehert

2001 An Epidemiological Approach to Assess the Economic Burden of NSAID-Induced Gastrointestinal Events in The Netherlands
by Ronald M.C. Herings & Olaf H. Klungel

2001 Quality of Life in Irritable Bowel Syndrome
by Richard Lea & Peter J. Whorwell

2001 An Economic Overview of Chronic Obstructive Pulmonary Disease
by Hirsch S. Ruchlin & Erik J. Dasbach

2001 Developing Guidance for Budget Impact Analysis
by Paul Trueman & Michael Drummond & John Hutton

2001 The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
by Leona Hakkaart-van Roijen & Paul Verboom & W. Ken Redekop & Karien R. Touw & Frans F.H. Rutten

2001 Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery
by Lars-Ake Levin & David Bergqvist

2001 Gastrointestinal-Related Healthcare Resource Usage Associated with a Fixed Combination of Diclofenac and Misoprostol versus Other NSAIDs
by Elham Rahme & Lawrence Joseph & Sheldon X. Kong & Douglas J. Watson & James M. Pellissier & Jacques LeLorier

2001 Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women: Use of Cochrane Collaboration Methods for Meta-Analysis Within Economic Evaluation
by Douglas Coyle & Ann Cranney & Karen M. Lee & Vivian Welch & Peter Tugwell

2001 Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada
by Michael Iskedjian & Thomas R. Einarson & Bernie J. O'Brien & J. Gaston De Serres & Ron Gold & Ian M. Gemmill & Natalie Milkovich & Andrew Rosner

2001 Economic Evaluation of Systemic Treatments for Cytomegalovirus Retinitis in Patients with AIDS
by Todd A. Lee & Sean D. Sullivan & David L. Veenstra & Scott D. Ramsey & Patrick J.K. Steger & Raffaele Malinverni & Andreas M. Pleil & Todd Williamson

2001 Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients
by Petra J. van Enckevort & Jan H. Zwaveling & Jan T. Bottema & John K. Maring & Ids J. Klompmaker & Maarten J.H. Slooff & Elisabeth M. Ten Vergert

2001 The Cost of Inadequate Prescriptions for Hypolipidaemic Drugs
by Luisa Cabello Ballesteros & M. Isabel Fernandez San Martin & Teresa Sanz Cuesta & Esperanza Escortell Mayor & Carmen Lopez Bilbao

2001 Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance
by Peter K. Schadlich & Josef Georg Brecht & Massimo Brunetti & Eva Pagano & Badrudin Rangoonwala & Eduard Huppertz

2001 The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
by Charles E. Begley & John F. Annegers & Alan C. Swann & Christopher Lewis & Sharon Coan & William B. Schnapp & Lynda Bryant-Comstock

2001 Cost Considerations in the Use of Anaesthetic Drugs
by Ian Smith

2001 Hip Fracture Prevention: Cost-Effective Strategies
by Peter Vestergaard & Lars Rejnmark & Leif Mosekilde

2001 Lifestyle Drugs: Determining Their Value and Who Should Pay
by Devora Mitrany

2001 Efavirenz: A Pharmacoeconomic Review of its Use in HIV Infection
by Greg L. Plosker & Caroline M. Perry & Karen L. Goa

2001 Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction: Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial
by Maria Grazia Franzosi & Massimo Brunetti & Roberto Marchioli & Rosa Maria Marfisi & Gianni Tognoni & Franco Valagussa

2001 Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis: An Analysis Based on Results from the L.I.ON. Study
by Ronald Jansen & W. Ken Redekop & Frans F.H. Rutten

2001 Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines
by M. Rhona M.T. Limcangco & Carol L. Armour & Eugene G. Salole & Susan J. Taylor

2001 The Cost of Treatment of Alzheimer's Disease in The Netherlands: A Regression-Based Simulation Model
by Joseph McDonnell & W. Ken Redekop & Nicole van der Roer & Elles Goes & Annemieke Ruitenberg & Jan J.V. Busschbach & Monique M.B. Breteler & Frans F.H. Rutten

2001 Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements
by Alan Woodfield

2001 Symptom and Health-Related Quality-of-Life Measures for Use in Selected Gastrointestinal Disease Studies: A Review and Synthesis of the Literature
by Anne M. Rentz & Carmelina Battista & Elyse Trudeau & Robert Jones & Patricia Robinson & Sheldon Sloan & Sonika Mathur & Lori Frank & Dennis A. Revicki

2001 Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
by Ettore Ambrosioni

2001 On Individual Preferences and Aggregation in Economic Evaluation in Healthcare
by Bengt Liljas & Bjorn Lindgren

2001 Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease
by Harriet M. Lamb & Karen L. Goa

2001 Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
by Adrian D. Griffin & Andrew S. Perry & Douglas M. Fleming

2001 Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel
by Gabriel Chodick & Yehuda Lerman & Tamar Peled & Hava Aloni & Shai Ashkenazi

2001 Cost of Treatment for Onychomycosis: Data from a 9-Month Observational Study
by David M. Stier & Curt Henke & Jeff Schein & Joe Doyle & Warren H. Schonfeld & Jeanette Broering

2001 Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
by Carlos Gouveia Pinto & Antoine Lafuma & Francis Fagnani & Mark J.C. Nuijten & Gilles Berdeaux

2001 Economic Burden of Chronic Obstructive Pulmonary Disease: Impact of New Treatment Options
by Mitchell Friedman & Daniel E. Hilleman

2001 Workplace Productivity: A Review of the Impact of Migraine and its Treatment
by Paul Stang & Roger Cady & Alice Batenhorst & Lynn Hoffman

2001 Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies
by Peter Cram & Susan G. Blitz & Arnold Monto & A. Mark Fendrick

2001 Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands
by Maarten J. Postma & Marielouise A. Heijnen & Johannes C. Jager

2001 Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making
by Bernard S. Bloom & Douglas J. Bruno & Daniel Y. Maman & Ravi Jayadevappa

2001 The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss
by William C. Gerth & George W. Carides & Erik J. Dasbach & W. Hester Visser & Nancy C. Santanello

2001 Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval
by Giovanni Apolone & Gianfranco De Carli & Massimo Brunetti & Silvio Garattini

2001 A Review of Health-Related Quality-of-Life Measures in Stroke
by Beatrice A. Golomb & Barbara G. Vickrey & Ron D. Hays

2001 Changing Therapeutic Regimens in Benign Prostatic Hyperplasia: Clinical and Economic Considerations
by Herman J. Stoevelaar & Joseph McDonnell

2001 Quality-of-Life Assessment in Comparative Therapeutic Trials and Causal Structure Considerations in Peripheral Occlusive Arterial Disease
by Philippe Lehert

2001 Direct-to-Consumer Promotion of Prescription Drugs: Economic Implications for Patients, Payers and Providers
by Steven D. Findlay

2001 Economic Analysis of Initial HIV Treatment: Efavirenz- versus Indinavir-Containing Triple Therapy
by J. Jaime Caro & Judith A. O'Brien & Kristen Migliaccio-Walle & Gabriel Raggio

2001 Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection
by Eva Susanne Dietrich & Bjorn Schubert & Winfried Ebner & Franz Daschner

2001 A General Model of the Effects of Sleep Medications on the Risk and Cost of Motor Vehicle Accidents and its Application to France
by Joseph Menzin & Kathleen M. Lang & Pierre Levy & Emile Levy

2001 Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis
by Ermanno Attanasio & Pierluigi Russo & Gabriella Carunchio & Luciano Caprino

2001 Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications
by William B. Hillegass & Anne R. Newman & Dominic L. Raco

2001 Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies
by T.V. Parasuraman & Kathleen Frenia & Jose Romero

2001 The Cost of HIV Treatment and Care: A Global Review
by Eduard J. Beck & Alec H. Miners & Keith Tolley

2001 Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer
by Melissa Young & Greg L. Plosker

2001 Direct Costs of Schizophrenia in Italian Community Psychiatric Services
by Livio Garattini & Carlotta Rossi & Fabrizio Tediosi & Cesare Cornaggia & Giampiero Covelli & Corrado Barbui & Fabio Parazzini

2001 Economic Evaluation of Collagenase-Containing Ointment and Hydrocolloid Dressing in the Treatment of Pressure Ulcers
by Elvira Muller & Martin W.F. van Leen & Rito Bergemann

2001 Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS
by John H. Kempen & Kevin D. Frick & Douglas A. Jabs

2001 Accounting for Noncompliance in Pharmacoeconomic Evaluations
by Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley

2001 Piperacillin/Tazobactam: A Pharmacoeconomic Review of its Use in Moderate to Severe Bacterial Infections
by Melissa Young & Greg L. Plosker

2001 Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer
by Greg L. Plosker & Miriam Hurst

2001 Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996)
by Bethan George & Anthony Harris & Andrew Mitchell

2001 Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK
by Ruth E. Brown & John Hutton & Anita Burrell

2001 Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia: Effects of Various Interventions
by Jose-Emilio Batista-Miranda & Marta De la Cruz Diez & Pedro Arano Bertran & Humberto Villavicencio

2001 Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?
by Dyfrig A. Hughes & Tom Walley

2001 Which Antifungal Agent for Onychomycosis?: A Pharmacoeconomic Analysis
by Vijay N. Joish & Edward P. Armstrong

2001 Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls
by Paula L. Hensley & H. George Nurnberg

2001 A Cost-Cost Study Comparing Etanercept with Infliximab in Rheumatoid Arthritis
by Mark J.C. Nuijten & Peter Engelfriet & Klaas Duijn & George Bruijn & David Wierz & Marc Koopmanschap

2001 Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis: Ontario Ministry of Health Perspective
by John K. Marshall & James M. Pellissier & Cheryl L. Attard & Sheldon X. Kong & Michael A. Marentette

2001 Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson's Disease: Impact of Motor Fluctuations and Dyskinesias
by Richard C. Dodel & Karin Berger & Wolfgang H. Oertel

2001 Barrett's Oesophagus: A Review of Costs of the Illness
by Miguel R. Arguedas & Mohamad A. Eloubeidi

2001 This Month's News
by Adis International Limited

2001 Combining Utility Measurements: Exploring Different Approaches
by Denise E. Bonds & Kenneth A. Freedberg

2001 Management of Pharmaceutical Resources for the Primary Prevention of Coronary Heart Disease in Catalonia (Spain) Based on Efficiency and Equity
by Pedro Plans-Rubio

2001 Measuring and Managing Health Outcomes and Quality of Care in End-Stage Renal Disease
by Kraig S. Kinchen & Neil R. Powe

2001 Improving Quality of Life for Patients with Angina Pectoris: A Team Approach to Disease Management
by Margaret E. Cupples & Martin Dempster

2001 Improving the Use of Data Sources in Disease Management Programs
by Jacob Abarca & Edward P. Armstrong

2001 This Month's News
by Adis International Limited

2001 Healthcare Reform and Disease Management in Italy: Promoting the Effectiveness and Appropriateness of Health Service Use
by Roberto Grilli & Andrea Donatini & Francesco Taroni

2001 Disease Management Programs for Hepatitis C: A Team Approach to Setting Goals
by Raymond S. Koff

2001 Effective Employer-Vendor Partnerships: Encouraging Positive Disruptive Innovations in Healthcare
by Julie A. Meek & Vince Kuraitis

2001 Patient-Centered Healthcare: The Role of the Internet
by Dixie B. Baker

2001 This Month's News
by Adis International Limited

2001 Management of Advanced Breast Cancer: Defining the Role of Anastrozole
by Gillian M. Keating & Karen L. Goa

2001 Hepatitis C Screening and Treatment versus Liver Transplantation: A Financial Option Appraisal and Commissioning Model for Purchasers
by Nevil Batra

2001 Implementation of Guidelines for Diagnosing and Treating Hypertension
by Finlay A. McAlister & Raj Padwal

2001 Disability Prevention: New Paradigm for the Management of Occupational Back Pain
by Patrick Loisel & Marie-Jose Durand & Diane Berthelette & Nicole Vezina & Raymond Baril & Denis Gagnon & Christian Lariviere & Claude Tremblay

2001 This Month's News
by Adis International Limited

2001 Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Shared Care Versus Secondary Outpatient Care in The Netherlands
by Raymond C.W. Hutubessy & Hindrik Vondeling & Jeroen J.J. de Sonnaville & Louisa P. Colly & Jan L..J. Smit & Robert J. Heine

2001 Improved Bone Health Behavior Using Community Pharmacists as Educators: The Geisinger Health System Community Pharmacist Osteoporosis Education Program
by Eric D. Newman & Philip Hanus

2001 Early Recognition and Intervention: The Key to Success in the Treatment of Schizophrenia?
by Jan Olav Johannessen

2001 Neonatal Care Management: An Integrated Approach
by Michael N. Musci & John J. Esslinger & Michael Kornhauser

2001 Sickle Cell Disease Screening Programs: Integration Into Managed Care
by Sally C. Davies & Lola Oni

2001 This Month's News
by Adis International Limited

2001 Management of Colorectal Cancer: Defining the Role of Raltitrexed
by Anna J. Matheson & Stuart Noble

2001 Analysis of Antidepressant Use Through Hierarchical Disease Analysis: Using a Managed Care Administrative Database
by Edward P. Armstrong

2001 The National Lung Health Education Program and Managed Care: The Importance of Early Identification and Intervention in Chronic Obstructive Pulmonary Disease
by Thomas L. Petty

2001 The Internet as a Resource for Consumer Healthcare
by Deborah Lewis & Kimberly Behana

2001 This Month's News
by Adis International Limited

2001 Management of Chronic Hepatitis B: Defining the Role of Lamivudine
by Blair Jarvis & Caroline M. Perry

2001 Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program: A Comparative Analysis of Utilisation and Expenditure
by Kenneth M. Shermock & M. Kay Sadik & Chris M. Kozma & Anne-Marie Sesti & C.E. Reeder

2001 The Role of the Patient in Maximizing Efficacy of Drug Therapy in Migraine
by William Pryse-Phillips

2001 Maximizing Treatment Outcome in Depression: Strategies to Overcome Social Stigma and Noncompliance
by Glen L. Stimmel

2001 This Month's News
by Adis International Limited

2001 Analysis of Asthma-Related Costs and Patterns of Resource Utilization in a Managed-Care Population
by Edward P. Armstrong & Kem Krueger & Paul C. Langley

2001 Assertive Community Treatment for People with Severe Mental Illness: Critical Ingredients and Impact on Patients
by Gary R. Bond & Robert E. Drake & Kim T. Mueser & Eric Latimer

2001 Utilizing and Integrating the Internet in Disease Management
by Marybeth Regan

2001 Managing Patients with Diabetes Mellitus and Mental Health Problems: Administrative and Clinical Challenges
by Barbara H. Warren & Cynthia K. Crews & Martina M. Schulte

2001 Role of the Workplace in Migraine Disease Management
by Leon J. Warshaw & Wayne N. Burton & William J. Schneider

2001 Behavioral Aspects of Arthritis and Rheumatic Disease Self-Management
by Julie J. Keysor & Shannon S. Currey & Leigh F. Callahan

2001 Training Issues in the Use of Inhalers
by Martin Duerden & David Price

2001 Pharmaceutical Restrictions: Possible Effect on Patient/Physician Buy-In of Disease Management Programs
by C. Daniel Mullins & Simu K. Thomas & David S. Roffman

2001 Community-Acquired Pneumonia and its Management: The Role of Levofloxacin
by Caroline M. Perry & Karen L. Goa

2001 Trends in the Rate of Self-Report and Diagnosis of Erectile Dysfunction in the United States 1990-1998: Was the Introduction of Sildenafil an Influencing Factor?
by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin

2001 Cost Effectiveness of Antibacterial Restriction Strategies in a Tertiary Care University Teaching Hospital
by Caterina Tsiata & Vassilis Tsekouras & Antonis Karokis & John Starakis & Harry P. Bassaris & Mihalis Maragoudakis & Athanasios T. Skoutelis

2001 Health Utility Attributes for Chronic Conditions
by Nicole Mittmann & Derek Chan & Kostas Trakas & Nancy Risebrough

2001 Data Warehousing Solutions and Internet Initiatives in the Disease Management Era: Important Issues to Consider
by Alejandro Jaramillo

2001 This Month's News
by Adis International Limited

2001 Management of Diabetes Mellitus: Defining the Role of Insulin Lispro Mix75/25 (Humalog(R) Mix75/25(TM))
by Christine R. Culy & Blair Jarvis

2001 Increased National Cholesterol Education Program (NCEP) Goal Attainment: Outcome Assessment of Department of Defense Conversion to Cerivastatin and Simvastatin
by Dennis Beaudoin & Emery Spaar & Susan Pitman Lowenthal & Karen C. Chung

2001 Primary Care Clinic-Based Chronic Disease Care: Features of Successful Programs
by Patrick J. O'Connor & JoAnn M. Sperl-Hillen & Nicolaas P. Pronk & Terry Murray

2001 Optimizing the Delivery of Effective Diabetes Care: An English Perspective
by Abdu Mohiddin & Martin Gulliford

2001 Health Plans and Disease Management: Threats and Opportunities
by Karen Ignagni

2001 This Month's News
by Adis International Limited

2001 Cost and Cost Effectiveness of Venous and Pressure Ulcer Protocols of Care
by Morris D. Kerstein & Eric Gemmen & Lia van Rijswijk & Courtney H. Lyder & Tania Phillips & George Xakellis & Katharine Golden & Catherine Harrington

2001 Unique Co-Operative Worksite-Based Osteoporosis Project: Employer, Healthcare Plan and Pharmaceutical Company Combine Efforts to Screen and Manage Women at Risk
by Larry K. Cantley & Cheryl Summers & David E. Rice

2001 Treatment Expectations in Hypertension: Implications for Patients Enrolled in Disease Management Programs
by Debbie Cohen & Raymond Townsend & Mark Miani & David Bernard

2001 A Fully Integrated Clinical Information System to Support Management of End-Stage Renal Disease: Design and Implementation
by William D. Mattern & Sue Scott

2001 The Role of Mental Health Patient Organizations in Disease Management: Focus on the US National Depressive and Manic-Depressive Association
by Lydia Lewis

2001 This Month's News
by Adis International Limited

2001 Chronic Obstructive Pulmonary Disease in a Managed-Care Setting
by Steven Kesten

2001 Technology-Based Disease Management: A Low-Cost, High-Value Solution for the Management of Chronic Disease
by Wally H. Gomaa & Thomas Morrow & Pieter Muntendam

2001 Comparing Smoking Cessation Interventions for Work-Site Disease Management
by Todd Greenwood

2001 Implementing Change: It's as Hard as it Looks
by Caren Heller & Ahsan Arozullah

2001 Work Productivity in Psychiatry: Trends in Interventions and Outcomes
by Pamela L. Moriearty & Eugene Oulvey & Karen Lee

2001 Specialty Pharmacies: Filling a Unique Position in the Disease Management Industry
by Thomas Morrow

2001 Broad Disease Management Interventions: Reducing Health Care Costs for Plan Members with Congestive Heart Failure
by Joel C. Hoffman

2001 articles: Information linkages in regional market networks with applications to healthcare markets
by Stephen F. Seninger

2001 Canada: Life beyond the Looking Glass
by John F. Helliwell

2000 Strategies for Success in Human Development
by Ranis, G. & Stewart, F.

2000 Strategies for Success in Human Development
by Ranis, G. & Stewart, F.

2000 Hospital Efficiency in Sub-Saharan Africa. Evidence from South Africa
by Zere, E.

2000 Waiting for Health Care in Canada: Problems and Prospects
by Barer, M.L. & Lewis, S.

2000 Age, Costs of Acute and Long-term Care and Proximity to Death: Evidence for 1987-88 and 1994-94 in Btitish Columbia
by McGrail, K. & Green, B. & Barer, M.L. & Evans, R.G. & Hertzman, C.

2000 Two Systems in Restaint: Contraccting Experiences with Cost Control in the 1990s
by Evans, R.G.

2000 Ending Waiting-List Mismanagement: Principles and Practice
by Lewis, S. & Barer, M.L. & Sanmartin, C. & Sheps, S. & Shortt, S.E.D.

2000 Waiting for Medical Services in Canda: Lots of Heat, but Little Light
by Sanmartin, C. & Shortt, E.D. & Barer, M.L. & Sheps, S. & Lewis, S. & McDonald, P.W.

2000 The Great Canadian Physician Exodus?
by Barer, M.L. & Webber, W.A.

2000 Setting Priorities for Waiting Lists: Defining Our Terms
by Hadorn, D.C.

2000 Setting Priorities for Waiting Lists: Defining Our Terms
by Hadorn, D.C.

2000 Hospital Downsizing and Trends in Health Care Use Among Elderly People in British Columbia
by Sheps, S.B. & Reid, R.J. & Barer, M.L. & Krueger, H. & McGrail, K.M. & Green, B. & Evans, R.G. & Hertzman, C.

2000 Where are all the Physicans? Private vs. Public Health Care
by Brekke, K.R. & Sorgard, L.

2000 Hospital Reimbursement in an Oligopolistic Industry
by Brekke, K.R.

2000 Dépenses de santé : l'hypothèse d'aléa moral
by Geoffard, P.-Y.

2000 Diagnosis Related Group Costs in a Regulated Environment: A Note About Their Economic Interpretation
by Berdeaux, Gilles & Le Pen, Claude

2000 African Traditional Healers and Outcome-Contingent Contracts in Health Care
by Leonard, K.L.

2000 How To Compensate Physicians When Both Patient and Physician Effort Are Unobservable
by Leonard, K.L. & Zivin, J.

2000 Health Care Expenditure across OECD Countries: A Public Choice Approach
by Levaggi, Rossella

2000 The determinants of health care expenditure: Testing pooling restrictions in small samples
by Herwartz, Helmut & Theilen, Bernd

2000 ¿Es posible reducir el gasto sanitario a través del subsidio a los seguros sanitarios privados? La doble cobertura sanitaria en Catalunya. Estimación de patrones de utilización de servicios sanitarios y simulación de costes asociados a la asistencia
by Ángel López Nicolás & Jaume Garcia Villar & Guillem López & Jaume Puig

2000 ¿Es posible reducir el gasto sanitario a través del subsidio a los seguros sanitarios privados? La doble cobertura sanitaria en Catalunya. Estimación de patrones de utilización de servicios sanitarios y simulación de costes asociados a la asistencia
by Ángel López Nicolás & Jaume Garcia Villar & Guillem López & Jaume Puig

2000 Public Expenditure Reform: The Health Care Sector in the United Kingdom
by Vincent Koen

2000 The Healthcare System in Hungary
by Eva Orosz & Andrew Burns

2000 Do Pharmaceutical Prices Respond to Insurance?
by Nina Pavcnik

2000 The Medical Treatment of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, and Price Indexes
by Ernst R. Berndt & Anupa Bir & Susan H. Busch & Richard G. Frank & Sharon-Lise T. Normand

2000 The Boskin Commission Report and its Aftermath
by Robert J. Gordon

2000 Population Change and the Requirements for Physicians: The Case of Ontario
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2000 Population Change and the Requirements for Physicians: The Case of Ontario
by Frank T. Denton & Amiram Gafni & Byron G. Spencer

2000 Antidepressant Treatment for Depression: Total Charges and Therapy Duration
by Deborah G. Dobrez & Catherine A. Melfi & Thomas W. Croghan & Thomas J. Kniesner & Robert L. Obenchain

2000 Unfinished Business: Inadequate Health Coverage for Privately Insured, Seriously Ill Children
by Nancy Swigonski & Eleanor D. Kinney & Deborah A. Freund & Thomas J. Kniesner

2000 Does Chronic Illness Affect the Adequacy of Health Insurance Coverage?
by Kevin T. Stroupe & Eleanor D. Kinney & Thomas J. Kniesner

2000 Pharmaceuticals and the Elderly: A Comparative Analysis
by Deborah A. Freund & Don Willison & Grant D. Reeher & Bernie O'Brien & Jarold Cosby & Amy Ferraro

2000 Définition des priorités sanitaires et rationnement. L'opinion des Suisses, des Administrateurs hospitaliers et des Départements sanitaires des Cantons
by Gianfranco DOMENIGHETTI & Jenny MAGGI

2000 Utilization of maternal health care services in South India
by K. Navaneetham & A. Dharmalingam

2000 Entry and the Number of firms in the Swedish Pharmaceuticals Market
by Rudholm, Niklas

2000 Private health care as a supplement to a public health system with waiting time for treatment
by Hoel,M. & Soether,E.M.

2000 Health insurance : treatment vs. compensation
by Asheim,G.B. & Emblem,A.W. & Nilssen,T.

2000 Productivity Changes in Finnish Health Centres: A Malmquist Index Approach
by Maija-Liisa Järviö & Kalevi Luoma

2000 An Empirical Research of Substitutability between Medical Services and Over-the-Counter Medication. An Analysis of Thirteen Different Minor Ailments
by Li, M. & Ohkusa, Y.

2000 Conjoint Analysis for the Demand of Health Care Related to Common Cold
by Suzuki, W. & Ohkusa, Y.

2000 The determinants of health care expenditure: a macroeconomic approach
by R. MAHIEU

2000 Waiting Lists and Patient Selection
by Barros, Pedro Luis Pita

2000 Public and Private Provision of Health Care
by Barros, Pedro Luis Pita & Martinez-Giralt, Xavier

2000 Regulated competition in health insurance markets
by Rudy Douven

2000 Negotiation Advantages of Professional Associations in Health Care
by Xavier Martinez-Giralt & Pedro Pita Barros

2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
by A. Brett Hauber & Josephine A. Mauskopf & Edward H. Snyder

2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
by Karen W. Linkins & John R. Lloyd & Gregory O. Hjelmstad & Holly J. Strausbaugh

2000 Inhaled Salmeterol/Fluticasone Propionate Combination: A Pharmacoeconomic Review of its Use in the Management of Asthma
by Anthony Markham & Julie C. Adkins

2000 Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting
by Maureen J. Lage & Beth L. Barber & Mohan Bala & Patrick L. McCollam & Daniel E. Ball

2000 Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia
by Eric T. Edgell & Scott W. Andersen & Bryan M. Johnstone & Brian Dulisse & Dennis Revicki & Alan Breier

2000 Effectiveness of Eletriptan in Reducing Time Loss Caused by Migraine Attacks
by Nicholas E.J. Wells & Timothy J. Steiner

2000 Stratified Administration of Serotonin 5-HT3 Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications
by Lisa A. Sanchez & Mark Holdsworth & Sylvia B. Bartel

2000 The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings
by Panos Kanavos

2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
by Ceri J. Phillips

2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
by Pekka Rissanen

2000 Inhaled Fluticasone Propionate: A Pharmacoeconomic Review of its Use in the Management of Asthma
by Harriet M. Lamb & Christine R. Culy & Diana Faulds

2000 Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy: In the Management of Postmenopausal Women with Climacteric Symptoms in the UK
by Jonathan M. Plumb & Julian F. Guest

2000 Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol: In the Treatment of Mild to Moderate Plaque Psoriasis
by Darren M. Ashcroft & Alain Li Wan Po & Hywel C. Williams & Christopher E.M. Griffiths

2000 Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy: A Randomised Trial of the Effect of Education and a Professional Allowance
by Shalom I. Benrimoj & Jane H. Langford & Geoffrey Berry & David Collins & Roberta Lauchlan & Kay Stewart & Michael Aristides & Matthew Dobson

2000 Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme: A Canadian Teaching Hospital and Ministry of Health Perspective
by Amy O. Wai & Luciana Frighetto & Carlo A. Marra & Emily Chan & Peter J. Jewesson

2000 Health-Related Quality-of-Life Measurement in Hypertension: A Review of Randomised Controlled Drug Trials
by Isabelle Cote & Jean-Pierre Gregoire & Jocelyne Moisan

2000 HIV-1 Drug Resistance Genotyping: A Review of Clinical and Economic Issues
by Carine Chaix-Couturier & Christopher Holtzer & Kathryn A. Phillips & Isabelle Durand-Zaleski & John Stansell

2000 The Concept of Clinically Meaningful Difference in Health-Related Quality of Life Research: How Meaningful is it?
by Ron D. Hays & J. Michael Woolley

2000 Cocaine Medications, Cocaine Consumption and Societal Costs
by William S. Cartwright

2000 The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS
by Aslam H. Anis & Daphne Guh & Robert S. Hogg & Xiao-Hua Wang & Benita Yip & Kevin J.P. Craib & Michael V. O'Shaughnessy & Martin T. Schechter & Julio S.G. Montaner

2000 Cost Effectiveness of Acute Imipramine Therapy versus Two Imipramine Maintenance Treatment Regimens for Panic Disorder
by Matig R. Mavissakalian & Jordana K. Schmier & Jennifer A. Flynn & Dennis A. Revicki

2000 Cost Effectiveness of Cephalosporin Monotherapy and Aminoglycoside/ Ureidopenicillin Combination Therapy: For the Treatment of Febrile Episodes in Neutropenic Patients
by Joseph A. Paladino & Debra A. Fong & Alan Forrest & Reuben Ramphal

2000 Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers
by Dewey C. Scheid & Robert M. Hamm & Kevin W. Stevens

2000 Socioeconomic Issues Affecting the Treatment of Obesity in the New Millennium
by Louis F. Martin & Alex Robinson & Barbara J. Moore

2000 Cost Effectiveness of Therapies for Atrial Fibrillation: A Review
by Mark P. Teng & Edward Catherwood & Daniel P. Melby

2000 The Impact of Health Economics on Healthcare Delivery: A Primary Care Perspective
by David P. Kernick

2000 Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus
by Rachel H. Foster & Greg L. Plosker

2000 The Economic Value of a New Insulin Preparation, Humalog(R) Mix 25(TM): Measured by a Willingness-To-Pay Approach
by George Dranitsaris & Christopher J. Longo & Loren D. Grossman

2000 Cost Effectiveness of Abciximab During Routine Medical Practice
by Shelby Ogilvie Reed & C. Daniel Mullins & Laurence S. Magder

2000 Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma
by Ronald J. Ozminkowski & Shaohung Wang & William D. Marder & John Azzolini & David Schutt

2000 Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice
by Josephine A. Mauskopf & Anke Richter & Lieven Annemans & Grant Maclaine

2000 Costs of Deep Foot Infections in Patients with Diabetes Mellitus
by Gunnel Ragnarson Tennvall & Jan Apelqvist & Magnus Eneroth

2000 The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?
by Neil Johnson & Tim Davis & Nick Bosanquet

2000 The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs
by Tracy L. Skaer & David A. Sclar & Linda M. Robison & Richard S. Galin

2000 Antiviral Therapies for Herpes Zoster Infections: Are They Economically Justifiable?
by Kenneth J. Smith & Mark S. Roberts

2000 Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate
by Jean-Pierre Marissal & Bernard Selke & Therese Lebrun

2000 Economic Evaluations of Influenza Vaccination in Healthy Working-Age Adults: Employer and Society Perspective
by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt

2000 Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery
by Douglas Coyle & Karen M. Lee & Dean A. Fergusson & Andreas Laupacis

2000 Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The Netherlands: The Dutch Results from the EUROMET Project
by Jeannette E.F. Zwart-van Rijkom & Hubertus G.M. Leufkens & Jan J.V. Busschbach & Andre W. Broekmans & Frans F.H. Rutten

2000 Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom
by Hugh Freeman & Steve Arikian & Alan Lenox-Smith

2000 Clinical Trials and the New Good Clinical Practice Guideline in Japan: An Economic Perspective
by Shunsuke Ono & Yasuo Kodama

2000 Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues
by Eva Lindstrom & Kerstin Bingefors

2000 Economic Issues in the Prevention of Vertical Transmission of HIV
by A.E. Ades & Julie Ratcliffe & Diana M. Gibb & Mark J. Sculpher

2000 Economic Evaluation of Enoxaparin Sodium versus Heparin in Unstable Angina: A French Sub-Study of the ESSENCE Trial
by Bruno Detournay & Xavier Huet & Francois Fagnani & Gilles Montalescot

2000 The Impact of Pituitary Adenoma on Morbidity: Increased Sick Leave and Disability Retirement in a Cross-Sectional Analysis of Swedish National Data
by Bjorn Jonsson & Bo Nilsson

2000 Health-Related Quality of Life in Asymptomatic Patients with HIV: Evaluation of the SF-36 Health Survey in Italian Patients
by Fabio Arpinelli & Giovanni Visona & Raffaele Bruno & Gianfranco Decarli & Giovanni Apolone

2000 Using Economic Evaluations to Make Formulary Coverage Decisions: So Much for Guidelines
by Aslam H. Anis & Yves Gagnon

2000 Long Term Treatment of Multiple Sclerosis with Interferon-beta May Be Cost Effective
by Malcolm Kendrick & K. Ian Johnson

2000 A Review of Alternative Approaches to Healthcare Resource Allocation
by Stavros Petrou & Jane Wolstenholme

2000 Social Phobia: Epidemiology and Cost of Illness
by Joshua D. Lipsitz & Franklin R. Schneier

2000 Introduction to the Pharmacoeconomics of Herbal Medicines
by Peter A.G.M. De Smet & Gouke Bonsel & Ary Van der Kuy & Yechiel A. Hekster & Marja H. Pronk & Mark J.A. Brorens & Jacques H.M. Lockefeer & Mark J.C. Nuijten

2000 Cost of Illness in Adult Patients with Hypopituitarism
by Christer Ehrnborg & Leona Hakkaart-Van Roijen & Bjorn Jonsson & Frans F.H. Rutten & Bengt-Ake Bengtsson & Thord Rosen

2000 Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia
by Josephine A. Mauskopf & Sheryl C. Cates & Adrian D. Griffin & Deirdre M. Neighbors & Sarah C. Lamb & Carolyn Rutherford

2000 Costs for Acute Myocardial Infarction in a Tertiary Care Centre and Nationwide in France
by Olivier Montagne & Carine Chaix & Alain Harf & Alain Castaigne & Isabelle Durand-Zaleski

2000 Cost-Effectiveness Analysis of Pneumococcal Vaccination of Adults and Elderly Persons in Belgium
by Diana De Graeve & Geert Lombaert & Herman Goossens

2000 Low-Flow Anaesthesia: Does it have Potential Pharmacoeconomic Consequences?
by Stefan Suttner & Joachim Boldt

2000 A Critical Review of Published Economic Modelling Studies in Depression
by Michael T. Jones & Paul C. Cockrum

2000 Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use
by Christopher Evans & Bruce Crawford

2000 Disease Management: A Global Cost-Containing Initiative?
by Karen Bloor & Alan Maynard

2000 Mirtazapine: A Pharmacoeconomic Review of its Use in Depression
by Kristin J. Holm & Blair Jarvis & Rachel H. Foster

2000 Testing the Validity of Cost-Effectiveness Models
by Chris McCabe & Simon Dixon

2000 Handling Uncertainty in Cost-Effectiveness Models
by Andrew H. Briggs

2000 Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application
by Mark Sculpher & Elisabeth Fenwick & Karl Claxton

2000 Modelling in Health Economic Evaluation: What is its Place? What is its Value?
by Alan Brennan & Ron Akehurst

2000 Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement
by Adis International Limited

2000 Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
by Kevin T. Stroupe & Melissa M. Forthofer & D. Craig Brater & Michael D. Murray

2000 Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
by Steven J. Crowley & David Tognarini & Paul V. Desmond & Michael Lees

2000 Cost Effectiveness of Competing Strategies to Prevent or Treat GORD-Related Dysphagia
by Amnon Sonnenberg

2000 Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol
by Stephen Almond & Owen O'Donnell

2000 Initial Treatment Choice in Depression: Impact on Medical Expenditures
by Eric T. Edgell & Timothy R. Hylan & JoLaine R. Draugalis & Stephen Joel Coons

2000 Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy: A Comparison of Raltitrexed and Fluorouracil plus Folinic Acid
by Mark Sculpher & Michael K. Palmer & Anne Heyes

2000 Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine
by A. Brett Hauber & Ari Gnanasakthy & Edward H. Snyder & Mohan V. Bala & Anke Richter & Josephine A. Mauskopf

2000 Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
by Anthony O'Hagan & John W. Stevens & Jacques Montmartin

2000 Economic Burden of Irritable Bowel Syndrome: Proposed Strategies to Control Expenditures
by Michael Camilleri & Donald E. Williams

2000 Cost Effectiveness of Combination HIV Therapy: 3 Years Later
by Richard D. Moore

2000 The Importance of Achieving Additional Drug Benefits at a Reasonable Cost: A Review of the Fluoxetine Years
by Nick Freemantle & James Mason

2000 Household Income Losses Associated With Ischaemic Heart Disease For US Employees
by Jeph Herrin & Charles B. Cangialose & Stephen J. Boccuzzi & William S. Weintraub & David J. Ballard

2000 The Cost Effectiveness of Misoprostol Prophylaxis Alongside Long Term Nonsteroidal Anti-Inflammatory Drugs: Implications of the MUCOSA Trial
by Peter J. Davey & Eric Meyer

2000 Economics of the Antithymocyte Globulins Thymoglobulin(R) and Atgam(R) in the Treatment of Acute Renal Transplant Rejection
by Mark A. Schnitzler & Robert S. Woodward & Jeffrey A. Lowell & Leah Amir & Timothy J. Schroeder & Gary G. Singer & Daniel C. Brennan

2000 Assessing Health Utilities in Schizophrenia: A Feasibility Study
by Lakshmi N. Voruganti & A. George Awad & L. Kola Oyewumi & Leonardo Cortese & Sandra Zirul & Ravinder Dhawan

2000 Evaluating the Potential
by Eric L. Eisenstein & Eric D. Peterson & James G. Jollis & Barbara E. Tardiff & Robert M. Califf & J. David Knight & Daniel B. Mark

2000 Clinical and Economic Factors Important to Anaesthetic Choice for Day-Case Surgery
by Edmond I. Eger & Paul F. White & Martin S. Bogetz

2000 ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations
by Andrew P. Davie

2000 Bridging Decision Analytic Modelling with a Cross-Sectional Study: Application to Parkinson's Disease
by Mark J.C. Nuijten

2000 Economic Analysis of Long Term Reversible Contraceptives: Focus on Implanon(R)
by Ceri J. Phillips

2000 Cost-of-Illness of Epilepsy in Italy: Data from a Multicentre Observational Study (Episcreen)
by P. Berto & P. Tinuper & S. Viaggi

2000 Impact of Zanamivir Treatment on Productivity, Health Status and Healthcare Resource Use in Patients with Influenza
by Fred Y. Aoki & Douglas M. Fleming & Adrian D. Griffin & Loretto A. Lacey & Sally Edmundson

2000 Pharmacoeconomics and Clinical Practice Guidelines: A Survey of Attitudes in Swedish Formulary Committees
by Anders Anell & Patrick Svarvar

2000 The Costs of Pharmacological Treatment for Major Depression: The Italian Prospective Multicentre Observational Incidence-Based Study
by Rosanna Tarricone & Giovanni Fattore & Simone Gerzeli & Giulio Serra & Cristina Taddei & Mauro Percudani

2000 Valuing Health-Related Quality of Life: A Review of Health State Valuation Techniques
by Colin Green & John Brazier & Mark Deverill

2000 Pharmacoeconomic Considerations in Treating Ovarian Cancer
by Diane Bodurka-Bevers & Charlotte C. Sun & David M. Gershenson

2000 New Generation Aromatase Inhibitors in Breast Cancer: Weighing Out Potential Costs and Benefits
by Gerald M. Higa

2000 Diagnosis Related Group Costs in a Regulated Environment: A Note About Their Economic Interpretation
by Claude Le Pen & Gilles Berdeaux

2000 Economic Cost of Male Erectile Dysfunction Using a Decision Analytic Model: For a Hypothetical Managed-Care Plan of 100 000 Members
by Howard L. Tan

2000 The Cost of Urinary Incontinence in Italian Women: A Cross-Sectional Study
by Fabrizio Tediosi & Fabio Parazzini & Angela Bortolotti & Livio Garattini

2000 Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre
by Eduard J. Beck & Sundhiya Mandalia & Rebecca Griffith & Jeni Beecham & M. D. Sam Walters & Mary Boulton & David L. Miller

2000 Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany
by Peter K. Schadlich & Josef G. Brecht

2000 A Comparative Review of Generic Quality-of-Life Instruments
by Stephen Joel Coons & Sumati Rao & Dorothy L. Keininger & Ron D. Hays

2000 Estimating the Long Term Cost Savings from the Treatment of Alzheimer's Disease: A Modelling Approach
by Peter J. Neumann

2000 Formulary Management of Low Molecular Weight Heparins
by William E. Wade & Bradley C. Martin & Jeffrey A. Kotzan & William J. Spruill & Marie A. Chisoholm & Matthew Perri

2000 Management of Acute Repetitive Seizures: Defining the Role of Rectal Diazepam Gel
by Matthew N. Lowe & Katharine J. Palmer & Michelle I. Wilde

2000 Management of Acute Otitis Media: Defining the Role of Cefuroxime Axetil
by Harriet M. Lamb & Caroline M. Spencer

2000 Self-Management of Epilepsy: A Review of the Concept and Its Outcomes
by Janice M. Buelow & Joyce Johnson

2000 The Role of Minimal- and No-Contact Behavioural Treatments in Migraine: A Review of Efficacy and Cost Effectiveness
by Lisa Scharff & Joseph Etherage

2000 Healthcare Reforms in Germany: Managed Care, An Opportunity?
by Reinhard Rychlik & Karin Guntertgomann & Anne Kilburg & Jeffrey B. Frazier

2000 Epoetin Alfa Drug Use Evaluation Using A Software System: Lessons Learned
by Edward P. Armstrong & Ruth E. Cherrick

2000 Economic Evaluations of Influenza Vaccination in the Elderly: Impact on Public Health Policy
by Susan C. Wood & Van Hung Nguyen & Claudia Schmidt

2000 Recombinant Human Erythropoietin as an Alternative to Blood Transfusion in Cancer-Related Anaemia
by Andreas Engert

2000 An Integrated Model for the Management of Co-Occurring Psychiatric and Substance Disorders in Managed-Care Systems
by Kenneth Minkoff

2000 Outcome Measures of Efficacy Associated with a Web-Enabled Asthma Self-Management Programme: Findings from a Quasi-Experiment
by Martin Atherton

2000 Targeting High Utilisers: Predictive Validity of a Screening Questionnaire
by Julie A. Meek & Brenda L. Lyon & Frederick E. May & Wendy D. Lynch

2000 Interventions for Families of Individuals with Schizophrenia: Maximising Outcomes for their Relatives
by Phyllis Solomon

2000 Breast Cancer Epidemiology, Prevention and Costs of Care: Implications for Disease Management Programmes
by K. Robin Yabroff & Ruth Brown & Michael Halpern

2000 The Role of Community Health Information Networks in Disease Management
by Francois M.H.M. Dupuits

2000 The Value of Disease Management: Approaching the Industrialisation of Modern Medicine
by Marc L. Berger & Peter Nebenfuhr & Richard K. Murray

2000 Economic Impact of an Asthma Education Programme on Medical Care Utilisation
by Dong-Churl Suh & Soungkook Shin & Robert M. Voytovich & Allan Zimmerman

2000 Smoking Cessation: The Contribution of Community Pharmacy
by James C. McElnay & Terry A. Maguire & Ashlinn Drummond & Carmel M. Hughes

2000 Dynamic Assessment in Disease Management
by Ira S. Nash

2000 Screening and Brief Intervention in the Management of Early Problem Drinkers: Integration into Healthcare Settings
by Vania Modestolowe & Ava Boornazian

2000 Disease Management as a Part of Total Health and Productivity Management
by Ron Z. Goetzel & Ronald J. Ozminkowski

2000 Management of Narcolepsy: Defining the Role of Modafinil
by Alison M. Comer & Caroline M. Spencer

2000 Recent Developments for Optimal End-Points in Rheumatoid Arthritis Clinical Studies
by Esmeralda T.H. Molenaar & Maarten Boers & Peter M. Brooks & Lee Simon & Vibeke Strand & Peter Tugwell

2000 Managing Influenza in Primary Care: A Practical Guide to Clinical Diagnosis
by Rene Snacken

2000 Lipid Clinics as Disease Management Programmes in the United States: Essential Elements and Practical Considerations
by Ralph L. Laforge

2000 Potential Role of Telecommunication Technologies in the Management of Chronic Health Conditions
by Joseph Finkelstein & Robert H. Friedman

2000 Medical Savings Account Plans: A Patient-Centred Approach to Medical Insurance
by David T. Springer

2000 Modification of Albumin Use Pattern After an Educational Intervention
by Veronica De Miguel & Emilio Vargas & Antonio Portoles & Miguel Puerro & Ana Isabel Terleira & Alfonso Moreno

2000 Cost Estimates for Chronic Diseases
by Jean Woo & Clive Cockram

2000 Psychosocial Components of Asthma Management in Children
by Shari L. Wade

2000 Impact of Disease and Health Management Strategies on Formulary Design and Management
by Michael Toscani & Dong Churl Suh & Brent Benedict

2000 The Economics of Hepatitis B Virus Vaccination: An Analysis of Cost-Effectiveness Results for Switzerland
by Pascal Zurn & Guy Carrin & Jean-Pierre Danthine & Raoul Kammerlander & Mark Kane

2000 Quality-of-Care Indicators for HIV/AIDS
by Albert W. Wu & Allen Gifford & Steven Asch & Susan E. Cohn & Samuel A. Bozzette & Robin Yurk

2000 Performance Measurement and Management of Healthcare Professionals: Some Topical Issues
by Martin N. Marshall & Huw T.O. Davies

2000 Electronic Point-of-Care Prescribing: Writing the `Script'
by Gordon Schiff & David W. Bates

2000 Management of Hypertension in Patients with Diabetes Mellitus: Defining the Role of Lisinopril
by Blair Jarvis & Caroline M. Spencer

2000 Formulary Management of Eradication Therapies for Helicobacter pylori: Drug Selection by Means of the SOJA Method
by Robert Janknegt & Leopold G.J.B. Engels

2000 Computer-Assisted Drug Therapy Problem Notification
by Ronald A. Lyon & Yvette J. Crockell & Nancy P. England

2000 Developments in Influenza Prevention and Treatment: A Managed Care Perspective
by Arnold S. Monto & A. Mark Fendrick

2000 Challenging Current Asthma Treatment Guidelines: Improved Control of Asthma Symptoms with Nebulised Budesonide in Patients with Severe Asthma Receiving Continuous Oral Steroids
by Kevin C. Connolly & Michael D. Peake & David M.G. Halpin & Lynda Golightly & Marlyn L. Turbitt

2000 The Management of Women at High Risk of Experiencing Hereditary Breast and Ovarian Cancer: The Lahey Guidelines
by Kevin S. Hughes & Constance A. Roche & Timothy Whitney & Robert McLellan

2000 Technology-Based Advances in the Management of Depression: Focus on the COPE(TM) Program
by John H. Greist & Deborah J. Osgood-Hynes & Lee Baer & Isaac M. Marks

2000 Assessing the Economic Impact of Telemedicine
by David M. Hailey & Bernard L. Crowe

2000 A Population-Based Approach to Asthma Disease Management
by Pamela J. Algatt-Bergstrom & Leona E. Markson & Richard K. Murray & Marc L. Berger

2000 Management of Major Depression in the Workplace: Impact on Employee Work Loss
by Howard G. Birnbaum & Pierre Y. Cremieux & Paul E. Greenberg & Ronald C. Kessler

2000 The Health Hero(R) Online Service: A New Internet-Based Communications Platform for Disease Management, Case Management and Performance Measurement
by Michael A. O'Connell & Julie Cheitlin Cherry

2000 Designing and Developing Effective Disease Management Programmes: Key Decisions for Programme Success
by Ann Scheck McAlearney

2000 Performance-Based Contracts and Provider Efficiency: The State of the Art
by Mingshan Lu & Cam Donaldson

2000 Patients' Views on Healthcare: A Driving Force for Improvement in Disease Management
by Michel Wensing & Richard Grol

2000 Management of Dyslipidaemias: The Role of Simvastatin
by Karen M. Hvizdos & Karen L. Goa

2000 The Role of Home Infusion Therapy in Haemophilia: A Disease Management Perspective
by Erik Berntorp & Stefan Lethagen

2000 Interactive Internet Web Sites: A Potentially Powerful Tool for Disease Management
by David W. Bulger & Chris Reeves

2000 The Patient's Responsibility for Optimum Healthcare
by Douglas P. Olsen

2000 The Patient Perspective as an Integral Part of Diabetes Disease Management
by Kathleen M. Rayman & Geraldine C. Ellison

2000 Monitoring Outcomes of Care in Older People in a UK Community Setting: The North East Fife Outcomes Project
by Petra Kliempt & Danny Ruta

2000 Health and Disease Management Within an Academic Health System
by David B. Bernard & Kenneth D. Coburn & Mark A. Miani

2000 Achieving Patient Buy-In and Long Term Compliance with Antihypertensive Treatment
by Frances B. Garfield & J. Jaime Caro

2000 Medicare Risk Plans and Disease Management Vendors: Present and Future Relationships
by Sam Forman

2000 Age segmentation in the Chilean health system
by Marcelo Tokman R.

2000 Hálapénz a magyar egészségügyben
by Kornai, János & Gál, Róbert Iván & Bognár, Géza

2000 Gesundheitsausgaben, Alter und medizinischer Fortschritt: Eine Regressionsanalyse
by Friedrich Breyer & Volker Ulrich

2000 Health Care for the Aging Baby Boom: Lessons from Abroad
by Uwe E. Reinhardt

2000 Optimal Risk Adjustment in Markets with Adverse Selection: An Application to Managed Care
by Thomas G. McGuire & Jacob Glazer

1999 Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population
by Lillard, L.A. & Rogowski, J. & Kington, R.

1999 Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population
by Lillard, L.A. & Rogowski, J. & Kington, R.

1999 Induction de la demande de soins par les medecins liberaux francais. Etude microeconomique sur donnees panel
by Delattre, E. & Dormont, B.

1999 A Macroeconomic Analysis of Publicly Funded Healthcare
by Bednarek, H.L. & Pecchenino, R.A.

1999 A Macroeconomic Analysis of Publicly Funded Healthcare
by Bednarek, H.L. & Pecchenino, R.A.

1999 Institutionalising New Policies in the Health Sector. The Challenge of the AIDS Epidemic
by Steffen, M.

1999 Market Incentives and Health Reform in Canada
by Maioni, A.

1999 Quels couts pour quels produits hospitaliers?
by Morard, B. & Huber, Z.S.

1999 Quels couts pour quels produits hospitaliers?
by Morard, B. & Huber, Z.S.

1999 Gatekeeping and Referral of Children and Adolescents to Specialty Care
by Forrest, C.B. & Glade, G.B. & Starfield, B. & Baker, A.E. & Kang, M. & Reid, R.J.

1999 Patterns of Specialist Referral for Patients with Newly-Diagnosed Diabetes in Alberta
by Redi, R.J. & Starfield, B. & Forrest, C.B. & Ladenson, P.W. & Diener-West, M.

1999 Estimating a Bargaining Model with Asymmetric Information: Evidence from Medical Malpractice Disputes
by Sieg, Holger

1999 Coût de la maladie d’Alzheimer et dépenses des aidants dans différents programmes de soins aux patients atteints de démence en Europe
by Joël, Marie-Eve & Colvez, Alain & Cozette, Elizabeth & Gramain, Agnès

1999 Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson's Disease
by Ziégler, Marc & Dujardin, Max & Moutard-Martin, Frédéric & Wait, Suzanne & Le Pen, Claude

1999 Health Insurance and Preventive Behavior
by Volker Meier

1999 Ärztliche Leistung und Compliance des Patienten: Der Fall des Double Moral Hazard
by Schneider, Urs

1999 Economies Of Scale In The Swiss Nursing Home Industry
by Massimo Filippini

1999 Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population
by Lee A. Lillard & Jeannette Rogowski & Raynard Kington

1999 Analysing Shared Service Contracts: The Case of Food Services for Winnipeg Hospitals
by Cyrenne, Philippe

1999 Competition and the Cost of Capital Revisited: Special Authorities and Underwriters in the Market for Tax-emempt Hospital Bonds
by Alec Ian Gershberg & Michael Grossman & Fred Goldman

1999 Health Insurance and Less Skilled Workers
by Janet Currie & Aaron Yelowitz

1999 Is There Monopsony in the Labor Market? Evidence from a Natural Experiment
by Douglas Staiger & Joanne Spetz & Ciaran Phibbs

1999 Health Care Capital Financing Agencies: The Intergovernmental Roles of Quasi-Government Authorities and the Impact on the Cost of Capital
by Alec Ian Gershberg & Michael Grossman & Fred Goldman

1999 Learning and Forgetting: The Dynamics of Aircraft Production
by C. Lanier Benkard

1999 Antitrust and Competition in Health Care Markets
by Martin Gaynor & William B. Vogt

1999 Did Community Rating Induce an Adverse Selection Death Spiral? Evidencefrom New York, Pennsylvania and Connecticut
by Thomas Buchmueller & John DiNardo

1999 Health Insurance and Consumer Welfare : The Case of Monopolistic Drug Markets
by Anlauf, Markus & Wigger, Berthold U.

1999 The Evolving Practice of Medicine: A View from the Front Line. 10th Annual Herbert Lourie Memorial Symposium on Health Policy
by Robert M. Corwin & Thomas H. Dennison & Patricia D. Franklin & Paul B. Ginsburg & David G. Murray

1999 Does Provision of an Evidence-Based Information Change Public Willingness to Accept a Screening Test ?
by Gianfranco DOMENIGHETTI

1999 Om Mulighederne For At Reducere De Offentlige Udgifter Til Lægemidler Gennem Øget Konkurrence
by Blomgren-Hansen, Niels

1999 The Australian Health Care System, CHERE Discussion Paper No 38
by Richard De Abreu Lourenco & Kim Foulds & Irenie Smoker & Jane Hall

1999 Is there any Substitution Between Medical Services and Over-the-Counter Medications in the Case of the Common Cold? -Analysis Based on an Original Survey-
by Li, M. & Ohkusa, Y.

1999 Acamprosate: Pharmacoeconomic Implications of Therapy
by Rachel H. Foster & Karen J. McClellan

1999 Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
by Christopher J. Dunn & Rachel H. Foster

1999 Annual Cost of Erectile Dysfunction to UK Society
by Jonathan M. Plumb & Julian F. Guest

1999 Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis
by Ron Goeree & Bernie O'Brien & Richard Hunt & Gordon Blackhouse & Andrew Willan & Jan Watson

1999 Health Economics in the Canadian Pharmaceutical Industry
by Lila Assiff & Michael R. Pollock & Patricia Manzi & Ben Faienza & Devidas Menon

1999 The Effect of Generic Competition on Prescription to Over-the-Counter Switching
by Christopher S. Hollenbeak

1999 Managing Pharmaceutical Expenditure while Increasing Access: The Pharmaceutical Management Agency (PHARMAC) Experience
by Richard Braae & Wayne McNee & David Moore

1999 Diagnosis and Management of Osteomyelitis: Decision Analytic and Pharmacoeconomic Considerations
by Manouche Tavakoli & Peter Davey & Benedict A. Clift & Huw T. O. Davies

1999 Measuring Quality of Life in Paediatric Patients
by Melinda A. Connolly & Jeffrey A. Johnson

1999 The Doctor-Patient Relationship and Prescribing Patterns: A View from Primary Care
by Doug T. Steinke & Thomas M. MacDonald & Peter G. Davey

1999 Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole
by Mike Chambers & John Hutton & John Gladman

1999 Economic Impact of Providing Workplace Influenza Vaccination: A Model and Case Study Application at a Brazilian Pharma-Chemical Company
by Emmanuel Burckel & Talat Ashraf & Jose P. Galvao de Sousa Filho & Eduardo Forleo Neto & Hubert Guarino & Caio Yauti & Fernando de Barros Barreto & Louis Champion

1999 Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
by Daniel J. Walters & Joseph S. Solomkin & Joseph A. Paladino

1999 Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK
by Terry N. Flynn & Stephen M. Kelsey & Dena L. Hazel & Julian F. Guest

1999 Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective
by Robert M. Balen & Carlo A. Marra & Peter J. Zed & Marc Cohen & Luciana Frighetto

1999 Cost Effectiveness of Fluticasone Propionate and Flunisolide in the Treatment of Corticosteroid-Naive Patients with Moderate Asthma
by Timm Volmer & Adrian Kielhorn & Hans H. Weber & Karl J. Wiessmann

1999 Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
by George Torrance & Valery Walker & Ronald Grossman & Jayanti Mukherjee & David Vaughan & Jacques La Forge & Noel Lampron

1999 Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease
by Nils-Olov Stalhammar & Jonas Carlsson & Robert Peacock & Stefan Mullerlissner & Marcandre Bigard & Gabriele B. Porro & Julio Ponce & James Hosie & Mairi Scott & Donald G. Weir & Claire Fulton & Keith Gillon & Karna D. Bardhan

1999 Linking Health-Related Quality-of-Life Indicators to Large National Data Sets
by John A. Rizzo & Jody L. Sindelar

1999 Cost Effectiveness, Quality-Adjusted Life-Years and Supportive Care: Recombinant Human Erythropoietin as a Treatment of Cancer-Associated Anaemia
by Pierre-Yves Cremieux & Stan N. Finkelstein & Ernst R. Berndt & Jeffrey Crawford & Mitchell B. Slavin

1999 Real World Designs in Economic Evaluation: Bridging the Gap Between Clinical Research and Policy-Making
by Rob Baltussen & Reiner Leidl & Andre Ament

1999 Measuring the Effects of Medication Use on Health-Related Quality of Life in Patients with Rheumatoid Arthritis: A Review
by Michael B. Nichol & Ann S. M. Harada

1999 Pharmacoeconomics and Health Policy: Current Applications and Prospects for the Future
by Paul E. Greenberg & Almudena Arcelus & Howard G. Birnbaum & Pierre-Yves Cremieux & Jacques LeLorier & Pierre Ouellette & Mitchell B. Slavin

1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects. The Authors Reply
by Sam S. Salek & Melvyn D. Walker & Anthony J. Bayer

1999 A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
by Stephen P. McKenna & Lynda C. Doward

1999 Costs of Mini Mental State Examination-Related Cognitive Impairment
by Linus Jonsson & Peter Lindgren & Anders Wimo & Bengt Jonsson & Bengt Winblad

1999 Costs Associated with Symptomatic Systolic Heart Failure
by Peter G. Davey & Peter B. Clarkson & Alex McMahon & Thomas M. MacDonald

1999 Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK
by Mark Nuijten & Liebeth Meester & Franz Waibel & Suzanne Wait

1999 Economic Evaluation of the Treatment of Chronic Wounds: Hydroactive Wound Dressings in Combination with Enzymatic Ointment Versus Gauze Dressings in Patients with Pressure Ulcer and Venous Leg Ulcer in Germany
by Rito Bergemann & Karl W. Lauterbach & Wolfgang Vanscheidt & Klaus-Dieter Neander & Reinhard Engst

1999 Decision Analysis of Histamine H2-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy: A Randomised Controlled Trial in Patients with Continuing Pain After Duodenal Ulcer
by Manouche Tavakoli & Andrzej T. Prach & Mo Malek & David Hopwood & Bernard W. Senior & Frank E. Murray

1999 Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer
by George Dranitsaris

1999 Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations
by Finn Wisloff & Nina Gulbrandsen & Erik Nord

1999 Herbal Remedies: Issues in Licensing and Economic Evaluation
by Darren M. Ashcroft & Alain Li Wan Po

1999 Decreased Medical Expenditures for Care of HIV-Seropositive Patients: The Impact of Highly Active Antiretroviral Therapy at a US Veterans Affairs Medical Center
by Larry Mole & Kimberly Ockrim & Mark Holodniy

1999 Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer: An Analysis of Triple Therapy Versus Two Dual Therapy Alternatives
by Gunnel R. Tennvall & Anna Norinder & Bo Ohlin

1999 Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed-Care Population
by Scott D. Ramsey & Katherine Newton & David Blough & David K. McCulloch & Nirmala Sandhu & Edward H. Wagner

1999 Pharmacotherapeutic Circles: Results of an 18-Month Peer-Review Prescribing-Improvement Programme for General Practitioners
by Liselotte von Ferber & Jurgen Bausch & Ingrid Koster & Ingrid Schubert & Peter Ihle

1999 A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure
by Colin Berry & John McMurray

1999 Formulary Management of Proton Pump Inhibitors
by Michael F. Byrne & Frank E. Murray

1999 Formulary Submission Guidelines for Blue Cross and Blue Shield o